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Hormonal Physiology of Childbearing: 
Evidence and Implications for Women, Babies, and Maternity Care
This report synthesizes evidence about innate hormonally-mediated physiologic processes in women 
and fetuses/newborns during childbearing, and possible impacts of common maternity care practices 
and interventions on these processes, focusing on four hormone systems that are consequential for 
childbearing. Core hormonal physiology principles reveal profound interconnections between mothers 
and babies, among hormone systems, and from pregnancy through to the postpartum and newborn pe-
riods. Overall, consistent and coherent evidence from physiologic understandings and human and animal 
studies finds that the innate hormonal physiology of childbearing has significant benefits for mothers 
and babies. Such hormonally-mediated benefits may extend into the future through optimization of 
breastfeeding and maternal-infant attachment. A growing body of research finds that common maternity 
care interventions may disturb hormonal processes, reduce their benefits, and create new challenges. 
Developmental and epigenetic effects are biologically plausible but poorly studied. The perspective of 
hormonal physiology adds new considerations for benefit-harm assessments in maternity care, and sug-
gests new research priorities, including consistently measuring crucial hormonally-mediated outcomes 
that are frequently overlooked. Current understanding suggests that safely avoiding unneeded maternity 
care interventions would be wise, as supported by the Precautionary Principle. Promoting, supporting, 
and protecting physiologic childbearing, as far as safely possible in each situation, is a low-technology 
health and wellness approach to the care of childbearing women and their fetuses/newborns that is  
applicable in almost all maternity care settings.
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Message from Debra L. Ness 
It is with great pride that we release Hormonal Physiology of Childbearing: Evidence and Implications for 
Women, Babies, and Maternity Care. We issue this report at a moment when there is growing recogni-
tion that patterns of maternity care in the United States are contributing to unnecessarily high rates of 
maternal and newborn morbidity and mortality and excess costs. The past year has brought important 
progress, including position statements from clinical professional societies that call for better alignment 
of practice with the best evidence and with the needs and interests of women and families. With this 
report, Childbirth Connection programs at the National Partnership for Women & Families adds strength 
and urgency to the case to improve the quality and value of maternity care in the United States.
 
Founded in 1918 as the Maternity Center Association, Childbirth Connection has worked for nearly a 
century to improve the quality of maternity care on behalf of women and families. A year ago, Childbirth 
Connection joined forces with and became a core program of the National Partnership, which has a pow-
erful, long-term commitment to quality, affordable health care. Together, we have become a stronger 
and even more effective force advocating for the needs and interests of childbearing women and fami-
lies and for maternity care system reform. 
For Childbirth Connection programs at the National Partnership, the release of this report is the first step 
in our work to ensure that its key messages reach diverse audiences and that its recommendations are 
promoted and adopted by the policy, practice, education, consumer engagement and research communi-
ties. Much of this dissemination is being done in partnership with key organizations, agencies, and lead-
ers. We invite all who are committed to the highest standard for maternity care to join us in this work.
I am enormously grateful to all who contributed to this report. Dr. Sarah Buckley’s synthesis of the vast 
literature compels us to move forward to transform maternity services. The five clinical leaders from the 
most relevant disciplines who wrote the Foreword are invaluable allies as we release the report and take 
the next steps. Carol Sakala, director of Childbirth Connection programs, and Maureen Corry, senior ad-
visor for Childbirth Connection programs, have shepherded this project every step of the way and made 
great strides in integrating Childbirth Connection within the National Partnership. Together, we thank 
the many leaders who provided wise counsel through interviews and who will help us bring the report to 
essential audiences. And without question, this project would not have been possible without generous 
funding and support from the Transforming Birth Fund, Lamaze International, and DONA International. 
We look forward to working with both established and new allies to reach the day when all women in this 
country can count on safe and effective maternity services that foster optimal maternal health and give 
babies the best start in life.
Debra L. Ness, President
National Partnership for Women & Families
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Foreword
This report, prepared by Dr. Sarah Buckley in collaboration with Childbirth Connection Programs at the 
National Partnership for Women & Families, will be retrospectively evaluated as one of the most revo-
lutionary and influential publications on maternity and newborn care ever issued. What is remarkable is 
that it is not about a new technology or drug. Rather, it compiles scientific evidence that “less is more” 
and if we get it right in the beginning there are potentially profound impacts on learning, brain develop-
ment, and well-being in the child.
As leaders from family medicine, midwifery, nursing, obstetrics, and pediatrics, we applaud the stellar 
compilation of scientific evidence on the hormonal physiology of childbearing. Buckley carefully weaves 
the hormonal lattice of oxytocin, beta-endorphins, epinephrine and norepinephrine and their related 
stress hormones, and prolactin to help the reader absorb the exquisite complexity of spontaneous labor, 
birth, maternal-infant attachment, and lactation. Physiologic preparation for birth is beautifully choreo-
graphed in pregnancy with critical hormonal and physical changes unfolding in the weeks, days, and (to 
date, only in animal studies) hours that lead to labor. The prelabor hormonal changes are neuroprotective 
in animal studies. The catecholamine surge in late labor is neuroprotective in humans. The critical message 
is to protect those processes for the health of the mother, the baby, and the future health of the child.
Our maternity care system works from a premise that “more technology is better.” Buckley dispels this 
myth by exposing how the hormonal balances of childbearing, bonding with parents, and lactation may 
suffer from cascades of interventions. Evidence is becoming clear that the body recognizes medications 
and procedures intended to artificially simulate labor and birth processes as counterfeits. Tools such 
as induction and epidurals are used at the cost of disrupting delicate interconnections that are biologi-
cally designed to optimally prepare baby and mother for birth. Mothers and babies are well designed for 
birth; interfering with the process when mother and baby are healthy is not supported by evidence and 
may cause unintended harm. That harm is expressed in the short term through prolonged labors and un-
necessary surgical births. Findings from animal models suggest short-, medium-, and long-term implica-
tions including, but not limited to, impaired lactation, diminished maternal attachment, effects on infant 
brain development and learning, and lifelong health. If overtreatment is defined as instances in which an 
individual may have fared as well or better with less or perhaps no intervention, then modern obstetric 
care has landed in a deep quagmire. Navigating out of that territory will be challenging.
The guidepost for the journey must steer us steadfastly down the path of “first, do no harm” in which 
we have been carefully schooled, but have not necessarily heeded. The “Precautionary Principle,” which 
requires demonstration of safety before introducing interventions that may adversely affect labor, birth, 
and the newborn, must become the mantra in maternity care practice. Every setting providing maternity 
and newborn care must critically evaluate its common maternity care routines and practices against the 
evidence presented in this report. Policies at every level must change to afford women the opportunity 
to achieve a healthy physiologic birth.
Buckley provides us with an opportunity to connect with a growing broad audience of stakeholders, 
including providers, academicians, researchers, administrators, and consumers, about resetting the tra-
jectories for health and well-being over the life course. Of these, the most crucial to reach are women 
and their families who want the very best for their child. We are aiming to achieve an era in which health 
care decisions are shared between the provider and client. Yet, most women and sadly, many providers 
do not know the information featured in this report.
vCHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | FOREWORD
Systems can be changed. The National Institutes for Health and Care Excellence (NICE), which holds 
Department of Health responsibility for developing guidance and quality standards in England and Wales,  
released a groundbreaking 2014 Intrapartum Guideline just weeks before this publication. They recom-
mended that at least 45 percent of low risk women should give birth outside of the hospital in birth cen-
ters or at home to avoid unnecessary interventions and harm. They have acted on the evidence within 
an integrated and responsive health care system. Our challenge is to consider how to best move forward 
with the findings from this report. Minimally, we would recommend the following:
1.  This monograph needs to be shared with all physicians, midwives, and nurse providers of mater-
nity and newborn care and administrative leadership of our maternity care units.
2.  Basic and advanced curricula for physicians, nurses, and midwives should be interprofessional and 
founded on this evidence.
3.  High-level opinion leaders and decision makers within health care systems and policy making  
bodies must understand how crucial it is to act on these findings to achieve our triple aim of  
a) improving the patient experience of care (including quality and satisfaction), b) improving 
the health of populations, and c) reducing the per capita cost of health care.
4.  Strategies must be implemented to help women and their families understand how crucial it is to 
trust the capability of their body and the fetus in pregnancy and childbearing processes. However, 
this is not enough if maternity care settings do not provide the environments that support hor-
monal physiology.
5.  Research to further our understanding of the evidence presented in this report is important. How-
ever, it should not preclude adoption of what is clearly understood – that supporting physiologic 
childbearing processes is good for the mother and baby. What will be as important is to understand 
what helps maternity care practices and units successfully implement the findings from this report.
Holly Powell Kennedy, PhD, CNM, FACNM, FAAN
Helen Varney Professor of Midwifery, Executive Deputy Dean, Yale University
Katherine Hartmann, MD, PhD, FACOG
Associate Dean for Clinical and Translational Scientist Development, 
Professor of Obstetrics and Gynecology and Medicine, Vanderbilt University
Maxine Hayes, MD, PhD, MPH, FAAP
Clinical Professor of Pediatrics, University of Washington
Retired State Health Officer, Washington State Department of Health
Lawrence Leeman, MD, MPH
Professor of Family Medicine and Obstetrics & Gynecology, University of New Mexico
Kathleen Rice Simpson, PhD, RNC, CNS-BC, FAAN
Perinatal Clinical Nurse Specialist
Editor in Chief, MCN: The American Journal of Maternal Child Nursing
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Preface
Preparing Hormonal Physiology of Childbearing has been an exciting opportunity for me, as a physician 
and writer on childbearing, to deepen my understanding of this topic and synthesize the current state  
of knowledge.
The synthesis contributes to our current efforts to clarify how best to care for childbearing women and 
their babies. First, the hormonal physiology of childbearing is a relatively new and evolving area, with lim-
ited content in the education of health professionals and no current and readily available overview. The 
original research findings discussed here may also be less available to clinicians and others, with many  
significant and clinically relevant findings published outside of medical, midwifery, or nursing journals. 
Second, maternity care services have changed in recent decades. A medically-intensive style of practice is 
now the norm, so that healthy childbearing women and their newborns generally experience many tests 
and interventions. While beneficial and even lifesaving in some situations, common or routine maternity 
care interventions may not be necessary or beneficial for the healthy majority. Their widespread use may 
result in unintended consequences, including known short- and longer-term impacts, and others that are 
currently less well researched. In clarifying what is both known and unknown about the possible impacts 
of widely used maternity care interventions on important hormone systems for childbearing, this report 
brings crucial knowledge and important questions to light.
Third, there is an urgent need to incorporate the hormonal physiology of childbearing into important 
newer frameworks and understandings that recognize the perinatal period as a window of heightened 
sensitivity, with potential longer-term impacts from early life experiences. These frameworks include  
developmental origins of health and disease (DOHaD), lifecourse health development (LCHD), and epi-
genetic models. While the possibility of enduring impacts from experiences during the prenatal and 
postpartum periods are well recognized within these frameworks, the potential consequences for off-
spring of perinatal experiences are relatively unexplored Longer-term outcomes in women may also be 
influenced by perinatal events, as detailed here. The hormonal physiology of childbearing can enrich 
these frameworks and their significance for maternity care policy, practice, education, and research.
This report can contribute to the work of organizations, agencies, and individuals with responsibilities for 
childbearing women and their babies. With its focus on physiologic processes and maternity practices, it is 
highly relevant to clinicians, and particularly those working with women and their babies from pregnancy 
through the early postpartum period. It includes essential knowledge for health professional educators 
and students in all disciplines of maternity care, and important foundational knowledge for other educa-
tors and students. This report can also expand the understanding of childbirth educators, doulas, and 
lactation and other personnel who support childbearing families.
For administrators, policy makers, health plans and systems, and employers, this synthesis suggests low-
cost opportunities to improve the quality, safety, outcomes, and value of maternal-newborn care. Prior-
ity research gaps, as highlighted, point researchers and funders of research to needed studies that are 
potentially of great consequence. Childbirth advocates and childbearing women themselves will gain in-
depth knowledge about the physiologic processes of childbearing and ways to foster healthy childbearing. 
This information will also be of interest to members of the general public who want to better understand 
mothers and babies, and their optimal care. Various related products will make key findings available to 
childbearing women and other groups.
viiCHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | PREFACE
This report describes the physiologic roles of four important hormone systems and their impacts on ma-
ternal-newborn adaptation around the time of birth, as well as evidence of impacts of widely used inter-
ventions on these physiologic processes. It also examines the synchronized maternal-fetal preparations 
that lead to the physiologic (spontaneous) onset of labor at term, and possible effects of foreshortening 
gestation by scheduled birth. There are many gaps in our current knowledge, some of which may have 
major implications for the health and wellness of mothers and offspring. 
Despite research gaps, a consistent and coherent mosaic is coming into view of a finely tuned hormonal 
physiology of childbearing, active from pregnancy to lactation and beyond, which supports health, con-
nection, and well-being of mother and baby, in the short term and even lifelong. When promoted with 
enabling policies, settings, and knowledge and skill sets; supported by appropriate care practices; and 
protected from environments and practices that can interfere, hormonal physiologic processes foster 
not only optimal transitions and outcomes at birth, but also optimal breastfeeding and mother-baby at-
tachment, with substantial positive long-term impacts for mothers and babies, according to the evidence 
presented in this report. This evidence also suggests that, even when intervention is needed, mothers 
and babies can benefit by also experiencing hormonal physiology processes as far as safely possible.
Recommendations in the concluding chapter provide further details, and identify implications for policy, 
practice, education, and research.
I intend Hormonal Physiology of Childbearing to be illuminating, to add value to present knowledge, and to 
practically inform current understandings and endeavors on behalf of mothers, babies, and maternity care.
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Executive Summary
Introduction
This report examines current understandings of the hormonal physiology of childbearing, first in relation 
to the physiologic onset of labor at term and scheduled birth, and then through chapters addressing four 
impactful hormonal systems: oxytocin; beta-endorphins; epinephrine-norepinephrine (adrenaline-nor-
adrenaline) and related stress hormone systems; and prolactin. Each chapter addresses physiologic hor-
monal processes followed by the possible impacts of common maternity care practices and interventions. 
The final chapter presents conclusions, a summary table, and recommendations.
The “hormonal physiology of childbearing” here refers to reproduction-related biologic processes from 
pregnancy through the postpartum and newborn periods in relation to innate, endogenous hormone 
systems. “Physiologic childbearing” refers to childbearing conforming to healthy biologic processes. 
Consistent and coherent evidence finds that physiologic childbearing facilitates beneficial (salutogenic) 
outcomes in women and babies by promoting fetal readiness for birth and safety during labor, enhanc-
ing labor effectiveness, providing physiologic help with labor stress and pain, promoting maternal and 
newborn transitions and maternal adaptations, and optimizing breastfeeding and maternal-infant at-
tachment, among many processes.
The perinatal period is highly sensitive for mother and baby in relation to hormonal and other biologic 
processes. Practices that promote (through favorable policies and system capacities), support (with 
direct facilitating practices), and protect (from disturbance) physiologic childbearing may have amplified, 
ongoing benefits—for example, through supporting breastfeeding.
Contemporary childbearing has benefitted from many medical advances, and from highly skilled and 
committed maternity care providers, especially for mothers and babies who require special care. How-
ever, current high rates of maternity care interventions may be disadvantageous for the healthy major-
ity. Common maternity care practices and interventions can impact the hormonal physiology of mother 
and baby, according to physiologic understandings and human and animal studies. Impacts on hormonal 
physiology and consequences for mother and/or baby may occur in the perinatal period or beyond. For 
example, prelabor cesareans are associated with reduced fetal/newborn epinephrine-norepinephrine 
due to loss of the “catecholamine surge,” which may contribute to increased respiratory and other mor-
bidities. Longer-term impacts from perinatal hormonal disruptions are possible in women and babies, 
according to provisional human findings and solid animal research. 
Core hormonal physiology themes and principles recur throughout results synthesized in this report, 
revealing profound interconnections at many levels and over time, as follows:
Evolutionary origins. The hormonal physiology of childbearing has evolved over millions of years to 
optimize reproductive success. Maternal and infant survival at birth is obviously critical for reproductive 
success, but equally important for long-term survival are successful lactation and maternal-infant attach-
ment immediately following birth. These hormonally-mediated processes are intertwined and continuous 
with the biologic processes of parturition. Disruption of perinatal hormonal physiology may thus impact 
not only labor and birth, but also breastfeeding and maternal-infant attachment. As humans share many 
reproductive processes with other mammals, animal research helps illuminate human hormonal physiol-
ogy, especially where human research is currently limited.
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Mother-baby dyad. Hormonal physiology is interrelated, coordinated, and mutually regulated be-
tween mother and baby to optimize outcomes for both. For example, maternal and fetal readiness for 
labor is precisely aligned at the physiologic onset of term labor to optimize labor efficiency and maternal 
and newborn transitions. Similarly, skin-to-skin contact after birth mutually regulates maternal and new-
born oxytocin systems. As a general principle, effects on maternal hormonal physiology impact fetal/
newborn hormonal physiology, and vice versa.
Beneficial hormonal physiology pathway. From pregnancy through labor and birth, breastfeed-
ing, and maternal-infant attachment, hormonal processes of physiologic childbearing anticipate and 
prepare for upcoming processes and biological needs. For example, prelabor upregulation of maternal 
uterine oxytocin receptors promotes labor efficiency, and prelabor epinephrine-norepinephrine recep-
tor upregulation optimizes fetal adaptations to labor hypoxia and newborn transitions via the fetal cat-
echolamine surge.
Interorchestration among hormone systems. The hormone systems described here have com-
plex interactions in the perinatal period, including promoting or inhibiting one another’s activity. This can 
amplify hormonal effects, leading to the peaks that characterize physiologic birth. For example, late-labor 
oxytocin peaks, promoted by high levels of prolactin and oxytocin itself, assist with the pushing stage. Simi-
larly, excessive stress and stress hormones may disrupt labor progress via hormonal interorchestration.
Cascade of intervention. Hormonal disruptions can be amplified when one intervention neces-
sitates and leads to another that is used to monitor, prevent, or treat its side effects. This escalation of 
technology can further disrupt hormonal physiology and introduce extra risks for mother and baby. For 
example, the reduction in maternal oxytocin that generally follows administration of epidural analgesia 
may lead to use of synthetic oxytocin to compensate. Prolonged use of synthetic oxytocin may desensi-
tize the oxytocin receptor system and increase the risk of postpartum hemorrhage.
Concern about long-term impacts. Non-physiologic exposures during the sensitive perinatal pe-
riod may disrupt offspring hormone systems, with amplified and/or enduring biological, developmental, 
and/or behavioral impacts, as found in animal offspring, likely via epigenetic programming effects. High-
quality, long-term human studies following fetal/newborn exposure to perinatal drugs and interventions 
are very limited. Thus, the current evidence-based approach to identifying safe and effective care, based 
on short-term follow-up and limited examination of hormonally-mediated outcomes such as breastfeed-
ing, may not provide adequate safeguards for mothers and babies. Similarly, conventional shorter-term 
pharmacologic considerations of fetal/newborn drug exposure (e.g., dose, duration, metabolism) may 
not adequately safeguard the baby. Current levels of uncertainty about long-term impacts suggest re-
search priorities and support avoiding unneeded interventions. 
Physiologic Onset of Labor at Term 
The physiologic (spontaneous) onset of term labor is a complex and incompletely understood process. 
Critical for survival, its timing is thought to be essentially determined by the baby’s maturity, via fetal 
cortisol production, coordinated with the mother’s readiness for parturition, via estrogen production and 
other processes. Timing of the physiologic onset of term labor is difficult to predict due to normal varia-
tion in the length of human gestation.
With the physiologic onset of labor at term, maternal and fetal systems are fully primed and precisely 
aligned for safe, effective, labor and birth, and for optimal postpartum physiologic transitions, including 
breastfeeding initiation and maternal-newborn attachment, according to physiologic understandings, 
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and human and animal studies. Physiologic prelabor preparations occur in the weeks, days, and (in ani-
mal studies) hours before the onset of labor. Maternal preparations include:
 rising estrogen levels, activating the uterus for an efficient labor
 cervical ripening due to increases in oxytocin and prostaglandin activity (receptors, levels)
 increasing inflammation, which also activates the cervix and uterus
  increasing uterine oxytocin receptors, giving effective contractions during labor, and after birth 
to reduce bleeding 
  increasing brain-based (central) receptors for beta-endorphins (animal studies), contributing to 
endogenous analgesia in labor
  elevations in mammary and central oxytocin and prolactin receptors (animal studies), which 
promote breastfeeding and maternal-infant attachment after birth
Similarly, processes before and during labor foster the baby’s adaptations for labor and peak readiness 
for the critical transition to life outside the womb. These include:
  prelabor maturing of the lungs and other organ systems, and of the processes that clear lung fluid 
in labor
  prelabor development of oxytocin neuroprotective processes (animal studies)
  prelabor increase in epinephrine-norepinephrine receptors, giving protection from labor hypoxia 
via the late-labor epinephrine-norepinephrine (catecholamine) surge
  in-labor preservation of blood supply to heart and brain, via the catecholamine surge, with 
neuroprotective effects
  in-labor catecholamine-mediated preparations that will promote newborn breathing, energy and 
glucose production, and heat regulation
Possible Impacts of Scheduled Birth
Scheduled birth—whether by labor induction or prelabor cesarean section—benefits mother and/or 
baby in selected circumstances. However, it may also significantly disrupt the processes discussed above. 
Possible maternal impacts of scheduled birth include:
  reduced contraction efficiency leading to risks of failed induction, instrumental birth (induction), 
and postpartum hemorrhage (induction, prelabor cesarean)
  reduction in prelabor oxytocin and prolactin receptor peaks in the breasts and brain (animal 
studies) with potential impacts on breastfeeding, maternal adaptations, and maternal-infant 
attachment (induction, prelabor cesarean)
Possible impacts of scheduled birth on the baby include:
  immature protective processes, including the catecholamine surge, with increased vulnerability 
to labor hypoxia and “fetal distress” (induction)
  increased risks of postpartum breathing difficulties, hypoglycemia, and hypothermia due to lack 
of exposure to catecholamine surge (prelabor cesarean)
  reduced maturity of brain, brain-hormone, and other organ systems (induction, prelabor cesarean)
  long-term offspring impacts (animal studies), likely via epigenetic programming effects (cesarean 
section, plausibly relevant to induction)
These are crucial knowledge gaps given the high incidence of scheduled birth.
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Oxytocin: Normal Physiology
Oxytocin is a powerful reproductive hormone with widespread effects on the brain and body of all 
mammals, for example, by mediating sperm ejection, labor contractions, and milk ejection. Oxytocin 
also reduces stress by centrally activating the parasympathetic nervous system, which promotes calm, 
connection, healing, and growth; and by reducing activity in the sympathetic nervous system, which 
reduces fear, stress, and stress hormones, and increases sociability. Oxytocin has a short half-life, but its 
effects can be prolonged because it modulates other brain-hormone systems (neuromodulation). 
In the perinatal period, oxytocin optimizes labor, birth, and postpartum transitions of mother and baby 
through:
  central oxytocin release into the maternal bloodstream, causing rhythmic uterine contractions, 
including the late-labor oxytocin surge that benefits pushing (Ferguson reflex)
  central calming and analgesic effects in mothers and babies in labor through the postpartum 
period
  positive feedback of central oxytocin on itself, especially in multiparous mothers, augmenting and 
accelerating in-labor effects (animal studies)
  postpartum maternal adaptations that reduce stress, increase sociability, and prime reward centers, 
imprinting pleasure with infant contact and care, therefore promoting longer-term infant survival
Prelabor increases in uterine oxytocin receptors (human studies) and oxytocin receptors in brain and 
mammary glands (animal studies) maximize these effects. 
The hour or so after physiologic birth is a sensitive period, when skin-to-skin maternal-newborn interac-
tions foster peak oxytocin activity. Benefits may include:
  stronger contractions, likely reducing postpartum hemorrhage risk
  natural warming for the newborn through vasodilation of mothers’ chest
  activation of hormonally-mediated maternal-infant biologic bonding 
  facilitation of breastfeeding initiation, including by reducing maternal and newborn stress
Common Maternity Care Practices That May Impact Oxytocin 
Physiology
Common maternity care practices may disrupt these and other beneficial oxytocin effects, with short- 
and longer-term impacts in mothers and babies. High-quality research is lacking. 
While the administration of synthetic oxytocin for induction or augmentation is beneficial in selected 
circumstances, adverse impacts have been found in women and babies. Synthetic oxytocin administered 
in labor is not thought to cross into the maternal brain in biologically significant amounts, and so may 
lack calming and analgesic effects. However, when synthetic oxytocin stimulates contractions, positive 
feedback cycles may lead to central oxytocin release, promoting further contractions, labor progress, 
and continued central release.
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Synthetic oxytocin may impact maternal oxytocin and physiology. Possible effects include:
  uterine hyperstimulation with potential fetal hypoxia, requiring monitoring
  stronger contractions and increased pain without central oxytocin analgesia
  synthetic oxytocin overexposure causing desensitization of oxytocin receptors, contributing to 
reduced contractility, prolonged pushing, instrumental birth, and/or postpartum hemorrhage
  disruption of newborn breastfeeding behaviors, reduced maternal oxytocin release with 
breastfeeding, and possible reduced breastfeeding duration
Physiologic principles, animal studies, and evolving human evidence suggest that perinatal synthetic 
oxytocin exposure may have longer-term impacts on offspring. While high-quality research is lacking, 
potential mechanisms include:
  direct fetal brain-hormone effects from synthetic oxytocin transfer through placenta 
  indirect signaling of maternal oxytocin to fetal brain
  indirect effects from subclinical hypoxia
  interference with fetal neuroprotective mechanisms (animal studies)
  fetal/newborn impacts from synthetic oxytocin co-interventions such as epidural
  long-term programming of offspring hormonal systems, likely via epigenetic effects (animal 
studies) 
  indirect effects via disruptions to maternal oxytocin systems that impact attachment, reward, 
breastfeeding, and/or mutual regulation
Epidural analgesia reduces maternal oxytocin in labor, likely due to numbing of the sensory feedback 
that promotes central oxytocin release. Possible impacts include:
  slowed labor with increased need for synthetic oxytocin
  prolonged pushing stage with increased use of assisted vaginal birth
  disruption of maternal adaptations and attachment
These can also adversely affect the newborn. High-quality research is lacking.
With prelabor cesarean section, mothers and babies miss their complete prelabor physiologic oxytocin 
preparations; and with any cesarean section, the full oxytocin processes, including the maternal late-labor 
oxytocin surge and postpartum oxytocin peaks, may be reduced or absent. Impacts on breastfeeding, 
maternal adaptations, and postpartum hemorrhage have been found. Scheduled cesarean carried out after 
the physiologic onset of labor may have fewer adverse oxytocin impacts than prelabor cesarean section. 
Postpartum separation of healthy mothers and newborns may have detrimental short-and longer-term 
impacts on the oxytocin system, including:
  reduced oxytocin due to lack of skin-to-skin contact, with increased newborn stress and stress 
hormones, hypoglycemia, and hypothermia 
  disruptions to breastfeeding initiation and long-term success
  deficits in maternal hormones and adaptations, with longer-term impacts on maternal-infant 
attachment
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In animal studies, variations in maternal caregiving in the newborn period lead to epigenetic programming 
of offspring oxytocin systems, with enduring effects on offspring stress reactivity, and on the maternal 
care given by female offspring.
Beta-Endorphins: Normal Physiology
Beta-endorphins are endogenous opioids that give analgesic and adaptive responses to stress and pain. 
Beta-endorphins also activate brain reward and pleasure centers, motivating and rewarding reproduc-
tive and social behaviors, and support immune function, physical activity, and psychological well-being.
From labor through the postpartum period, beta-endorphins promote:
  endogenous analgesia though prelabor increase in central receptors (animal studies) and increases 
in beta-endorphins as labor progresses
  an altered state of consciousness that may help with labor stress and pain
  fetal neuroprotection from hypoxia (animal studies)
  postpartum peaks of beta-endorphins (along with oxytocin) that may facilitate maternal euphoria 
and prime reward centers, imprinting pleasure with infant contact and care 
  reward and reinforcement of breastfeeding in both mother and baby
  newborn support with the stress of postpartum transition, including via beta-endorphins in 
colostrum 
Excessive maternal stress in labor may lead to excessive (supraphysiologic) beta-endorphins, which may 
inhibit oxytocin and slow labor (animal studies). Alternatively, too-low levels of beta-endorphins (in-
fraphysiologic) may not give adequate stress and pain reduction, or activate postpartum pleasure and 
reward. Optimal levels of beta-endorphins to reduce stress and pain and promote labor progress likely 
vary among women. 
Common Maternity Care Practices That May Impact  
Beta-Endorphins Physiology
Laboring women may experience excessive stress in relation to their maternity care providers and birth 
environments (e.g., if not familiar, calm, and private), which may increase BEs to supraphysiologic levels 
and slow labor. (Stress mechanisms in women are not clear but may also involve oxytocin and/or epi-
nephrine-norepinephrine.) 
Labor analgesia that effectively reduces pain will reduce maternal beta-endorphins to some degree. This 
may be beneficial if excessive stress is inhibiting labor. However, reduced beta-endorphins, as found 
with epidurals, may also reduce postpartum reward center activation and priming, potentially impacting 
hormonally-mediated maternal adaptations and attachment, also involving oxytocin. 
Women experiencing a cesarean section may miss prelabor opioid receptor increases (animal studies), 
in-labor peaks of beta-endorphins, and/or postpartum reward center activation. Cesarean newborns 
have lower levels of beta-endorphins at birth than vaginally born babies, but levels may rise after birth 
with separation stress. 
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Separation of mother and newborn in the early sensitive period following physiologic birth, when levels 
of beta-endorphins are elevated, may interfere with reward center activation of both. In animal studies, 
repeated brief separations in the newborn period leads to detrimental impacts on offspring opioid sys-
tems, likely via epigenetic programing, with enduring effects on pain sensitivity and addiction.
Epinephrine-Norepinephrine and Related Stress Hormones:  
Normal Physiology
Epinephrine (adrenaline) and norepinephrine (noradrenaline) mediate “fight or flight” stress responses. 
Epinephrine-norepinephrine release with perceived danger has promoted safety for laboring females in 
the wild through human evolution by:
  slowing or stopping labor, giving time for fight or flight 
  redistributing blood to heart, lungs, and major muscle groups, and away from uterus and baby, to 
maximize fight-or-flight actions 
This epinephrine-norepinephrine response, which acts at an instinctive, subcortical level in all laboring  
mammals, may inhibit labor when women do not feel private, calm, safe, and undisturbed in labor. 
However, if the laboring female perceives stress or danger in late labor, epinephrine-norepinephrine el-
evations may paradoxically stimulate contractions via differential receptor effects. This “fetus ejection 
reflex” may also occur physiologically when labor has been largely undisturbed, creating powerful, effec-
tive, and involuntary pushing. High-quality research in relation to this reflex and its implications for birth 
is lacking.
In addition to maternal epinephrine-norepinephrine elevations with perceived stress or danger, a physi-
ologic rise in epinephrine with advancing labor has been found in women. This may benefit laboring 
women by promoting alertness and may promote labor progress by increasing prostaglandin production. 
The healthy stress (eustress) of labor also elevates the medium-term stress hormone cortisol as much as 
ten-fold. Cortisol may promote contractions, increase central oxytocin effects on maternal adaptations 
and attachment, and enhance postpartum mood.
For the baby, late-labor epinephrine-norepinephrine elevations (catecholamine surge) provide critical 
adaptations to labor hypoxia and facilitate newborn transitions, e.g., by:
  preserving blood flow to heart and brain
  promoting respiratory transitions, including clearing of lung fluid
  mobilizing metabolic fuels for the newborn period
  promoting newborn thermoregulation by burning brown fat
  promoting newborn alertness and energy for breastfeeding initiation
After birth, epinephrine-norepinephrine levels drop steeply in mother and baby. These decreases pro-
mote uterine contractions, which may limit maternal bleeding, and, for the newborn, reduce energy con-
sumption. Warmth and undisturbed skin-to-skin contact may be important in facilitating maternal and 
newborn epinephrine-norepinephrine reductions.
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Common Maternity Care Practices That May Impact Epinephrine-
Norepinephrine and Related Stress Hormones
Aspects of contemporary pregnancy care may have unintended negative (nocebo) effects by increas-
ing maternal stress and anxiety. Stress and anxiety in pregnancy can elevate maternal stress hormones, 
including epinephrine-norepinephrine and cortisol, with detrimental long-term effects on offspring, 
including impacts on brain development and stress responsiveness, as established in human and animal 
studies. Studies suggest that maternal relaxation techniques may reduce pregnancy stress and its detri-
mental effects, but high-quality research is lacking in this important area.
In labor, anxiety or situations in which the woman does not feel private, safe, and undisturbed may pro-
voke epinephrine-norepinephrine elevations, which may slow or stall labor and reduce fetal blood supply 
via epinephrine-norepinephrine effects. Stress may also slow labor by reducing pulsatile oxytocin and/or 
by increasing beta-endorphins. 
Attention to emotional well-being may promote labor progress. The reduced need for labor interven-
tions associated with doula and midwifery care may reflect this beneficial focus. Conversely, many com-
mon maternity care practices may be stressful for laboring women. High-quality research is lacking in 
relation to physiologic aspects of labor stress, and methods for ameliorating this.
Epidural analgesia can beneficially reduce maternal pain and epinephrine levels, which may have been 
inhibiting labor. However, the rapid drop in epinephrine may contribute to hypotension and uterine 
hyperstimulation. More commonly, contractions reduce over time because oxytocin also decreases. Re-
ductions in both epinephrine-norepinephrine and oxytocin with epidural analgesia may contribute to a 
prolonged pushing stage and assisted vaginal birth. Epidurals do not assist with, and may increase, fetal 
hypoxia, stress, and stress hormones in labor, and the risk of cesarean for fetal distress.
With cesarean section, both mothers and babies may miss late-labor epinephrine-norepinephrine eleva-
tions, and be less alert after birth for breastfeeding initiation. Lack of the fetal catecholamine surge may 
significantly contribute to newborn morbidities following cesarean section, including breathing difficul-
ties, hypoglycemia, hypothermia, and drowsiness that may impact interactions and breastfeeding. Cesar-
ean birth may impair newborn and infant stress responses. 
Separation of healthy mothers and newborns is more likely following cesarean section, leading to new-
born stress and stress hormone elevations. Early separation may also be stressful to the mother, depriving 
her of the opportunity to reduce epinephrine-norepinephrine for herself and her baby through oxytocin 
elevations with skin-to-skin contact and mutual interactions. In animal studies, repeated brief separations 
in the newborn period can lead to detrimental impacts on offspring stress hormone systems, likely via 
epigenetic programming, with enduring effects including depression-like behaviors in adult offspring and 
also in separated new mothers.
Prolactin: Normal Physiology
Prolactin is a major hormone of reproduction as well as breast-milk synthesis. Prolactin adapts maternal 
physiology for pregnancy and breastfeeding, promotes maternal adaptations, and is a caregiving hor-
mone in mammalian mothers and fathers. Outside of reproduction, it is a stress and growth hormone. 
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Maternal prolactin elevations from early pregnancy may have stress-reducing effects that also benefit 
the fetus. Late-pregnancy prolactin elevations promote the formation of prolactin receptors in the brain 
and mammary gland (animal studies). Near term, prolactin production also increases in the uterine lining 
(decidua), and may be involved in labor processes. Prolactin in amniotic fluid, which fills the fetal lungs, 
may assist with respiratory preparations. Fetal prolactic production increases close to the physiologic 
onset of labor, and may promote newborn transitions.
Maternal prolactin paradoxically declines as labor advances (outside of labor, stress triggers prolactin 
release). Prolactin increases steeply as birth nears, likely due to peaks of beta-endorphins and oxytocin, 
both of which stimulate prolactin release. In addition, prolactin stimulates oxytocin release, contributing 
to oxytocin peaks in late labor and birth.
Postpartum prolactin elevations, persisting for several hours after birth, may promote breast-milk produc-
tion and maternal adaptations. Peaks in prolactin and cortisol, together with early and frequent breast-
feeding, may promote prolactin receptor formation, with benefits to ongoing milk production (“prolactin 
receptor theory”). Prolactin levels released during early breastfeeding have been correlated with mater-
nal adaptations, including: reduced anxiety, aggression, and muscular tension; and increased social desir-
ability (conformity), which may help mothers to prioritize infant care.
Common Maternity Care Practices That May Impact Prolactin 
Physiology
High-quality research is lacking in relation to possible impacts of maternity care practices on prolactin 
physiology. Stress in labor may paradoxically reduce prolactin secretion, giving infraphysiologic levels in 
labor and birth, possibly contributing to the negative impacts of labor stress on breastfeeding. Epidurals 
may cause in-labor prolactin elevations and postpartum prolactin reductions, with unknown impacts. 
Induction with synthetic oxytocin may also impact physiologic prolactin release. Prostaglandins may 
inhibit prolactin with possible impacts on breastfeeding success.
With cesarean section, the expectant mother may miss her pre-labor prolactin elevation, late-labor peak 
and/or postpartum elevations, which may all impact milk production and maternal adaptations. Following 
cesarean section, prolactin release with early breastfeeding may be reduced or absent. These and other 
factors may contribute to reduced breastfeeding success following prelabor cesarean section. Following 
cesarean section, newborns may have lower prolactin levels, possibly contributing to breathing difficul-
ties and low temperature. Lack of the catecholamine surge may also contribute. 
Separation of mothers and their healthy newborns, which typically follows cesarean section, may also 
impact postpartum maternal prolactin levels. If separation interferes with early breastfeeding initiation 
and frequency, disruption to prolactin receptor formation may impact ongoing milk production and 
breastfeeding success.
Conclusions and Recommendations
Overall, consistent and coherent evidence from physiologic understandings and human and animal stud-
ies finds that that the innate, hormonal physiology of mothers and babies—when promoted, supported, 
and protected—has significant benefits for both in childbearing, and likely into the future, by optimizing 
labor and birth, newborn transitions, breastfeeding, maternal adaptations, and maternal-infant attachment. 
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There are likely additional benefits from avoiding potential harms of unnecessary interventions, including 
possible adverse epigenetic programming effects. 
From the perspective of hormonal physiology, these are not all-or-nothing benefits, but rather accrue 
along a continuum. Every mother and baby is likely to benefit from additional support for physiologic 
childbearing, as far as safely possible, including when interventions are used. The hormonal physiology 
perspective provides additional considerations for weighing possible benefits and harms of maternity care 
interventions, and suggests new agendas for research. Research priorities include better understanding of 
many aspects of hormonal physiology and of impacts of maternity interventions on breastfeeding, mater-
nal adaptations, maternal mood, and other short-, medium-, and longer-term hormonally-mediated and 
developmental outcomes.
Given the uncertainty and potential for significant harms to women and babies in relation to maternity 
care interventions, application of the Precautionary Principle would be wise in maternity care. Such a 
standard would involve:
  rigorously verifying the benefits of proposed interventions in individual circumstances before 
undertaking them
  limiting routine practices to those of proven benefit to healthy mothers and babies
  avoiding the use of interventions for the convenience of women or maternity care providers 
and systems 
  initially using less invasive measures to address challenges, and stepping up to more consequential 
interventions only as needed
A table in the report summarizes the established and potential effects of the maternity care practices 
addressed in the report on the four hormone systems.
The following recommendations for education, policy, practice, and research arise from the synthesis 
presented here. Care practice recommendations below are intended to apply whenever safely possible. 
To optimize hormonal physiology in childbearing:
  Educate all maternity care providers in the hormonal physiology of childbearing.
  Use effective policies and quality improvement strategies to foster consistent access to 
physiologic childbearing.
  Strengthen and increase access to care models that promote physiologic childbearing and safely 
limit use of maternity care interventions.
  Use effective consumer engagement strategies to inform women about physiologic childbearing 
and involve them in related aspects of their care.
  Provide prenatal care that reduces stress and anxiety in pregnant women.
  Foster the physiologic onset of labor at term.
  With hospital birth, encourage admission in active labor. 
  Foster privacy and reduce anxiety and stress in labor.
  Make nonpharmacologic comfort measures for pain relief routinely available, and use analgesic 
medications sparingly.
  Make nonpharmacologic methods of fostering labor progress routinely available, and use 
pharmacologic methods sparingly.  cont’d
xixCHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | EXECUTIVE SUMMARY
  Promote continuous support during labor.
  Foster spontaneous vaginal birth and avoid unneeded cesareans. 
  Support early and unrestricted skin-to-skin contact after birth between mother and newborn.
  Support early, frequent, and ongoing breastfeeding after birth.
  Identify and carry out priority research into hormonal physiology of childbearing, and routinely 
incorporate this perspective in maternity care research.
The Appendix identifies resources for learning more and improving maternity care, including a booklet 
that presents essential findings from this report to childbearing women.
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1
Introduction: 
Overarching Themes and Scope
This introduction provides an overview and context for the hormonal physiology of 
childbearing. Evolutionary perspectives are presented, followed by a discussion of 
contemporary childbirth practices. Overarching themes, including the Hormonal 
Physiology Pathway, are identified and discussed. The alignment of the report with other 
frameworks and understandings, such as developmental origins of health and disease, 
provides a wider context. Finally, the scope is described.
1
1.1 Human Childbearing: Evolution and Safety
Human birth has evolved over millions of years to optimize reproductive success for mother and offspring, 
and for our species as a whole. Critical to reproductive success is offspring survival not only at birth, but 
also in the postpartum period and beyond, which depends on successful lactation and mother-infant 
attachment. Processes that promote lactation and maternal-infant attachment have therefore evolved to 
be intertwined and continuous with the biologic processes of birth.
Modern human birth and the powerful, innate childbearing capacities of twenty-first century women 
and babies are the result of more than 60 million years of mammalian evolution.1 
Over these millions of years, complex, orchestrated hormonal systems have evolved for mothers and 
babies to optimize safety during labor and birth (parturition) and in the critical postpartum transitions of 
both. Equally critical to offspring survival and reproductive success for our evolutionary ancestors have 
been successful lactation and maternal-infant attachment, including the maternal adaptations that pro-
mote infant survival by motivating and rewarding maternal caregiving. The biologic processes that pro-
mote the onset of lactation and maternal-newborn attachment immediately following birth, and the on-
going success of these quintessentially mammalian processes, have therefore evolved to be intertwined 
and continuous with the biologic processes of parturition. 
While breastfeeding and the biologic processes of maternal-infant attachment (“biologic bonding”) are 
no longer essential for our offspring’s survival, they continue to promote long-term health and well-
being of women and babies.2-6
Similarly, parturition in our mammalian cousins also requires successful birth, lactation, and mother-
infant attachment, and much of the basic research in hormonal physiology derives from animal studies, 
as further discussed in 1.4. 
1.2 Contemporary Childbirth Practices
Contemporary childbirth has benefitted from medical advances. However, current high rates of maternity 
care interventions may be disadvantageous for mothers and babies in the short and possibly longer terms. 
Women’s experiences of childbearing in the United States and other high-income countries are very 
different from the evolutionary experiences of our foremothers.
Contemporary resources and practices, including access to modern medical care, have advanced survival 
at birth, with benefits to mothers, babies, and society. Beneficial practices include modern hygiene and 
nutrition, the use of antibiotics to treat infections, skilled treatment for childbirth emergencies, maternal 
care for high-risk conditions, and neonatal care for sick and premature babies. 
However, high rates of maternity care interventions have become standard practice in US hospitals even 
as most childbearing women and newborns are healthy. This includes interventions that are used liber-
ally or routinely in healthy women and babies, the use of interventions outside of indications supported 
by high-quality evidence, and the use of more consequential interventions when less invasive measures 
could suffice. The use of interventions in these situations exposes women and babies to potential harms, 
both known and as-yet unknown, as discussed in detail in this report, without commensurate benefit. 
Accumulating evidence suggests that current rates of cesarean section7-12 and other interventions12-14 
may have exceeded the threshold for benefit, and may now be causing more harm than good. 
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Maternity care providers are highly skilled and deeply committed to the welfare of women and babies, and 
to providing the best possible care. However, complex factors within the broader maternity and health care 
systems profoundly shape practice norms. These include professional education in settings where high use 
of technology is the norm and experience with other approaches may be limited, financial and delivery 
systems that reward consequential maternity care interventions above less invasive and costly alternatives, 
loss of essential skills and knowledge such as simple non-pharmacologic measures for labor progress and 
comfort, practice variation reflecting local and regional norms, and lack of systems to track important and 
longer-term maternal and newborn outcomes, including outcomes related to hormonal physiology. 
In addition, because of the episodic nature of maternity care, and the division of care for women and 
babies among many disciplines, including obstetricians, family physicians, midwives, nurses, pediatri-
cians, and lactation consultants, possible links between the childbearing experience and consequential 
longer-term outcomes for women, children, and childbearing families, as discussed in detail this report, 
may not be clear.
Many efforts are now under way to address these challenges and develop high-performing maternity 
and health care systems with better care, outcomes, and value for investments. This report is aligned 
with those efforts.
Vital records from 2012 show some of the highest intervention rates on record in the United States, with 
major departures from our evolutionary and hormonal blueprint in a large proportion of the nation’s 
women and newborns. Data from 86 percent of births, as collected in states using the revised birth cer-
tificate form, show that:15
  23 percent of birthing women experienced labor induction
  21 percent experienced augmentation of established labor
  72 percent used an epidural or spinal for pain relief
  33 percent gave birth by cesarean section (CS)
  only 10 percent of women with a history of CS gave birth vaginally
The national Listening to Mothers III survey of women who gave birth to single babies in US hospitals 
from mid-2011 to mid-2012, found that these official figures may significantly underreport some proce-
dures,16 and that many women and newborns also experienced various maternity care interventions not 
recorded in vital records. Among all survey participants:17, 18
  30 percent reported medically induced labor 
  50 percent received synthetic oxytocin to start and/or hasten labor 
  83 percent used various types of pain medications, 
  11 percent had vacuum- or forceps-assisted births
  12 percent had episiotomies
  26 percent of mothers and babies were separated immediately following birth for routine care 
Given the novelty and extremely recent appearance of many of these widely-used interventions from an 
evolutionary standpoint, it is important to understand their possible impacts on the physiology and well-
being of mother and baby. Hormonal physiology is a framework that adds value to, and complements, 
other frameworks and understandings of the processes and outcomes of childbearing, as addressed 
elsewhere. 
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1.3 Current Understandings of the 
Hormonal Physiology of Childbearing
In this report, the “hormonal physiology of childbearing” refers to reproduction-related biologic processes 
from pregnancy through the postpartum and newborn periods in relation to innate, endogenous hormone 
systems. 
1.3.1 Benefits for Mothers and Babies
Consistent and coherent evidence suggests that physiologic childbearing (conforming to healthy biologic 
processes) facilitates beneficial (salutogenic) outcomes in mothers and babies, including by promoting: 
fetal readiness for birth and safety during labor, labor effectiveness, hormonal support for labor stress 
and pain; and postpartum breastfeeding success and maternal-infant attachment, among other benefits. 
Greater conformity to healthy biologic processes in childbearing is likely to promote greater benefit for 
mothers and babies, compared with lesser conformity.
While the hormonal physiology of childbearing is not fully understood, consistent and coherent evidence 
from physiologic understandings and human and animal studies, as presented here, suggests that physi-
ologic childbearing (conforming to healthy biologic processes) promotes important beneficial outcomes 
in mothers and babies from pregnancy through to the postpartum and newborn periods. These include:
  precisely aligning readiness for birth between mother and baby with the physiologic onset of 
labor at term (2.1.)
  preparing the baby for life outside the womb, including maturing the fetal lungs in preparation 
for breathing (5.1.2)
  protecting the baby from reduced oxygen (hypoxia) during labor (3.1.3, 5.1.3)
  enhancing labor effectiveness, including during the pushing phase (3.1.3)
  providing the mother with physiologic pain and stress reduction (3.1.3, 4.1.3)
  helping to prevent maternal bleeding after birth (3.1.4)
  preparing mother and baby for breastfeeding (3.1.4)
  promoting postpartum maternal adaptations, including activation of pleasure and reward centers, 
which maximize maternal satisfaction, supporting maternal-infant attachment and infant survival 
(3.1.4)
The hormonal physiology of childbearing offers a biologic framework that is essentially “salutogenic”—
promoting positive health and well-being19—for mother and baby in childbearing. Factors that promote 
physiologic childbearing (conforming to healthy biologic processes) are likely to move mothers and babies 
toward better health and wellness. This means that physiologic childbearing is not an all-or-nothing pro-
cess: any practices that support hormonal physiology are likely to benefit mothers and babies, and greater 
conformity to healthy biologic processes in childbearing is likely to be more beneficial than less conformity. 
In addition, because of the sensitivity of the perinatal period, and the potential for epigenetic program-
ming and amplification effects (discussed below), relatively simple hormonal support, such as facilitating 
skin-to-skin contact in the hour after birth, may have substantial longer-term effects, for example, fos-
tering longer-term maternal-infant attachment and breastfeeding, with exceptional health benefits for 
mothers and babies. (See “Skin-to-skin contact” in 3.1.4.) 
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Maternal-newborn attachment differs to some extent between humans and other mammals, especially 
given that human parents can form strong attachments to non-biologic children. However, biologic, 
hormonally-mediated attachment processes are measurable in women, as in other mammals, with ben-
efits in the postpartum period and beyond (3.1.4). These processes involve changes in the limbic system 
(middle brain) in relation to hormonal activity before, during and after birth, and may contribute to off-
spring survival by enhancing the reward value (pleasure) of infant contact and care. These processes may 
be more accurately called “biologic bonding.”20
Recommendations in the final chapter suggest actions to safely support hormonal physiology of women 
and babies in childbearing, with expected and possibly long-term benefits to health and well-being, as 
discussed in this report.
1.3.2 Possible Impacts of Maternity Care interventions
Common maternity care practices can impact the hormonal physiology of mother and baby, as described 
in detail in this report.
Maternity care practices may disrupt hormone systems. Examples of well-known clinical phenomena 
that are consistent with hormonal physiology effects include:
  slowing or cessation of labor when a laboring women arrives in the unfamiliar hospital environ-
ment, due to stress-related increases in epinephrine-norepinephrine, and/or beta-endorphins, 
and/or reductions in oxytocin (4.1.3, 4.2.1, 5.1.3, 5.2.1)
  prolonged and less effective pushing stage for women using epidural analgesia due to reductions 
in late-labor oxytocin and/or epinephrine-norepinephrine peaks (3.1.3)
  disruption to newborn transitions with prelabor cesarean due to lack of the fetal late-labor cat-
echolamine surge (5.1.3) 
  increased postpartum hemorrhage risk for women following prolonged synthetic oxytocin admin-
istration, due to oxytocin receptor downregulation (3.1.3)
Because research in this area is limited, there may be many as-yet unknown hormonal physiology effects 
from common maternity care interventions, including medium- and longer-term impacts on mother and 
baby, as discussed in detail in this report.
Hormonal disruptions may contribute to the “cascade of intervention” where one intervention necessi-
tates and leads to another that is used to monitor, prevent, or treat its side effects, with an escalation of 
technology that can introduce extra risks for mother and baby. Hormonal disruptions can lead to further 
hormonal disruptions. For example, the reduction in maternal oxytocin that follows epidural analgesia 
may lead to the use of synthetic oxytocin to compensate. Prolonged use of synthetic oxytocin can desen-
sitize the oxytocin receptor system and increase the risk of postpartum hemorrhage. Interorchestration 
among hormone systems, discussed below, may also contribute to cascades of intervention.
1.3.3 The Hormonal Physiology Pathway
The Hormonal Physiology Pathway reflects that physiologic childbearing is a temporal pathway, travers-
ing pregnancy, labor, birth, the postpartum and newborn periods, and into the future, and possibly even 
to subsequent generations, according to epigenetic principles. Each stage includes preparation for up-
coming physiologic processes and tasks. The hormonal physiology of mothers and babies is interconnect-
ed and interdependent. In addition, hormonal systems interact and interorchestrate with one another, 
suggesting that disruptions on one hormonal system may spill over to others. This may contribute to the 
“cascade of intervention.” 
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Physiologic childbearing can be seen as a temporal biologic pathway to a healthy birth and beyond, evolved 
over millions of years to enhance reproductive success. Beginning from earliest pregnancy, this pathway 
traverses pregnancy, labor, birth, and the postpartum and newborn periods, and may continue into the 
future, even to subsequent generations, according to epigenetic principles. Both maternal and fetal/
newborn processes are present and interconnected at each stage of the pathway. Recurring and cohe-
sive themes and principles illuminate important properties of this pathway, as seen through this report.
One major, overarching theme is that episodes on this pathway are both processes in themselves and 
also preparation for upcoming physiologic processes and tasks. This is well illustrated in chapter 2, which 
describes the prelabor physiologic preparations that ensure peak readiness for term labor and birth of 
mother and baby. Following on, the processes of labor then prepare for postpartum transitions, for ex-
ample, the hormonal peaks in late labor likely facilitate the establishment of breastfeeding and promote 
the maternal adaptations that optimize maternal-infant attachment (described in 3.1.4 in relation to 
oxytocin). These stages and preparations also overlap, with some prelabor preparations contributing to 
postpartum processes. For example, prelabor increases in prolactin receptors, as found in animal stud-
ies, promote postpartum breast-milk production.
Another illuminating theme on this pathway is the interdependence of hormone systems between moth-
er and the fetus/baby, who can essentially be seen as one biologic system from pregnancy through the 
postpartum/newborn period. Prelabor preparations, for example, are extensively coordinated, so that 
readiness of both woman and fetus for labor are precisely aligned at the physiologic onset of term labor. 
Similarly, when in skin-to-skin contact after birth, mother and baby mutually regulate and promote oxy-
tocin release, and at the same time reduce epinephrine-norepinephrine for each other, with physiologic 
and ongoing benefits for both (3.1.4, 5.1.4). This coordination also implies that, as a general principle, 
effects on maternal hormonal physiology can be expected to impact fetal/newborn hormonal physiol-
ogy, and vice versa.
In addition, these hormone systems interact and interorchestrate with one another, within the biologic 
systems of mother and baby. Important perinatal hormonal interorchestrations, as found in the maternal 
system, according to human and animal studies, include that:
  beta-endorphins inhibit oxytocin release in the lead-up to labor, helping to regulate labor onset 
(3.1.2) 
  oxytocin stimulates its own release within the brain, contributing to the establishment and 
acceleration of labor, with greater effects in multiparous females (3.1.3)
  oxytocin promotes beta-endorphins, giving endogenous analgesia to help with contractions 
(3.1.3, 4.1.3)
  beta-endorphins promote prolactin release in labor, preparing for breastfeeding (4.1.3, 6.1.3)
  prolactin promotes beta-endorphins (4.1.3, 6.1.3)
  extreme levels of beta-endorphins in labor can inhibit oxytocin, slowing labor in situations of 
excessive stress (4.1.3)
  excessive levels of epinephrine-norepinephrine may also inhibit oxytocin and slow labor when 
the laboring women feels unsafe or disturbed (5.1.3, 5.2.1)
  pulsatile oxytocin promotes prolactin release in labor (3.1.3, 6.1.3)
  prolactin also promotes oxytocin, contributing to late labor and postpartum peaks of both 
(5.1.3, 6.1.3)
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These interorchestrations suggest that disruption to one hormone system may spill over to other systems, 
with additional consequences for processes that involve one or both systems. This may contribute to the 
cascade of intervention, discussed above. For example, epidural-related disruptions to maternal perinatal 
oxytocin (3.2.5) could also impact prolactin systems, with potential detrimental effects on breastfeeding 
(see “Synthetic Oxytocin and Breastfeeding” in 3.2.3). Hormonal interorchestrations, and the complex 
implications for maternity care practices, are not well studied. 
1.4 Alignment with Other Frameworks 
The hormonal physiology of childbearing is aligned with other major models and frameworks that share an 
evolving understanding of the critical nature of early development, and the potentially significant impacts 
of experiences at this time on future health and well-being. The hormonal physiology of childbearing may 
help to elucidate and extend current understandings within these frameworks, which include the develop-
mental origins of health and disease, epigenetics, and lifecourse health development. Evidence-based and 
pharmacologic approaches to identifying safe and effective care for mothers and babies may not currently 
provide adequate safeguards because medium- and long-term outcomes are not well measured. 
Outcomes of maternity care and maternity care interventions have traditionally focused on important 
short-term outcomes such as perinatal mortality, newborn morbidity (e.g., measured by Apgar score, cord 
blood analysis, and/or admission to advanced care), and certain maternal outcomes. There is increasing 
recognition, including from other frameworks, that exposures during the highly sensitive perinatal period 
may have implications for longer-term health and well-being. 
Evidence of impacts over time in relation to maternity care exposures is limited, mainly because of very 
limited medium- and longer-term follow-up. For example, researchers analyzed the larger and more influ-
ential randomized studies of effects of perinatal interventions, as found in Cochrane systematic reviews, 
and found that only 16 percent (40 studies) made any measurement of offspring outcomes beyond hospi-
tal discharge.21 Markedly missing from current research are high-quality studies of the impact of perinatal 
interventions on medium-term outcomes such as breastfeeding success and duration, maternal-infant 
attachment, maternal emotional well-being, and other hormonally-mediated salutogenic outcomes.19 
The growing body of work on the developmental origins of health and disease (DOHaD) recognizes that  
“. . . a stimulus or insult at a critical period of development has lasting or lifelong effects.”22(p.115) While 
this model has, up until now, been mainly applied to events during gestation that may “program” the 
fetus for later life, (also called “fetal origins of adult disease”, FOAD), there is growing awareness that the 
baby may be equally vulnerable during the perinatal period which, though relatively brief, is pivotal for 
the complex newborn transitions that promote offspring survival.23-31 
The term “fetal programming” is generally used to imply maladaptive changes, but this is essentially a 
mechanism to optimally adapt the baby to the future environment.32-34 Programming effects that are 
associated with optimal hormonal processes are likely to be adaptive. For example, animal studies show 
that high levels of maternal care program low stress responsiveness in adult offspring.35
Fetal programming effects are now recognized to involve epigenetic mechanisms—biochemical processes 
that switch genes on or off.32, 33 Epigenetic programming due to early life experiences can have endur-
ing effects, which can also be transmitted across generations, with implications for human health and 
development.36 For example, transgenerational effects have been found following gestational exposure 
to diethylstilbestrol (DES),37 with epigenetic mechanisms identified in animal studies.38 In addition, human 
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studies have linked epigenetic changes found in the placenta, particularly those affecting cortisol metabo-
lism (and therefore the transmission of maternal stress to the fetus), with newborn neurobehavior.39 
In relation to epigenetic effects following perinatal experiences, several studies have found increased 
DNA methylation, a marker of epigenetic changes, in human newborn tissues following cesarean com-
pared with vaginal birth.23-25
Epigenetic mechanisms may also account for the alterations in adult behavior and brain function found 
among caesarean- compared with vaginally born animal offspring.27-31 Other possible changes among 
cesarean-born compared with vaginally-born human offspring, such as altered stress responses in infancy26 
and the well-recognized increased risks of some adult diseases,40 may derive from epigenetic mechanisms.23 
(See 5.2.6 for more discussion of possible CS effects on offspring stress systems and adult disease.)
If epigenetic programming in the perinatal period (also called “hormonal imprinting” in relation to hor-
mone and hormone-like exposures) applies to humans, as it does to all other species tested so far,41 the 
implications for fetal/newborn exposures to perinatal drugs and procedures are considerable.
These concerns have generated the “epigenetic impact of childbirth” (EPIIC) hypothesis.42 This suggests 
that:
Physiological labor and birth have evolved to exert eustress (a healthy positive form of stress) on the 
fetus, and that this process has an epigenomic effect on particular genes . . . . Reduced or elevated 
levels of cortisol, adrenalin, and oxytocin produced during labor may lead to fetal epigenomic re-
modeling anomalies which exert influence on abnormal gene expression. This reprogramming could 
manifest in a range of non-communicative diseases and biobehavioral problems in the neonate and 
adulthood.42(p.657)
The impacts of perinatal experiences, whether physiologic or altered to some extent by maternity care 
interventions, may be amplified for offspring in the longer term, according to lifecourse health develop-
ment (LCHD) perspectives.43 This sophisticated multi-system model predicts that small deviations in bio-
behavioral systems in early life can alter the health and development trajectory, with large effects into 
adulthood. According to the LCHD model, “time-specific pathways” exist during critical sensitive periods 
when developing systems are most vulnerable to alteration, underscoring the crucial importance of the 
perinatal period for lifelong well-being. 
Such alterations in developmental trajectories may also occur indirectly in offspring, via maternal ex-
posures and behaviors. Animal studies (mentioned above) show that the quality of maternal caregiving 
can epigenetically program offspring stress responses and also the subsequent mothering behaviors of 
female offspring.35 This may be relevant to human mothers and babies, including through the possible 
impacts of maternity care on maternal adaptations and maternal-infant attachment. (See also “Oxytocin 
and Maternal Adaptations and Attachment” in 3.1.4, “Synthetic Oxytocin and Maternal Adaptations and 
Attachment” in 3.2.3, and “Epidural Analgesia and Maternal Adaptations in 3.2.5.)
Other biologic models and frameworks, notably the human microbiome and endocrine disruption, also 
recognize early sensitive periods that may have significant impacts later in life. Given the burgeoning in-
terest and research in the early origins of health and disease, and the recognition of non-communicable 
disease as a growing global burden,44 work to understand the links between sensitive periods and long-
term health outcomes is critical for global health.
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Congruent with these various frameworks, the hormonal physiology of childbearing, as detailed in this 
report, takes a longitudinal focus in relation to health and wellness. As discussed in relation to evolution,  
perinatal hormonal systems support reproductive success, which will be optimized when mother and 
baby not only survive the birth, but also go on to thrive, and produce more offspring who survive and 
thrive and so on. Hormonal processes during labor and birth that optimize breastfeeding, maternal-infant 
attachment, epigenetic programming, and health development trajectories thus are likely to contribute 
to the broader continuum of long-term health and well-being of mother and offspring. Conversely, peri-
natal hormonal disruptions could have enduring consequences, with researchers and clinicians expressing 
concerns and suggesting possible mechanisms, as further detailed in this report.42, 45-54 
Other models used to assess safety for mother and baby may have shortcomings, from these wider per-
spectives of hormonal physiology. The use of evidence-based health care, including high-quality studies 
and rigorous up-to-date systematic reviews, has been beneficial in assessing possible benefits and harms 
in maternity care, albeit with well-documented lags in bringing practice in line with best evidence. How-
ever, this model also has significant limitations, because it is limited to the research evidence as it currently 
exists, reflecting current perspectives and paradigms, and has been primarily focused on a narrow range 
of short-term outcomes. Other concerns in relation to evidence-based medicine include:
  lack of a physiologic childbearing comparison group experiencing minimal or no interventions in 
most studies, so that differences may be underestimated
  difficulty of measuring effects of interventions due to the common involvement of co-interventions
  frequent lack of data on critical hormonally-mediated outcomes such as breastfeeding and 
attachment, which are plausibly impacted by preceding maternity care interventions
  minimal follow up beyond hospital discharge in most studies, including most randomized con-
trolled trials, the preferred study design of evidence-based medicine
  to date, no consideration of possible epigenetic programming effects
Because of these limitations, the use of evidence-based health care may be an insufficient safeguard for 
maximizing benefits and minimizing harms in mothers and babies in relation to maternity care. 
Similarly, in relation to fetal/newborn drug exposure, conventional pharmacologic considerations, such 
as dose, duration, metabolism and excretion, also do not encompass longer-term and possibly epigenetic 
effects,55-58 and so may not adequately safeguard the baby, especially in the sensitive perinatal period. For 
example, studies are now suggesting possible long-term developmental effects from early exposure to 
anesthetic drugs. According to animal models, “Most clinically utilized anesthetic drugs have been found 
to induce neuronal cell death in the developing brain and to potentially cause long-term neurological 
impairment.”59(p.944), 60 Impactful drugs in these studies include local anesthetics and, to a lesser extent, 
opioids,59 which are very common exposures for babies in the perinatal period, including via epidurals. 
Due to the current high levels of exposure of mothers and babies to maternity care interventions, and 
the biological plausibility of as yet unknown unintended, consequences, research into potential impacts of 
medications and other perinatal practices, including medium- and longer-term outcomes, is a high priority.
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1.5 Scope of This Report
1.5.1 Content and Organization
This report examines current understandings of the hormonal physiology of childbearing. The following 
chapter considers the physiologic onset of term labor and scheduled birth. The subsequent four chapters 
address four hormonal systems: oxytocin, beta-endorphins, epinephrine-norepinephrine (adrenaline-nor-
adrenaline) and related stress hormone systems, and prolactin. Each considers physiologic functioning of 
the hormone system, followed by possible impacts of common maternity care practices and interventions. 
The final chapter presents conclusions, a summary table, and recommendations.
The chapter following this introduction summarizes current knowledge about the physiologic onset of 
labor at term and the possible effects of birth scheduled before physiologic onset by labor induction or 
planned prelabor cesarean. The specific hormone systems covered in the subsequent four chapters are 
first described as they function when promoted (through favorable policies and system capacities), sup-
ported (with direct facilitating practices), and protected (from disturbance). Following this, the chapters 
summarize current knowledge of effects of common maternity care practices. The first of these four 
chapters, on oxytocin systems, is far longer than the others due to the disproportionate amount of re-
search on oxytocin. 
Research was available to begin to clarify impacts on the respective hormonal systems of the following 
widely used labor and birth practices and interventions:
  differing maternity care providers and birth environments
  prostaglandins for cervical ripening and labor induction
  synthetic oxytocin for induction, augmentation, and postpartum care
  opioid drugs for pain relief
  epidural analgesia pain relief 
  cesarean section
  the early separation of healthy mothers and newborns
Other maternity care practices and interventions such as electronic fetal monitoring, artificial rupture 
of membranes, restrictions on oral intake, and restrictions on maternal positioning and mobility could 
not be included because of lack of research data in relation to hormonal physiology. However, some may 
have direct hormonal impacts, and indirect hormonal effects are also likely in many of these practices. 
For example, continuous electronic fetal monitoring61 and being supine and immobile during the first 
stage of labor62 increase risk of cesarean section, which has established hormonal impacts, as discussed 
in the following chapters. 
The final chapter gives overall conclusions, provides a summary table of possible impacts of common 
maternity care interventions, and presents a series of high-level recommendations for clinicians, policy-
makers and others. An appendix lists selected related resources.
Because of the extremely broad range of material and the large amount of research that is cited, in-depth 
critical appraisal of individual studies was beyond the scope of this report. It is hoped that this initial syn-
thesis will inspire others to pursue more focused hormonal physiology topics and questions in depth,  
including the important process of more detailed evaluations of the relevant studies. In addition, many 
of the hormonal physiology studies cited here are older, reflecting earlier interest in these topics. This 
basic research deserves revisting with more recent approaches and understandings. 
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1.5.2 Inclusion of Animal Studies
Animal studies provide valuable information in relation to reproductive physiology. This report includes 
such studies to illuminate mammalian reproductive physiology, to consider potential human findings, 
and/or to explore the possible consequences of interventions, where human research is not currently 
available or feasible.
Much of the current basic understanding of human reproductive biology, including the hormonal physiol-
ogy of childbearing, comes from research conducted on other mammals such as rats, mice, and sheep 
and, less often, non-human primates. These animals are widely used in government-funded and other 
research as models for human physiology, reproductive physiology, and endocrinology because of the 
extensively documented commonalities with human physiology, the result of millions of years of shared 
mammalian evolution.63, 64 In addition, because of shorter lifespans, animal models can provide important 
information about possible epigenetic programming and transgenerational effects, as discussed above. 
Animal research is cited in this report to illuminate mammalian reproductive physiology, to clarify provision-
al human findings, and/or to explore the possible consequences of intervention, where research cannot be 
conducted on women and babies for practical and ethical reasons, or has not been conducted to date. 
In this report, the use of animal studies is consistently specified. When no human studies were available 
to examine a specific question or outcome, restriction of knowledge to animal studies is clearly indicated. 
This implies that similar processes and impacts are possible in humans, but specific research is needed to 
answer these questions. Where ethical and feasible, it will be important to conduct human studies in the 
coming years to fill the significant research gaps.
1.6 Introduction: Summary
This report examines current understandings of the hormonal physiology of childbearing, first in rela-
tion to the physiologic onset of labor at term and scheduled birth, and then through chapters addressing 
four impactful hormonal systems: oxytocin; beta-endorphins; epinephrine-norepinephrine (adrenaline-
noradrenaline) and related stress hormone systems; and prolactin. Each chapter addresses physiologic 
hormonal processes followed by the possible impacts of common maternity care practices and interven-
tions. The final chapter presents conclusions, a summary table, and recommendations.
The “hormonal physiology of childbearing” here refers to reproduction-related biologic processes from 
pregnancy through the postpartum and newborn periods in relation to innate, endogenous hormone 
systems. “Physiologic childbearing” refers to childbearing conforming to healthy biologic processes. 
Consistent and coherent evidence finds that physiologic childbearing facilitates beneficial (salutogenic) 
outcomes in women and babies by promoting fetal readiness for birth and safety during labor, enhanc-
ing labor effectiveness, providing physiologic help with labor stress and pain, promoting maternal and 
newborn transitions and maternal adaptations, and optimizing breastfeeding and maternal-infant at-
tachment, among many processes.
The perinatal period is highly sensitive for mother and baby in relation to hormonal and other biologic 
processes. Practices that promote (through favorable policies and system capacities), support (with direct 
facilitating practices), and protect (from disturbance) physiologic childbearing may have amplified, ongo-
ing benefits—for example, through supporting breastfeeding.
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Contemporary childbirth has benefitted from many medical advances, and from highly skilled and com-
mitted maternity care providers, especially for mothers and babies who require special care. However, 
current high rates of maternity care interventions may be disadvantageous for the healthy majority. 
Common maternity care practices and interventions can impact the hormonal physiology of mother 
and baby, according to physiologic understandings and human and animal studies. Impacts on hormonal 
physiology and consequences for mother and/or baby may occur in the perinatal period or beyond. For 
example, prelabor cesareans are associated with reduced fetal/newborn epinephrine-norepinephrine 
due to loss of the “catecholamine surge,” which may contribute to increased respiratory and other mor-
bidities. Longer-term impacts from perinatal hormonal disruptions are possible in women and babies, 
according to provisional human findings and solid animal research. 
Core hormonal physiology themes and principles recur throughout results synthesized in this report, 
revealing profound interconnections at many levels and over time, as follows:
Evolutionary origins. The hormonal physiology of childbearing has evolved over millions of years to 
optimize reproductive success. Maternal and infant survival at birth is obviously critical for reproduc-
tive success, but equally important for long-term survival are successful lactation and maternal-infant 
attachment immediately following birth. These hormonally-mediated processes are intertwined and 
continuous with the biologic processes of parturition. Disruption of perinatal hormonal physiology may 
thus impact not only labor and birth, but also breastfeeding and maternal-infant attachment. As humans 
share many reproductive processes with other mammals, animal research helps illuminate human hor-
monal physiology, especially where human research is currently limited.
Mother-baby dyad. Hormonal physiology is interrelated, coordinated, and mutually regulated be-
tween mother and baby to optimize outcomes for both. For example, maternal and fetal readiness for 
labor is precisely aligned at the physiologic onset of term labor to optimize labor efficiency and maternal 
and newborn transitions. Similarly, skin-to-skin contact after birth mutually regulates maternal and new-
born oxytocin systems. As a general principle, effects on maternal hormonal physiology impact fetal/
newborn hormonal physiology, and vice versa.
Beneficial hormonal physiology pathway. From pregnancy through labor and birth, breastfeed-
ing, and maternal-infant attachment, hormonal processes of physiologic childbearing anticipate and 
prepare for upcoming processes and biological needs. For example, prelabor upregulation of maternal 
uterine oxytocin receptors promotes labor efficiency, and prelabor epinephrine-norepinephrine recep-
tor upregulation optimizes fetal adaptations to labor hypoxia and newborn transitions via the fetal cat-
echolamine surge.
Interorchestration among hormone systems. The hormone systems described here have com-
plex interactions in the perinatal period, including promoting or inhibiting one another’s activity. This can 
amplify hormonal effects, leading to the peaks that characterize physiologic birth. For example, late-labor 
oxytocin peaks, promoted by high levels of prolactin and oxytocin itself, assist with the pushing stage. Simi-
larly, excessive stress and stress hormones may disrupt labor progress via hormonal interorchestration.
Cascade of intervention. Hormonal disruptions can be amplified when one intervention neces-
sitates and leads to another that is used to monitor, prevent, or treat its side effects. This escalation of 
technology can further disrupt hormonal physiology and introduce extra risks for mother and baby. For 
example, the reduction in maternal oxytocin that generally follows administration of epidural analgesia 
may lead to use of synthetic oxytocin to compensate. Prolonged use of synthetic oxytocin may desensi-
tize the oxytocin receptor system and increase the risk of postpartum hemorrhage.
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Concern about long-term impacts. Non-physiologic exposures during the sensitive perinatal pe-
riod may disrupt offspring hormone systems, with amplified and/or enduring biological, developmental, 
and/or behavioral impacts, as found in animal offspring, likely via epigenetic programming effects. High-
quality, long-term human studies following fetal/newborn exposure to perinatal drugs and interventions 
are very limited. Thus, the current evidence-based approach to identifying safe and effective care, based 
on short-term follow-up and limited examination of hormonally-mediated outcomes such as breastfeed-
ing, may not provide adequate safeguards for mothers and babies. Similarly, conventional shorter-term 
pharmacologic considerations of fetal/newborn drug exposure (e.g., dose, duration, metabolism) may 
not adequately safeguard the baby. Current levels of uncertainty about long-term impacts suggest re-
search priorities and support avoiding unneeded interventions. 
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2
Physiologic Onset of
Labor and Scheduled Birth
14
This chapter summarizes current understandings of the physiologic (spontaneous) onset of 
labor at term and the hormones and hormonal processes involved. It also considers possible 
impacts on mother and baby of scheduled birth—by induction or prelabor cesarean 
section—from the perspective of hormonal physiology. 
2.1 Physiologic Onset of Labor at Term
Much remains unknown about mechanisms of the physiologic onset of labor in humans. Processes that 
lead to readiness for labor, birth, and postpartum transitions are coordinated at term labor between 
mother and baby, whose maturity ultimately determines timing, according to current understanding. The 
timing of labor onset makes a critical contribution to long-term outcomes of mother and baby by optimiz-
ing not only survival at birth, but also the hormonal physiology that supports longer-term well-being and 
survival via breastfeeding and attachment.
Despite decades of research, the events that trigger the onset of human labor are poorly understood.65-67 
With this limited understanding, there is also a limited ability to effectively halt premature labor and 
birth, which causes an enormous burden for affected children and families, and for the maternity care 
system. Prematurity accounts for an estimated 75 percent of newborn deaths in the US.68 
This chapter highlights the highly complex, orchestrated events that lead to full readiness for labor, birth, 
and the critical postpartum transitions of mother and baby. These include upregulation of hormone and 
receptor systems that will maximize labor efficiency and, after birth, will enhance maternal and newborn 
transitional physiology, breastfeeding, and maternal adaptations, with longer-term benefits to mother and 
baby. The full consequences of foreshortening these processes are poorly researched and understood.
In addition, because of the wide range of duration of normal human gestation69 (discussed further in 2.2), 
it is not currently possible to predict for individual women the day, or even the week, of the physiologic 
onset of term labor. Therefore, in relation to scheduled birth (induction or prelabor cesarean, PLCS), the 
degree of foreshortening of gestation, and the potential deficits in fetal maturation and maternal readi-
ness, are also not fully predictable. 
Whatever the final trigger for the onset of labor at term, “. . . some mechanism synchronizes fetal devel-
opment and maturation with the maternal mechanisms that effect the birth.”70(p.569) This coordination 
likely follows weeks of progressive changes and preparations.
Current understanding is that the fetus determines the duration of pregnancy, through the culmination 
of prelabor physiologic preparations, and signals this readiness to the mother’s body.71 The mother’s 
physiology determines the time of day that labor commences, through day-night (circadian) rhythms.72
The physiologic onset of labor at term represents the end of a series of processes that begins as early as 
midpregnancy. This onset is timed to optimize readiness of the mother, maturity of the fetus, survival at 
birth, and long-term survival of both. The pregnant woman’s uterus goes through several states:73
 quiescence: in pregnancy, when the uterus is inactive
 activation: preparing for labor, when the uterus becomes capable of being activated
 stimulation: labor itself, with stimulation of uterine activity
 involution: postpartum return to prepregnancy state (not described here)
2.1.1 Quiescent Phase 
Progesterone and relaxant prostaglandins are among factors that maintain uterine quiescence in pregnancy. 
Many factors inhibit contractions and maintain uterine quiescence through pregnancy. These include: re-
laxin; nitric oxide (NO); and the female hormone progesterone, which blocks estrogen receptors, inhibits 
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cervical softening, and may also block oxytocin (OT) effects by inhibiting OT receptor (OTR) functions,74 
among other “progestation” actions.66, 71 Prostaglandins (PGs) can also have quiescent effects in preg-
nancy, through acting on different PG receptors,75 as described below.
2.1.2 Activation Phase 
In the last weeks of term pregnancy, the maturing fetal adrenal glands produce both cortisol, which ma-
tures the fetal lungs and other organs, and a chemical precursor for estrogen, which is then produced in 
the placenta and activates the uterus. This ensures coordination of fetal and maternal readiness. Estrogen, 
inflammation, prostaglandins, and corticotropin releasing hormone all contribute to uterine activation, 
including oxytocin receptor upregulation. Prelabor physiologic preparations, as seen in animals, also in-
clude increases in: oxytocin receptors in the maternal brain and mammary glands, endogenous analgesic 
systems, fetal neuroprotective processes, and maternal and fetal prolactin systems. These contribute to 
maternal adaptations, labor analgesia, maternal and newborn transitions, and breastfeeding success. 
The activation phase begins many weeks before term labor actually starts, and lasts until the physiologic 
onset of labor. This phase is concerned with maternal readiness for an effective, efficient labor. Many of 
the maternal processes of activation, and of the subsequent stimulation phase, are initiated by rising lev-
els of the activating hormone estrogen, which has opposite effects of progesterone. Fetal preparations 
that promote maturity and readiness for labor, birth, and life outside the womb—obviously essential for 
fetal survival—occur in parallel, thus coordinating maternal readiness and fetal maturity. 
Maternal estrogen levels rise because the baby’s maturing adrenal gland produces increasing amounts 
of the estrogen precursor dehydroepiandrosterone-sulfate (DHEAS) in the four to six weeks before birth. 
DHEAS is converted to estrogen in the placenta and then enters the mother’s circulation.71 Changes in the 
ratios of estrogen to progesterone, of the estrogen subtypes estriol and estrone, and/or of progesterone 
receptors A and B may all be involved in uterine activation, and possibly in the physiologic onset of labor.76 
Over the final weeks preceding physiologic onset of labor at term, estrogen begins to prepare the moth-
er’s body for labor through: 
  increasing the number (upregulation) of OTRs
  electrically connecting her uterine muscle cells for coordinated contractions in labor via the 
substance connexin-43
  promoting cervical ripening 
  shifting the balance of prostaglandin (PG) receptors towards those that stimulate contractions75 
(below)
  increasing other uterine activating substances and processes76 
  activating spinal cord pain-relieving pathways (involving non-beta-endorphin opiates) in prepara-
tion for labor and birth77
As well as DHEAS, the fetal adrenal also produces increasing amounts of cortisol at this time, which acts 
to mature all of the baby’s organs, especially the lungs. In the days preceding the physiologic onset of 
term labor, the fluid that has filled the developing lungs begins to reduce in amount, and the physiologic 
mechanisms that will fully clear this fluid before birth begin to mature.78, 79 
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Other important fetal prelabor physiologic preparations, largely mediated by cortisol, include: upregula-
tion of epinephrine-norepinephrine (E-NE) receptors in the lung and heart, which support fetal adapta-
tions to labor hypoxia via the “catecholamine [CA] surge” (5.1.4); thyroid maturation, which assists with 
early newborn heat production and lung clearance; increases in lung surfactant to promote newborn 
respiratory transition; and gut and metabolic preparations to ensure sufficient fuels for the postnatal 
period78 5.1.3). Fetal brain development is also completed in the final weeks of gestation, with likely im-
portant contributions to maturation of brain-hormone systems (2.2).
In this way, readiness of the baby (maturing adrenal, maturing effects from cortisol, E-NE receptor up-
regulation, completion of brain development) is coordinated with preparation of the mother’s body for 
labor, via increasing estrogen and other activating effects. Increasing levels of maternal cortisol may also 
contribute to uterine activation by blocking the quiescent effects of progesterone.73
Prostaglandins, mentioned above, have an important role in maternal preparations for labor and birth. 
Prostaglandin F2alpha and E2, synthetic versions of which are used medically to “ripen” the pregnant wom-
an’s cervix, promote cervical changes in the lead-up to labor, including increases in water and elastin, and 
decreases in collagen. These lead to increased cervical softening and elasticity in preparation for opening 
during labor.71 Cervical changes occur progressively over several weeks, triggered by rising PGs, estrogen, 
and other factors such as inflammation, described below, which also contributes to uterine activation.
As labor draws closer, PG receptors increase differentially in the uterus. As some of these stimulate, and 
some relax the uterus, this may contribute to a shift from uterine relaxation to activation, especially in 
the top of the uterus (fundus). Increased PG production and reduced PG breakdown may also contribute.75 
Prostaglandins are also made in the amnion layer of the fetal membranes, with large amounts detectable 
in the amniotic fluid as labor draws closer. From the amnion, PGs can act on the cervix, as above, and 
also reach the uterine lining (decidua) and deeper myometrium, where they stimulate contractions and 
may also promote OT release.75 Prostaglandin effects are also increased through local positive feedback 
cycles with cortisol80 and oxytocin (3.1.3).
Inflammation is usually associated with tissue damage or infection, and involves an increase in white 
blood cells and inflammatory substances, including PGs, arachadonic acid, a PG precursor, and interleu-
kin-1 beta. Inflammatory changes in the amnion, cervix, and uterus develop over the weeks before the 
physiologic onset of labor, and may even precede changes in progesterone, estrogen, and OT, making in-
flammation a possible early trigger for term labor, as it is for preterm labor.81 Inflammation in the amni-
on weakens the membranes in preparation for membrane rupture, which further accelerates inflamma-
tory changes in labor by allowing vaginal bacteria to access the uterus.82, 83 Under physiologic conditions, 
membrane rupture predominantly occurs after full dilation.84 In addition, the inflammatory substance 
interleukin-1beta promotes OTR formation in the amnion, which promotes the formation of PGs that will 
stimulate the myometrium, as above.82, 83 85
Under the influence of factors including estrogen, PGs, and inflammation, OTRs are upregulated in the 
uterus close to the physiologic onset of term labor, giving peak sensitivity and labor efficiency, as detailed 
below (2.1.3). Animal studies also show OTR upregulation in the expectant mother’s mammary glands86, 87 
and brain88 in the days preceding the onset of labor at term, giving important preparations for lactation, 
maternal adaptations, and postpartum behaviors, all essential for offspring survival (2.1.2).
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Rises in corticotropin releasing hormone (CRH) activity have also been implicated in uterine activation, and 
possibly the physiologic onset of labor (5.1.2, 5.1.3). This brain-based stress hormone has a different role 
in pregnancy, when it is made by the placenta and contributes to fetal adrenal maturation and subsequent 
cortisol/estrogen increases (above). The rate of rise of maternal CRH in early to midpregnancy may indi-
cate the length of gestation, earning CRH the name “placental clock.”82, 83 
CRH also enhances the laboring mother’s uterine response to OT and PGs,89, 90 promotes the formation 
of activating PGs76 and other inflammatory substances,91 and participates in several activating positive 
feedback cycles involving fetal cortisol, and maternal cortisol and prostaglandins.76
Animal studies have contributed to understandings of important events in the lead-up to labor.77, 92-96 
For the fetus, neuroprotective mechanisms involving the OT system are activated in the 24 hours before 
the physiologic onset of term labor, and give maximal protection in late labor97 (3.1.3). Mechanisms in-
volving E-NE and beta-endorphins (BEs) also protect the fetal brain in labor, as described below. For the 
mother, brain-based (central) activity of beta-endorphins (levels, receptors) rises in late pregnancy and 
peaks at the physiologic onset of term labor,92-94, 96 when other endogenous opioid analgesic systems are 
also upregulated.77 Prelabor increases in central connections between OT and BEs make BEs powerful at 
restraining OT release before labor.95
Animal studies also show extensive central prelabor preparations for postpartum maternal behaviors, 
including in the OT system.98, 99 Some of the changes that are essential for postpartum maternal behav-
iors occur only in the few hours before the physiologic onset of term labor, and are completed by the 
processes of labor and birth.100, 101 (See also “Maternal Oxytocin in Pregnancy” in 3.1.2 and “Maternal 
Prolactin in Pregnancy” in 6.1.2.)
In women, prolactin (PRL) levels increase as pregnancy progresses, doubling between 35 and 38 weeks, 
according to one study.102 These elevations are likely to stimulate upregulation in mammary prolactin re-
ceptors (PRLRs), as demonstrated in animals late in pregnancy.103-105 For the human fetus, late-gestation 
PRL elevations may assist with lung maturation and begin to prepare for newborn heat production106 (6.1.2).
Because all of these changes happen in parallel, cervical changes may approximate uterine changes, 
including OTR numbers, and temporal proximity to term labor, therefore suggesting responsiveness to 
induction (3.2.3). Researchers who assessed daily pregnant women’s cervical status (Bishop score) and 
uterine responsiveness to synthetic oxytocin (by cardiotocogram, CTG) in the lead-up to the physiologic 
onset of labor at term, found parallel increases, with both peaking with the last measurement before 
physiologic labor onset107 (see 3.1.4). In addition, the coordination of maternal readiness and fetal matu-
rity suggests that maternal cervical status may also indicate fetal maturity (see also 3.2.6).
2.1.3 Stimulation Phase
Peak maternal sensitivity to oxytocin and prostaglandins occurs at the physiologic onset of labor at term, 
and both substantially contribute to labor processes, including via positive feedback cycles. Hormonal 
interorchestrations involving prolactin and endorphins augment labor and postpartum hormonally-medi-
ated processes, including breastfeeding and maternal adaptations. Fetal in-labor processes, upregulated 
before labor onset, protect against hypoxia and also assist with newborn transitions.
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The physiologic onset of term labor involves a shift from the irregular, low-frequency uterine activity of 
pregnancy (contractures) to the high-frequency, high-intensity uterine contractions of labor. Processes 
within the fetus and placenta are thought to initiate this shift,71 which usually begins at night, with noc-
turnal surges in OT triggering contractions.72, 108 The sleep hormone melatonin increases uterine sensi-
tivity to OT,109 making labor more likely to begin at night in humans and other day-living species. Lower 
nocturnal levels of E-NE, which generally inhibit labor, may also contribute.110
With the physiologic onset of labor at term, levels of the substance connexin-43 increase in the uterus, 
contributing to the formation of gap junctions that electrically connect uterine muscle cells for the coor-
dinated contractions of labor.71 
The physiologic onset of term labor is also the time of maximum sensitivity to the uterine stimulants 
OT and PGs, with receptor activity for both OT111 and PGs75 peaking at this time. Prostaglandins pro-
mote contractions in many ways, including by directly stimulating the myometrium and increasing gap 
junctions, and may promote further PG production in a positive feedback cycle.112 Prostaglandins also 
promote uterine sensitivity to oxytocin in vitro,113 and in vivo,114 possibly by promoting the formation of 
OTRs.112, 115 By causing contractions, PGs also stimulate central OT release in a positive feedback cycle 
(3.1.3). Prostaglandins also participate in local positive feedback cycles with cortisol.80
Oxytocin reaches the laboring woman’s uterus from her pituitary and limbic system and is also made lo-
cally in the placenta, decidua, and fetal tissues. Within these local tissues, OT-OTR binding stimulates the 
production of PGs, and PGs stimulate OT activity directly and/or indirectly, as above, creating a positive 
feedback cycle that accelerates labor (3.1.3). Oxytocin produced in the amnion crosses to the adjacent 
decidua and stimulates contractions in the deeper myometrium.116 (See 3.1.3 for more about OT in labor.)
As term approaches, endogenous opioids such as beta-endorphins, which have been acting to restrain 
OT release within the maternal brain, begin to decline,117, 118 according to animal studies, further promot-
ing OT’s stimulating effects (4.1.2). The substance surfactant-related protein A (SP-A), made in the fetal 
lungs, may also contribute to the onset of labor. This is secreted into the amniotic fluid, and may be 
transmitted through the fetal membranes and into the adjacent uterine lining (endometrium) and deep-
er myometrium, triggering uterine contractions.83 Increased maternal levels of fetal (“cell free”) DNA 
may also have stimulating effects close to labor onset.119
Increased connections within the brain between the OT, BEs, and PRL systems in the lead up to term labor 
contribute to a hormonal cascade that promotes physiologic labor, birth, and postpartum adaptations:
  OT promotes release of BEs in labor,120 assisting with stress and pain.
  Both BEs121 (2.1.3) and pulsatile OT in labor promote PRL release, preparing for breastfeeding.122, 123
  PRL promotes OT release, also important in breastfeeding124 (3.1.1).
  PRL promotes BEs, giving pleasure and reward after birth and with breastfeeding.125
According to animal studies, PRL receptors are further upregulated during term labor,126 preparing 
for effective lactation, central maternal adaptations, and the maternal behaviors that optimize infant 
survival (6.1.3). 
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For the baby, prelabor and in-labor physiologic preparations and processes confer substantial benefits in 
labor, with a large investment in neuroprotection, as discussed above. In summary, these include: 
  neuroprotective systems involving the OT system, which are activated just prior to the physiologic 
onset of term labor (animal studies, 2.1.2, 3.1.3)
  upregulation in E-NE receptors, which optimize efficacy of the fetal CA surge (below) (5.1.2)
  the late-labor CA surge, which preserves blood and glucose supply to the fetal heart and brain, 
giving additional neuroprotective effects, and begins preparations for respiratory, metabolic, and 
thermoregulatory transitions78, 127 (5.1.3)
  further neuroprotective effects from BEs released with labor stress and hypoxia128, 129 (animal 
studies, 4.1.3)
These overlapping mechanisms for the initiation of labor at term, and the many prelabor hormonal or-
chestrations and interorchestartions that promote optimal transitions for mother and baby, underline 
the complexity of perinatal hormonal physiology. The critical importance for species survival of the pre-
cise alignment of readiness between mother and baby at the physiologic onset of term labor suggests 
that multiple systems and processes likely converge, with built-in redundancy and backup systems.66, 71 
(Further details of the role of each hormone in the onset and progress of labor are found in 3.1.3, 4.1.2, 
5.1.3, and 6.1.3.)
2.2 Possible Impacts of Scheduled Birth
Induction and prelabor cesarean foreshorten these beneficial preparatory processes of mother and baby, 
with greater effects following prelabor cesarean, as the hormonal processes of labor are also absent in 
both. While beneficial in some situations, possible impacts of scheduled birth in relation to hormonal 
disruption include, for induction, reduced contraction efficiency leading to failed induction, instrumental 
birth, and postpartum hemorrhage. Possible hormonal impacts from prelabor cesarean include deficits 
in fetal maturity and adaptations leading to respiratory, thermoregulatory, and metabolic vulnerability. 
Animal studies suggest possible long-term effects. Deficits in maternal prelabor physiologic preparations, 
including lack of upregulation in central and mammary oxytocin and prolactin receptors, as shown in ani-
mals, could hinder breastfeeding, maternal adaptations, and maternal-infant attachment. High quality-
research is lacking in these important areas.
Recent research suggests that fewer than half of US mothers and babies experience the spontaneous, 
physiologic onset of labor, as described above. In response to a national survey of women who had given 
birth from mid-2011 to mid-2012, 30 percent reported medically induced labor, 18 percent reported a 
planned PLCS, and two percent reported a cesarean following an attempted induction that did not bring 
labor on, with yet other women unsure whether attempted induction had caused their labor to begin.18 
In some situations, induction or PLCS is medically indicated, with clear benefits for mother and/or 
baby.130, 131 However, the expected benefits of scheduled birth in many cases may not outweigh the full 
range of potential harms, including incomplete prelabor physiologic preparations, with potential com-
promise to in-labor and/or postpartum outcomes in mothers and babies. From the perspective of hor-
monal physiology, “elective induction” and “elective cesarean,” with no medical indication or benefit, 
are particularly concerning as there are no benefits to balance the hormonal impacts and other possible 
adverse effects, both known and plausible yet inadequately researched, in mother and baby. 
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Current methods of calculating the estimated date of delivery (EDD) can have wide margins,132 especially 
later in pregnancy.133, 134 Women have a particularly large variation in the normal duration of pregnancy, 
even compared with other primate species.69 One recent study using accurate timing of ovulation found 
a variation in normal gestation of up to five weeks (37 to 42 weeks).69 These factors increase the pos-
sibility that scheduled birth will occur before, and perhaps well before, maternal and fetal readiness is 
aligned, with increased likelihood of maternal and newborn morbidities.
Recent moves to avoid early elective delivery by limiting induction and PLCS to 39 weeks or beyond135 will 
increase average fetal maturity and are consistent with improved outcomes. However, dates may not be 
accurate (discussed above) and this may still be days, or even weeks before the time when the physiologic 
onset of labor would otherwise have occurred in some women and babies. Mother and baby may still 
miss important prelabor physiologic preparations, some of which only occur in the hours before physi-
ologic labor onset according to animal research,97, 100, 101 also discussed above.
The body of clinical studies of the impact of induction on mothers and/or babies is complex and includes 
contradictory results. Its assessment is beyond the scope of this report. However, the physiologic pro-
cesses described here suggest that the foreshortening of gestation may have a wider range of adverse 
impacts than generally recognized, including impacts on hormonally-mediated outcomes such as breast-
feeding and maternal adaptations. The use of synthetic oxytocin (synOT) as an induction agent may have 
additional impacts on mothers and/or babies (3.2.3, 4.2.3, 5.3.3, 6.2.3), and the possible effects of pros-
taglandins on hormonal physiology are not well studied (3.2.2, 4.2.2, 5.2.2, 6.2.2). 
Babies born by PLCS miss not only the prelabor physiologic preparations described above, but also the 
beneficial stress (eustress) of labor. As discussed in detail in “Fetal Epinephrine-Norepinephrine and Re-
lated Stress Hormones in Labor and Birth” in 5.1.3, and in “Cesarean and the Fetus/Newborn” in 5.2.6, 
labor eustress activates E-NE and many other hormonal and non-hormonal processes that promote op-
timal newborn transitions. Alterations in stress responses have been found among newborns136, 137 and 
infants26 born by PLCS compared with vaginal birth. Long-term effects on offspring stress and hormonal 
systems are biologically plausible,20 as suggested in animal studies of cesarean offspring 27-31, 138-141 (fur-
ther described in “Cesarean and the Fetus/Newborn” in 5.2.6).
Mothers experiencing PLCS may miss in-labor processes that promote breastfeeding and maternal adap-
tations, including increases in OT and PRL receptors, as seen in animal studies (3.1.4, 4.1.4, 5.1.4, 6.1.4, 
with implications discussed in detail in 3.2.6). Deficits in prelabor uterine OTR upregulation may increase 
risks of postpartum hemorrhage (PPH) following PLCS. (See also Table 3. Established and plausible oxyto-
cin processes and impacts, by type of cesarean, and discussion in 3.2.6).
Table 1 summarizes possible adverse impacts of induction and prelabor cesarean on the hormonal physi-
ology of mother and baby, according to physiologic understandings and human and animal studies, as 
detailed in this chapter and report.
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Table 1.  Established and biologically plausible adverse impacts of labor induction and 
prelabor cesarean
Deficits that may arise with foreshortened 
pregnancy/gestation Possible impacts on mother and/or baby
Deficits in prelabor OTR upregulation in uterus
Deficits in other uterine activating factors such as 
PGs, CRH, inflammation (2.1)
Reduced uterine OT sensitivity and contraction 
efficiency leading to:
• slow labor (IOL)
• failed induction (IOL)
•  delay in pushing stage, increase in forceps/vacuum 
(IOL)
• increased PPH risk (IOL, PLCS)
•  need for synOT at supra-physiologic levels (IOL for 
labor progress, IOL, CS to reduce PPH risk)
(see also 3.2.3)
Deficits in prelabor OTR upregulation in mammary 
gland*
Reduced breastfeeding success (IOL, PLCS) 
(see also “Synthetic Oxytocin and Breastfeeding” in 
3.2.3 and “Cesarean and Breastfeeding” in 3.2.6)
Deficits in prelabor OTR upregulation in the mater-
nal brain*
Reduced maternal adaptations (IOL, PLCS), including 
reduced:
•  personality adaptations, potentially increasing 
anxiety and tension (see “Maternal adaptations” 
in 3.1.4) 
•  reward center activation, potentially impacting 
maternal mood, and pleasure from her baby
•  maternal-newborn attachment (see “Maternal-
infant attachment and childbearing” in 3.1.4 ) 
(see also “Synthetic Oxytocin and Maternal 
Adaptations” in 3.2.3 and “Cesarean and Maternal 
Adaptations and Attachment” in 3.2.6)
Deficits in prelabor activation of fetal OT neuropro-
tection*
Increased neurologic vulnerability in labor (IOL); 
these deficits have been linked with animal models 
of autism
(see “Fetal neuroprotection” in 3.1.3)
Deficits in prelabor activation of BEs and other opi-
oid analgesic systems in maternal brain and spinal 
cord*
Increased pain, requirement for analgesia (IOL)
(see also 4.1.2)
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cont’d
Deficits that may arise with foreshortened 
pregnancy/gestation Possible impacts on mother and/or baby
Deficits in fetal prelabor E-NE upregulation and in-
labor CA surge that support:
•  protection against hypoxia by preserving blood 
flow to heart, brain
•  respiratory preparations
•  metabolic transitions
•  thermoregulatory transitions
Increased risks during labor and with newborn 
transitions, including (IOL and especially PLCS):
•  vulnerability to hypoxic effects, especially heart 
and brain
•  respiratory morbidity 
•  hypoglycemia 
•  hypothermia
(see “Fetal catecholamine surge” in 5.1.3)
Animal studies show long-term disruption to brain-
hormone systems following PLCS (see “Cesarean and 
the Fetus/Newborn” in 5.2.6)
Deficits in other late-term respiratory preparations, 
e.g., PRL-related (6.1.2)
Detrimental impacts on respiratory transition (IOL, 
and especially PLCS)
Deficits in maternal prelabor PRL preparations, 
including PRLR upregulation in mammary gland* 
(6.1.2)
Reduced breastfeeding success (IOL, PLCS) 
(see also “Synthetic Oxytocin and Breastfeeding” in 
3.2.3 and “Cesarean and Breastfeeding” in 3.2.6)
Note: BE = beta-endorphins, CA = catecholamine, CRH = corticotrophin releasing hormone, CS = cesarean 
section, E-NE = epinephrine-norepinephrine, IOL = induction of labor, OTR = oxytocin receptor, PGs = 
prostaglandins, PLCS = prelabor cesarean section, PPH = postpartum hemorrhage, PRL = prolactin, PRLR 
= prolactin receptor, synOT = synthetic oxytocin. 
*Results have only been reported in animal studies to date
In addition to these concerns, studies suggest many extra-hormonal implications of induction and/or 
PLCS that may have long-term impacts. These include foreshortening of the final critical weeks of brain 
development,142-146 and long-term cesarean impacts on gut flora147 and immune function,148 which are 
beyond the scope of this report. (See also 3.2.3 and 5.2.6 for discussion of possible programming effects 
of exposure to synOT and PLCS.)131
The salutogenic aspects of prelabor hormonal physiology and the physiologic onset of labor at term, as  
described in this chapter, along with the current paucity of evidence about possible consequential 
longer-term impacts of scheduled birth in mothers and babies, raise serious concerns about the current 
high rates of labor induction and PLCS, particularly in healthy women with healthy babies. Also concern-
ing are recent suggestions that routine labor induction could be implemented to improve outcomes for 
healthy mothers and babies, including to reduce the chance of cesarean section,149-152 for which there are 
many evidence-based practices with fewer known and plausible adverse effects.131, 153 Clear understand-
ings about the possible impacts of scheduled birth on women and babies, including established and 
plausible hormonal deficits as summarized in Table 1, are essential before routine elective induction of 
labor or prelabor cesarean could be safely advocated.
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As described in detail in this report, the innate hormonal physiology of mother and baby incorporates 
many processes that support and protect mother and baby through the major transitions of labor and 
birth. The hormonal physiology of childbearing also promotes ongoing survival and well-being of mother 
and baby by optimizing breastfeeding and the maternal adaptations that enhance maternal reward and 
maternal-infant attachment. Other possible positive, but as yet unstudied, effects—for example, benefi-
cial fetal programming from exposure to physiologic hormonal processes—could give additional long-
term benefits to offspring. 
Scheduled birth is beneficial for mothers and babies in some circumstances. However, from the perspec-
tive of hormonal physiology, the established and plausible consequences of induction and PLCS, as 
discussed in this and the following chapters, raise further concerns for maternity care providers and 
women to include in assessing benefit/harm trade-offs. 
The full impacts of scheduled birth on mother and baby, including possible impacts on hormonally-
mediated processes including breastfeeding, maternal adaptations, and maternal-infant attachment, are 
critical areas for future research.
2.3 Physiologic Onset of Labor and Scheduled Birth: Summary
2.3.1 Physiologic Onset of Labor
The physiologic (spontaneous) onset of term labor is a complex and incompletely understood process. 
Critical for survival, its timing is thought to be essentially determined by the baby’s maturity, via fetal 
cortisol production, coordinated with the mother’s readiness for parturition, via estrogen production 
and other processes. Timing of the physiologic onset of term labor is difficult to predict due to normal 
variation in the length of human gestation.
With the physiologic onset of labor at term, maternal and fetal systems are fully primed and precisely 
aligned for safe, effective, labor and birth, and for optimal postpartum physiologic transitions, including 
breastfeeding initiation and maternal-newborn attachment, according to physiologic understandings, 
and human and animal studies. Physiologic prelabor preparations occur in the weeks, days, and (in 
animal studies) hours before the onset of labor. Maternal preparations include: 
  rising estrogen levels, activating the uterus for an efficient labor
  cervical ripening due to increases in oxytocin and prostaglandin activity (receptors, levels)
  increasing inflammation, which also activates the cervix and uterus
  increasing uterine oxytocin receptors, giving effective contractions during labor, and after birth 
to reduce bleeding 
  increasing brain-based (central) receptors for beta-endorphins (animal studies), contributing to 
endogenous analgesia in labor
  elevations in mammary and central oxytocin and prolactin receptors (animal studies), which 
promote breastfeeding and maternal-infant attachment after birth
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Similarly, processes before and during labor foster the baby’s adaptations for labor and peak readiness 
for the critical transition to life outside the womb. These include:
  prelabor maturing of the lungs and other organ systems, and of the processes that clear lung fluid 
in labor
  prelabor development of oxytocin neuroprotective processes (animal studies)
  prelabor increase in epinephrine-norepinephrine receptors, giving protection from labor hypoxia 
via the late-labor epinephrine-norepinephrine (catecholamine) surge
  in-labor preservation of blood supply to heart and brain, via the catecholamine surge, with 
neuroprotective effects
  in-labor catecholamine-mediated preparations that will promote newborn breathing, energy and 
glucose production, and heat regulation
2.3.2 Possible Impacts of Scheduled Birth
Scheduled birth—whether by labor induction or prelabor cesarean section—benefits mother and/or 
baby in selected circumstances. However, it may also significantly disrupt the processes discussed above. 
Possible maternal impacts of scheduled birth include: 
  reduced contraction efficiency leading to risks of failed induction, instrumental birth (induction), 
and postpartum hemorrhage (induction, prelabor cesarean)
  reduction in prelabor oxytocin and prolactin receptor peaks in the breasts and brain (animal 
studies) with potential impacts on breastfeeding, maternal adaptations, and maternal-infant 
attachment (induction, prelabor cesarean)
Possible impacts of scheduled birth on the baby include: 
  immature protective processes, including the catecholamine surge, with increased vulnerability 
to labor hypoxia and “fetal distress” (induction)
  increased risks of postpartum breathing difficulties, hypoglycemia, and hypothermia due to lack 
of exposure to catecholamine surge (prelabor cesarean)
  reduced maturity of brain, brain-hormone, and other organ systems (induction, prelabor cesarean)
  long-term offspring impacts (animal studies), likely via epigenetic programming effects (cesarean 
section, plausibly relevant to induction)
These are crucial knowledge gaps given the high incidence of scheduled birth.




This chapter details oxytocin research as relevant to reproduction, presenting firstly what is 
known about the oxytocin system in relation to healthy, physiologic, childbearing processes 
and then the possible impacts of specific maternity care practices and interventions, including 
administration of synthetic oxytocin, on the oxytocin systems of mothers and babies.
3.1 Oxytocin: Normal Physiology 
Oxytocin has been called the “hormone of love,” as well as “hormone of trust” and “hormone of calm and 
connection.” Current areas of oxytocin research include brain-based and psychological effects in humans, 
and behavioral and programming effects in animals, including in relation to early oxytocin manipulations.
Oxytocin (OT) has been the focus of a large amount of research over recent decades, with particular inter-
est in its brain-based (central) and psychologic effects. These have earned it names such as the “hormone 
of love,”154 “hormone of calm and connection,”52 and “hormone of trust,”155 with a growing interest in its 
role in human parenting.156 In parallel with these developments, animal research has been uncovering 
other important aspects of the OT system, including studies suggesting that the perinatal oxytocin sys-
tem is very modifiable (plastic) in mother and offspring, with possible epigenetic programming effects in 
offspring in relation to both endogenous OT (produced within the body) and exogenous or synthetic OT 
(synOT, administered from outside the body) (see “Oxytocin effects,” below, 3.1.3, and 3.2.3).
3.1.1 Oxytocin: Introduction 
Oxytocin is a hormone that is released into both the body, with physical effects, and the brain, with pow-
erful and widespread physiologic, psycho-emotional, and behavioral effects that benefit reproduction and 
social behaviors. Synthetic oxytocin is chemically identical to endogenous oxytocin, but has different ef-
fects because it is not released from and within the brain.
Oxytocin was discovered in 1906 as a pituitary extract that causes a fast (oxy) birth (tocin).157 The OT 
molecule comprises a chain of nine amino acids and acts in the body of humans and all other mammals 
as a hormone, that is, a substance that is produced in one part of the brain or body and has effects on 
distant areas through passage in the bloodstream. 
In the brain, OT is produced in the supraoptic and paraventricular nuclei (SON, PVN) within the hypo-
thalamus. From there, within the middle layer of the brain (limbic system), OT is released into local and 
distant brain areas, giving widespread brain-based (central) effects, and also into the bloodstream via 
the posterior pituitary gland, giving bodily (systemic) effects. In the brain, OT acts by transmitting signals 
between nerve cells (neurotransmitter), and by affecting the function of other hormone and brain sys-
tems (neuromodulator),158, 159 with important roles in interorchestrating hormone systems in childbear-
ing. The OT system is also very modifiable in response to physiologic and environmental stimuli.160 These 
properties make OT a powerful regulator of biologic processes, especially in relation to reproduction and 
social behaviors, both of which make major contributions to mammalian survival.
The chemically similar hormone arginine vasopressin (AVP, vasopressin, previously known as antidiuretic 
hormone, ADH) is also released from the posterior pituitary and has some OT-like effects, and vice versa, 
from stimulation of each other’s receptors.158 Arginine vasopressin may be critically involved in fetal adap-
tations to labor pain,161 and in postpartum maternal protective behaviors, according to animal studies.160 
Synthetic oxytocin (Pitocin, Syntocinon) is chemically identical to the naturally released, endogenous OT 
molecule, and binds to the same receptor (see “Oxytocin Regulation and Receptors,” below) but has dif-
ferent effects, largely because it is usually administered into the body, rather than being released from 
and within the brain (see “Oxytocin Effects” below). In this report, “oxytocin” refers to naturally-released, 
endogenous oxytocin, and “synthetic oxytocin” refers to synthetic, exogenously-administered oxytocin. 
(See 3.2.3 for a detailed discussion of the possible impacts of synOT on mothers and offspring.)
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Oxytocin Effects
Coordination of brain and body oxytocin release may be critical in coordinating the physical processes of 
labor, birth, and breastfeeding with the brain-based maternal adaptations that foster maternal-infant 
attachment and infant survival. Synthetic oxytocin does not generally have central, brain-based effects in 
adults when injected into the body. However, maternal endogenous oxytocin released during labor (and 
also synthetic oxytocin) may access the fetal brain via the placenta and more permeable fetal blood-brain 
barrier, according to animal studies.
Systemic oxytocin, released into the body from the pituitary gland, causes the smooth (involuntary) 
muscle contractions that characterize: male and female orgasm, the rhythmic contractions of labor, and 
the let-down (milk ejection) reflex in lactation, among other effects. Oxytocin is usually released within 
the brain in parallel with systemic release and acts centrally to ensure that biological instincts and be-
haviors are coordinated with reproductive events. For example, during labor and birth, OT is released 
systemically from the mother’s pituitary, causing the uterine contractions of labor, and at the same time 
is released centrally into her limbic system, where it activates maternal circuits that foster the rapid and 
beneficial responses to her offspring after birth that promote infant survival. 
Central OT levels, as measured in the cerebrospinal fluid (CSF, which circulates around the brain) are 
generally five to ten times higher than levels measured in the bloodstream.159 Oxytocin release from the 
pituitary is constant in most situations, but pulsatile in parturition and lactation.162 Pulsatile release may 
have different effects—for example, stimulating prolactin release (6.1.3)—and may also be important in 
maintaining tissue sensitivity. (See “Synthetic oxytocin and oxytocin receptor desensitization” in 3.2.3.)
Like other peptide molecules (made of amino acids), OT has minimal passage through the adult blood-
brain barrier, a structure that protects the brain by filtering out most substances from entering via the 
bloodstream. 163 Researchers have suggested that one to two percent of synOT administered systemi-
cally may cross the blood-brain barrier, so that, with five- to ten-fold higher central levels, systemic ad-
ministration needs to be around 1,000 times higher than doses administered directly into the brain for 
equivalent central effects.159, 164 In one rat study, just 0.002 percent of synOT injected subcutaneously 
was measured in the brain, peaking 10 minutes after systemic administration.163 These findings imply 
that, while systemically-administered synOT can have effects on the body, it does not cross into the 
adult brain in biologically significant amounts and so its central effects are regarded as minimal in most 
circumstances.158 (See “Psychological and therapeutic roles of oxytocin,” below, for intranasal OT effects, 
and 3.2.3 for full discussion of implications of synOT exposure in labor and birth.)
However, the fetal blood-brain barrier is more permeable. Animal studies have found that, during labor, 
OT at physiologic levels transfers from the mother to the fetal brain, with beneficial neuroprotective ef-
fects. (See “Fetal neuroprotection” and “Fetal Oxytocin in Labor and Birth” in 3.1.3, and “Synthetic Oxy-
tocin and the Baby” in 3.2.3 for implications of fetal synOT exposure.) 
As well as being released from and within the brain, OT is also made in local tissues, including the preg-
nant woman’s uterus and uterine lining (decidua) and the baby’s amniotic sac and membranes. Local OT 
production may also be important in the processes of labor and birth (3.1.3). 
Oxytocin, whether endogenous or synthetic, has a short half-life (time taken to reduce levels by 50 per-
cent) of between 3 and 20 minutes in the bloodstream and around 28 minutes in the brain.165, 166 However, 
OT can have profound and long-lasting effects because, as a neuromodulator, it initiates, reorganizes, and 
interorchestrates other hormone systems and physiologic systems167 Oxytocin’s effects can therefore per-
sist, even lifelong in some circumstances, according to animal studies. This is particularly relevant during 
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the perinatal period, when offspring hormonal experiences can cause epigenetic changes, with program-
ming effects through to adulthood and even to subsequent generations.35, 41, 168, 169 (See “Synthetic Oxyto-
cin and Offspring, Longer Term” in 3.2.3.)
Physiologic roles of oxytocin. Oxytocin has a large and growing number of recognized effects on 
the brain and body. Oxytocin especially benefits reproduction and sociality, including by reducing fear 
and stress responses involving the sympathetic nervous system, and increasing relaxation and receptiv-
ity via the parasympathetic nervous system. These effects generally require elevations in central (brain-
based) oxytocin.
Currently recognized oxytocin effects include:
  Sexual behavior and pair bonding: OT is released during sexual activity, when it increases re-
ceptivity and initiates pair bonding among monogamous animals.170 In humans, OT levels increase 
during sexual arousal and peak at orgasm, causing the rhythmic contractions of sperm ejection in 
men, and the pelvic floor contractions of female orgasm.171
  Lactation: OT, released in pulses, mediates the milk-ejection (let-down) reflex, which makes milk 
available to the suckling infant. At the same time, pulsatile OT promotes central release of prolac-
tin (PRL), which stimulates breast milk production.53, 172 Animal studies also show involvement of 
OT in milk secretion,173 and OT is present in human breast milk.174
  Maternal adaptations: OT promotes the species-specific maternal adaptations and behaviors 
that begin immediately after birth, and also primes brain circuits that support ongoing maternal 
adaptations and behaviors in animals, with evidence for this in women also (3.1.4).
  Warming: OT opens up peripheral blood vessels (vasodilatation), creating a warming effect. Va-
sodilatation of superficial blood vessels on the new mother’s chest, in response to postnatal OT 
peaks, keeps her newborn in skin-to-skin contact (SSC) warm after birth.175 (3.1.4).
  Social-affiliative behavior: OT is a prosocial hormone, motivating social interactions and in-
creasing sociability in all mammals.176 In human research, both endogenous OT and exogenous 
(intranasal) synOT promote trust, empathy, generosity, eye contact, recognition of familiar faces, 
and discrimination of emotional states.177 Oxytocin is released during social and physical contact, 
including social vocalization178 and massage.179 
  Regulation of the autonomic nervous system (ANS): OT increases activity in the parasympathetic 
nervous system (PNS) branch of the ANS, which slows the heart, reduces blood pressure and 
energy expenditure, and promotes rest, digestion, and affiliation, producing a “calm and connec-
tion” effect.52 (The ANS controls the internal organs and other key involuntary body functions.)
  Social engagement: OT is an effector of the “social nervous system,” a more recent and higher-
order branch of the ANS, according to the Polyvagal Theory.180 This promotes social engagement 
as a first response to stress among mammals, especially humans. 
  Stress reduction: Release of OT during times of excessive stress can restore physiologic balance 
(homeostasis). OT reduces activity in the flight-or-flight, or sympathetic nervous system (SNS) 
branch of the ANS, reducing levels of the stress hormones epinephrine (E, adrenaline) and norepi-
nephrine (NE, noradrenaline). As well, OT reduces activity in the hypothalamic-pituitary-adrenal 
pathway (HPA system), reducing medium-term stress response hormones, including corticotropin 
releasing hormone (CRH), adrenocorticotropic hormone (ACTH), beta-endorphins (BEs), and corti-
sol (5.1.1). These stress-reducing effects also benefit women during labor, birth, and the postpar-
tum period, and with breastfeeding.52  cont’d
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  Fear and anxiety reduction: OT reduces activity in the amygdala, the brain’s fear center,181 which 
reduces anxiety and promotes social behaviors and interactions.53 Reduced anxiety may persist 
long term after repeated exposure to OT, such as during lactation in mother and baby53 (3.1.4).
  Tend and befriend: Moderate levels of stress may provoke an OT-mediated “tend and befriend” 
response, which promotes gathering together for mutual support.182-184 Through evolution, a 
tend-and-befriend response to danger by caretaking women may have been more beneficial to 
offspring survival than an individual-oriented fight-or-flight response.
  Pain reduction: OT has natural pain-relieving properties, which may help both mother and baby 
during labor,53, 185 and may also involve AVP161 (3.1.3).
  Changes in memory and attention: OT reduces the memory of aversive experience186 and may 
also reduce attention to environmental distractions,186 benefitting laboring and nursing mothers.
  Pleasure and reward: OT released within the brain activates dopamine-associated brain reward 
pathways, giving pleasure and reinforcing reproductive and survival behaviors, including sexual be-
havior and mating, attachment between infant and mother, and adult social interactions.156, 187-189
  Olfaction: In other animals, the OT system is closely related to olfactory (smell) centers in the 
brain. These primitive connections may also exist for humans, contributing to brain-based re-
sponses to odors and also to pheromonal effects (below, in this section).52
  Healing and growth: In animal studies, OT alleviates cell damage in areas including the skin, stom-
ach, liver, bowel, heart, and brain by reducing oxidation and oxidative damage,190 and has benefi-
cial anti-inflammatory effects.191-193 OT also facilitates growth in adult brain cells in the memory 
center (hippocampus),194 where dysfunctions have been implicated in anxiety and depression.195 
  Regulation of other body systems: OT is involved with many other physiologic functions, includ-
ing: kidney function and water balance; food intake, digestion, and satiety; insulin release; tem-
perature control; regulation of bone density; prostate function; and pain tolerance, among other 
known functions.196
Many of these effects—including pain relief, stress and fear reduction, and maternal adaptations—
depend on central release. Synthetic oxytocin administered systemically, for example during labor, does 
not readily cross into the maternal brain (“Oxytocin effects,” above) and so may not facilitate the calm, 
reward, and pain relief, or the maternal adaptations that benefit maternal-newborn attachment, which 
centrally-released, endogenous oxytocin provides, according to current understandings (see “Synthetic 
Oxytocin and Maternal Adaptations in 5.2.3 for a detailed discussion of these complexities). 
Animal research suggests that oxytocin can act pheromonally, that is, transmitted between individuals 
through the vomeronasal organ in the nose. Studies show that the cagemate of a rat that has had high-
dose synOT injected centrally also experiences OT-type central effects, including pain reduction197 and 
reduced energy loss.198 Similarly, the extreme maternal OT peaks that follow physiologic labor and birth, as 
described below (3.1.4), could transmit calm, connection, and positive mood states to nearby individu-
als. Anecdotally, relatives and caregivers can report euphoria after being present at physiologic birth.199 This 
could plausibly help to connect those present to the newborn, benefitting offspring protection and survival. 
Psychological and therapeutic roles of oxytocin. Oxytocin has an important role in psycho-
logical well-being, according to human research. Conversely, early relational deprivation and trauma has 
been associated with oxytocin dysregulation. Therapeutic intranasal synthetic oxytocin, which has central 
effects, has been trialed or used in many conditions, including anxiety, depression, addiction, posttrau-
matic stress disorder, and autism.
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Human studies show that adults who report anxiety or depression, less closeness to parents, less ten-
dency to express and share emotions, a history of childhood neglect or abuse, severe childhood depriva-
tion or institutionalization, and/or parental loss or separation before age 12, as well as men with a life 
history of aggression and mothers who report poor attachment from their own childhood, have disrup-
tions in OT systems, with shifts in baseline OT levels and/or lack of expected situational rise.156, 166, 196, 200, 
201 This rapidly expanding area of research strongly suggests that early relational deprivation or trauma 
can have a lifelong impact on OT systems, correlated with psychological morbidity.156, 201 
Consistent with OT’s powerful and positive psycho-emotional effects, synOT administered via intranasal 
spray has been suggested or trialed as a treatment for many psychological and psychiatric conditions. 
(Intranasal delivery gives central effects, possibly via a direct route164 and may activate a central OT feed-
forward cycle that elevates levels for many hours.202) Conditions that may respond to synOT include: 
anxiety, depression, drug and alcohol addiction, eating disorders, obesity, obsessive-compulsive disorder, 
posttraumatic stress disorder, schizophrenia, and autism 203-206 (see “Synthetic oxytocin and offspring, hu-
man studies” in 5.2.3 for more about synthetic oxytocin and autism). In healthy subjects, intranasal synOT 
can reduce anxiety and increase trust, among other effects,207 although effects may also be complex and 
unpredictable (see “Oxytocin complexities,” below). 
Oxytocin Regulation and Receptors 
Oxytocin regulation. Activity in the oxytocin system (levels, receptors, effects) is impacted and regu-
lated by many other hormones and systems, including estrogen, opioids, and prolactin. Oxytocin can 
increase its own release from the brain by autoregulation, contributing to extreme oxytocin peaks and 
effects at birth.
Important regulatory hormones include estrogen, which increases OT activity throughout the brain and 
body (including leading up to labor), and endogenous opioids such as beta-endorphins and dynorphan, 
which can reduce OT release from the brain, and may help regulate the physiologic onset of labor, ac-
cording to animal studies95, 124 (4.1.1, 4.1.2). Conversely, the pulsatile release of OT in labor and lactation 
stimulates PRL release, with even greater effects as labor and birth approach due to increased connec-
tions between these hormone systems within the brain in the perinatal period.122 (See also 2.1.2.) 
Within the brain, OT can influence its own release (autoregulation). Autoregulatory positive feedback 
mechanisms can lead to the extreme peaks of OT that characterize the physiologic events of labor, birth, 
and lactation.196 Animal studies suggest that the stimulating effect of central OT on its own release de-
velops during pregnancy and peaks during labor.208, 209 Also developing in late pregnancy, and distinctive 
at this time, is the ability of OT cells in the hypothalamus to “burst fire” in a coordinated way, producing 
the large pulses of OT that promote discrete labor contractions. Between pulses, uterine rest allows the 
fetus to replenish blood and oxygen, and this pause in OT exposure also maintains OTR sensitivity (3.1.3). 
The same mechanism during lactation delivers milk in intermittent pulses that the suckling infant can 
comfortably ingest.95
Oxytocin receptors. Oxytocin acts by binding with oxytocin receptors, which vary over time and 
location, and are upregulated before labor due to rising estrogen levels. Multiparous females may have 
greater central oxytocin receptors and autoregulation effects, according to animal studies.
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As with other hormones, OT acts by binding with its receptor (oxytocin receptor, OTR) on the surface 
of the target cell, activating a chemical signaling system within the cell. OT has one specific receptor, 
according to current understanding, and many OT functions are regulated by dynamic changes in OTRs 
in the brain and/or body. These changes may include increases or decreases in receptor numbers (up- 
or downregulation) and/or changes in how easily OT binds with the receptor (binding capacity). These 
changes determine sensitivity to OT in the local area—brain, uterus, etc.48 Substances that can affect 
OTR functions include magnesium and cholesterol, which both increase OT-OTR binding,210 and prosta-
glandins (PGs), which may promote the formation of OTRs in the uterus (2.1.3).
The number and distribution of OTRs change through development, and in some specific situations, espe-
cially in response to sex hormones. This leads to increases or decreases in sensitivity to OT, and to changes 
in OT effects in the affected tissue. For example, OTR numbers rise dramatically in the expectant mother’s 
uterus close to the time of labor due to rising estrogen levels,111 increasing her uterine sensitivity to OT 
and promoting labor efficiency. (See 3.1.3.)
According to animal studies, reproductively experienced (multiparous) females have higher OTRs in the 
brain during labor, and especially in brain areas concerned with OT autoregulation.211 This increases cen-
tral OT positive feedback, substantially augmenting OT release into brain and body and enhancing the 
efficacy of labor, birth, lactation, and postpartum maternal behaviors.212, 213 In women, this is consistent 
with the shorter duration of labor214 and reduced need for intervention215 that is well recognized in mul-
tiparous women (see 3.1.3).
Oxytocin complexities. While oxytocin has generally positive associations and effects, these can vary in 
complex and unpredictable ways according to the social and psychological context, and can even give nega-
tive physiologic or social effects. In addition, levels and effects of endogenous and synthetic oxytocin can be 
complex and difficult to measure and interpret. Epigenetic changes associated with early life programming, 
including changes in oxytocin receptors and oxytocin sensitivity, may contribute to this complexity. 
Human studies show large inter-individual variation in baseline OT levels (for example, from 32 to 2230 
pcg/ml in one study216), and levels also vary with gender, and with psychological and social context.217, 218 
For example, in some human studies, higher OT levels have been correlated with elevated anxiety.219-221 
It is uncertain whether such altered levels reflect the causes or consequences of psychological altera-
tions.158 For example, OT elevation in anxious individuals could reflect compensation for low OT sensitivi-
ty, with reduced central receptor numbers due to early OT disruptions (see “Oxytocin Regulation and Re-
ceptors,” below) and/or stress-induced OT release to restore homeostasis. In addition, elevated basal OT 
levels may have different implications than OT elevations in response to challenges or situations, which 
may more accurately reflect OT system functioning. While stress in general may increase OT release to 
restore homeostasis, as above, stress during labor, birth, and breastfeeding may disrupt pulsatile release 
as a mechanism to ensure that these important reproductive events occur in safe environments. (See 
also 3.2.1 and 5.2.1.)
The effects of synOT can also be unpredictable, possibly because OT can have different effects accord-
ing to site and tissue, route and frequency of administration, dose, time of observation, and other factors, 
including species differences.159 In human studies, effects may also vary with the social context. For example, 
in one study, administration of intranasal synOT was found to worsen, rather than improve, self-reported 
mood in women with postpartum depression.222 In addition, accurate and standardized methods for mea-
suring OT levels in the blood and body remain problematic, especially salivary and urinary measurements,156, 
223, 224 and measurement of OT in the blood may not reflect central levels, in many circumstances.156, 223
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There has been recent interest in genetic and epigenetic variations in human OT systems. Genetic varia-
tions in OTR structure and in the CD38 enzyme, which influences OT secretion, have been linked with 
differences in OT-related functions, including stress responses, adult attachment security, and parenting 
sensitivity,225 although these have been found to account for less than five percent of variance in parent-
ing behaviors, according to one review.226 
Alterations in OT systems due to epigenetic programming effects, are especially likely to occur during 
early sensitive periods, including the perinatal period.227 Epigenetic changes in the OTR have been impli-
cated in autism, callous-unemotional traits, and aspects of social perception.227 Such epigenetic mecha-
nisms may contribute to the inter-generational transmission of parenting patterns in humans.226, 227 In 
animal studies, high levels of early maternal care cause epigenetic changes in the OT and estrogen sys-
tems of exposed female offspring, programming them to give high levels of maternal care to their own 
infants,228 and also positively impacting stress, fear, and attentional processes; brain and cognitive devel-
opment; and female reproductive behavior.229 Animal studies also show offspring epigenetic changes fol-
lowing exposure to perinatal stress.169 (For relevance to childbearing, see 3.1.4, 3.2.3, and 3.2.7.)
3.1.2 Oxytocin in Pregnancy
Preparations for effective labor, birth, breastfeeding, and newborn care, and for maternal and newborn 
transitions, are obviously critical for survival among all mammalian species. The oxytocin system is involved 
in many associated prelabor physiologic preparations in mother and baby, from early pregnancy to the 
onset of labor.
Maternal oxytocin in pregnancy
Oxytocin levels and activity generally rise through pregnancy due to increased estrogen levels, reducing 
maternal anxiety and stress responses. Prelabor physiologic preparations include increased uterine oxy-
tocin receptors in preparation for efficient labor contractions and, according to animal studies, increased 
mammary and brain oxytocin receptors. In pregnant women, high or rising oxytocin levels may predict 
positive mothering behaviors and longer breastfeeding duration, perhaps reflecting optimal early oxyto-
cin experiences and secure attachment, compared with women with low or decreasing oxytocin.
Studies generally show an increase in maternal blood OT levels as pregnancy progresses.216, 230-232 This re-
flects the rising estrogen levels that increase activity in the OT system (blood levels, receptor numbers).233 
In women, pregnancy also involves a physiologic increase in cholesterol levels,234 which may be important 
in increasing OTRs and OTR binding.235 Psychological studies show reductions in anxiety from early preg-
nancy236 that may reflect central OT effects.237 Oxytocin has a diurnal pattern in pregnant women, as mea-
sured in the blood, with peak levels around midnight.238, 239 This may contribute to enhanced nocturnal 
uterine activity in late pregnancy. (See also 2.1.3.)
In one large study, first-time (primiparous) mothers had higher late-pregnancy OT levels than multiparous 
women,216 which may reflect reduced OT sensitivity and fewer OTRs due to reproductive inexperience 
(3.1.1).238, 239
Researchers also found correlations between elevated OT from early pregnancy, and postpartum mater-
nal behaviors such as gaze, vocalization, positive affect, affectionate touch, and frequent checking of the 
infant.240 In other studies, elevated OT levels in pregnancy predicted breastfeeding at three months,241 
and reduced risk of early postpartum depression.242 
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These results may reflect more maternal attachment behaviors, including breastfeeding, and better mood 
among mothers who are more securely attached from their own infancy and childhood, with higher OT 
levels compared with less securely attached mothers (3.1.4). However, one study found that women with 
higher OT levels in late pregnancy experienced a longer labor and greater chance of epidural use,216 which 
may relate to differences among primiparous women, who have higher OT levels as well as longer labor,214 
and greater epidural use.243 (See also “Oxytocin complexities” in 3.1.1.)
Animal studies show extensive prelabor physiologic preparations within the maternal brain that promote 
efficiency in labor and birth (3.1.3), and optimize postpartum maternal behaviors (3.1.4). Oxytocin-pro-
ducing cells in the hypothalamus reorganize for coordinated pulsatile release in labor and lactation, and 
pituitary OT stores increase by about 50 percent.98, 99 In rats, central OTRs have been shown to increase 
by up to 50 percent in OT-associated areas in the final two days before labor onset,88 sensitizing the ma-
ternal brain for effective OT responses in labor, birth, and the postpartum period. The most important 
brain changes that switch on maternal behaviors may only occur in the final hours before the physiologic 
onset of labor.100, 101 Brain OTRs increase even more during labor in some areas of the brain88, 244 (3.1.3). 
Animal studies also show increases in breast (mammary) OTR numbers as gestation advances, with fur-
ther increases close to the physiologic onset of labor. In rats, mammary OTRs increase 100-fold from early 
pregnancy to lactation;87 and in pigs, mammary OTRs increase four-fold over the few days prior to physi-
ologic onset of labor.86 While it is not possible to verify these changes in pregnant women by directly sam-
pling the brain or breast, hormone-associated prelabor physiologic preparations are also likely in humans 
to maximize maternal and offspring survival and well-being by promoting lactation and infant care.
In women, OTRs and receptor binding capacity increase in the uterine muscle (myometrium) in late preg-
nancy,111 with increases in women’s sensitivity to synOT as the physiologic onset of labor approaches,107 
and a further increase with the onset of labor, also found in other mammals.111 Both hormonal changes 
and uterine stretch may contribute to OTR upregulation111 (2.1). One study found that OTR numbers tri-
pled in women from late pregnancy to early labor,245 with higher OTRs at the fundus, and lower numbers 
close to the cervix,98, 111, 245 in preparation for effective expulsion.
Oxytocin receptors also increase in feto-maternal tissues, likely due to increases in estrogen and also 
cortisol.246 Cortisol is elevated in amniotic fluid in late pregnancy247 and promotes OTR formation, ac-
cording to animal research.246 Increased OTRs in the fetal membranes (amnion and chorion) and decidua 
contribute to feedback cycles that increase PGs, promoting contractions in the adjacent myometrium.111 
Local inflammation also has an increasingly recognized role in labor onset (2.1.2) and the inflammatory 
substance interleukin 1-beta also promotes OTR upregulation.82, 83 Increasing OTRs, PGs, and cervical rip-
ening all contribute to labor efficiency and effectiveness following physiologic labor onset (2.1.2).83 In-
creased uterine OTRs also promote the effective OT-mediated contractions immediately after birth that 
reduce postpartum hemorrhage (PPH) (3.1.3). 
In the lead up to labor, maternal melatonin, a hormone that is secreted from the pineal gland during 
sleep periods, enhances myometrial sensitivity to OT and the formation of gap junctions, according to in 
vitro human studies.109 Gap junctions connect myometrial cells together, increasing uterine contractility. 
These effects contribute to nocturnal contractions and to the more common physiologic onset of labor 
at night in women and other day-living species. (For a fuller account of the prelabor physiologic prepara-
tions that precede the physiologic onset of labor, see 2.1.)
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Fetal Oxytocin in Pregnancy
Fetal oxytocin production increases as gestation progresses and may contribute to parturition.
The fetus produces increasing amounts of oxytocin during pregnancy, according to both animal248, 249 and 
human250 studies. It has been suggested that fetal oxytocin may contribute to the initiation of labor. (See 
“Fetal Oxytocin in Labor and Birth” in 3.1.3.)
3.1.3 Oxytocin in Labor and Birth
Oxytocin is involved in the processes of labor and birth among all mammals. The exact role of oxytocin in 
labor initiation is not fully understood.
Maternal Oxytocin in Labor and Birth 
During labor, pulsatile oxytocin release from the laboring mother’s pituitary gland promotes rhythmic 
uterine contractions, and also helps maintain oxytocin receptor sensitivity and the effectiveness of con-
tractions. Oxytocin is involved in several positive feedback cycles that promote and accelerate labor prog-
ress, involving feedback from uterine sensations and central oxytocin autoregulation. Peaks of oxytocin in 
late labor promote expulsion by a positive feedback cycle (Ferguson reflex). Central oxytocin systems are 
also activated in labor, according to animal studies, assisting with stress and pain, and promoting mater-
nal adaptations that benefit infant survival.
In laboring women, oxytocin is released in pulses from the pituitary into the bloodstream, reaching the 
uterus and binding with OTRs in the myometrium, where it promotes contractions by increasing calcium 
and calcium sensitivity.98 Oxytocin also binds with OTRs in the decidua, stimulating the production of 
PGs, which promote contractions in the adjacent myometrium.98 In turn, PGs may sensitize the myome-
trium to OT by increasing OTRs,112, 114, 115 and PGs also promote contractions that give sensory feedback 
and increase central OT release (described below). These mechanisms initiate an important positive 
feedback cycle, where OT-OTR binding increases PG formation, and PGs promote OT activity. 83 The ad-
ministration of exogenous PGs (and other methods of labor induction) may initiate labor by activating 
these mechanisms (3.2.2).
Animal research suggests another positive feedback cycle active on the day of labor. Researchers have 
found that the sensations from uterine contractions, transmitted via sensory nerves, stimulate brain 
centers that link to the central oxytocin nuclei (SON and PVN, 3.1.1) and promote the release of central 
OT, causing further contractions, feedback, and OT release.251 This positive feedback cycle, operative 
throughout labor, depends on the sensations of labor and is similar to the late-labor Ferguson reflex (de-
scribed below). In addition, a central OT positive-feedback cycle involving noradrenergic pathways and 
maximally active in labor, as found in animals,208, 209, 252 further promotes OT release into the maternal 
brain and body and accelerates labor progress (see “Oxytocin regulation” in 3.1.1). 
Levels of OT are difficult to measure in the bloodstream of women in labor because of its pulsatile release 
and because it is rapidly broken down (metabolized) by the enzyme oxytocinase, which the placenta makes 
during pregnancy and produces in even higher amounts in labor.98 This rapid metabolism reduces the OT half-
life to around three minutes in labor,253 so that it may almost disappear from the bloodstream between con-
tractions. This ensures that uterine OTRs are exposed to OT intermittently, rather than continuously, which 
critically maintains receptor sensitivity and contraction efficiency during labor and after birth.254 As with oth-
er hormone systems, exposure to constant high OT levels can lead to receptor reduction (downregulation), 
with loss of sensitivity and ineffective contractions. (See “Synthetic oxytocin and oxytocin receptor desensiti-
zation” in 3.2.3.) Episodic exposure may also benefit the fetus, supporting recovery between contractions.
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Blood OT levels, as sampled in spontaneously laboring women, have not been found to increase substan-
tially until the pushing stage of labor,255-257 although the frequency of OT pulses increases as labor pro-
gresses, reaching about six pulses per ten minutes at the end of labor, according to one study.258 
Figure 1258, 259 illustrates the gradual rise of OT in labor and the large increases from birth through the 
early postpartum period.
Figure 1. Women’s oxytocin levels in late pregnancy, in early labor, at birth, and after birth
Source: adapted from Fuchs258 (solid, left scale) and Nissen259 (dashed, right scale)
Oxytocin is also produced locally within the decidua during labor.111 Local OT release and associated pos-
itive feedback cycles (below) may be even more important than centrally-released OT in human labor.98
In late labor, strong contractions guide the baby deep into the mother’s pelvis, where the baby’s pre-
senting part (usually head) stimulates specialized nerves that detect stretch in her lower vagina and 
cervix. These nerves send a signal to the laboring woman’s brain, triggering an outpouring of OT, which 
further increases contractions and fetal descent, and further stimulates these nerves. This positive feed-
back cycle, known as the Ferguson reflex,260 fosters an efficient birth and elevates OT levels into the ear-
ly postpartum period. Vaginocervical stimulation (VCS) has an analgesic effect in animals and humans, 
likely via OT,261 and this may also benefit women during late labor. 


































Late pregnancy Early labor Birth
Large amounts of OT are also released within the maternal brain during labor and birth, as directly sam-
pled in animal studies.211, 262, 263 In women, OT levels are elevated in the CSF during labor, also indicating 
increased central release.230 The central positive feedback cycle, whereby OT increases its own release 
from and within the maternal brain (3.1.1), further elevates OT levels, both in the body, contributing to 
labor efficiency, and in the brain, facilitating beneficial maternal responses after birth. Central OT eleva-
tion in labor may also counter maternal fear and pain,45, 264 and may enhance trust and support-seeking 
behaviors at this critical time (3.1.1). Central OT may also increase BEs in the brain, according to animal 
studies,120 aiding with labor stress and pain. Brain-based OT effects are prolonged because OT has a 
longer half-life in the brain—around 28 minutes166—and because OT activates and reorganizes other hor-
monal and biologic systems48 (3.1.1).
These high levels of central OT in labor act on the augmented OTRs in brain areas critical for maternal 
behavior, according to animal studies.88 In some brain areas, including the supraoptic and paraventricular 
nuclei, where oxytocin is produced (3.1.1), OTRs further increase in labor (3.1.3),88, 244 making parturition 
“. . . a key time point for full expression of maternal behavior.”244(p.1441) This major activation of the central 
OT system in labor fosters the rapid and appropriate maternal postpartum responses that enhance off-
spring survival. 
The transformation in maternal responsiveness toward infants that follows mammalian birth, is “notably 
conserved” in humans,156 for whom effective responses to offspring after birth have also promoted spe-
cies survival.156
As discussed in 3.1.1, animal studies show that previous reproductive experience increases OTRs in brain 
areas involved with OT autoregulation,211 greatly enhancing the efficiency of labor, birth, and lactation, 
and the onset of maternal behaviors among experienced mothers of all mammalian species.212 
Activities that increase endogenous OT release could enhance labor progress in women, and may even 
trigger the onset of labor when maternal readiness and uterine OTR numbers are maximal, very close 
to the physiologic onset of labor. Studies have shown mixed results in terms of coitus and labor initia-
tion,265-270 possibly because few women in these studies were sufficiently close to the physiologic onset 
of labor, and they therefore had insufficient OTRs to trigger labor initiation with the transient OT eleva-
tions from sexual activity.
However, studies using prolonged nipple (breast) stimulation (e.g., for 30 minutes) have found increased 
OT levels,271 and a systematic review found enhanced cervical ripening, increased chance of labor onset 
within 72 hours (among women with a ripe cervix), and a major reduction in PPH.272 Researchers suggest 
caution in women with high-risk pregnancies because one study found increased fetal risks.272 One ran-
domized study found that nipple stimulation using a breast pump was an effective alternative to synOT 
to enhance labor progress,273 with benefits in half of the women, likely those with higher OTR numbers. 
Sexual activity, which also elevates OT levels,171, 274 could also be effective in augmenting labor,275 al-
though this has not been specifically researched. The analgesic effect of vaginocervical stimulation261 
could also be beneficial.
Genetic variations (polymorphisms) in OT and its receptor may influence OT-related functions (3.1.1), in-
cluding labor progress. One study found that labor was 10 percent slower among women with a common 
OTR variation,276 although other researchers have not found polymorphisms that explain slow labor or 
dystocia.277 It seems unlikely that OT polymorphisms that were significantly detrimental to labor progress 
would survive evolutionary pressures, given the additional dangers of prolonged labor in the wild (5.1.3).
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Other hormonal influences on oxytocin in labor and birth. Healthy, physiologic levels of 
stress (eustress) and stress hormones in labor, including cortisol, may be important to promote contrac-
tions and labor progress. Excessive stress, or stress hormones, may inhibit labor via oxytocin disruption.
Other hormones and endogenous substances may influence OT release and/or effects in labor. Excessive 
levels of stress and stress hormones may inhibit OT release and labor progress (3.2.1). However, expect-
ed physiologic stress (“eustress”) in labor, with moderate elevations of hormones, may be beneficial. 
In animal studies, the stress hormone cortisol upregulates local OTRs and augments the stimulating ef-
fects of OTRs on local PGs about 100-fold,98, 246 as described below. In addition, physiologic increases in 
the executive stress hormone CRH in women in late pregnancy and labor enhance uterine responsiveness 
to OT and PGs,89, 90 and may even be involved in the initiation of labor.278, 279 (See 5.1.1 and 5.1.3 for discus-
sion of eustress in labor, 5.2.1 for discussion of impacts of excessive stress, and 2.1 for initiation of labor.) 
The hormone leptin, which is made in fat tissue and is present in higher amounts in obese individuals, 
has been found to inhibit contractions and block OT’s pro-contraction (uterotonic) effects when directly 
applied to human myometrial samples. 280 Leptin is also made by the placenta during pregnancy, but lev-
els decline significantly just before birth.281 Researchers speculate that elevated leptin levels may help to 
explain the slower labors282 and lower rates of vaginal birth280 that obese women experience.
However, other studies have found no correlation between obesity and the contractile ability of uterine 
muscle,283 and only modest differences in outcomes for obese women in settings that promote physi-
ologic birth.284 In animal research, high maternal leptin levels are associated with successfully raising 
larger litters, which may reflect a greater investment in offspring when maternal nutritional stores are 
high.285 
In addition, some studies have shown longer labor and/or increased risks of cesarean 285 and other ma-
ternity care interventions in relation to maternal age among nulliparous women,285-290 while another 
found increased age was associated with shorter active labor and longer pushing stage, up to 40 years.291 
Reduced myometrial contractility has been found with advancing age in both nulliparous and multipa-
rous women.289, 290 As with obesity,292 these potential effects suggest that adjustment of labor expecta-
tions and management may be required for older first-time mothers. 
Obese and older women and their babies may benefit from promotion of physiologic childbearing, in-
cluding by minimizing labor stress (5.2.1) and unnecessary maternity care interventions, as discussed in 
the recommendations.
Positive feedback cycles. Oxytocin is involved in several positive feedback cycles that are known to 
promote and accelerate labor progress, producing the hormonal cascade of “active labor.” Activation of 
these cycles is promoted by prelabor physiologic preparations, including receptor upregulation, which is 
maximal at the physiologic onset of labor. External induction agents may provoke the full activation of 
these cycles, which is most likely to occur close to the physiologic onset of labor.
In summary, as described above, positive feedback cycles active in labor that promote and accelerate OT 
release and establish labor processes include:
  OT-OTR binding, which increases PG production in the decidua. PGs increase OT activity indirectly 
by promoting contractions and possibly also directly. Cortisol may substantially increase PG 
effects, according to animal research.  cont’d
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  The sensations of uterine contractions, transmitted to specific brain areas, give positive feedback 
to central OT-releasing areas, promoting OT release and creating more contractions and more OT 
release, according to animal models.
  In late labor, fetal descent stimulates specialized nerves in the laboring woman’s lower vagina, 
which give positive feedback to her pituitary, causing more OT release, stronger contractions, 
more fetal descent, and more nerve stimulation (Ferguson reflex).
  Central OT release promotes more OT release by positive feedback on central autoregulatory mech-
anisms, leading to extreme OT peaks in the brain and body during labor and birth. Effects are more 
pronounced in multiparous mothers, who have more central OTRs. (Found in animal studies.)
These cycles contribute to a hormonal cascade that promotes efficiency in mammalian labor and birth 
and, through central effects, contributes to the postpartum maternal adaptations that further enhance 
offspring survival (3.1.4). 
Activation of these positive feedback cycles adds momentum to labor, so that the process, when estab-
lished, is less vulnerable to disruption. This underlies the clinical phenomenon of “active labor.” The more 
effective central mechanisms in multiparous females, likely due to increased central OTRs as above, may 
give less vulnerability to disruption than in primiparous females. This is consistent with the shorter duration 
of labor214 and reduced need for intervention in multiparous women,215 and in women who are admitted to 
hospital at later stages of cervical dilation and labor,215 when these mechanisms are well established.
This cascade may be activated or strengthened in women by exogenous agents that trigger contractions, 
including synOT, exogenous PGs, and stretch, which may also contribute to the labor induction effects 
of balloon catheters.85 These can lead to the full manifestation of labor, including the release of endog-
enous OT from and within the laboring woman’s brain, and its binding to OTRs in her brain and body. 
The full expression of these cycles, with optimal efficiency of labor, is most likely to occur with the physi-
ologic onset of labor, when OTRs are at maximal levels in the maternal brain and body.
Fetal neuroprotection. Oxytocin mechanisms may help to protect the fetal brain from labor hypoxia, 
according to animal studies. This mechanism involves the transfer of maternal oxytocin through the 
placenta and into the fetal brain, and may be inactive before the physiologic onset of labor. High-dose 
synthetic oxytocin and oxytocin antagonist drugs (used in women to treat threatened premature labor) 
inactivate this neuroprotection in animal studies. Deficits in this neuroprotection are associated with 
animal models of autism.
Oxytocin may have an important role in protecting the fetal brain (neuroprotection) during labor and birth. 
According to animal studies, maternal OT crosses into the fetal brain in labor via the placenta and perme-
able fetal blood-brain barrier where, uniquely, around the time of birth, it activates a switch involving the 
neurotransmitter gamma-aminobutyric acid (GABA), which reduces fetal brain activity. This effect begins 
in the 24 hours preceding physiologic labor onset, with maximal effects during late labor that reduce cen-
tral blood and oxygen requirements, and protect fetal brain cells (neurons) against hypoxia.97, 293, 294 
In these studies, the neuroprotective effects of OT were reduced, and vulnerability to hypoxic brain 
damage increased, when high levels of synOT were administered,293 and with administration of the oxy-
tocin antagonist (OTA) atosiban,97 which blocks OTRs and effects. Deficits in this neuroprotection mecha-
nism have been found in animal models of autism.295, 296 (See also “Oxytocin Antagonist Drugs” in 3.2.3.)
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These mechanisms are likely to be operative in human babies, who have the same need for neuroprotec-
tion in labor and may even produce their own neuroprotective OT, as the human limbic system is more 
mature than other mammals at birth.185, 297 These findings imply that fetal neuroprotection may be re-
duced in the absence of the physiologic onset of labor, with administration of high-dose synOT, and/or 
with the use of OT antagonists (3.2.3). 
Oxytocin-deficient mice. Mice bred to be deficient in oxytocin or oxytocin receptors have essentially 
normal labor and birth, but unsuccessful lactation. This suggests that there are overlapping mammalian 
processes to ensure successful labor and birth.
Mice that are genetically engineered to produce no OT (OT knock-out, OTKO) have surprisingly been 
found to labor and birth normally,298 although OTKO mice mothers have no letdown reflex for lactation 
and so offspring do not naturally survive. Mice lacking OTRs have similar deficits.293, 299 These unexpected 
findings do not negate the role of OT in labor. In animal studies, OT antagonists, which block OTRs, re-
liably inhibit labor,300 with modest effects in women,301 suggesting that the OT system is functionally 
important for mammalian labor. Because birth is critical to survival, it is likely that there are overlapping 
mechanisms to ensure success. For example, the related hormone AVP (3.1.1) may cross-react with OTRs 
at high levels and contribute to uterine contractions in labor.48
Fetal Oxytocin in Labor and Birth
The eustress of labor activates important adaptations for the fetus. Fetal oxytocin release with labor may 
assist with stress and pain, and may even promote contractions by a local effect.
For the baby, the processes of labor and birth involve physical pressures, such as intense squeezing of the 
body and head,302, 303 and intermittent loss of blood and oxygen, producing some degree of stress. The 
eustress of physiologic labor benefits the fetus and newborn by turning on adaptive mechanisms. (See 
“Fetal catecholamine [CA] surge” in 5.1.3). Researchers have generally found higher newborn OT levels or 
production (assessed by differences between umbilical artery and vein levels) following labor, compared 
with prelabor cesarean section (CS).255, 304-309 Newborn OT elevations may counteract “the stress of being 
born,”175 with natural painkiller effects.161, 185 See also “Newborn and Later Oxytocin,” below.)309
In rats, fetal oxytocin released by electrical stimulation of the hypothalamus crosses into the maternal 
circulation and can cause uterine contractions near term.310 Human studies also suggest that fetal OT 
may reach the mother’s uterus, possibly via amniotic fluid, potentially causing uterine contractions and 
even contributing to the initiation of labor.305 It has been suggested that, in response to hypoxic stress, 
increased fetal OT could beneficially hasten labor.255, 311 While this would be adaptive for offspring sur-
vival, evidence is contradictory.309 (See “Synthetic Oxytocin and Offspring, Longer Term” in 3.2.3 for dis-
cussion of passage of OT from mother to fetus.)
In animal studies, maternal OT peaks at birth benefit the newborn by synchronizing brain-cell activity in 
the hippocampus, an area involved with learning and memory.312
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3.1.4 Oxytocin after Birth
Peaks of oxytocin during labor and birth continue into the early postpartum period, with beneficial effects 
for mothers and newborns.
Maternal Oxytocin After Birth
High maternal oxytocin levels at physiologic birth are further elevated through early skin-to-skin contact 
and newborn prebreastfeeding behaviors. This elevation promotes contractions that prevent postpartum 
hemorrhage, and may prime longer-term maternal adaptations through central oxytocin effects, accord-
ing to human studies. 
Maternal OT levels are elevated at physiologic birth due to the oxytocin surge that promotes effective 
pushing (Ferguson reflex, 3.1.3). Levels increase even further during the first hour after birth, correlated 
with skin-to-skin contact and newborn prebreastfeeding behaviors, according to studies discussed be-
low. High OT levels are crucial at this time for contracting the new mother’s uterus and preventing PPH. 
Oxytocin also has critical postpartum roles in switching on the central maternal adaptations that promote 
maternal-infant attachment (biologic bonding) and lactation in all mammals, as detailed below. After birth 
that follows the physiologic onset of labor, high levels of OTRs in the new mother’s uterus, and likely her 
brain and breasts (as found in animal studies) will assist with these processes (3.1.3).
Oxytocin and maternal-newborn contact and interactions. One study found correlations be-
tween infant breast massage behaviors and maternal oxytocin elevations in the first two hours. Diminish-
ing oxytocin responsiveness over this time suggests a rapid loss of oxytocin sensitivity over the first one to 
two hours and supports the concept of a “sensitive period” in relation to maternal hormonal physiology.
Maternal OT release after birth may be stimulated by maternal-newborn contact. One study found around 
1.8-fold average elevations of OT at 15 and 45 minutes after spontaneous birth among new mothers 
who were in immediate SSC with their newborn before breastfeeding initiation, as measured by blood 
samples.259 
Newborn OT elevations may contribute to the alert newborn state that follows physiologic birth and 
persists for two hours or so.313 At this time, an unmedicated and undisturbed newborn in SSC can enact 
a series of behaviors that culminate in self-attaching to the mother’s breast and suckling. This sequence 
can take one hour or longer.314, 315 (See also “Breastfeeding initiation” in 3.1.4.)
One study of SSC mothers and babies found maternal postpartum OT peaks that correlated with their 
newborns’ instinctive hand massage of the breasts (predominantly the areola and nipple) and with early 
suckling. These interactions elevated maternal OT levels up to ten-fold, as seen from the data of one 
mother and baby.316 In these data, the new mother’s OT levels peaked at 45 minutes then decreased into 
the second hour, even though breast stimulation from her infant’s breast massage was maximal at 75 
minutes, and suckling occurred at 90 minutes. 
Similar findings were seen in another study (mentioned above) that measured postpartum maternal OT 
with SSC.259 In this study, peaks of maternal OT occurred at 15 and 45 minutes and then subsided, even 
though first suckling, which might be expected to maximally stimulate OT release, occurred at 87 minutes.
Together, these findings suggest that new mothers may have increased nipple sensitivity, possibly via 
peaks of central OTRs, which subsides after the first hour. This supports current understanding of the 
importance of SSC, with newborn access to the mother’s breasts, in the first hour after birth to promote 
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breastfeeding and biologic aspects of maternal-infant attachment. (See “Postpartum sensitive period,” 
below.) In addition, according to these findings, newborn breast contact may be more important than 
actual breastfeeding for elevating maternal OT levels. (See also 3.2.7.) 
Kennell and McGrath comment, “Before the availability of medications such as Pitocin, the newborn’s 
touches were probably crucial for the survival of mothers by raising OT levels to cause strong, repeated 
uterine contractions, which prevented a fatal hemorrhage.”317(p.20)
Oxytocin and postpartum hemorrhage. The postpartum oxytocin elevations that follow physi-
ologic birth and undisturbed postpartum skin-to-skin maternal-newborn contact likely reduce the risk of 
postpartum hemorrhage. Evolving evidence supports this model.
The risk of postpartum hemorrhage has not been assessed in relation to maternal postpartum OT lev-
els. Undisturbed SSC provides the necessary context for the newborn’s prebreastfeeding behaviors and 
breast massage, which increase maternal OT levels (see “Oxytocin and maternal-newborn contact and 
interactions,“ above). 
While the relationships between postpartum OT levels and PPH risk have not been directly researched, 
studies suggest lower PPH incidence in low-technology settings, where SSC is more likely to be sup-
ported. Observational studies of birth at home318-322 show a reduction in PPH risk compared with routine 
hospital care, although obviously risks are likely to be reduced among a healthy home birth population. 
Population323 and cohort324, 325 studies have also found lower PPH risk among low-risk women experienc-
ing physiologic (or “holistic psychophysiological”) care compared with “active management of the third 
stage of labor,” and a systematic review found equivalent PPH rates (SSC status not stated).326
Other researchers have found a reduced time from birth until the mother expelled her baby’s placenta 
among women randomized to SSC,327 and quicker uterine involution, as well as reduction in bleeding, 
among SSC mothers compared with controls.328, 329 (See also “Synthetic oxytocin and postpartum hemor-
rhage” in 3.2.3.) 
Postpartum hemorrhage is a life-threatening complication, especially in low-resource settings. Under-
standing and fostering physiologic processes to prevent hemorrhage is an important area for high-quali-
ty research.
Newborn and Later Oxytocin
Elevated newborn oxytocin levels at birth may have calming and analgesic effects that assist with the 
baby’s postpartum transition, and promote breastfeeding initiation. Maternal-newborn interactions – in-
cluding through skin-to-skin contact, vocalizations, and maternal odor – may further beneficially elevate 
newborn oxytocin, reduce stress, and stabilize newborn physiology. Physiologic hormonal experiences in 
the newborn period may optimally program hormonal systems longer term by epigenetic mechanisms, as 
found in animal studies. 
Following labor and birth, the newborn has high OT levels, as measured in cord blood, and compared 
with levels in babies born by prelabor cesarean (PLCS) or to non-pregnant adult levels.305-307 Higher levels 
in the umbilical artery than vein suggest fetal OT production during labor174, 305 (3.1.3). Newborn oxytocin 
levels peak at around 30 minutes after birth,174 and may give feelings of calm, connection, and pleasure 
to newborns at this time, consistent with OT effects in adults (3.1.1). One study found pulsatile OT re-
lease among newborns in NICU.330
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Researchers have found a physiologic analgesia among vaginally-born human302 and animal185 newborns 
that declines over several hours and that may reflect the analgesic effects of OT (3.1.1). Beta-endorphins 
and norepinephrine may also contribute.302 The closely related hormone AVP, which can occupy the OTR 
(3.1.1), also peaks following labor and birth and may be an even more powerful analgesic than OT for the 
fetus and newborn.161 Breastmilk also has analgesic properties,331 and postpartum breastfeeding and SSC 
may have additive analgesic effects.332
Newborn blood OT levels were found to decline by more than 50 percent in the hour after birth in one 
study, but were elevated above adult levels for the first four days.174 Oxytocin’s calming effects likely 
benefit the newborn through this period of transition.
Newborn OT may be further released through early interactions with the mother,52, 333 as shown in ani-
mal studies.334 Contributing factors may include:
  skin-to-skin and eye-to-eye contact (3.1.1)
  social vocalizations178
  maternal and milk odors, which are soothing for the newborn335
  suckling, which releases OT (3.1.1)
  food intake and digestion, which releases OT (3.1.1)
  ingestion of breast milk, which contains OT174
These newborn OT elevations, and the interactions that promote them, may be important in activating 
the PNS-related calm and connection system (3.1.1). This reduces the birth-related surge of E-NE, which 
can be harmful after birth if prolonged, especially in relation to energy consumption (5.1.4). The more 
stable temperature, heart rate, breathing, and neurobehavioral responses of babies experiencing SSC 
compared with separated babies336 are likely due to this OT-mediated shift from the SNS to PNS333 (3.1.1). 
This PNS shift also conserves newborn energy stores,333, 337 contributing to higher blood glucose levels 
among SSC newborns compared with separated newborns.336 (See 5.1.4 for more about newborn stress 
hormone levels.) OT may mediate the analgesic effects of SSC338 (see “Skin-to-skin contact,” below).
Newborn OT elevations in association with SSC and breastfeeding may begin to sculpt the brain for posi-
tive social-affiliative behaviors.339 In humans, elevated OT levels increase gaze to the eyes, the ability to 
read the emotions of others from facial cues, and interpersonal trust.340 As with the mother, newborn 
experiences during this sensitive period may also imprint pleasure and reward in relation to maternal-
infant contact, creating brain connections that have longer-term benefits. (See “Pleasure and reward,” 
below.) One study found correlations between newborn OT levels in the cerebrospinal fluid, reflecting 
brain levels, and prosocial behavior at three and six months.341
In addition, the newborn period, including the days that follow birth, may be crucial for setting life-long 
programs in brain-hormonal systems. In animal studies, maternal and social interactions during the new-
born period program subsequent biologic functions and behaviors by altering sensitivity to neuropeptides, 
including OT and AVP.342-344 (See Introduction for more about fetal/newborn programming and “Synthetic 
Oxytocin and Offspring, Longer Term” in 3.2.3 for a detailed discussion of possible epigenetic impacts from 
perinatal exposures.)
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Oxytocin and Breastfeeding 
The maternal oxytocin system is involved with important physiologic preparations to optimize lactation. 
These processes may begin even before the physiologic onset of labor, with late-pregnancy breast oxyto-
cin receptor increases, as found in animals. During lactation, oxytocin is released in pulses and mediates 
the let-down reflex, which makes milk available to the suckling baby, also promoting prolactin release and 
possibly directly stimulating milk secretion.
In other animals, upregulation of mammary OTRs occurs before the onset of labor,86, 345 ensuring ef-
fective mammary responses to the early postpartum OT elevations (“Maternal Oxytocin After Birth” in 
3.1.4). Direct OTR sampling is not possible in women, but similar preparations are likely because of the 
evolutionary benefits of successful lactation for reproduction. Oxytocin also promotes PRL secretion346 
(3.1.1), giving even more benefits to prelabor OT and OTR preparations. 
Oxytocin mediates the milk ejection (“letdown”) reflex by causing rhythmic contractions in the myo-
epithelial cells that line the milk ducts. This pushes milk through the ducts for a suckling baby to ingest. 
Blood OT levels rise during a nursing episode, peaking at 5 to 10 minutes, and remaining elevated for 20 
to 30 minutes after initiation,237 with brain levels likely elevated for a longer period because of the longer 
half-life.347 The pulsatile release of OT from the pituitary is only present during labor, birth, and lacta-
tion;209 at other times, OT is released in a constant manner (3.1.1).
Breastfeeding initiation. During the hour or so after physiologic birth, peak oxytocin activity for 
both mother and baby promotes an ideal “calm and connection” state for breastfeeding initiation. In-
stinctive newborn behaviors, including “breast crawl” and prebreastfeeding breast massage, can facili-
tate self-attachment. Early breastfeeding may enhance longer-term success by optimizing the oxytocin 
and prolactin systems. Even brief separation and/or exposure to analgesia can disrupt newborn sequenc-
ing, and breastfeeding initiation.
Newborn OT elevations, along with elevations in NE (5.1.4), may contribute to the alert newborn state 
that follows physiologic birth and persists for two hours or so.313, 315 At this time, an unmedicated and un-
disturbed newborn, placed naked and skin-to-skin on the mother’s body, can enact a series of behaviors 
that involves: locating and moving to the breast (“breast crawl”348, 349); breast massage with the hand; fist 
or finger sucking, promoting saliva flow; and finally culminating in self-attaching to the mother’s breast 
and suckling.315 The full sequence can take one hour or longer,315, 316 and can be significantly disrupted 
by even brief separation (e.g., for weighing, washing, and dressing) and/or by exposure to labor analge-
sia.350, 351 When fully enacted, breast crawl can benefit the onset of lactation and limit early weight loss, 
possibly through early, effective feeds,352 leading to strong OT and PRL responses.
In addition, early SSC and breastfeeding initiation (with or without breast crawl) may enhance longer-term 
breastfeeding success.336, 353 A recent systematic review found that newborn mortality was halved when 
breastfeeding was initiated during the first hour, compared with after this time.353 The mechanisms be-
hind the critical sensitive nature of the first hour or so after birth for breastfeeding are not fully under-
stood but may include the peak in oxytocin sensitivity, as discussed above. In addition, early maternal PRL 
elevation, which is stimulated by OT release, and PRL itself, may stimulate PRL receptor formation, with 
benefits to ongoing milk supply (5.1.4). 
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One study measured women’s hormone levels during breastfeeding two days after cesarean or vaginal 
birth, and found that earlier first suckling increased the number of OT pulses during breastfeeding and 
the subsequent duration of breastfeeding. Vaginal birth was also associated with more OT pulses com-
pared with CS. Authors comment, “. . . early mother-infant contact together with the passage of the 
fetus through the vagina during the second stage of labour can enhance the stimulation of OT neurons 
leading to a more pulsatile pattern of OT release,” with ongoing benefits to breastfeeding success.354(p.116) 
Early newborn contact with the mother’s nipple, which maximally stimulates maternal OT release in 
the first hour,316 may also be very effective in promoting maternal adaptations355 and biologic maternal-
infant bonding (See “Postpartum sensitive period,” below.)
The World Health Organization-sponsored Baby-Friendly Hospital Initiative (BFHI) prioritizes SSC imme-
diately after birth, with support for early and frequent breastfeeding, as effective strategies to increase 
long-term breastfeeding success.356-358 Growing knowledge of the major health disadvantages associated 
with lack of breastfeeding4, 6, 359 highlights the importance of early SSC and of minimizing maternal-new-
born separation to promote lifelong well-being of women and their offspring. 
Breastfeeding benefits. Researchers have found reduced anxiety and increased sociability among 
new breastfeeding mothers, compared with adult norms, in proportion to oxytocin release during 
breastfeeding. Brain scans show greater activation of empathy and bonding centers in response to infant 
cues in breastfeeding versus nonbreastfeeding mothers, which may promote attachment and infant care, 
and ultimately enhance survival. Repeated hormonal exposure with breastfeeding may give long-term 
maternal health benefits, related to the duration of breastfeeding. For offspring, oxytocin exposure with 
breastfeeding may optimally prime oxytocin systems, reducing stress responses longer term, as found in 
animal studies. 
The release of OT during early breastfeeding and its pulsatile pattern are optimized following physiologic 
birth, as described above,354, 360 possibly through the peaks of OT during birth and the early postpartum 
period. Oxytocin, released during breastfeeding, reduces maternal anxiety, and increases calmness and 
desire for social contact.360 In addition, pulsatile OT, released with breastfeeding, promotes PRL release, 
with possible benefits to early PRL receptor formation and ongoing milk production (see “Prolactin re-
ceptor theory” in 6.1.4). 
Conversely, dysregulation in the maternal OT system may affect the new mother’s mood. Researchers 
measured women’s OT (and other hormone) levels and mood from late pregnancy through to eight weeks 
postpartum and found that, at eight weeks, women with lower OT levels during lactation had poorer 
mood scores, including more anxiety and depression.361 The cause for dysregulation was not clear, and 
detailed birth variables were not included in this analysis.
Measurements before and after a nursing episode show reductions in women’s stress reactivity and 
stress hormone levels,354 and an elevation in mood.362 Repeated exposure to breastfeeding hormones, 
including OT and PRL, which also has stress-reducing effects (6.1.1), may give long-term physical as well 
as psycho-emotional benefits. One study found lower risks of diabetes, high blood pressure, and cardio-
vascular disease in older women in proportion to their lifetime duration of breastfeeding.363 
Magnetic resonance imaging (MRI) scans comparing the brain responses of breastfeeding and formula-
feeding mothers to their infant’s cues in the first month found, among breastfeeding mothers, more acti-
vation in brain areas concerned with bonding and empathy and, when assessed in interactions with their 
infants at four months, greater maternal sensitivity.364 Other studies have shown that a breastfeeding 
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mother is less likely to abuse or neglect her child, which researchers have also linked to the OT system.365 
According to these authors, “Breastfeeding represents a set of maternal behaviors that enhance the emo-
tional bond between mother and infant via close physical contact and affectionate dyadic interactions . . . 
breastfeeding may contribute to the development of a range of sensitive maternal behaviors during the 
early postpartum period.”364(p.1) Mechanisms likely involve OT and other hormonal systems such as beta-
endorphins and PRL. (See “Beta-endorphins and Breastfeeding” in 4.1.4 and “Prolactin and Breastfeeding” 
in 6.1.4.)
Newborn and infant effects of OT exposure during breastfeeding have not been well studied, but elevated 
levels, repeated with each nursing episode via suckling-related release, and OT present in breast milk,174 
may contribute to the established lifelong benefits for breastfed offspring,4, 6, 359, 366, 367 including possible 
benefits to mental health.368 
In animal studies, synOT administered daily for two weeks after birth, or stroking (which releases endog-
enous OT) for five minutes daily over seven days produced lifelong reductions in blood pressure, including 
in animals genetically programmed for high blood pressure.369 (In contrast, similar treatments in adult-
hood had effects that persisted for several days.159, 370) These findings suggest that regular OT-rich behav-
iors in the postpartum period (e.g., SSC, breastfeeding) may also powerfully program human offspring, 
with long-term benefits, even to the next generation, as shown in animal offspring receiving high levels 
of nurturing. (See “Maternal-infant attachment: possible impacts of childbearing,” below, and “Synthetic 
oxytocin and epigenetics” in 3.2.3.) 
In addition, early contact with the mother’s breast also gives long-term benefits for mothers and babies 
in relation to digestion and nutrition. Klaus summarizes:
. . . when the infant suckles from the breast, there is an outpouring of 19 different gastrointestinal 
hormones in both the mother and the infant, including insulin, cholesystokinin, and gastrin. Five of 
these hormones stimulate the growth of intestinal villi in the mother and the infant. As a result, with 
each feeding, there is an increased intestinal surface area for nutrient absorption. The hormonal 
release is stimulated by the touch of the mother’s nipple by her infant’s lips. This increases OT in 
both the mother’s brain and the infant’s brain, which stimulates the vagus nerve, then causes the 
increase in the output of gastrointestinal hormones.348(p.1246)
Oxytocin and Maternal Adaptations and Attachment
The perinatal maternal oxytocin peaks that follow prelabor and in-labor physiologic preparations (e.g., in-
creases in receptor numbers) promote maternal adaptations. These include both bodily adaptations (e.g., 
breast adaptations that promote lactation) and brain-based adaptations, including activation of limbic 
system circuits that foster maternal well-being and species-specific maternal behaviors. 
Among mammals, peaks of OT during and following birth, acting on areas that have been primed by physi-
ologic prelabor and in-labor preparations (e.g., increase in receptor numbers), promote critical maternal 
adaptations and behaviors. For example, in rats, increased central OT activity after birth (OT, OTRs) fosters 
licking, grooming, and arched-back nursing behaviors, as well as aggressive defense of offspring.160 In some 
species, such as sheep, birth-related vaginocervical stimulation is critical for the rapid onset of maternal 
adaptations and caregiving, and postpartum VCS can facilitate acceptance of unrelated newborns.212 
46CHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | 3 OXYTOCIN / 3.1.4
Postpartum sensitive period. During the initial one to two hours after birth, central maternal 
peaks of oxytocin and oxytocin receptors promote maternal behaviors that are critical for newborn sur-
vival in all mammals. Skin-to-skin and nipple contact may maximally stimulate hormonal systems for 
mother and newborn at this time, with long-term benefits to maternal adaptations and maternal-infant 
attachment (via “biologic bonding”), and breastfeeding. The subsequent newborn period may continue to 
be “sensitive” to some extent for mother-newborn contact and evolving hormone systems.
Maternal brain elevations of OT may continue for several hours after birth. A study of parturient cows 
showed high levels of OT in the CSF for at least two hours after birth,263 with similar results in sheep.371 
This may reflect ongoing central positive feedback, stimulation of release by maternal-newborn interac-
tions, and/or the longer half-life of OT in the brain, around 28 minutes according to animal studies.166 
This peak activity of OT (and other birth-related hormonal systems; see 4.1.4, 5.1.4, 6.1.4) promotes the 
maternal behaviors that are critical for newborn survival in all mammals.372 These include facilitating 
newborn suckling, and, in women, this may include positioning to facilitate newborn movements and 
proximity seeking.373 Like other mammals, human newborns also seek proximity for warmth and safety, 
and can give a “separation distress cry” when separated.374
Following physiologic labor and birth, the new mother has exceptional sensitivity to tactile stimulation, 
including nipple contact,316, 333 likely due to high numbers of central OTRs, as found in animals (3.1.2), which 
sensitize brain areas critical for maternal adaptations and behaviors. Oxytocin released in response to such 
stimulation therefore likely has greater effects in the postpartum sensitive period than at any other time. 
In animal studies, the birth-related peaks of OTRs decline within four to twelve hours in the new mother’s 
brain88 and uterus.48 A postpartum decline in uterine OTRs and sensitivity may be important in preventing 
excessive contractions and pain during lactation. Oxytocin responsiveness to nipple stimulation may also 
decrease rapidly over two hours following birth in women.316 (See “Maternal Oxytocin After Birth,” above.) 
Consistent with this mammalian sensitive period and its heightened effects on maternal responsiveness 
and adaptations, one human study found that new mothers whose newborns licked or touched their nip-
ple in the first 30 minutes after birth left their babies alone in the nursery for shorter periods (enhanced 
proximity seeking); talked more to their babies while breastfeeding on day four; and had lower serum 
levels of gastrin (indicative of lower stress) during a breastfeeding episode, compared with control group 
mothers, whose babies first sucked at a median age of eight hours.355 
One study randomized new mothers and babies in the first two hours to either early SSC contact, new-
born swaddling, or nursery care. At one-year follow up, researchers found positive effects of early SSC on 
infant self-regulation and mother-infant interactions.375 Other studies have also found longer-term ben-
efits to maternal-infant relationships from early SSC,376-380 although methodology has been controversial 
in some SSC studies. The Cochrane systematic review found positive effects of early SSC on breastfeeding 
duration and maternal confidence, and possible effects on early maternal-infant relationships.336 (See also 
“Skin-to-skin contact,” below.)
These findings are consistent with the biologic activation of hormonally-mediated limbic system programs 
that facilitate maternal-newborn attachment (bonding) among all mammals.20 This hormonally-mediated 
biologic bonding may be distinct from “attachment” as commonly understood. According to Bergman, at-
tachment is a uniquely human process that involves the higher-order cortical brain, and can compensate 
for situations where biologic bonding is missed, (e.g., with adoptive parenting) but may not achieve for 
example, the prolonged breastfeeding that follows biologic bonding.20
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While maternal-infant contact in the first hour or so seems to be most consistently associated with, and ef-
fective at promoting, the longer-term maternal adaptations of biologic bonding, maternal responsiveness 
may continue to be elevated for many hours after birth, perhaps reflecting the important plasticity of the 
maternal brain at this time, as seen in animal studies.381, 382 Studies have shown benefits to breastfeeding and 
maternal adaptations from “rooming in” during the days following birth, compared with nursery care for 
newborns,383-388 including one older study that found lower levels of abuse and neglect at 17 months among 
mothers and babies who had roomed in during their two-day hospital stay, compared with controls.386 
Skin-to-skin contact. Skin-to-skin contact immediately after birth, the biological norm among all 
mammals, promotes oxytocin release, which reduces stress and fosters “calm and connection.” Postpar-
tum skin-to-skin contact also: stabilizes newborn physiology, promotes maternal-newborn sensory interac-
tions, keeps the newborn warm through maternal oxytocin-related vasodilation, and facilitates newborn 
self-attachment to the breast, with longer-term benefits to breastfeeding duration and maternal confi-
dence. Through the early weeks, skin-to-skin contact may benefit maternal psychological well-being by 
release of oxytocin and other hormones. From the perspective of hormonal physiology, maternal-infant 
separation that disallows skin-to-skin contact is a major intervention that requires a strong indication. 
Skin-to-skin contact immediately after birth promotes OT release,259, 316 activating the PNS and facilitating 
calm and connection for mother and baby (“Newborn and later oxytocin” in 3.1.4). Skin-to-skin contact 
provides the environment that not only facilitates breastfeeding initiation, but also the maternal-infant in-
teractions that regulate and stabilize maternal and newborn biologic processes (mutual regulation). Early 
postpartum SSC facilitates mutual regulation of newborn temperature, acid-base status, energy use and 
metabolism, respiration, crying, and breastfeeding behavior. In the mother, SSC benefits maternal atten-
tion and behaviors, OT release, initiation and maintenance of breastfeeding, and energy economy, with 
these benefits continuing through the breastfeeding period.333 
Skin-to-skin contact also provides the environment that the newborn requires to enact instinctive behav-
iors, including finding the mother’s breast and self-attaching (see “Breastfeeding initiation,” above). As 
described, even brief separation for weighing can disrupt newborn sequencing and reduce the chance of 
successful suckling.350, 351, 389 
In addition, early SSC provides a context for other interactions with the newborn that can also release 
OT, including visualizing390 and vocalizing.178 In one study, mothers and fathers in skin-to-skin contact af-
ter cesarean had more vocal communications with their babies compared with non-SSC parents, which 
may reflect the pro-social effects of oxytocin released with SSC.391 
Olfaction during SSC may also stimulate OT release of newborn and mother,392 as it does in other mam-
mals52 (3.1.1), with breast odors found to have calming effects on human newborns.393, 394 Oxytocin levels 
in mothers or fathers who are close to, but not in SSC with, their newborn have been found to rise, likely 
due to non-tactile sensory cues.395 (See “Newborn and Later Epinephrine-Norepinephrine and Related 
Stress Hormones” in 5.1.4, for NE and smell.)
During the early sensitive period, vasodilation of the new mother’s chest wall due to oxytocin peaks 
(3.1.1) provides a natural warming mechanism for her newborn.52 (This is also seen as an OT-mediated 
flush with female sexual arousal.) One study measuring maternal breast and axillary temperatures after 
birth in relation to postpartum care practices found that mothers in SSC with their newborns had more 
variation in breast temperature compared with women whose babies were swaddled or separated. 
Breast temperature variations were even greater among multiparous mothers and those whose new-
borns successfully suckled.396 
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Researchers suggest that these SSC mother’s breasts are pulsing heat, perhaps related to maternal puls-
es of OT, which is more efficient for heat transfer than a steady temperature. As reported elsewhere, the 
SSC newborns in this study had warmer axillary and foot temperatures,175 even 23 hours later (see 3.2.7). 
Consistent with this, the Cochrane systematic review of skin-to-skin contact reports warmer tempera-
tures among SSC babies compared with babies wrapped and placed in a bassinet.336 
Skin-to-skin contact also reduces newborn stress and stress hormone levels (5.1.4), and provides the 
habitat for breastfeeding initiation. (See “Newborn and Later Oxytocin,” above.) The Cochrane system-
atic review336 also found the following longer-term benefits of early SSC:
  less maternal anxiety and more confidence with their babies at hospital discharge 
  higher breastfeeding rates in the early months
  longer total duration of breastfeeding
  no negative effects
Early SSC may also enhance maternal breastfeeding self-efficacy and confidence in the early weeks.397 
These findings support long-term effects on maternal adaptations from early SSC, likely via hormonally-
mediated activation of biologic bonding within the central limbic system. (See also “Postpartum sensi-
tive period,” above, and “Pleasure and reward,” below.) Keeping healthy mothers and babies together 
for this time also enhances maternal and newborn physiology and postpartum physiologic adaptations. 
From the perspective of hormonal physiology, maternal-infant separation is a major intervention that 
requires a strong indication.398 (For a full discussion of the possible impacts of separation of healthy 
mothers and newborns, see 3.2.7.)
Ongoing skin-to-skin contact may provide significant maternal benefits through the early weeks. One 
study found lower cortisol levels and depression scores over the first month for women experiencing six 
extra hours of skin-to-skin contact with their newborn in the first week, compared with women in the 
control group. Two hours of SSC daily through the first month also reduced depression scores and cortisol 
levels among these new mothers, relative to controls. Researchers highlight SSC as an accessible, cost-
effective intervention strategy with no adverse effects, and suggest that OT elevation may be involved.399 
These findings underscore the great benefits of ongoing SSC for infant survival through human evolution, 
and the development of maternal reward and motivation systems to support this.
Maternal adaptations. Maternal postpartum adaptations include activation of protective and at-
tachment behaviors that promote well-being and survival in all mammalian offspring. In women, shifts in 
personality have been found following unmedicated birth, with both reduced anxiety and increased desire 
for social contact promoting maternal caretaking. Maternal attachment behaviors, and especially prox-
imity-seeking, may foster secure attachment, which has lifelong benefits to offspring psychological and 
physical health. Maternal attachment and protective behaviors are linked to OT systems in humans and 
animals. OT levels in pregnant women have been correlated with positive aspects of mothering behaviors. 
A growing body of research from both animal100, 244, 400-404 and human5, 240, 244, 374, 404-413 studies is expanding 
current understandings of the neurobiology of maternal-infant attachment and its long-term implications. 
However, the precise origins of, and mechanisms to promote, maternal-infant attachment in humans re-
main uncertain, especially in relation to healthy full-term infants.
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Maternal adaptations are obviously more complex in humans than in other animals,156, 414, 415 perhaps 
reflecting cortical involvement in human attachment.20 However, the OT system has been linked to a rep-
ertoire of maternal behaviors in women. These include enface (face-to-face) gaze, smiling, high-pitched 
vocalizations (“motherese”), affectionate touch, and the synchronizing of these behaviors with infant 
emotional states and responsiveness.405, 414 In human mothers and babies, these behaviors promote infant 
brain maturation,416 cognitive development,417-419 and attachment security.420 Oxytocin also promotes 
proximity seeking, according to animal studies.406 Proximity seeking keeps newborns in safe, physical 
contact with the mother, and may also be central for secure attachment in human mothers and babies 
(see “Maternal-infant attachment and childbearing,” below). 
Adaptations in personality have been found in women following unmedicated labor and birth, compared 
with non-pregnant women, suggesting psychological effects from central hormonal peaks. These include 
reduced anxiety and guilt, and increased desire for social contact, correlated with OT elevations during 
breastfeeding, as discussed above.237, 360 Studies have found fewer personality changes among women 
who may have missed the OT peaks at birth due to epidurals (3.2.5) and cesareans (3.2.6). 
In animal studies, OT also promotes “aggressive-defensive” maternal behavior in protection of offspring, 
which may also involve the related hormone AVP160 (3.1.1), and possibly PRL (6.1.1). In women, OT may 
enhance infant survival by increasing vigilance.421 In one study of women with postpartum depression, 
intranasal synOT increased maternal protective behaviors, although it had a negative impact on mood.422 
(Intranasal OT gives central effects, possibly via a direct route;164 see 2.1.1.) 
The hormone peaks of labor and birth may also contribute to longer-term adaptations in the brain and 
OT system of women. Researchers used MRI to record brain activity in new mothers in response to hear-
ing their own infant’s cry two to four weeks after birth. They found that women who had given birth 
vaginally had more activation in arousal, motivation, and reward brain circuits, compared with women 
who had given birth by PLCS. The authors suggest that exposure to peaks of OT during labor and birth 
may facilitate these adaptations.423 (See also 3.2.7.)
Such changes may be faster and/or greater in, multiparous females, who have more central OTRs, with 
a wider distribution, according to animal studies,211, 424 likely from previous OT peaks (3.1.3). One study 
found a more rapid onset of these personality adaptations after birth for multiparous compared with 
primiparous women.425 
The influence of the OT system on maternal adaptations may begin in pregnancy. In one human study, 
OT levels in women in early and late pregnancy were positively correlated with maternal behaviors in 
the early postpartum weeks such as gaze, vocalizations, positive affect, and affectionate touch.240 There 
is also evidence for a trans-generational effect of maternal care in animals228 and humans,426, 427 which is 
thought to act via the OT system. (See “Maternal-infant attachment and childbearing,” below.)
Biologic bonding following early SSC may contribute to these adaptations, although early maternal-infant 
contact was not noted in these studies and models.
Pleasure and reward. Oxytocin activates the dopamine-associated central reward (meso-cortico-
limbic) pathways, which motivate and reward maternal behaviors in all mammals. The peaks of oxytocin 
(and other hormones) that follow physiologic birth can give a natural euphoria. Animal and human stud-
ies suggest changes in central reward centers, also likely due to postpartum hormonal peaks, which in-
crease the reward associated with infant contact and care, benefitting maternal care and infant survival.
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Central OT changes are found in postpartum animals, according to anatomical brain studies,428 and 
women, according to MRI studies,405, 423, 429 discussed in detail below. Effects are likely augmented in new 
mothers by upregulated brain OTRs in the early sensitive period,88 acted on by OT elevations with birth 
and early SSC (see “Postpartum sensitive period,” above). Elevated levels of opioids, including BEs, which 
also activate these reward centers, may also contribute (4.1.4). 
These birth and postpartum OT elevations, acting on upregulated central OTRs, may also boost mood 
and give feelings of euphoria or even ecstasy in postpartum women in relation to birth and baby.430, 431 
This postpartum physiologic OT activation, with elevations in mood, could plausibly protect against post-
traumatic stress disorder after birth, as OT dysfunctions have been implicated in this condition (3.1.1). 
In addition, these OT elevations may contribute to modifications in central reward circuits that imprint 
ongoing pleasure and reward in association with newborn contact and care. One MRI study (discussed 
above in “Maternal adaptations“) found greater activation of reward centers in response to infant cues 
among new mothers who had experienced a vaginal birth, compared with women experiencing PLCS.423 
These different OT experiences may also impact maternal mood, as discussed below.432 The corelease of 
OT with BEs, which also activate reward centers (4.1.1), during episodes of lactation and infant contact 
may be important in decreasing opioid tolerance,433 which maintains reward-center sensitivity and the 
“addictive” aspects of maternal-infant contact (see “Beta-Endorphins and Maternal Adaptations and At-
tachment“ in 4.1.4). Activation of reward pathways may contribute to biologic bonding, as discussed in 
“Postpartum sensitive period,” above.
Another study found improved mood in hospital and eight months later among women who experienced 
earlier, compared with later contact with their babies after birth,432 suggesting more effective imprinting 
of reward systems in the early postpartum sensitive period, compared with the subsequent hours after 
birth (3.1.4). In addition, in one prospective study, women reported an elevation in self-esteem from 
pregnancy to the postpartum period following spontaneous vaginal birth, a diminution following CS, and  
no change following instrumental birth,434 also suggesting hormonally-mediated increases in reward and 
pleasure. A study of supportive care in labor (see 3.2.1) found significant reductions in postpartum de-
pression (PPD) scores and elevations in self-esteem scores for women randomized to doula care. In this 
study, 90 percent of supported women had low depression scores at six weeks versus 40 percent of 
women without doula support.435
The stress-reducing and mood-enhancing effects of OT, released with episodes of breastfeeding and ma-
ternal caregiving, may make an important contribution to the ongoing emotional well-being of women, 
as of other mammalian mothers,45 and may also contribute to the mental health benefits of breastfeed-
ing.436 In addition, oxytocin released during breastfeeding may enhance maternal sensitivity in caregiv-
ing, which has been linked to activation of brain empathy centers, according to one MRI study,364 and to 
secure infant attachment.437, 438
As discussed in “Breastfeeding benefits” above, OT dysregulation has been implicated in postpartum 
depression,361 but studies were not found exploring PPD and OT in relation to childbirth experiences or 
maternity care interventions. (See also 5.2.1 in relation to posttraumatic stress disorder and childbirth.)
Reward center activation has also been linked to episodes of mother-baby synchrony, where maternal 
behavior is coordinated with infant signals.405 Activation of these pathways in association with infant 
contact augments the “reward value” of offspring,226 making a critical contribution to offspring survival. 
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Maternal-infant bonding and attachment. Maternal-infant bonding has been a biological ne-
cessity for survival in mammals. The full spectrum of biologic bonding involves prelabor preparations, in-
labor hormonal peaks, and postpartum maternal-infant interactions, which all help optimize maternal ad-
aptations, maternal-infant bonding, and offspring survival. In humans, these processes may also promote  
secure attachment of mother and babies, with ongoing benefits to offspring psychological well-being. 
Bonding and attachment have been extensively studied among animals in relation to early maternal-
newborn interactions. In other mammals, labor and birth peaks of oxytocin and other hormones, acting 
on brain areas primed by prelabor physiologic preparations,400 activate central circuits that switch on 
maternal adaptations,100, 244 promoting maternal caregiving and infant survival.156, 401 Postpartum mater-
nal-infant contact may also contribute, as discussed above (“Postpartum sensitive period”), facilitating 
biologic aspects of mammalian bonding through hormonally-mediated limbic system activation.20 
The resulting hormonally-mediated maternal adaptations of biologic bonding foster proximity seeking, 
which facilitates suckling, milk production, and species-appropriate care of the young.402 Maternal adap-
tations and behaviors are reinforced through central reward centers,403 that are likely activated with par-
turition, ensuring that the new mother is motivated and rewarded to give the dedicated care that every 
mammalian infant requires until maturity (see “Pleasure and Reward,” above).
In mammals, these limbic-based maternal adaptations, along with reinforcing cues and behaviors from 
offspring in the postpartum period (e.g., vocal, tactile, olfactory, and visual stimuli), lead to the forma-
tion of maternal-infant attachment bonds, which program lifelong well-being for offspring, including by 
optimizing brain-hormone systems.402, 404 Oxytocin promotes biologic bonding and attachment by pro-
moting proximity-seeking in mothers and newborns,406 by activating central reward circuits (also likely 
involving endorphins410), and by facilitating lactation and milk transfer. Other hormone systems are also 
involved.404 Every episode of lactation reinforces these maternal adaptations and maternal-infant bond-
ing through the release of OT, beta-endorphins (4.1.4), and prolactin (6.1.4).
This animal model of biologic bonding is also relevant to women and babies, for whom the rapid onset 
of maternal care following birth has also been an evolutionary benefit. Important contributing factors to 
human maternal-infant biologic bonding and attachment, based on animal models and physiologic un-
derstandings, may include:
  prelabor physiologic preparations in central maternal circuits, e.g., upregulation in central OTRs 
(“Maternal Oxytocin in Pregnancy” in 3.1.2)
  peaks of hormones in labor and birth that activate these receptor systems (OT, beta-endorphins, 
prolactin, norepinephrine) (3.1.3, 4.1.3, 5.1.3, 61.3)
  maternal-infant SSC in the early sensitive period, when peaks in hormones and receptor levels 
give maximal sensitivity and effects (see “Postpartum sensitive period,” above)
  newborn responsiveness, especially in the early sensitive period when maternal systems are 
primed for interaction and breastfeeding initiation
  increased central autoregulatory OTRs in multiparous women, which may facilitate earlier onset 
of maternal behaviors (3.1.1)
  the postpartum initiation and maintenance of breastfeeding which reinforces maternal adapta-
tions and reward through hormonal release
  preexisting maternal personality and attachment history, which may influence central oxytocin 
systems and responsiveness 
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The maternal adaptations and behaviors that may be promoted through this model, as relevant to 
human biologic bonding and attachment, may include:
  changes in maternal personality that promote infant care, including reduced anxiety and guilt 
and increased desire for social contact
  proximity seeking, with physical contact and sensory exchanges (e.g., gaze, odor, and affectionate 
touch) that reinforce hormonal release 
  mother-infant vocalizations (e.g., “motherese”)
  mother-infant interactions, including “affect synchrony,” which adapts maternal behaviors to 
moments of infant responsiveness
  ongoing breastfeeding, including related maternal-infant interactions
These behaviors, many of which are also displayed by human fathers, have been linked to the oxytocin 
system240 and to the development of “secure attachment” as a personality characteristic. (See “Maternal 
adaptations,” above.) According to Bowlby, who pioneered Attachment Theory as applied to human 
psychology, secure attachment is formed through mothers and babies maintaining proximity.411 
Attachment security in infancy has been found to significantly predict attachment security in childhood 
and adulthood,439-443 with long-term consequences for health and well-being.3, 412, 444, 445 One review con-
cludes, “Secure attachment acts as a buffer against HPA activation in response to excessive stress. Infants 
with insecure attachment lack this buffering effect and may be predisposed to depression and other 
psychiatric disorders in response to psychosocial stressors.”413(p.219) 
In animal research, females who receive high levels of maternal care in infancy give high levels of care to 
their own offspring, even among females selectively bred to give low levels of maternal care. These well-
mothered mothers have more brain OTRs in infancy, and during pregnancy and birth. Offspring given 
high levels of maternal care are also less susceptible to excessive stress reactions in adulthood, and have 
enhanced learning and brain function.228 Animal researchers explain, “These patterns of maternal care 
initiate a cascade of epigenetic processes that uniquely shape gene expression, organize the Oxytocin-
ergic system that supports bond formation in mammals, and determine the infant’s lifetime capacity to 
handle stress.”405(p.2604) 
Human research also supports the transmission of maternal care patterns across generations. In an MRI 
study, first-time mothers with secure adult attachment, as assessed during pregnancy and largely re-
flecting the quality of maternal care received in early life, had more activation of brain reward centers, 
and other OT-related brain areas, as they gazed at their infant’s face. These secure mothers also had 
higher OT levels during interactions with their infants at seven months.427 These researchers comment 
elsewhere, “. . . a mother’s attachment experiences from her own childhood may shape neural circuits 
which influence how she perceives and responds to her infant’s cues one generation later,”446(p.327) with 
these responses contributing to secure attachment in her child.
In other studies, adults reporting better parental care in childhood showed higher peripheral OT, greater 
activation in OT-rich brain areas, and more sensitive parenting, compared with adults reporting lower-
quality parental care. (See Feldman217 for a summary of research linking OT with parenting behaviors.)
This proposed framework for human maternal biological bonding does not imply that attachment or care 
is deficient outside of these biological processes, as obviously human parents can form close and enduring 
bonds with nonbiological children. However, in the context of hormonal physiology, the limbic processes 
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of biologic bonding may foster the most rapid and effective onset and maintenance of maternal-infant 
attachment, as has been advantageous through human evolution. 
Conversely, disruption to these processes at any level may impair the biologic aspects of bonding. In 
this situation, maternal-infant attachment may become a more deliberate, cortical process,20 whereby 
the mother intellectually “learns” to love her baby, rather than an instinctive, hormonally-mediated, 
limbic process. As with other perinatal processes, and as seen in animal studies, biologic deficits at this 
time could plausibly change expected trajectories in maternal and infant brain-hormone systems, with 
possible ongoing programming effects. (See also 3.2.7, 4.2.7, 5.2.7, and 6.2.7 for possible programming 
effects in relation to maternal-newborn separation.) 
Given the great potential of maternity care practices to facilitate or disrupt the hormonal physiology of 
childbearing (3.2, 4.2, 5.2, 6.2), including the hormonal systems underlying mammalian biological bond-
ing, as described in this model, and considering the potentially significant impacts of attachment secu-
rity for offspring well-being, research to further understand and support the processes of biologic bond-
ing and the formation of secure attachment of human mothers and babies in relation to childbearing, 
including longer-term impacts, is a high priority.
3.2 Common Maternity Care Practices That 
May Impact Oxytocin Physiology
Common maternity care practices can impact oxytocin physiology. This section examines possible impacts 
on the oxytocin systems of mothers and babies of: maternity care provider and birth environment; prosta-
glandins for cervical ripening and labor induction; use of synthetic oxytocin for induction, augmentation, 
and postpartum care; opioid analgesic drugs; epidural analgesia; cesarean section; and early separation 
of healthy mothers and newborns. 
3.2.1  Maternity Care Provider and Birth Environment: Possible Impacts on Oxytocin 
The maternity care provider and birth environment may impact the oxytocin systems of mothers and 
babies by increasing or decreasing maternal stress and/or stress hormones, with possible effects on 
oxytocin and labor progress, and/or by increasing or decreasing the chances of interventions that can 
impact these systems.
In relation to direct measurements of the possible impacts of maternity care providers on maternal OT, 
one small, randomized study measured maternal OT before and one hour after allocation to emotional 
support from an untrained labor companion (doula), or control. No between-group difference was seen in 
OT levels over this time, which may have been too brief to detect significant differences. Other outcomes 
were not recorded.447 A similar study of labor support in relation to E-NE also found no hormonal differ-
ences at one hour. However, researchers found significant benefits in the group with support to reported 
in-labor pain and anxiety, and to breastfeeding and maternal emotional well-being at six weeks,448, 449 
including higher self-esteem and reduced anxiety and depression scores, compared with women without 
such support.435 These outcomes suggest longer-term enhancement of hormonal physiology, likely includ-
ing OT, through labor support, although the mechanisms are unclear.
Maternity care providers and birth environments could also alter hormonal physiology of mother and/or 
baby by increasing or decreasing the likelihood of exposure to maternity care practices and interventions 
that are known to have hormonal impacts, including practices such as early mother-newborn SSC. 
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While there is broad practice variation within and across providers, settings, and regions, overall, the 
chance of induction may be reduced among women choosing midwifery compared with physician care, 
according to a systematic review,450, 451 and among women planning a home compared with hospital 
birth.452, 453 Planned home birth is also associated with decreased use of labor augmentation and CS.452, 453 
Studies have also found that the same midwife’s practice, including use of interventions, can vary in 
different environments.454, 455 Other researchers suggest that “. . . the provision of an environment that 
midwives experience as calm, non-threatening and supportive may, through the production and release 
of OT, enhance their capacity to facilitate positive social relationships and provide emotionally sensitive 
care to childbearing women.”456(p.279) 
Differences in practice styles among care providers and birth environments could also influence the OT 
systems of mother and baby by increasing or decreasing stress for the laboring woman. 
As discussed in “Labor and Birth Stress in Animals” in 5.2.1, animal studies show that excessive stress in 
labor can disrupt OT release and inhibit contractions, possibly via elevations in E-NE and/or endogenous 
opioids. Stress can also inhibit pulsatile OT release460 and the let-down reflex461 in breastfeeding women, 
although no studies were found that directly measured the effects of stress on OT levels in laboring 
women. Stress during reproductive events may inhibit pulsatile OT, inhibiting labor and lactation in un-
safe environments, for example, whereas stress outside reproduction increases continuous OT release, 
which may be differentially regulated462, 463 (3.1.1).
The possible impacts of maternity care provider and birth environment on the OT systems of mother and 
baby, potential mechanisms by which stress may inhibit labor, and effective practices to reduce labor 
stress are important areas for future research.
3.2.2  Prostaglandins for Cervical Ripening and Labor Induction: Possible Impacts on 
Oxytocin 
Prostaglandins for cervical ripening and labor induction may interact with the maternal oxytocin system 
by triggering positive feedback cycles that progress labor. Prostaglandin induction may be more success-
ful when there is sufficient readiness (including of oxytocin systems) to trigger this cycle, closer to the 
physiologic onset of labor. 
Several studies have investigated interactions between exogenous PGs for induction and endogenous 
OT release in women. Studies have found variable elevations in OT following PG administration but, in 
general, PG induction was successful when elevations in OT,464 or OT and PGs, followed.256, 465-467
These findings suggest that induction of labor with PGs may require activation of OT positive feedback 
cycles, as discussed in 3.1.3. Prostaglandins not only cause changes in the cervix, but also promote con-
tractions and may stimulate the production of OTRs (2.1).113 Increased OTRs sensitize the uterus to OT, 
and the ensuing contractions cause more OT release by another central positive feedback cycle (3.1.3).113 
Activation of these cycles, and the establishment of labor, following PG administration is more likely to 
occur closer to the physiologic onset of labor, when receptors for both prostaglandins and oxytocin in-
crease. The baby is also more likely to be ready for labor and birth at this time (2.1, 2.2).
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3.2.3  Synthetic Oxytocin in Labor for Induction, Augmentation, and Postpartum Care: 
Possible Impacts on Oxytocin 
Synthetic oxytocin is used in a variety of clinical situations, including: as a primary induction agent; 
together with other induction methods; to augment labor; and/or to prevent postpartum hemorrhage. 
Exposure to synthetic oxytocin in any of these circumstances may have short-term effects on mother 
and/or baby, as well as longer-term direct and/or indirect impacts on their respective oxytocin systems, 
including impacts on breastfeeding and maternal adaptations and attachment. Animal studies have 
found long-term effects on offspring from perinatal exposure to high-dose synthetic oxytocin, with 
possible implications in human offspring. 
Induction of Labor 
Induction of labor may foreshorten the complex and interorchestrated prelabor physiologic preparations 
that precede the physiologic onset of labor in mother and baby, and may hasten the onset of labor before 
full readiness.
As described in 2.1, there is limited current understanding of the complex, interorchestrated processes 
that prepare mother and baby for labor and birth, and that also contribute to adaptations that continue 
through the postpartum and newborn periods and beyond. Induction, whether with synOT or another 
method, limits the full expression of prelabor physiologic preparations and may hasten the onset of la-
bor and birth before full readiness is established in mother and baby. (See 2.2 for a detailed discussion of 
possible impacts of scheduled birth, by either induction of labor and PLCS, on the hormonal physiology 
of mother and baby.)
Efforts to distinguish the complex effects of induction and induction agents on outcomes in mothers and 
babies have generally not included a hormonal physiology perspective,130, 131, 135, 151-153, 468-480 which has not 
been well delineated up to this point.
Augmentation of Labor 
The administration of synthetic oxytocin to augment labor carries the risks of drug exposure and effects 
on mother and baby, with uncertain clinical benefits.
Augmenting (stimulating, speeding) labor with synthetic oxytocin carries the potential risks of this drug 
to mother and baby, as detailed below. Major clinical benefits remain uncertain. 
The most recent Cochrane systematic review found that administering synOT to augment labor in women 
assessed as making slow progress may reduce labor length by two hours but neither reduces the CS rate,481 
which has been the major aim, nor increases the likelihood of non-instrumental vaginal birth. This study 
also found increased risks of hyperstimulation, and, while authors found no detrimental outcomes for 
mothers or babies, they note that numbers were too small to assess perinatal mortality.481 
Synthetic oxytocin has recently been designated as a “high alert” medication, as discussed below. Clark 
comments, “We know of no other area in medicine in which a potentially dangerous drug is administered 
to hasten the completion of a physiologic process that would, if left to its own devices, usually complete 
itself without incurring the risk of drug administration.”482(p.35e3) (For more about slow labor and stress, 
see 5.2.1.)
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Synthetic Oxytocin and the Mother 
Synthetic oxytocin is recognized as a high-alert drug with potentially dangerous effects. Differences be-
tween synthetic and natural, endogenous oxytocin include lack of analgesic and calming effects, increased 
risks of fetal hypoxia that necessitate monitoring, risk of oxytocin receptor desensitization with prolonged 
exposure, and possible drug effects in mother and baby.
The administration of synOT in labor can be beneficial for mothers and/or babies in some circumstances. 
However, the potential hazards of this drug, as discussed below, may not be fully recognized in maternity 
care settings due to its widespread use and its reputation as a “natural” hormone. Synthetic oxytocin 
is the drug most commonly associated with preventable adverse events during childbirth,482 and is one 
of 12 “high-alert medications” that the Institute for Safe Medication Practices identifies as “bearing a 
heightened risk of harm” and requiring “special safeguards to reduce the risk of errors.”482, 483 According 
to Clark, approximately half of all paid obstetric litigation claims allege misuse of synOT.482
Physiologic versus synthetic oxytocin in labor and birth. Synthetic oxytocin, as administered 
in the perinatal period, is chemically identical to natural (endogenous) oxytocin, but has different effects 
in the body, mainly because of its route of administration.
Table 2 summarizes a broad range of known and plausible differences between endogenous OT, as re-
leased during physiologic labor, birth, and postpartum processes, and synOT, administered exogenously 
for labor induction, labor augmentation, and/or postpartum hemorrhage prevention, as discussed below.
Table 2.  Established and biologically plausible impacts of physiologic versus synthetic oxytocin in 
labor and birth
Physiologic (Endogenous) oxytocin Synthetic (Exogenous) oxytocin
Source Released from maternal brain (3.1.1) 
(intravenous line not required)





Has brain-based calming, stress-reducing, 
and analgesic effects (3.1.1) 
Switches on maternal adaptations and 
maternal-infant attachment in all mam-
mals (3.1.1), with long-term benefits; may 
foster “biologic bonding” in the early sen-
sitive period (3.1.4)
Doesn’t effectively cross adult blood-brain 
barrier; minimal central calming, stress-
reducing, and analgesic effects (3.1.1)
Unclear effects on maternal adaptations 
and attachment; may interfere with OT 
release during breastfeeding; may partly 
restore maternal adaptations when endoge-
nous OT is iatrogenically reduced (“Oxytocin 
and Maternal adaptations and attachment” 
in 3.1.4, and “Synthetic oxytocin and central 
maternal oxytocin,” and “Synthetic Oxyto-
cin and Maternal Adaptations,” below)
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Released from fetal brain at physiologic 
levels (3.1.3); brain-based calming, stress-
reducing, and pain-relieving effects on 
fetus and newborn (3.1.1)
Physiologic release with labor and birth 
likely to positively epigenetically program 
evolving offspring OT systems
May cross placenta and into fetal brain 
at supraphysiologic levels with unknown 
impacts (“Synthetic Oxytocin and the Baby” 
and “Synthetic Oxytocin and Offspring, 
Longer Term,” below); indirect impacts via 
maternal effects of synOT also possible
Long-term adverse programming effects 
possible by direct exposure to high doses 
(as found in animal studies) and/or by 
indirect mechanisms (“Synthetic Oxytocin 
and the Baby” and “Synthetic Oxytocin and 




Released in pulses at physiologic levels, 
with rapid metabolism by oxytocinase, 
giving episodic uterine exposure (3.1.3)
OTR sensitivity maintained (3.1.3) 
Administered in continuous supraphysi-
ologic doses, giving constant uterine expo-
sure (“Synthetic Oxytocin and the Mother,” 
below)
Prolonged use can cause OTR desensitiza-
tion with reduced OT sensitivity and in-
creased PPH risk; reduced contractions also 
possible (“Synthetic oxytocin and oxytocin 
receptor desensitization,” below) 
OTR numbers OTRs peak at physiologic onset of labor 
(3.1.3)
Peak uterine OTRs optimize contractions, 
labor progress (3.1.4, 3.1.5) 
Peak OTRs in breasts, brain optimize 
breastfeeding and maternal adaptations, 
according to animal studies (3.1.3)
OTR numbers likely to be lower with induc-
tion, reducing OT sensitivity (3.1.2, 2.2)
Supraphysiologic dosage needed to stimu-
late contractions (2.2); possibility of failed 
induction, CS (2.2)
Low OTRs in breasts, brain may impact 
breastfeeding, maternal adaptations, and 
attachment (2.2, “Synthetic oxytocin and 





Physiologic levels are matched to uterine 
responsiveness, determined by OTRs 
Unlikely to cause hyperstimulation or 
fetal hypoxia (3.1.4, 3.1.5)
Pharmacologic levels produce unpredictable 
results, as uterine sensitivity (determined 
by OTRs) is uncertain (2.2) 
Risk of hyperstimulation (“Physiologic ver-
sus synthetic oxytocin in labor and birth,” 
below)
58CHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | 3 OXYTOCIN / 3.2.3
cont’d
Physiologic (Endogenous) oxytocin Synthetic (Exogenous) oxytocin
Impacts on 
contractions
Healthy fetus tolerates physiologic 
contractions well (3.1.3)
Continuous monitoring not required
Contractions are longer, stronger, and 
closer together, with an increased resting 
tone of the uterus; fetal blood supply 
reduced to some extent 
Continuous monitoring required (“Physi-






Full development of fetal CA systems at 
physiologic labor onset, including E-NE re-
ceptors in heart and lungs; protective CA 
responses to labor hypoxia fully activated.
Strongest physiologic contractions occur 
in late labor, when fetal head is low and 
CA surge fully activated (“Fetal catechol-
amine surge” in 5.1.3)
CA protection from hypoxia, according 
to animal studies (“Fetal catecholamine 
surge” in 5.1.3)
Reduced development of CA systems if 
induced, including E-NE receptors in heart 
and lungs (5.1.3, 5.2.3); protective CA 
responses may be reduced
Strong contractions can occur earlier in 
labor before CA surge fully activated 
Hypoxia risks increased, monitoring re-
quired (“Physiologic versus synthetic oxyto-
cin in labor and birth,” below)
Fetal neuro-
protection
OT provides fetal neuroprotection around 
time of physiologic onset of labor, accord-
ing to animal studies, (“Fetal neuropro-
tection” in 3.1.3)
Neuroprotective effects reduced outside 
physiologic onset of labor, and/or with high 
synOT doses, according to animal studies 
(“Fetal neuroprotection” in 3.1.3)
Pain and 
analgesia
Analgesic systems, including central OT 
receptors, active at physiologic onset of 
labor (3.1.2, 4.1.2)
Contractions and pain build slowly as 
labor progresses; physiologic rise in OT, 
BEs to counteract pain (3.1.3, 4.1.3)
Analgesic medications less likely to be 
used
Analgesic systems, including central OT 
receptors (animal studies), less mature 
before physiologic onset of labor (3.1.2)
Strong contractions in early labor; limited 
time to build physiologic analgesia (“Syn-
thetic oxytocin and central maternal oxyto-
cin,” below) 




Physiologic labor and birth more likely 
(3.1.3)
Higher likelihood of cascade of intervention, 
with further drugs and procedures, includ-
ing risk of failed induction and CS (2.2)
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Peak uterine OTRs with physiologic onset 
of labor (3.1.2)
Physiologic processes maintain uterine 
OT sensitivity (3.1.3)
Postpartum mother-baby skin-to-skin 
interactions facilitate elevation in mater-
nal OT (3.1.4)
Lower PPH risk likely (3.1.4)
Reduced OTRs with scheduled delivery 
(induction or PLCS) (2.1, 2.2)
Possibility of OTR desensitization follow-
ing prolonged, constant, supraphysiologic 
exposure
Effects of synOT exposure on postpartum 
physiologic OT release unknown
Increased PPH risk (“Synthetic oxytocin and 
oxytocin receptor desensitization,” below)
Note: BE = beta-endorphin, CA = catecholamine, CS = cesarean section, E-NE = epinephrine-norepineph-
rine, OT = oxytocin, OTR = oxytocin receptor, PLCS = prelabor cesarean section, PPH = postpartum 
hemorrhage, synOT = synthetic oxytocin. 
The administration of synOT for labor induction has unpredictable impacts because an individual wom-
an’s uterine response, determined by her OTR numbers, will vary according to how close she is to the 
physiologic onset of term labor. (See 3.1.2 and 2.1 on proximity to the physiologic onset of labor and 
cervical status.) If she is very close to the physiologic onset of labor, she will have more uterine OTRs, 
and lower doses (e.g., four to six mU/minute, which appear to be equivalent to physiologic levels in nor-
mal labor256) may be effective in inducing labor. If she is further from physiologic onset of labor, she will 
require higher doses (e.g., 10 to 16mU/minute), which are commonly used in “low-dose” protocols and 
may give approximately double the levels detected in the physiologic first stage of labor.256
Supraphysiologic doses of synOT administered for induction or augmentation may cause more frequent 
contractions, with an increased resting tone of the uterine muscle (hypertonus), which may compromise 
fetal replenishment of blood and oxygen between contractions.484, 485 These effects may occur because, 
with constant synOT administration, levels do not decline between contractions as much as in physiolog-
ic labor, which involves pulsatile OT release, along with increased oxytocinase production486 (see 3.1.3). 
Synthetic oxytocin and central maternal oxytocin. Synthetic oxytocin-mediated contractions 
may increase central oxytocin by a physiologic positive feedback cycle. Some studies show a reduction in 
maternal oxytocin release with early breastfeeding following synthetic oxytocin exposure, but mechanisms 
are unclear. It is not clear whether synthetic oxytocin might cross into the maternal brain in biologically sig-
nificant amounts, and what effects it could have, including on maternal endogenous oxytocin release.
In contrast to many other hormone systems, OT release from the brain is generally not controlled by feed-
back from OT levels in the body or bloodstream52, 157, 196 (3.1.1). Thus, according to current understanding, 
administration of synOT in labor and birth, even at high doses, is unlikely to directly reduce the release 
of central, endogenous OT from the pituitary. (This is difficult to measure because current testing cannot 
distinguish physiologic OT and synOT in the bloodstream.)
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However, synOT administration can lead to contractions that activate the OT positive feedback cycle 
whereby the sensations of contractions give feedback to the brain and increase the central release of OT 
(3.1.3). This increases OT release into the brain and body, accelerating labor. This activation is more likely 
if uterine OTRs are high, very close to the physiologic onset of labor, giving enhanced uterine responsive-
ness, stronger sensations, and greater feedback. 
It is not clear whether synOT administered to women in labor might have effects within the maternal 
brain. In non-pregnant adults, central effects require very high synOT dosages given by intravenous in-
jection or, more commonly, administered intranasally,207 which seems to bypass the blood-brain barrier. 
(See “Oxytocin Effects” in 3.1.1.) Lower synOT doses administered systemically would be expected to 
have minimal or no central effects. However, OT sensitivity and effects within the mother’s brain may be 
greatly enhanced due to elevated central OTRs at the physiologic onset of labor, as seen in animal stud-
ies (3.1.2). This could heighten central OT sensitivity such that the very small amounts of synOT that likely 
cross from the body into the brain (from 0.002 percent in animal studies to perhaps 1 percent in humans) 
following labor synOT administration could have central effects. (See also “Oxytocin Effects” in 3.1.1.)
In support, some studies have shown maternal OT changes following perinatal synOT exposure, including 
reductions in new mothers’ OT release during breastfeeding,395, 487 and impacts on baseline maternal OT 
levels at two months216 (see “Synthetic Oxytocin and the Mother, Longer Term,” below). In addition, small 
positive impacts on maternal adaptations have been found, particularly for women who have missed the 
OT peaks of labor and birth due to epidural or CS (see Synthetic Oxytocin and Maternal Adaptations and 
Attachment, below). However, indirect effects (for example, stronger synOT-related contractions giving 
greater stimulation of central OT release via positive feedback cycles) and/or other non-central mecha-
nisms may also explain these effects.50, 54 
Reports of greater pain by women administered synOT for augmentation compared with unexposed 
women488 suggest that synOT does not have significant central analgesia (3.1.1). (For more detailed dis-
cussions, see “Synthetic Oxytocin and Breastfeeding,” “Synthetic Oxytocin and Maternal Adaptations,” 
and “Synthetic Oxytocin and the Mother, Longer Term,” below.)
Synthetic oxytocin and oxytocin receptor desensitization. Prolonged exposure to synthetic 
oxytocin in labor may lead to a compensatory reduction in oxytocin receptors (receptor desensitization). An 
increased risk of postpartum hemorrhage is recognized following synthetic oxytocin exposure. Oxytocin de-
sensitization could also compromise labor progress and pushing efficacy. Desensitization effects on breast 
oxytocin receptors, with possible impacts on breastfeeding are biologically plausible but not researched. 
According to biologic principles, exposure to constant, high levels of a hormone may lead to a reduction (down-
regulation) in receptor numbers to protect against overstimulation.489 This is also called receptor desensitiza-
tion. This does not occur with OT in physiologic labor and birth because of its pulsatile release from the pi-
tuitary and rapid metabolism by the enzyme oxytocinase (also called placental leucine aminopeptidase), which 
is produced by the placenta in increasing amounts in pregnancy490 (3.1.3) and even greater amounts in labor.258 
Both of these mechanisms contribute to intermittent uterine OT exposure, which maintains OTR sensitivity.
In vitro animal and human studies have found that constant synOT exposure, at clinically relevant concen-
trations, leads to a time- and dose-related decrease in uterine OTRs, giving a significant loss of response 
to OT.489, 491-495 In one study using human myometrium, responsiveness to OT was reduced to 50 percent 
after four hours of exposure, and to less than 5 percent after six hours.495 The duration of OTR desensitiza-
tion effects is not known but, as the biologic processes needed to restore OTR numbers are complex, full 
restoration could take hours, or even days.45
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These mechanisms could lead to an eventual slowing of labor with lack of response to both endogenous OT 
and synOT. Receptor desensitization could also contribute to the prolonged pushing stage and increased 
risks of operative birth and unplanned CS that have been found in some studies of women administered 
synOT, compared with unexposed women.496-500 From the perspective of hormonal physiology, induction 
may further increase these risks, compared with synOT exposure following the physiologic onset of labor, 
due to foreshortening of prelabor OTR upregulation. A prolonged pushing stage and associated outcomes 
such as operative birth and PPH501-506 may reflect disruption to OTRs due to induction and/or desensitiza-
tion, as discussed below. (See “Synthetic oxytocin and postpartum hemorrhage” and also 2.2.2 for fur-
ther discussion of induction impacts on mother and baby.)501-506
Mammary OTRs are also elevated at the physiologic onset of labor according to animal studies86, 87 (3.1.2), 
and could plausibly also be desensitized from synOT exposure, with potential adverse impacts on breast-
feeding. (See “Synthetic Oxytocin and Breastfeeding,” below.) 
Several studies have compared pulsatile synOT with continuous dosage for induction and/or augmenta-
tion, finding equivalent outcomes in mothers and babies at significantly lower doses.507-513 For example, 
one study used six-fold lower dosage in the pulsatile group.512 No difference was found in PPH rates, 
which were low in both groups (see below).
Synthetic oxytocin and postpartum hemorrhage. The well-recognized increased risk of post-
partum hemorrhage following induction and/or synthetic oxytocin exposure may reflect: fewer oxytocin 
receptors before the physiologic onset of labor, lack of other physiologic preparations for effective contrac-
tions, and/or receptor desensitization from prolonged constant synthetic oxytocin exposure. Increased risk 
of postpartum hemorrhage following cesarean, and extra risk of retained placenta following synthetic 
oxytocin exposure, suggest similar mechanisms. Because cervical changes parallel uterine priming, cervi-
cal ripeness may be a surrogate for hemorrhage risk after induction and prelabor cesarean.
Many studies have found an increased risk of PPH following induced or augmented labor.514-524 The prophy-
lactic administration of synOT after birth has been found to reduce these extra risks in some studies.514, 525, 526
Mechanisms for these findings could include:
  reduced OTR numbers due to induction before the physiologic onset of labor
  lack of other prelabor preparations such as PG receptors (2.1)
  OTR desensitization due to synOT exposure (see “Synthetic oxytocin and oxytocin receptor 
desensitization,” above)
Reduced uterine contractility following exposure to synOT with labor induction or augmentation could 
also increase the risk of retained placenta, as found in bovine research.527 Studies in women have found 
higher risks of retained placenta following induction versus physiologic onset of labor,528 including corre-
lation of risk with duration of exposure to synOT.529 This is an important area for further research. 
Extra PPH risks are also possible following both PLCS and in-labor CS that follows induction and/or expo-
sure to prolonged synOT administration. One study found that, for women exposed to synOT in labor, the 
dose required to give adequate uterine contractions following surgery was nine times higher than for wom-
en with no prior labor (or synOT exposure). Even with this higher dose, average blood loss was doubled to 
1.1 liters. The authors suggest that non-synOT uterotonics may be important in this situation to circumvent 
OTR desensitization effects.530 Important areas for further research include hormonal and other effects of 
non-synOT uterotonics and possible negative effects of PGs on prolactin and breastfeeding (see 6.2.2).
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Given these understandings from hormonal physiology, it is possible that commonly stated risk factors for 
PPH may reflect common OT disruptions. For example, associations between prolonged pushing stage, 
instrumental birth, and PPH501-506 may reflect low OTRs from induction and/or OTR desensitization effects. 
Optimizing OT physiology, for example through reducing induction and synOT exposure as far as safely 
possible, and promoting postpartum SSC (3.1.4), may help prevent PPH. This model also suggests that 
physiologic labor and birth with early SSC may be an effective strategy for reducing PPH risk without pre-
ventative oxytocic drugs. (See “Oxytocin and Postpartum Hemorrhage” in 1.1.4 for a fuller discussion.)
From the perspective of hormonal physiology, a woman’s cervical status parallels, to some extent, her prela-
bor physiologic preparations, including developments in her uterine responsiveness107 (2.1). Her cervical 
status might therefore give some guidance in relation to her PPH risk following scheduled birth, including 
induced labor, PLCS, or in-labor CS following induction (3.2.6). This is an important area for further research. 
Synthetic oxytocin when administered postpartum. Following physiologic birth, skin-to-skin 
contact and mother-newborn interactions may substantially increase maternal oxytocin, even up to ten-
fold, giving physiologic protection from hemorrhage. The routine use of postpartum synthetic oxytocin 
may not be necessary in these circumstances. In addition, biologically plausible effects of postpartum 
synthetic oxytocin administration, including transfer to the newborn before cord closure and possible im-
pacts on breastfeeding, raise additional concerns for benefit-harm considerations, including uncertainty 
about possible longer-term outcomes. 
The prophylactic use of synOT, or drug combinations including synOT, after birth is near-universal in 
modern maternity care, due to its reported effectiveness in reducing blood loss greater than 500 ml 
(about 16 ounces) immediately after birth.531
As discussed in 1.1.4, increases in the new mother’s own OT release, triggered by interactions with her 
newborn, can increase her OT levels from 50 percent259, 316 up to ten-fold, as found in some individuals 
at this time,316 conferring physiologic protection against PPH. Standard routines frequently involve sepa-
rating mother and baby soon after birth, giving no opportunity for endogenous OT release to help limit 
bleeding. For example, less than half of women who participated in the recent national Listening to 
Mothers III survey had their baby mainly in their arms during the first hour after birth.17 Maternal-new-
born separation has other implications for the newborn and breastfeeding initiation and success (3.2.7). 
The postpartum administration of synOT, which involves a substantially higher bolus dose than synOT 
used during labor,469 could also impact the OT system of the mother, with potential effects on breast-
feeding, although studies of postpartum synOT administration have not generally measured breastfeed-
ing as an outcome.531 (For further discussion, see “Synthetic Oxytocin and Breastfeeding,” below.) 
Because the umbilical vessels remain patent for several minutes after birth,532, 533 any drug administered 
to the mother before cord closure could potentially cross the placenta. Standard protocols for third-stage 
management recommend synOT administration during, or immediately after birth,531 giving opportunity 
for passage to the baby. 
In addition, synOT and other drugs used at this time may have unwanted effects in mothers and babies,469, 
534-536 also discussed further below in relation to breastfeeding (see Synthetic Oxytocin and Breastfeeding, 
below.)
Animal studies, discussed in “Synthetic Oxytocin and Offspring, Long Term,” below, raise concerns about 
possible longer-term effects on offspring exposed to synOT in the newborn period. Given the widespread 
exposure of mothers and babies to synOT postpartum, and lack of research about hormonally-mediated 
outcomes including breastfeeding and epigenetic effects, research in this area is urgently needed.
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Oxytocin Antagonist Drugs 
Because of the major role of oxytocin in labor and birth, oxytocin antagonist drugs have been trialed and 
used clinically to treat premature labor. Potential adverse effects, according to hormonal physiology un-
derstandings, could include interference with the innate fetal neuroprotective mechanisms found in ani-
mal studies, and/or with maternal oxytocin processes, including breastfeeding and maternal adaptations. 
Offspring programming effects are also biologically plausible.
Studies of the effectiveness of OTAs, currently used to halt premature birth, have had mixed results. The 
most recent Cochrane systematic review found no benefit of the OTA drug atosiban over conventional 
treatment with beta-agonist drugs or placebo, and noted an excess of fetal-infant deaths in one large 
trial.537 No human research was found that looked at other OTA impacts for mothers or babies.
As discussed in “Fetal neuroprotection” in 3.1.3, animal studies suggest that maternal endogenous OT, 
released during labor, crosses into the fetal brain where it has neuroprotective effects. In these studies, 
the administration of OTAs, including atosiban, negated these effects97, 293 (3.1.5). The human fetus has a 
relatively more mature brain and may produce its own neuroprotective OT, which could also be blocked 
by OTAs.293 In women, atosiban crosses the placenta to the fetus,538 and likely also crosses the permeable 
fetal blood-brain barrier.539, 540
In one animal study, atosiban administered to pregnant rats increased oxidative stress in the plasma and 
cardiac tissue of offspring. Researchers suggest that atosiban may reverse the anti-oxidant effects of OT, 
which limit tissue damage due to perinatal inflammation and injury190 (3.1.1). Atosiban also blocks recep-
tors of the related hormone AVP, which could further compromise fetal adaptations to physiologic labor 
stress.540
Atosiban administered to pregnant animals disrupts OT release with subsequent lactation, reducing 
offspring growth and survival,541 and also blocks milk ejection when administered to lactating cows.542 
Human impacts on breastfeeding are also plausible but no research was found in this area. In animal stud-
ies, OTAs that are administered centrally, or that enter the maternal brain, can also significantly disrupt 
maternal behaviors.543-546 Atosiban is not thought to cross the maternal blood-brain barrier or have di-
rect central effects in women, but no studies were found that assessed this outcome. In animal research, 
a single OTA administration to the newborn led to disruptions of sexual and parenting behaviors in adult 
males, suggesting long-term OT and/or AVP disruptions.539, 547
Given the current use of OTA drugs to prevent preterm birth, these are critical areas for future research.
Synthetic Oxytocin and the Baby
Exposure to synthetic oxytocin in labor may have impacts on the baby before and/or after birth. Possible 
mechanisms include: direct effects from synthetic oxytocin transfer through the placenta to the baby; 
indirect or subtle effects from excessive contractions, including effects from hypoxia and oxidative stress 
(possibly exacerbated by lack of fetal prelabor physiologic preparation, if following induction); impacts 
from co-interventions such as epidurals; interference with fetal OT-related neuroprotection, as found in 
animal studies; and indirect effects via impacts on maternal hormones, oxytocin-related signaling, and 
related processes, including breastfeeding. Long-term programming effects, as found in animals, are also 
biologically plausible. Newborn oxytocin disruptions from synthetic oxytocin exposure may impact breast-
feeding success, and studies also suggest impacts on the newborn autonomic nervous system. There is 
conflicting evidence about synthetic oxytocin transfer across the placenta. 
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Synthetic oxytocin is biochemically identical to endogenous oxytocin, made in and released from the body 
and brain of the human fetus/newborn. Synthetic oxytocin is regarded as safe to administer to non-preg-
nant adults (usually intranasally), and is used experimentally and therapeutically to benefit psychological 
functions and dysfunctions (3.1.1). However, exposure of the fetus/newborn to synthetic oxytocin at sup-
raphysiologic levels via maternal administration raises concerns because of the extreme sensitivity of the 
fetus at this time. 
As discussed in the introduction, evolving evidence highlights this time as a critical period for fetal/new-
born programming, when exogenous exposures may have impacts far beyond dose-related, pharmaco-
logic, effects and side-effects.41 Exposures to hormones and hormone-like substances are especially like-
ly to be have programming and mis-programming effects in the perinatal period, which has been called 
“hormonal imprinting.” This phenomenon has been consistently demonstrated in animal research41 (see 
“Synthetic oxytocin and epigenetics,” below). 
Synthetic oxytocin could impact the baby by direct effects via placental transfer (discussed below) and/or 
indirectly via maternal effects. For example, synOT could cause excessive uterine contractions, increas-
ing the risks of fetal hypoxia,478, 548 as reflected in the “high-alert medication” status of synthetic oxytocin 
(see “Synthetic Oxytocin and the Mother,” above).
From a hormonal physiology perspective, fetal hypoxia risks may be even further increased when synOT 
is used for, or follows, labor induction, because endogenous fetal protective systems involving OT may 
not be fully developed until just before the physiologic onset of labor, according to animal research (see 
“Fetal neuroprotection” in 3.1.3). (Additional protective mechanism involving E-NE and the fetal catechol-
amine surge are also unregulated before labor,78, 337 as discussed in “Fetal Epinephrine-Norepinephrine 
and Related Stress Hormones in Pregnancy” in 5.1.2.) In addition, high maternal doses of synOT may 
counteract these neuroprotective OT effects, according to this research293 (see “Fetal neuroprotection” 
in 1.1.3). Suggestions of an additional risk of cerebral palsy in term babies following synOT exposure549 
could reflect the absence of these neuroprotective effects, which have also been implicated in animal 
models of autism.295 Given the widespread exposure to induction and/or synOT in labor, these are critical 
areas for future research.
Also concerning in relation to fetal synOT exposure are studies showing increased oxidative stress550 and 
free radical formation551 in healthy newborns following augmentation with synOT, compared with unex-
posed babies. These findings suggest that synOT may not have the anti-oxidant effects of endogenous 
fetal OT, released during labor (3.1.3), and may even promote oxidation, with unknown consequences. 
Three studies discussed below (“Synthetic Oxytocin and Breastfeeding”) have found detrimental impacts 
of synOT on newborn breastfeeding behaviors and initiation.552-554 The mechanisms are not known. As 
OT is a hormone of satiety (3.1.1), researchers suggest that synOT, acting centrally, could plausibly reduce 
newborn motivation to suckle.553
Another study suggests that synOT exposure in labor may have impacts on the newborn autonomic ner-
vous system (ANS). In an analysis of newborn skin-temperature response to skin-to-skin breastfeeding on 
the second day after birth, unexposed newborns showed a gradual warming, likely due to OT-mediated 
vasodilation, with return to baseline over 30 minutes. In contrast, synOT-exposed babies had a steeper 
temperature rise with a prolonged elevation.555 In addition, one in-labor study found increased fetal 
scalp temperature with synOT exposure,556 also suggesting synOT-induced vasodilation. 
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The mechanisms for these autonomic effects are not known. Possible explanations include: excessive 
newborn parasympathetic nervous system (PNS) activity mediated by central effects of synOT; indirect 
effects from synOT-mediated disruptions to maternal temperature; and/or dysregulation of maternal-
newborn temperature synchronizing, by which the mother regulates her baby’s temperature when skin-
to-skin (see “Skin-to-skin contact” in 3.1.4). The authors comment, “Given the large numbers of women 
receiving these treatments, even minor effects on newborns might have important future physiological 
and behavioural consequences for the human population.”555(p.7) (See also “Synthetic Oxytocin and 
Breastfeeding” and “Synthetic oxytocin and offspring, human studies,” below, for more about possible 
central fetal/newborn effects from synOT exposure in labor.)
In relation to possible placental transfer of synOT from mother to baby in labor, and potential transfer 
to the fetal brain, one human in-vitro study found that synOT can easily cross the placenta in both direc-
tions.557 In addition, transfer of substances from the fetal blood into the brain can occur in humans because 
the fetal blood-brain barrier (BBB) is more permeable, compared with the adult BBB,558 and may even be 
permeable to OT in some areas.54 Permeability is increased in newborns under conditions of inflamma-
tion and hypoxia,559 which may be more likely with synOT exposure. Transfer of maternal endogenous OT 
to the fetal brain occurs in animals, with beneficial neuroprotective effects at physiologic levels, which are 
negated by high synOT exposures, suggesting synOT passage to, and impacts in, the fetal brain (3.1.3).
Several studies have measured OT levels in the umbilical artery (UA) and vein (UV) in human newborns 
who were exposed and unexposed to synOT. In general, unmedicated newborns show greater OT levels 
in the UA than UV, suggesting endogenous OT production and/or placental degradation (“Fetal Oxytocin 
in Labor and Birth” in 3.1.3). One study of synOT-exposed newborns found elevations in both UA and UV 
OT levels,560 compared with unexposed newborns, while another found a reversal of the usual UA-UV dif-
ference, suggesting a net OT transfer from mother to baby.305 Other researchers have found high correla-
tions between fetal and maternal OT, also suggesting placental transfer.561 In contrast, other studies have 
found no significant difference in UA or UV OT levels and/or ratios compared to unexposed babies.308, 562 
Manufacturers of synOT state, “Small amounts of the drug probably reach the fetal circulation.”469 Given 
the widespread administration of synOT, this is a critical area for future research.
Other possible mechanisms for fetal/newborn synOT effects from maternal exposure in labor include 
signal-transduction without transplacental transfer. For example, synOT-related changes in maternal 
physiology could impact the fetus, and/or synOT could disrupt physiologic roles of OT in signaling be-
tween mother and fetus.54 (See “Fetal neuroprotection” in 3.1.4.) 
There has been little consideration of the possible effects of maternal postpartum synOT exposure, which 
involves a single high dose, on the baby. This exposure could have direct newborn effects if administered 
before cord closure, and/or indirect effects via maternal hormones and processes. (See also “Synthetic oxy-
tocin when administered postpartum,“ above, and “Synthetic Oxytocin and Breastfeeding,” below.)
Synthetic Oxytocin and Breastfeeding
The possible impacts of synthetic oxytocin administration in labor on breastfeeding have been poorly re-
searched, despite synthetic oxytocin being widely used, and oxytocin being a major hormone of breastfeeding. 
A shorter duration of breastfeeding following exposure has consistently been found. Possible mechanisms 
include: inadequate preparation (e.g., insufficient mammary oxytocin receptors); receptor desensitization 
effects; maternal and/or newborn hormonal disruptions; and/or effects of synthetic oxytocin co-interven-
tions such as epidurals. Research suggests changes in the release of oxytocin and other hormones in new 
mothers following synthetic oxytocin exposure in labor, which could impact breastfeeding success. 
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Observational and population studies have found detrimental impacts of synOT on breastfeeding, 
including:
  deficits in newborn suckling behavior,553 early suckling,554 and prebreastfeeding cues,552 compared 
with unexposed newborns (detailed below)
  more women abandoning their intention to breastfeed following elective induction than follow-
ing physiologic onset of labor563 
  lower breastfeeding rates at 48 hours following exposure to IV synOT after birth compared with 
an unexposed group564 
  lower breastfeeding or exclusive breastfeeding rates at discharge following induction,565 elective 
induction,566 induction with synOT or prostaglandins,567 and exposure to synOT in labor,568 com-
pared with unexposed groups
  shorter duration of breastfeeding following synOT exposure in labor compared with unexposed 
group553, 569
Mechanisms for these reported impacts remain unknown, but could plausibly include:
  lack of prelabor physiologic preparations for lactation (for example, lower numbers of breast 
OTRs and/or PRL receptors (see 6.2.3)
  desensitization of OTRs in the new mother’s breasts due to prolonged exposure to synOT, similar 
to impacts on uterine OTRs
  consequences of co-interventions such as epidurals and CS in mother and baby
  hormonal and/or other disruptions to the newborn’s ability to establish and continue breastfeed-
ing, including satiety from synOT (see “Synthetic Oxytocin and the Baby” above)
  impacts on maternal hormonal systems, including via central synOT exposure (see “Synthetic 
oxytocin and central maternal oxytocin,” above)
SynOT exposure at high, constant levels could plausibly override pulsatile OT release, which could impact 
prolactin release (see “Prolactin and breastfeeding” in 6.1.4).
In relation to maternal hormonal systems, one study found that women who received synOT in labor had 
a dose-related reduction in their own endogenous OT release during skin-to-skin breastfeeding two days 
after birth. In this study, the more synOT a woman had received during labor, the lower her OT release 
was during breastfeeding. Researchers speculate that exposure to synOT in labor may activate a negative 
OT feedback cycle that persists for at least two days.570 New mothers exposed to synOT also had higher 
baseline cortisol, likely reflecting loss of oxytocin’s stress-reducing effects.487 The mechanisms and dura-
tion of these impacts are not known. 
One large population study found that women exposed to intravenous (IV) or, to a lesser extent, intra-
muscular (IM), synOT postpartum had a 32 percent reduced chance of successful breastfeeding at 48 
hours compared with unexposed women.564 (In this survey, the impacts of exposure to synOT only during 
labor could not be accurately assessed, as virtually all women who received synOT in labor also received 
it postpartum to prevent PPH.) Authors comment:
Exogenous oxytocin has the potential to interrupt initiation of lactation by: disruption of endogenous 
pulsatile secretion and fluctuating concentrations when crucial changes in neuronal architecture are 
occurring; augmentation of the stress response, which replaces pulsatile secretion with continuous 
secretion and inhibits lactation; desensitization of myoepithelial receptors and local feedback mecha-
nisms; and, more speculatively, infant or maternal behavior.564(p.1627)
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Newborn impacts from exposure to synOT may also contribute to breastfeeding difficulties. Studies 
(mentioned above) have found:
  dose-related disturbances in both early sucking, as assessed up to 48 hours after birth, and 
breastfeeding duration553 
  more exposed newborns with low prebreastfeeding cues (21 of 47 compared with 0 of 11 unex-
posed newborns)552 
  fewer synOT-exposed babies suckled in the first four hours after birth compared with unexposed 
newborns 554 
The effect of synOT on breastfeeding is a critical area for future research.
Synthetic Oxytocin and Maternal Adaptations and Attachment
Administration of synthetic oxytocin could potentially impact hormonally-mediated maternal adaptations 
involving the oxytocin system. Small beneficial effects have been found following epidural and cesarean, 
where women may miss the oxytocin peaks of labor and birth. In this situation, synthetic oxytocin may 
partially compensate and beneficially promote oxytocin-related adaptations. The mechanisms by which 
synthetic oxytocin might have these central effects are not known.
During the perinatal period, peak activity in the maternal OT system (levels, receptors) activates central 
hormonally-mediated maternal circuits that adapt the new mother to care for her offspring. In women, 
recognized OT-related adaptations include specific infant-directed behaviors and changes in personality 
that reduce stress and increase caregiving (3.1.4). Exposure to synOT and other maternity care interven-
tions may impact these adaptations.
One study assessed postnatal changes in personality profile at two days, two months, and six months 
after birth among 55 breastfeeding mothers with various birth experiences. Following an unmedicated 
birth, new mothers’ anxiety and muscular tension were found to decrease, and social satisfaction and 
social conforming, which may help mothers to prioritize their baby’s needs, increased, with these chang-
es persisting from two days to six months after birth. Women receiving synOT in labor had small but 
significant dose-related benefits in several personality scales. In contrast, women who received epidural 
analgesia had minimal early personality changes, which positively shifted over six months, likely due to 
repeated hormone exposure (OT, beta-endorphins, prolactin) with each breastfeeding episode (3.2.5). 
However, those women who received synOT in addition to epidural analgesia had some of these adap-
tive changes from the second day after birth,571 suggesting that synOT exposure may partly compensate 
for the negative effects of epidurals on oxytocin release in labor and maternal adaptations (see 3.2.5).
Authors suggest that synOT could have these effects by acting centrally, perhaps bypassing the blood-
brain barrier, and/or could activate peripheral reflexes by increasing contraction strength and initiating 
some of the positive feedback cycles that increase central OT release571 (3.1.4). Other researchers have 
suggested that the OT molecule, or biologically active fragments, may access the brain through routes 
that bypass the blood-brain barrier.572 Increases in central OT sensitivity, due to peak OTRs at the physi-
ologic onset of labor (3.1.4), may also contribute. 
Another study compared nulliparous women post-cesarean who were administered standard doses of 
synOT (5 international units, IU) with women receiving additional synOT (50 IU) by infusion for clinical 
reasons. New mothers who received the synOT infusion had more positive personality changes two days 
after birth, similar to women following unmedicated birth (3.1.4). These mothers also released OT with 
the first breastfeeding, which did not occur for those who received a single dose of synOT.395 The author 
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suggests, “The infusion of oxytocin may have substituted for the release of oxytocin normally occurring 
during labor.”395(p.67) (See also 3.2.6.) 
These two studies of postpartum personality changes found significant positive effects from synOT fol-
lowing epidurals and CS, where maternal endogenous OT release would be reduced (3.2.5, 3.2.6). How-
ever, detrimental effects of synOT have been found in relation to OT release during early breastfeeding487 
(see “Synthetic Oxytocin and Breastfeeding,” above), and also dose-related changes in OT levels at two 
months216 (see “Synthetic oxytocin and the mother, longer term,” below). The diverse findings of these 
studies highlight the complexity of the OT system in the perinatal period, current limited understandings, 
and the possibility of longer-term impacts on the OT system. (See also “Oxytocin and Maternal Adapta-
tions and Attachment” in 3.1.4.)
With the widespread use of synOT in labor, birth, and the postpartum period, longer-term outcomes on 
the OT system, including effects on maternal adaptations and attachment, are critical areas for future 
research.
Synthetic Oxytocin and the Mother, Longer Term
Given the perinatal plasticity of the maternal brain, longer-term impacts from synthetic oxytocin expo-
sure in labor are possible but poorly researched. Preliminary findings from single studies suggest possible 
reduced oxytocin sensitivity and lengthening of subsequent labors. There are major gaps in research and 
understanding in this area. 
Postpartum maternal adaptations due to priming of the maternal brain, from prelabor (2.2) through 
physiologic birth and the early sensitive period (3.1.4), may give longer-term benefits to infant care and 
survival. Conversely, disruptions to perinatal maternal hormonal physiology could plausibly have longer-
term effects. This is not well researched.
In the only identified study that assessed the possible impacts of synOT exposure into future childbear-
ing, multiparous women who had received synOT in a previous labor were found to have a longer active 
labor, compared with those who were previously unexposed to synOT. Effects were even greater for 
women with a higher number of previous treated labors.573 
In another study, women who received synOT in labor had a dose-related increase in basal levels of OT 
at two months postpartum, compared with unexposed women. Higher OT levels were also found among 
primiparous compared with multiparous women, and among those who had stopped breastfeeding com-
pared with women who were still lactating.216 The mechanisms are not clear. It is possible that excessive 
synOT exposure in labor could lead to a long-term loss of sensitivity (e.g., by reduced OTR numbers), with 
a compensatory increase in endogenous OT levels. This is supported by the low OT levels found in women 
unexposed to synOT in labor and/or during lactation, which may reflect greater OTRs and OT sensitivity. 
(See also “Oxytocin complexities” in 3.1.1.) 
The findings of this study are in opposition to the study discussed above (“Synthetic Oxytocin and Breast-
feeding”), which found lower OT release in women during early breastfeeding, in inverse proportion to 
the dose of synOT administered in labor. The reasons for these differences are not clear, but could reflect 
early, evolving OT systems within the plastic maternal brain;381 the difference between basal levels and a 
situational rise with lactation (see “Oxytocin complexities” in 3.1.1); and/or other mechanisms. In relation 
to maternal effects, OT researchers suggest, “Given the action of natural oxytocin on various endocrine 
pathways, we anticipate that any effects of intrapartum synthetic oxytocin would be dose dependent and 
influenced by individual context and maternal history.”45(p.2)
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With the widespread maternal exposure to synOT in labor, birth, and the postpartum period, longer-term 
outcomes on the OT system, including during the next labor and birth, are critical areas for future research.
Synthetic Oxytocin and Offspring, Longer Term
There has been very little research on possible long-term impacts of synthetic oxytocin exposure in the 
perinatal period on human offspring. However, effects are biologically plausible, through direct exposure, 
which gives enduring effects in animal studies, or via indirect effects. 
Researchers and clinicians have expressed growing concerns about possible longer-term impacts of 
synOT on human offspring.42, 45-54 As discussed in “Synthetic Oxytocin and the Baby,” above, several 
mechanisms are biologically plausible, including:
  direct fetal brain-hormone effects from synOT transfer through placenta 
  indirect signaling of maternal OT to fetal brain
  indirect effects from subclinical hypoxia/or oxidative stress (see “Oxytocin Effects” in 3.2.3)
  interference with fetal neuroprotective mechanisms, as found in animal studies (see “Fetal 
neuroprotection” in 3.1.3)
  fetal/newborn impacts from synOT co-interventions, such as epidural 
  long-term programming of offspring OT and other hormonal systems, as found in animal new-
borns exposed to high-dose synOT, likely via epigenetic effects (see Synthetic oxytocin and off-
spring, animal studies” below)
  indirect effects via disruptions to maternal OT systems that impact attachment, reward, breast-
feeding, and mutual regulation (see 3.1.4; “Synthetic Oxytocin and Breastfeeding,” above; and 
“Synthetic Oxytocin and Maternal Adaptations and Attachment,” above)
Synthetic oxytocin and offspring, animal studies. Animal research clearly shows that synthetic 
oxytocin, administered systemically at supraphysiologic levels in the newborn period, can have long-term 
impacts on offspring oxytocin systems and related functions, including reproduction and parenting be-
haviors. In addition, newborn synOT administration at physiologic levels, or early-life manipulations that 
raise endogenous oxytocin can have effects into adulthood, with positive effects found in some studies. 
The implications for perinatal synOT exposure in human offspring are not known.
Animal studies of perinatal synOT exposure have largely involved prairie voles, a small mammal native 
to North America that is monogamous and biparental (both parents involved in infant care) and has an 
extensive central OT system. Among prairie voles, newborn exposure to a single high dose of synOT, 
administered into the body (via the peritoneal cavity) has dose-dependent impacts on the OT, estrogen, 
and AVP systems in adulthood, with many impacts differing for males and females (sexually dimorphic).168 
These impacts include:
  more rapid selection of sexual partner among males 
  more aggression among females, especially towards other females 
  changes in female alloparenting (caring for unrelated young)
  reduction in the number of ovarian germ cells (which later become mature eggs) 
  delayed sexual maturity among females, possibly related to fewer germ cells 
  increase in cardiac OTRs
  increase in brain estrogen receptors in female offspring 
  changes in the way the brain responds during social interactions
  changes in central OTRs
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In these and related studies, summarized by Carter168 and Bales,574 relatively low synOT doses facilitated 
mating-related pair bonding in males, who were more sensitive to effects, possibly by effects on the 
related AVP system (see 3.1.1). 
In addition, experimental manipulations expected to increase newborn endogenous OT had sexually 
dimorphic effects on OTRs, which also varied with the valance of the condition. For example, maternal 
separation in newborn rats, expected to cause stress-induced OT elevation, led to reduced central OTRs 
in adulthood, whereas high levels of maternal care, expected to elevate OT levels with a positive valence, 
led to increased central OTRs in females. Even subtle changes in handling of newborn voles produced 
changes in adult OTRs,574 reflecting the sensitivity of OT systems at this time. Other researchers found 
that a single high-dose injection of synOT in newborn rats caused decreases in adult brain dopamine, 
serotonin, and norepinephrine levels, with greater effects in males.575 
Because of these animal findings, researchers have warned against administering synOT for the treatment of 
labor dystocia in experimental mice, citing “Limited knowledge of the complex physiologic and molecular 
mechanisms of action of oxytocin”576(p.10) and “significant and increasingly recognized behavioral effects.”576(p.12)
In general, the synOT doses administered directly to offspring in these studies are substantially higher 
than the equivalent levels that human offspring could be indirectly exposed to via the mother in labor. 
(Doses administered to pregnant or laboring females are generally limited by uterine OT sensitivity: ex-
cessive doses will cause uterine hyperstimulation with deleterious impacts on the fetus/newborn. See 
“Synthetic oxytocin and central maternal oxytocin,” above.)
In relation to synOT exposure with induction, equine researchers found alterations in early pancreatic 
endocrine development and glucose regulation in foals induced with synOT. Researchers suggest that 
higher newborn cortisol levels following induced labor may impair glucose metabolism, with possible 
prolonged metabolic sequelae.148
Other studies found impacts through to adulthood from administering synOT at physiologic-type doses 
to newborn rats, or from manipulations that increased endogenous OT such as stroking with a paint-
brush. These include: reduced blood pressure and stress hormone levels; reduced responses to pain; and 
greater weight. Exposed female offspring subsequently bore larger babies with larger placentas, suggest-
ing possible transgenerational effects.577 Prairie vole studies involving newborn manipulations that cause 
high-physiologic OT levels, discussed above, also found long-term impacts on the OT system that varied 
with the valence of the manipulation.574 (See “Synthetic oxytocin and offspring, human studies,” below, 
for relevance to human synOT exposure.)
Synthetic oxytocin and epigenetics. These impacts of synthetic oxytocin exposure on animal 
offspring into adulthood are consistent with epigenetic effects causing fetal/newborn programming, also 
called “hormonal imprinting,” in relation to exposures during the perinatal period. 
According to veteran researcher Csaba:
Hormonal (chemical) imprinting . . . is a general biological phenomenon which takes place when the 
developing receptor meets its target hormone for the first time . . . . In mammals, hormonal imprint-
ing takes place perinatally and determines the function of receptor-signal-transduction systems as 
well as hormone production for life . . . . Excess of the target hormones or presence of foreign mol-
ecules which are able to bind to the receptors, provokes faulty imprinting in the critical periods with 
life-long morphological, biochemical, functional or behavioural consequences.578(p.1) 
71CHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | 3 OXYTOCIN / 3.2.3
In some hormonal imprinting studies, changes have been inherited through several generations.41, 578 
Dahlen and colleagues call this perinatal phenomenon “epigenetic impact of childbirth” (EPIIC).42 
The heightened potential for epigenetic changes in the perinatal period, with the possibility of long-term  
programming effects, is consistent with the “developmental origins of health and disease” (DOHaD) model,579 
and more recently the “developmental origins of health, behavior and disease, DOHBaD33), which consid-
ers long-term impacts of gestational exposures; and with the “lifecourse health development model” 
(LCHD).43 These models acknowledge the extreme plasticity of offspring physiology in the perinatal pe-
riod, with biologic amplification of experiences at this time. (See further discussion in 1.4.)
Synthetic oxytocin and offspring, human studies. Short- to longer-term human impacts from 
exposure to synthetic oxytocin in labor are biologically plausible, but studies are lacking. Preliminary find-
ings suggest possible effects on social and developmental behaviors, with concerns raised about possible 
links between synthetic oxytocin exposure in labor and autism.
This area is very poorly researched. One survey found correlations between the duration of exposure to 
synOT in labor and risk of medically-confirmed attention-deficit hyperactivity disorder (ADHD) among 
surveyed 3- to 25-year-olds.580 The authors suggest that subclinical birth hypoxia and/or epigenetic 
mechanisms may contribute.295, 580 A recent large population study also found links between induction 
and ADHD, which researchers relate to shortening of gestation.581 
In the most detailed study to date, researchers comprehensively evaluated the development of 148 chil-
dren at age five in relation to synOT exposure in uncomplicated labor. They found that, with uncompli-
cated labor and birth, exposure to synOT significantly increased the risks of poor developmental scores 
among children of younger and older mothers, possibly related to prolonged synOT exposure. Exposed 
children born by instrumental birth or cesarean had lower risks, which researchers ascribe to possible 
shortening of complicated labors.582, 583 Duration of breastfeeding was also shorter for exposed children 
in this cohort,569 which may contribute to these findings. Researchers conclude, “. . . synthetic oxytocin 
should be used with caution, reducing fetal exposure as far as possible by administering the lowest ef-
fective dose, or even resorting to alternative therapies.”584(p.9)
One preliminary survey assessed psychosocial function among normal children in relation to synOT ex-
posure, and found subtle shifts among exposed compared with unexposed three-year-olds.585 
Several researchers have suggested the possibility of links between exposure to synOT in labor and au-
tism,46, 586, 587 largely because of the deficits in OT-associated social functions found in autistic individuals. 
In addition, OTR dysfunctions have been implicated in both animal models and humans with autism,227 
and synOT has been found to ameliorate some aspects of autism.588 Persisting downregulation of fetal 
OTRs in response to synOT exposure in labor has been suggested as a possible mechanism.587 
A recent review and meta-analysis found a 20 percent increased risk of autism following induction or 
augmentation of labor; authors suggest that fetal hypoxia may contribute.589 An animal model of autism 
has implicated faulty OT-related neuroprotection295 (see “Fetal neuroprotection” in 3.1.3). This mecha-
nism is only active around the physiologic onset of labor, and is also compromised by high-dose synOT, 
according to animal research.97, 293 This model contributes additional complexity and hypotheses in re-
searching possible links between autism and perinatal exposures.
Kenkel, along with veteran OT researcher Sue Carter and colleagues, comment in relation to developmental 
risks in human populations: “. . . manipulation of oxytocin levels around the time of birth holds the poten-
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tial to induce persistent changes in the fetal brain and behavior, perhaps by affecting not only the oxytocin 
peptide and its receptor, but also other related peptides such as vasopressin and its receptors.”54(p.2) 168
Given the widespread exposure of mothers and babies to synOT for induction and augmentation in 
labor,18 the possible impacts of this drug in relation to breastfeeding, maternal-infant attachment, and 
long-term maternal and offspring adaptations and development are critical areas for future research.
3.2.4 Opioid Analgesic Drugs: Possible Impacts on Oxytocin Physiology 
Opioid drugs, including those naturally derived from the opium poppy (opiates), are widely used as anal-
gesics in labor and birth, either systemically by intramuscular or intravenous injection, or as components 
of epidural analgesia. Opioid drugs can have hormonal impacts because they have similar effects to beta-
endorphins and other natural (endogenous) opioid hormones.
Opioid drugs used in labor, administered systemically by IM or IV injection, or as a component of epidu-
ral analgesia, include:
  morphine, a natural opiate
  meperidine (Demerol, pethidine), derived from morphine
  fentanyl (Sublimaze), sufentanyl (Sufentanyl), and remifentanil (Ultiva), synthetic opioids, also 
commonly used in epidurals 
  tramadol, a synthetic opioid that also impacts serotonin and NE
  meptazinol (Meptid), nalbuphine (Nubain), pentazocine (Fortral), butorphanol (Stadol), and 
buprenorphine (Temgesic, Buprenax), partial agonists, which partly activate and partly block 
opioid receptors
These drugs have differing pharmacologic and adverse effects profiles. Systematic reviews have not 
found one opioid to be superior when administered systemically by intramuscular or intravenous injec-
tion for labor analgesia, from current evidence, but quality studies are lacking.590, 591
Opioid Drugs and the Mother
Endogenous opioids such as beta-endorphins reduce oxytocin release within the brain, possibly as part of 
a contraction-inhibiting response to labor stress. Studies suggest that opioid drugs, working on the same 
receptors, may also reduce maternal oxytocin release and slow labor. Opioids may also act directly in the 
uterus to reduce contractions. Opioid drugs may reduce beta-endorphins and may also counter the eu-
phoric and amnesic effects of oxytocin in labor and after birth.
One study found incremental reductions in OT levels, measured in blood, following the gradual IV admin-
istration of morphine to women in early labor.592 Opioid-induced OT reductions would be expected to pro-
long labor, although this has not been well studied. In a literature review of the impacts of pethidine (me-
peridine) on labor, Thomson and Hillier concluded, “There is a strong suggestion in the literature that the 
use of this drug is associated with a lengthening of labor and that this association is dose-related.”593(p.448) 
In addition, studies have found that laboring women are more frequently administered synOT following  
systemic administration of meperidine594 and fentanyl,595 compared with no medication, suggesting 
reduced contraction efficacy. Researchers have found mu opioid receptors (MORs, receptors for beta-
endorphin and most opioid drugs) in the human uterus with relaxant effects,596 suggesting that opioid 
drugs may slow labor by acting locally, as well as centrally to reduce OT release. One human study did 
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not find changes in uterine contractions following a single low systemic meperidine dose.597 The 2011 
Cochrane systematic review of systemic opioid analgesia in labor found no increase in instrumental 
delivery or CS for laboring women using meperidine compared to placebo,591 but did not assess labor 
length.591, 597, 598
Slowing of labor in response to opioid drugs may mirror the physiologic effects of endogenous opioids 
such as BEs, which may reduce contractions as an adaptive response to stress in labor (see 4.1.3). The opi-
ate drug morphine has been recommended systemically to facilitate “therapeutic rest” for women with 
a prolonged latent stage of labor.598 According to Greulich, 85 percent of women administered meperidine 
for prolonged latent phase will benefit from 6 to 10 hours of rest and awaken in active labor.598
One study found that, for women who had received systemic opioid drugs in labor, the memory of labor 
pain intensified over time, compared with women who used no medication, whose recall of labor pain 
diminished with time.599 Possible mechanisms include a more intense experience of labor pain and/or 
an opioid-mediated reduction in central OT, with loss of its amnesic and euphoric effects. (See also 
“Epidural Analgesia and the Mother” in 3.2.5.)
Opioid Drugs and the Fetus/Newborn 
Opioid drugs can readily cross the placenta and enter the fetal brain. Many detrimental opioid effects re-
late to fetal and newborn sedation. In addition, opioid drugs could plausibly reduce central oxytocin in the 
baby, although cord blood measurements have not shown oxytocin reductions in the blood of newborns 
exposed to systemic opioids, compared to unexposed babies. Opioid exposure via epidurals may also have 
fetal/newborn effects.
Fetal opioid sedative effects may include: reduced fetal heart rate accelerations, reductions in beat-to-
beat variability600 and, for the newborn, added risks of respiratory depression601 and deficits in prebreast-
feeding behaviors and abilities.315, 350, 351, 602-604 Some of these effects may also occur following epidural 
opioid exposure (3.2.5).
Opioid drugs can easily cross the placenta and enter the fetal brain.591 According to hormonal physiology 
understandings, opioids could reduce central fetal OT, potentially reducing neuroprotective and calming 
effects. While studies did not find reductions in cord blood OT levels in relation to labor exposure to sys-
temic meperidine309 or morphine,605 central OT in labor is obviously impossible to measure.
Uninterrupted skin-to-skin contact, which physiologically increases OT (3.1.1), has been found to lessen 
the impacts of labor opioid exposure on newborn prebreastfeeding behaviors.351 This suggests that OT-
related “calm and connection” effects may be important for newborns exposed to opioid drugs in labor 
(3.1.2).309, 351, 605
Opioid Drugs and Breastfeeding 
Opioid drugs may detrimentally impact breastfeeding through maternal and/or newborn sedation and 
possibly through oxytocin reductions in both. There is a lack of high-quality research in this area.
Few high-quality studies have looked at breastfeeding success in relation to opioid exposure in labor com-
pared to no medication.591 One large observational study found a significant reduction in breastfeeding 
success at 48 hours following opioid use in labor, compared with no analgesics.564 It is unclear whether 
this is due to maternal factors, such as OT inhibition; newborn factors, as above, including sedation after 
birth; or both (4.2.4). 
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One study found that low-therapeutic doses of morphine inhibited the maternal OT surge associated 
with breastfeeding in new mothers.606 Morphine administration also caused a dose-related OT reduction 
in dairy cows, with inhibition of the OT-mediated let-down reflex at high doses.607 Opioid drugs such as 
meperidine may also have prolonged pharmacologic effects, especially for the baby, whose metabolizing 
systems are immature.608
These possible opioid impacts on maternal OT and breastfeeding are important considerations, as opioids 
are commonly used for post-CS analgesia,609 and are often administered for several days postpartum, 
when early lactation is being established. While newborn exposure may be minimal, because most opioid 
drugs are excreted in only small amounts in breast milk,610, 611 impacts on the maternal OT system and 
let-down reflex could have significant detrimental effects on breastfeeding success. One study found re-
duced breastfeeding episodes and lower newborn weight gain over 11 days among women randomized 
to post-CS epidural with the opioid buprenorphine, compared with epidural with only local anesthetic 
(bupivacaine).612 These are critical areas for future research.
Opioid Drugs and Offspring, Longer Term 
As with other drugs administered in the perinatal period, it is possible that opioid drugs could have 
longer-term programming effects, including on offspring OT systems. 
Possible programming effects of perinatal opioid exposure on offspring are discussed in 2.2.4. 
3.2.5 Epidural Analgesia: Possible Impacts on Oxytocin Physiology 
Epidural analgesia is the most commonly used and effective analgesia in labor. However, epidurals can signifi-
cantly disrupt hormonal systems, including oxytocin, leading to common side effects such as slowing of labor.
Epidural analgesia involves the administration of local anesthetic (LA) drugs into the epidural space around 
the covering of the spinal cord. This blocks the nerves that traverse this space, similar to the action of a 
dental anesthetic, including both the sensory nerves, leading to numbness, and the motor nerves that 
control movement, giving some degree of paralysis in the lower body. Modern epidurals typically also 
include opioid drugs, which augment LA effects. This allows for effective analgesia using lower concen-
trations of LA drugs, with potentially less motor block and paralysis.
Epidural analgesia is widely understood to be the most effective form of pain relief in labor and birth.613 
It is the most widely used method of pain relief among US women, with 67 percent of respondents to a 
recent national survey reporting that they had received an epidural around the time of birth.17 While epi-
dural analgesia can be beneficial for many women, it can also have significant impacts on the progress 
of labor and birth, as well as side effects for mother and baby, many of which are attributable to impacts 
on the OT system. Recent studies have also shown subtle disruptions in maternal and newborn postpar-
tum physiology following epidural exposure in labor, raising concerns about possible prolonged impacts 
on OT systems, as detailed below.
Epidural Analgesia and the Mother
Epidural analgesia can have significant effects on the mother, many of which may be due to OT impacts.
The most recent Cochrane systematic review614 documents the following impacts for laboring women 
using epidural analgesia, most of which are consistent with OT disruptions, as described below:
  increased use of synOT augmentation
  prolonged second stage of labor 
  increased use of forceps or vacuum assistance at birth
  increased use of CS for “fetal distress” 
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Epidural analgesia and oxytocin systems in labor. Epidurals reduce maternal oxytocin, likely 
because of lack of the sensations and sensory feedback that releases oxytocin from the brain. This can 
lead to slower labor and increased need for synthetic oxytocin. Late-labor oxytocin reductions may con-
tribute to a longer pushing stage and extra need for forceps or vacuum assistance. The administration of 
synthetic oxytocin as a common co-intervention may also contribute to epidural impacts.
Studies show a decline, or a lack of the expected rise, in laboring women’s OT levels after epidural adminis-
tration,615-618 as shown in Figure 2.616 A small transient OT rise preceding this decline, as seen in another study,618 
may reflect a sudden drop in epinephrine, which may have been inhibiting OT (3.3.5). The subsequent OT decline 
occurs following epidurals both with616 and without618 opioids and also spinal analgesia,618 which generally in-
volves an opioid drug injected close to the spinal cord. (See 3.3.5 for more about spinal effects and side effects.)
Figure 2. Maternal oxytocin levels, with and without epidural analgesia
(0 = level just before epidural administration or, for control group, at similar 4.5 cm cervical dilation. 
Duration from 0 to birth: 128 minutes without epidural, 200 minutes with epidural.)
Source: adapted from Rahm616
Low OT levels in the pushing stage, as seen in Figure 2, may be due to loss of the normal positive feedback 
cycle (“Ferguson reflex,” see 3.1.3), which gives peak OT levels that ensure an effective pushing stage.619 
Loss of this OT peak may contribute to the prolonged pushing stage and increased risks of instrumental 
birth following epidural analgesia.614, 619 
























Maternal postpartum OT levels, as measured in the blood, are around 50 percent of normal at birth fol-
lowing epidural analgesia.616, 619 Animal studies of sheep620 and cows,263 where central OT levels can be 
measured, have found reductions in brain as well as blood levels of OT following LA-only epidural admin-
istration, with significant impacts on maternal behaviors. (See “Epidural Analgesia and Maternal Adapta-
tions,” below.) 
The exact mechanism by which epidurals reduce OT release is not certain. Epidural-induced numbness 
interrupts the uterine sensations that activate a central positive feedback cycle, augmenting OT release 
from the brain (see “Positive feedback cycles” in 3.1.3). According to mammalian physiology principles, 
“Sensory input from female reproductive structures is paramount for the co-ordination of neuroendo-
crine changes at parturition.”621(p.1013) In addition, local anesthetic drugs are derivatives of cocaine, which 
reduces central OT in animal studies.622
Reduced OT release likely accounts for the increased use of augmentation, longer second stage of labor, 
and increased risk of instrumental birth among women receiving an epidural.614 The increased use of synOT 
in women receiving compared with not receiving epidurals623 may mask impacts on the length of the first 
stage of labor. In addition, prolonged synOT exposure leading to OTR desensitization (see “Synthetic oxyto-
cin and oxytocin receptor desensitization” in 3.2.3) could further contribute to prolonged pushing and in-
creased instrumental birth. Reduced endogenous OT release in labor and the postpartum period, following 
epidural exposure, also raises concerns about breastfeeding and maternal adaptations, explored below. 
Epidural analgesia and maternal temperature regulation in labor. Around one in ten 
women receiving an epidural develop a fever in labor, which may be related to oxytocin changes. 
It is estimated that 10 to 20 percent of women who receive an epidural experience a temperature eleva-
tion in labor,624, 625 whereas epidurals generally decrease temperature outside of labor.626 The mechanism 
behind this paradoxical effect is currently thought to involve maternal inflammation and inflammatory 
processes.627
Oxytocin disruptions could contribute to epidural fever through loss of OT anti-inflammatory effects (3.1.1) 
and/or through changes in brain-based temperature regulation, which may also involve the OT system.48 
Maternal inflammation likely contributes to the increase in inflammatory substances found in cord blood of 
epidural-exposed newborns compared with unexposed babies,628 with unknown implications.625, 628-630
Fetal/newborn effects of maternal fever are discussed below (“Epidural Analgesia and the Fetus/Newborn”).
Epidural Analgesia and the Fetus/Newborn
Drugs administered via epidural will pass to the baby and may impact the fetal/newborn oxytocin system. 
This has not been well studied. Preliminary studies show elevated newborn oxytocin with epidural exposure, 
which may reflect increased fetal stress, and also subtle disruption to newborn oxytocin-related autonomic 
nervous system functions, possibly persisting into infancy. Maternal fever can increase risks to the baby’s 
brain, and also necessitate newborn separation and testing, with loss of early oxytocin-rich mother-
newborn interactions and breastfeeding initiation. Epidural co-interventions may also impact the baby. 
The opioid drugs commonly used in epidurals pass through the placenta to the baby and can also cross 
to the fetal brain. In some cases, fetal central opioid exposure with epidurals may be high enough to cause 
newborn respiratory depression.631 Such high central levels could also disrupt OT release, although this has 
not been directly measured. One older study found that fetal OT production was increased with exposure 
to epidurals, although opioid drugs were likely not administered in epidurals at that time.309 Stress-induced 
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OT release could contribute (see 4.2.5 for more about epidurals and fetal/newborn stress). Epidurals may 
also impact newborn neurobehavior, as suggested by dose-response findings in relation to LA drugs,632-636 
and by findings from more comprehensive testing.635-637 However, findings are controversial and compli-
cated by differing understandings and measurements of newborn neurobehavior,638 and by comparisons 
with newborns exposed to opioid drugs, which can impact newborn neurobehavior via sedation.
A study of newborn skin temperature response to skin-to-skin breastfeeding, mentioned above (“Synthet-
ic Oxytocin and the Baby” in 3.2.3), also found disruptions in relation to epidural exposure. In contrast to 
the normal physiologic gradual elevation and decline with SSC breastfeeding, epidural-exposed newborns 
had an initial, elevated skin temperature, which decreased during skin-to-skin breastfeeding.555 Authors 
speculate that epidurals may adversely impact newborn OT-related ANS functions, perhaps due to the im-
pacts of the opioid drug sufentanil, used in this study, which easily crosses the placenta to the fetal brain, 
where it could inhibit OT release.555 In this study, slightly younger infants had higher initial skin tempera-
tures, suggesting a short-term and/or pharmacologic effect on the baby, or possibly on the mother via 
epidural-related disruptions in maternal temperature responses.
Maternal fever in labor (see “Epidural analgesia and maternal temperature regulation in labor,” above) 
can have detrimental impacts on the baby, whose body and brain will also be heated. Fetal heating increas-
es vulnerability to neurologic damage and increases the risk of low Apgar scores, severe breathing difficul-
ties, and early-onset neonatal seizures, all with possible longer-term impacts.625 In addition, newborns of 
febrile mothers are likely to be separated for a “septic workup,” with blood tests and, usually, presumptive 
treatment with antibiotics.630 Separation may last several days, interfering with important OT-related inter-
actions, such as SSC and breastfeeding, with possible impacts on the newborn OT system (3.2.7). 
Another study found abnormal defense-type autonomic reactions to novel stimuli among eight-month-
old infants who had been exposed to epidurals at birth, compared with normal orienting reactions among 
unexposed infants.639 This defensive reaction also suggests ANS disruption. Long-term follow-up studies 
of monkey offspring exposed to epidurals also suggest developmental impacts.640 (See 4.2.4 and 4.2.5 for 
animal studies on long-term impact of opioid drugs and epidurals.)
Because epidurals generally slow labor and increase the need for synOT to compensate (above), the 
fetal/newborn impacts of epidurals may also include the impacts of synOT (see “Synthetic Oxytocin and 
the Baby” in 3.2.3). 
Given current widespread exposures, the full effects of epidurals on the baby in the short and longer 
term are critical areas for future research.
Epidural Analgesia and Breastfeeding
Epidurals may negatively impact breastfeeding success, with some evidence for shortened duration, but 
studies are contradictory, and high-quality research is lacking. Exposure to both epidurals and synthetic 
oxytocin in labor may significantly reduce maternal oxytocin release with breastfeeding. The exact mech-
anisms and short or long-term implications are not known. Epidural effects on the newborn may also im-
pact breastfeeding. 
Many factors contribute to breastfeeding initiation and continuation, including maternal and fetal/new-
born hormones and other factors. These are complex to disentangle in epidural studies, including the 
effects of co-interventions such as synOT.642
Randomized studies in this area are problematic, as it has not been possible to include women random-
ized to no analgesia, for ethical reasons.643, 644 Observational studies report contradictory findings.47, 286, 
487, 554, 555, 570, 604, 642, 645-657 Reduced duration of breastfeeding has been found in several studies.286, 642, 649-651
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Studies in settings that strongly support breastfeeding, with routine postpartum SSC and rooming in for 
mothers and babies have generally better outcomes.642, 653-656 Early SSC may benefit newborn breastfeed-
ing initiation by activating maternal and infant OT, beta-endorphins, and PRL systems, with calming and 
rewarding effects for both that may reduce epidural-related hormonal disruptions (3.2.5, 4.2.5, 5.2.5, 
6.2.5). Early SSC enhances breastfeeding initiation and success,336 as promoted by the Baby-Friendly Hos-
pital Initiative (3.1.4, 4.1.4, 5.1.4, 6.1.4).
From a hormonal physiology perspective, epidural-related maternal OT reductions in labor and birth 
could impact OT functions and release during breastfeeding, including OT-related prolactin secretion 
(6.1.4). Researchers analyzed the release of hormones during breastfeeding in new mothers according to 
interventions in labor, and found that women exposed to epidurals alone had no differences in OT or PRL 
release. However, exposure to synOT in addition to epidurals was associated with the lowest OT levels 
during breastfeeding, 487 and also the highest levels of the stress hormone cortisol,570 compared with any 
other intervention or with unmedicated labor. These findings570 suggest that the combination of epidur-
als plus synOT may be especially disruptive to postpartum OT release, and may impact stress responses, 
although the mechanism is not clear.
Given current widespread exposures, and the increasingly recognized detrimental effects in mother and 
baby of not breastfeeding, the full effects of epidurals on breastfeeding are critical areas for future research. 
Epidural Analgesia and Maternal Adaptations
Epidural-related reductions in oxytocin, especially the oxytocin peak at birth, could potentially affect ma-
ternal adaptations in women, as has been demonstrated in animals. Studies in women have found subtle 
disturbances in maternal adaptations and in maternal-newborn interactions that may compromise evolv-
ing attachment.
Researchers have administered epidurals to laboring sheep620 and cows,263 and found reduced or absent 
maternal behaviors such as licking and maternal bleating (ewes), along with reduced central OT levels. In 
the sheep studies, primiparous ewes, and those administered early epidurals were more affected than 
their multiparous and later-administration counterparts.620 Researchers subsequently injected synOT 
into the brain of affected ewes, replacing the epidural-related central loss, and found a substantial but 
not total reinstatement of mothering behaviors.262 This is consistent with the understanding that hor-
mones such BEs, NE, and PRL, which can all be affected by epidurals, may also influence maternal adap-
tations and behaviors (4.2.5, 5.2.5, 6.2.5).
As discussed in the Introduction (1.2), maternal behaviors are much more varied and complex, and dif-
ficult to quantify in women, compared with other mammals. However, several studies have found subtle 
differences in maternal adaptations and maternal-infant interactions following epidural analgesia, which 
may reflect disruptions to maternal OT attachment systems.
Findings include:
  reduced proximity seeking in new mothers in hospital, in proportion to epidural dosage of the LA 
drug bupivacaine635
  more unsettled newborn behavior, in proportion to bupivacaine exposure636
  more unsettled newborn behaviors and lower scores on Neonatal Behavioral Assessment Scale 
compared with unexposed mothers637
  maternal characterization of babies as less social and rewarding and more bothersome at one 
month, compared with unexposed mothers637 
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Dose-response findings in some of these studies suggest that, from a hormonal perspective, the numb-
ing effects of LA drugs may disrupt the laboring woman’s sensory feedback, which usually increases OT 
release within her brain as labor progresses (see “Positive feedback cycles” in 3.1.3). Lack of central OT 
elevations may give subtle disruption to maternal adaptations, including reduced OT-related adaptations 
and attachment systems. The postpartum OT system usually promotes proximity seeking (see “Mater-
nal-infant bonding and attachment” in 3.1.4) and activates reward centers that promote ongoing contact 
and care, likely also involving beta-endorphins (4.1.4). With epidural-associated OT reductions, maternal 
reward center activation in relation to infant contact and care may be reduced, so that the baby is less 
rewarding, in a biologic sense (see “Oxytocin and Maternal Adaptations and Attachment” in 3.1.4 and 
also 4.2.5 for epidural-related reductions in BEs). Epidural-associated shifts in newborn neurobehavior 
and functioning may also contribute.637
In another study, researchers found that women exposed to epidurals in labor did not experience the 
normal early-postpartum shift in personality, whereby anxiety and muscular tension decrease and “social-
ization” increases571 (see “Maternal Adaptations” in 3.1.4). Authors comment, “. . . lack of oxytocin during 
this “sensitive period” may result in a lack of development of long-term maternal adaptations.571(p.344)
Due to limited research, these findings are not definitive, and do not imply that women receiving epidural 
analgesia in labor will have deficits in mothering, or in relationships with their infants. However, from the 
perspective of hormonal physiology, epidurals may interfere with OT-related processes that give calm, 
connection, and ongoing pleasure and reward to new mothers in relation to contact and care with their 
newborn, and may interfere with biologic aspects of bonding (3.1.4). Findings also suggest that epidural-
exposed mothers and babies may benefit from assistance with OT-related processes after birth, including 
breastfeeding and SSC, which may both be important in optimizing maternal OT systems. 
Given the current high use of epidurals, and the low level of understanding of the impacts of epidurals 
on OT–related processes, including breastfeeding and biologic aspects of maternal adaptations and 
bonding, these are critical areas for future research.
Epidural impacts on memory and reward
Epidural-related oxytocin disruptions, and the related co-interventions, may contribute to dissatisfaction 
with the experience of birth. Loss of positive oxytocin effects on memory may contribute to a stronger 
memory of labor pain and distress. 
Studies have shown that, while women using an epidural generally experience effective pain relief,614, 658 
they are no more satisfied with the birth overall,658-662 and may even be more dissatisfied with their birth 
experience, compared with women who used no analgesia. 663-666 In addition, even though women using 
epidural analgesia report less pain during labor, they may remember more distress and trauma, even five 
years later, according to one study.667 
These findings may relate to preexisting characteristics, to co-interventions, and/or to a more intense ex-
perience of pain before epidural administration. However, OT impacts may also contribute. As discussed 
in “Oxytocin Effects” in 3.1.1, OT not only relieves pain, but also reduces the memory of pain. Epidural-
associated decreases in OT, and especially loss of the late-labor OT surge, may leave women with a stronger 
memory of pain and distress, without the assistance of OT-mediated analgesia and calm, and without 
post-birth euphoria mediated by OT and other hormones (see “Pleasure and reward” in 3.1.4 and  
“Maternal Beta-Endorphins After Birth“ in 4.1.4).
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3.2.6 Cesarean Section: Possible Impacts on Oxytocin Physiology
The impacts of cesarean section on the oxytocin systems of mothers and babies will vary with cesarean 
timing (pre- or in-labor), with the nature of labor onset (with an in-labor cesarean following induction im-
plying deficits in physiologic prelabor preparations for mother and baby), and, for prelabor cesarean, with 
the proximity to when physiologic onset of labor would otherwise have occurred. In relation to oxytocin 
hormonal physiology, an in-labor non-emergency cesarean may be the most beneficial type of cesarean 
for mother and baby.
 
With a cesarean section, mothers and babies lack the full processes of labor and birth, including full activa-
tion of the OT system, and the physiologic OT peaks of labor and birth. With a prelabor CS (or an in-labor 
CS following induction), both may also miss important OT preparations, including OTR upregulation in the 
maternal uterus, and possibly also in the breasts and maternal brain (as found in animal studies; see 3.1.2, 
3.1.3). In addition, following a cesarean, mother and baby may also miss postpartum skin-to-skin contact 
during the early sensitive period (see “Postpartum sensitive period” in 3.1.4). Disruption of OT physiology 
may contribute to increased risks for healthy mothers and babies undergoing CS, compared with those ex-
periencing vaginal birth.
Table 3 summarizes this information and is ordered according to the increasing impact on the OT systems 
of mother and baby. The physiologic differences in CS types may explain some variations in research find-
ings about effects of CS.
A CS could also be planned and in-labor following physiologic onset of term labor. Although this approach 
is not common or well researched, prelabor physiologic preparations for mother and baby in this situa-
tion may promote newborn transitions and breastfeeding, and reduce risk of PPH, among other benefits 
(3.1.4). A planned in-labor CS be may be beneficial to the oxytocin adaptations of the large group of 
women and babies having planned repeat CS. Non-hormonal aspects of surgery will obviously influence 
benefit/harm considerations. This is an important area for future research.
In any CS situation, the mother’s cervical changes may give an indication of her readiness for labor and 
birth, likely including her uterine OTR numbers. This may also indicate her risk of postpartum hemor-
rhage (see “Oxytocin and postpartum hemorrhage” in 3.1.4). Because readiness is coordinated between 
mother and baby, this may also indicate her baby’s readiness for life outside the womb and risk of CS 
morbidities, especially respiratory morbidity. Possible associations between pre-cesarean maternal cer-
vical status, newborn outcome, and PPH (below) are important areas for future research.
With PLCS, labor has not been initiated or experienced, and so there is likely to be significantly reduced 
prelabor physiologic preparations in mother or baby (3.1.2, 2.1, 2.2), and no labor processes or peak 
hormone levels to complete these preparations. With an unplanned in-labor CS, labor may have been 
physiologically initiated, with full prelabor preparations for mother and baby, or labor may have been 
induced, with an unknown degree of readiness for birth. Mother and baby will have experienced some 
labor processes and hormonal activation. In addition, exposure to synOT for labor augmentation may 
impact OT systems (3.2.3), including via OTR desensitization effects that may increase post-CS PPH risk.
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Cesarean and the Mother
With a cesarean, the mother misses the oxytocin peak at birth and may also miss early contact with her 
newborn, which can beneficially activate both maternal and newborn oxytocin systems, giving calm and 
connection, an ideal environment for breastfeeding initiation, and possibly important central oxytocin 
adaptations and biologic bonding processes for both. Fewer uterine oxytocin receptors due to lack of prela-
bor physiologic preparations with prelabor cesarean, or to receptor desensitization following prolonged syn-
thetic oxytocin exposure in labor, may increase risk of postpartum hemorrhage. The frequent lack of mother-
newborn skin-to-skin contact after cesarean section could also contribute to increased hemorrhage risks. 
Following any type of cesarean, the maternal peak of OT during the pushing stage (see “Maternal Oxy-
tocin in Labor and Birth” in 3.1.3) will be absent, giving lower OT levels at birth. Skin-to-skin contact 
between mother and newborn, and the first opportunity to breastfeed, are typically delayed after CS,17, 
432 so that the new mother may miss opportunities to release her own OT, which would activate central 
OT systems and may also help to reduce bleeding (see “Oxytocin and postpartum hemorrhage” in 3.1.4). 
Delayed SSC and/or breastfeeding initiation may also impact longer-term success (see “Cesarean and 
Breastfeeding,” below; 3.2.7; and 3.1.4).
There may be a sensitive period for mothers following CS as for vaginal birth (3.1.4), which may be trig-
gered by contact with her baby391, 395 (see “Cesarean Section and Maternal Adaptations,” below).
Studies show that CS is a risk factor for PPH, including bleeding severe enough to require blood transfu-
sion and even postpartum hysterectomy.668-671 For women with a PLCS, or who experience an unplanned 
cesarean following an induced labor, low uterine OTR numbers due to lack of physiologic prelabor prepa-
rations may contribute. Women whose cesarean follows the physiologic onset of labor may have the nor-
mal prelabor increase in OTRs, and lower PPH risk, although this subset has not been specifically studied. 
Even if labor onset is physiologic, prolonged exposure to synOT with labor augmentation may desensitize 
OTRs and increase PPH risk following CS. As discussed above, pre-CS cervical status could be a marker 
for proximity to physiologic labor onset, uterine OT sensitivity, and PPH risk, excluding in-labor synOT 
exposure (see “Synthetic oxytocin and postpartum hemorrhage” in 3.2.3).
Skin-to-skin newborn contact may help to release maternal OT and could plausibly reduce PPH risk after 
CS, as after physiologic birth, when mother-newborn interactions may increase maternal OT by two-
fold, and even up to ten-fold (see “Oxytocin and maternal-newborn contact and interactions” in 3.1.4). 
One CS study showed elevations in maternal OT (maximum around 50 percent) in the first hour, with 
equivalent levels for mothers with SSC or close non-physical contact. In this study, fathers who were in 
contact with their babies also had OT elevations.395 
Cesarean and the Fetus/Newborn
Oxytocin levels are lower in newborns in the early hours following prelabor cesarean, likely from lack of 
labor eustress. Maternal skin-to-skin contact and breastfeeding may be important to elevate newborn OT 
and reduce stress hormones. Levels of immature forms of the oxytocin molecule are elevated following 
cesarean, with unknown implications. 
Immediately following PLCS, newborns have OT levels that are one-half to one-third of levels in vaginal-
ly-born babies,174, 306, 307 likely due to lack of the beneficial eustress of labor (3.1.3). Low OT levels may 
contribute to higher newborn pain sensitivity following CS.302 After the initial hours, newborn levels may 
be equivalent for CS and vaginally born babies.174 Newborn OT elevations with SSC and breastfeeding pro-
duce “calm and connection” effects and may be important in reducing high E-NE levels, which can persist 
following CS672 (see also “Oxytocin and maternal-newborn contact and interactions” in 3.1.4 and “Cesar-
ean and the fetus/newborn” in 5.2.6).
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One study found that, following PLCS, newborns had higher levels of “extended forms” of OT, also called 
OT-X, compared with vaginally born babies.673 These are immature forms of the OT molecule that have not 
had the terminal section enzymatically cleaved. The role of OT-X in labor and for the newborn is uncertain. 
OT-X levels are elevated in autistic individuals674 and increased risks of autism following CS compared with 
vaginal birth have been found in some studies.675-678 (See also “Cesarean and Offspring, Longer Term,” be-
low, and “Cesarean and the Fetus/Newborn” in 5.2.6 for more discussion of possible long-term CS effects.)
Cesarean and Breastfeeding 
Breastfeeding initiation rates are lower following prelabor cesarean, but continuation rates following cesar-
ean and vaginal birth may be similar. Following in-labor unplanned cesarean, oxytocin and prolactin release 
may be reduced, possibly reflecting a prolonged delay to first breastfeed. Early mother-newborn contact and 
breastfeeding initiation may be important following cesarean to optimize hormonal physiology for both. 
A recent systematic review concluded that breastfeeding initiation rates are reduced following PLCS, but 
not in-labor unplanned CS, compared with vaginal birth. Authors suggest, “ . . . the metabolic or endocrine 
milieu of labor may be paramount to initiating lactation.”679(p.1131) This implicates the OT system and likely 
also PRL, where receptor numbers may also be low when full preparations for labor are missed (6.1.2). 
If breastfeeding is initiated, rates are not reduced at six months following CS compared to vaginal birth, 
according to this review.679
Researchers have found disruption to hormonal release during breastfeeding, two days after an emergency 
CS. Specifically, new mothers had reduced or absent OT pulses, along with lack of the expected rise in 
PRL levels (probably due to reduced OT), compared with women following vaginal birth. Breastfeeding 
initiation occurred on average at 240 minutes after CS compared with 75 minutes following vaginal birth, 
and the delay in first breastfeeding correlated with fewer OT pulses. In addition, the number of OT pulses 
predicted the duration of excusive breastfeeding following vaginal birth.354 Authors suggest, “. . . early 
mother-infant contact together with the passage of the fetus through the vagina during the second stage 
of labour can enhance the stimulation of oxytocin neurons . . . .”354(p.96) Both vaginal birth and early con-
tact promote OT elevations in mother and baby, which may contribute to these breastfeeding benefits. 
Oxytocin-stimulated PRL elevation may also contribute (6.1.4).
In a CS study mentioned above, newborns who were randomized to uninterrupted maternal SSC breast-
fed earlier than infants in the control group, who were separated from their mothers for 25 minutes 
while in SSC with the father.395 The calming effects of SSC and maternal odors may contribute via new-
born OT release (see “Skin-to-skin contact” in 3.1.4). 
These findings suggest that early SSC, with opportunities to initiate breastfeeding, may be especially 
important for mothers and babies following CS. 
Cesarean and Maternal Adaptations and Attachment
Peaks of oxytocin and other hormones released during labor, birth, and the early postpartum period pro-
mote maternal adaptations that enhance infant care and survival. The absence of these peaks has major 
impacts on maternal behaviors in animals, but high-quality human research is lacking.
Cesarean and psychological well-being. Psychological well-being after cesarean has not been 
well studied. Research has suggested poorer maternal adaptations, elevated risk of postpartum depres-
sion, and the possibility of post-traumatic stress disorder, along with a reduction in self-esteem from  
pregnancy levels. Lack of the hormonal peaks of physiologic birth may contribute
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Psychosocial studies show that women who have experienced a cesarean, compared with those who birth 
vaginally, may have: lower satisfaction with the birth,680 with high numbers of women reporting one or 
more distressing events;681, 682 poorer mood in hospital and at 8 months, correlated with the delay in first 
contact with their newborn;432 and diminution in mood and self-esteem from levels in pregnancy, com-
pared with women birthing vaginally who experienced an elevation in self-esteem (detailed below).434
Some but not all studies have found associations between CS and postpartum depression.683 A 2007 
review of psychosocial outcomes after CS concluded, “ . . . women who deliver by cesarean section 
have more negative perceptions of their birth experience, their selves, and their infants, exhibit poorer 
parenting behaviors, and may be at higher risk for postpartum mood disturbance compared to women 
delivering infants vaginally.”680(p.2272)
Because CS studies are not randomized, these findings may reflect some degree of preexisting psycho-
logical differences among mothers with CS.684 However, a prospective trial of new mothers showed that, 
following vaginal birth, women experienced an elevation in mood and self-esteem, compared with their 
levels in pregnancy, while women who experienced CS had diminished mood and self-esteem, with 
women having instrumental births experiencing, on average, no change compared with pregnancy base-
line.434 Central effects from hormonal peaks may contribute (3.1.4).
Other studies have suggested that post-traumatic stress symptoms, or even full post-traumatic stress 
disorder (PTSD), may be more likely after planned685 and/or unplanned CS.686-688 The relative roles of sub-
jective traumatic experiences and loss of hormones such as OT, which reduce stress and increase calm 
and connection, have not been investigated. Outside of childbearing, therapeutic synOT has been trialed 
as a treatment for PTSD,206 and postpartum OT elevations following birth and/or with newborn contact 
could plausibly be protective against PTSD for new mothers (see “Pleasure and reward” in 3.1.4). 
Researchers have also found a decrease in the expected shifts in maternal personality—decreased anxi-
ety and increased “social desirability” (3.1.4)—among women who experienced an unplanned in-labor 
CS compared with women who gave birth vaginally. Researchers suggest that peaks of central OT with 
birth (see “Maternal adaptations” in 3.1.4) may play a role in these adaptations to motherhood.360 
This is a complex area with many determinants, but absence of the positive central effects of labor-
related hormones may be a significant unintended adverse effect of CS for new mothers. Early newborn 
skin-to-skin contact may be especially important for women following CS to activate OT systems and 
elevate mood. Given current high rates of cesarean section, and concerns about maternal postpartum 
psychological well-being, these are critical areas for future research.
Cesarean and attachment. Maternal-infant attachment following a cesarean may be impacted by 
reduced prelabor and in-labor physiologic preparations, including the central oxytocin receptor elevations 
that promote maternal-infant attachment in animal studies. Post-operative delays in maternal-infant 
contact, and surgery-related reductions in maternal odors and hormonally-mediated warmth may also 
have adverse effects in mother and baby. Central maternal circuits may be less activated in new mothers 
following cesarean. A hormonally sensitive period may exist following cesarean.
Animal studies show adverse impacts on maternal behavior and attachment following CS.100, 212, 372 In some 
species, vaginocervical stimulation, mimicking the process of birth and releasing a surge of OT (see “Mater-
nal Oxytocin in Labor and Birth” in 3.1.3), reinstates maternal behaviors.211
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Attachment between human mothers and babies following CS has not been well studied. One review  
found that “Caesarean delivery may exert at least short-term adverse impacts on mother-infant attach-
ment.”432(p.73) A recent study using magnetic resonance imaging (MRI) (also discussed in “Maternal adap-
tations” in 3.1.4) found a reduction in the brain responses of new mothers on hearing their babies’ cry 
two to four weeks after PLCS, compared with mothers who had given birth vaginally. In particular, sen-
sory processing, empathy, arousal, motivation, reward, and habit-regulation circuits were less activated. 
Authors suggest that “. . . differential release of oxytocin with the vagino-cervical stimulation of VD [vag-
inal delivery]” may explain these findings.423(p.1045) Loss of early contact, with opportunities for biologic 
bonding (3.1.4), may also contribute.
One study that randomized post-CS newborns to SSC with the mother or father found that newborns cried 
more in SSC with the mother than the father. Researchers suggest that surgical cleaning, leading to lack of 
maternal skin and breast odors, which are soothing to the newborn;689 and/or cooler body temperature, 
due to lack of OT-associated postpartum vasodilation, may contribute. (In contrast, fathers “presumably 
retained their natural capacity to calm the infant, by warmth, pleasant odors, and vocalizations.”395(p.63)) 
Cooler maternal body temperatures could also fail to activate, and mutually regulate, newborn OT systems 
(see “Skin-to-skin contact” in 3.1.4).
In this study, mothers in SSC released moderate levels of oxytocin (levels elevated about 50 percent com-
pared with those at birth), with equivalent levels in women who were close to, but not touching, their 
babies. These are lesser elevations compared with mothers in SSC following physiologic birth, whose OT 
increased around two- and even, in one case, ten-fold. These findings suggest significant maternal reduc-
tions in OT sensitivity, perhaps due to lack of OT prelabor physiologic preparations and/or birth peaks 
(3.1.2), with likely additional effects from surgery and stress.
This study (also discussed in “Synthetic Oxytocin and the Mother, Longer Term” in 3.2.3) found that women 
who received extra synOT by IV infusion post-CS (but not those who received only a standard single dose) 
had an increase in their own OT levels, with several peaks, during subsequent breastfeeding and also 
experienced the usual maternal adaptations and personality changes two days after CS (see “Maternal ad-
aptations” in 3.1.4). Researchers suggest that synOT in this situation may have central effects, although the 
mechanism is unknown, and conclude that a sensitive period may also exist for women following CS, with 
possible benefits to future mother-infant interactions.395
As with epidurals (3.2.5), possible CS effects on maternal adaptations are subtle, according to current un-
derstandings, but may be significant in the longer term. Post-CS, mother and newborn may benefit from 
strong support for early and uninterrupted mother-baby contact, including undisturbed SSC for the first 
hour or more after cesarean birth. These are important areas for further research.
Cesarean and Offspring, Longer Term
Evolving evidence suggests long-term impacts of cesarean birth, including possible impacts on oxytocin 
systems. Preliminary findings in relation to childhood social functioning are contradictory. Animal studies 
suggest changes in brain structure and function. High-quality long-term human studies, especially studies 
with a control group unexposed to other drugs and procedures, are lacking.
From the perspective of hormonal physiology, cesarean birth is a very different experience for offspring 
from the stimulation and eustress of labor and birth (3.1.3, 4.1.3, 5.1.3, 6.1.3). Evolving evidence sug-
gests that CS birth may have ongoing, even lifelong impacts on human offspring,40, 690-693 some of which 
may be due to deficits in hormonal experiences and exposures, including lack of hormonal stimulation. 
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Animal studies show enduring effects on brain-hormone systems.27-31, 138-141 (further described in “Cesar-
ean and the Fetus/Newborn” in 5.2.6.) Associations between CS and childhood obesity691, 692 could also 
involve the OT system and its role in satiety and autonomic nervous system balance. Cesarean newborns 
also experience major alterations in gut colonization, which could also contribute.147 (See also “Cesarean 
and the Fetus/Newborn” in 5.2.6 for discussion of possible long-term impacts for CS offspring in relation 
to stress systems.) 
Studies examining psychosocial functioning in CS offspring, compared with children from vaginal births, 
have found both beneficial694 and detrimental695 CS effects. A Chinese study found the highest levels of 
negative internalizing and externalizing behaviors among children born with forceps and the lowest by 
maternal-request CS. The drugs and interventions that accompanied vaginal birth were not stated in 
this study, and exposure to synOT and other drugs may have mediated the poorer outcomes for children 
following vaginal birth. (Similarly, a study of children exposed or not to synOT, found worse developmen-
tal scores among children following vaginal birth compared with CS, which was related to the duration 
of synOT exposure582, 584 (see “Synthetic oxytocin and offspring, human studies” in 3.2.3). In contrast, 
another study found more internalizing, and also anxiety/depression, withdrawal, and sleep problems, 
among five-year-old children born by CS, compared with vaginal birth.695
Given current high CS rates, including CS for non-clinical reasons, elucidating and modeling the links be-
tween CS, offspring hormonal functions, and later health are critical areas for future research.
3.2.7 Early Separation of Healthy Mothers and Newborns: Possible Impacts on Oxytocin
Early separation disallows the maternal-infant contact that activates the oxytocin systems of mother and 
baby, with beneficial longer-term effects for both. 
Postpartum transitions for mother and baby are optimized by early and ongoing SSC696 during the post-
partum sensitive period (see “Skin-to-skin contact” and “Postpartum sensitive period” in 3.1.4). The 
pre- and in-labor physiologic preparations of physiologic birth, as detailed in 2.2, 3.1.2 and 3.1.3, can 
maximize these benefits, with peak postpartum levels of oxytocin,259, 316 acting on peak oxytocin recep-
tors in the brain and mammary gland, according to animal studies.86-88, 98, 99, 244 Early uninterrupted SSC 
and breastfeeding initiation can benefit maternal breastfeeding hormones,354 maternal adaptations and 
attachment,336, 375, 384 newborn aspects of breastfeeding,351 and possibly postpartum hemorrhage, as 
discussed in 3.1.4.316 Separation of mother and baby after birth disallows these processes, and may ad-
versely affect OT system functions in the short and possibly longer-terms. 
Early Separation and the Mother
For the mother, early separation removes the opportunity to release her own oxytocin through interac-
tions with her newborn, which may give physiologic protection against postpartum hemorrhage.
Postpartum SSC between mother and baby is a prerequisite for the maternal-newborn interactions, es-
pecially infant hand massage of the mother’s breast, that increase maternal OT release during the hour 
after birth, as measured in the blood in women.316 Release of oxytocin in response to breast stimulation 
seems to be maximal in the first hour after birth (see “Oxytocin and maternal-newborn contact and 
interactions” in 3.1.4). Postpartum oxytocin peaks also occur in the maternal brain, according to animal 
studies.263, 371 
Women experiencing early separation may miss these opportunities for OT release, which may act on 
upregulated uterine OTRs to cause uterine contractions and reduce PPH, although this has not been well 
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researched (see “Oxytocin and postpartum hemorrhage” in 3.1.4). In addition, central OT peaks, acting 
on maximally sensitive brain areas with peak OTRs at this time (animal studies), may activate maternal cir-
cuits and adaptations, with ongoing benefits to maternal caregiving and maternal-infant attachment375, 384 
via biologic bonding processes (see “Early Separation and Maternal Adaptations and Attachment,” below, 
and 3.1.4).
Early Separation and the Newborn
For the baby, lack of skin-to-skin contact, and the associated oxytocin elevations, may increase, or fail to 
decrease, stress and stress hormone levels, with possible detrimental effects to newborn stress systems. 
For the newborn, OT release through SSC reduces the “stress of being born”337 and associated stress 
hormone elevations175 (5.1.4). One study of newborns who were randomized to separation or SSC for the 
first two hours postpartum found persisting detrimental impacts on autonomic function (colder feet, re-
flecting higher levels of E-NE and/or lower levels of OT) for up to 23 hours postpartum among separated 
newborns.175 (For a full discussion about newborn stress with separation, see 5.1.4 and 5.2.7.)
Other studies have found less stable temperature, heart rate, and breathing, and less optimal neurobe-
havioral responses among separated babies compared with SSC newborns. (See Moore336 for a system-
atic review.) This homeostatic dysregulation may reflect excessive stress hormones and low OT levels 
among separated newborns (5.1.7). 
Early Separation and Breastfeeding
Early separation has well-established, detrimental effects on breastfeeding initiation, possibly via oxyto-
cin and/or prolactin disruptions.
The detrimental impacts of early separation, with delayed initiation of breastfeeding, on overall breastfeed-
ing success are well established.336, 353 Loss of early stimulation of the OT system likely contributes (3.1.4), 
possibly also affecting PRL, which is stimulated by OT release. (See also “Prolactin receptor theory” in 6.1.4.)
Early Separation and Maternal Adaptations and Attachment
Studies have suggested that early maternal-newborn separation and loss of skin-to-skin contact during 
the hour or so after birth can compromise maternal adaptations and behaviors, with longer-term detri-
mental impacts on the mother-infant relationship.
Studies comparing SSC and separated mothers and newborns have found impacts on attachment behav-
iors for up to three years.697-700 One randomized study that analyzed mother-infant interactions at one 
year found that mother-newborn contact soon thereafter (“rooming in”) did not compensate for loss of 
early SSC after birth,375 perhaps highlighting the critical and brief nature of this sensitive period for bio-
logic aspects of bonding (see “Postpartum sensitive period” in 1.1.4). Although not well studied, there 
may also be a maternal sensitive period for attachment following CS birth,395 so that early SSC may also 
be important in this situation (3.2.6, 5.2.6).
Early separation and attachment. The detrimental impacts of early separation of healthy mothers 
and newborns could have long-term consequences by disrupting the early development of offspring at-
tachment and attachment systems. Trans-generational programming effects are possible via epigenetic 
mechanisms, according to animal models.
Optimizing early attachment through supporting SSC for healthy mothers and newborns may be a simple 
strategy that benefits all mothers and babies in the period after birth, including those at risk of poor 
89CHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | 3 OXYTOCIN / 3.2.7
attachment, neglect, and abuse, by initiating hormonally-mediated biologic bonding (3.1.4). Conversely, 
early separation, with loss of hormonal support for maternal adaptations and attachment, may be es-
pecially detrimental in this group. In one study, separation after birth was associated with twice the risk 
of infant abandonment, compared with mothers and babies who experienced postnatal SSC contact in a 
Baby-Friendly Hospital.701 These are important areas for future research.
In animal studies, maternal-newborn separation also negatively impacts the offspring HPA-stress system, 
giving lifelong increased susceptibility to stress among offspring separated for several hours per day dur-
ing the newborn period (5.3.7).35, 702 Lack of OT generated through maternal contact could contribute to 
these impacts. (See 5.2.7.)
In addition, animal studies show epigenetic changes in the OT systems of female offspring in relation to 
the quantity of maternal care received during infancy. Females exposed to low levels of maternal care 
give low levels of care to their own offspring, and have reduced central OTRs.35 (See “Maternal-infant 
attachment” in 3.1.4 for full discussion.)
Early separation and maternal well-being. Maternal well-being may also be impacted by early 
separation, according to animal studies, with anxiety and depression-like effects among separated moth-
ers. Loss of the positive effects of oxytocin and other hormones may contribute. 
Separating the mother from her newborn, or delaying reunion after birth, may have detrimental impacts 
on maternal physiology and well-being. Animal studies show anxiety and depression-like behavior in 
mothers who have been separated from their newborns for several hours per day.703, 704 This has been 
suggested as an animal model for postpartum depression.704 Loss of opportunities to release OT through 
lactation and infant contact may contribute. 
In women, a longer period before first contact after birth has been correlated with poorer mood in hos-
pital and at eight months, compared with those who had earlier contact with their newborns.432 Lack of 
OT and other mood-elevating hormones (3.1.4, 4.1.4, 6.1.4) and their longer-term central reorganizing 
effects that promote biologic bonding and reward center activation in the early sensitive period (3.1.4), 
likely contribute. The mood-enhancing benefits of maternal-infant SSC may continue after birth. One 
study found reduced postpartum depression scores during the first month among mothers who had at 
least two hours of SSC daily with their newborns399 (see 3.1.4). 
Given the major morbidities for mothers and babies affected by postnatal depression,705 the correlations 
between SSC/early separation and maternal emotional well-being are critical areas for future research.
3.3 Oxytocin Physiology: Summary
3.3.1 Oxytocin: Normal Physiology
Oxytocin is a powerful reproductive hormone with widespread effects on the brain and body of all mam-
mals, for example, by mediating sperm ejection, labor contractions, and milk ejection. Oxytocin also 
reduces stress by centrally activating the parasympathetic nervous system, which promotes calm, connec-
tion, healing, and growth; and by reducing activity in the sympathetic nervous system, which reduces fear, 
stress, and stress hormones, and increases sociability. Oxytocin has a short half-life, but its effects can 
be prolonged because it modulates other brain-hormone systems (neuromodulation). 
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In the perinatal period, oxytocin optimizes labor, birth, and postpartum transitions of mother and baby 
through:
  central oxytocin release into the maternal bloodstream, causing rhythmic uterine contractions, 
including the late-labor oxytocin surge that benefits pushing (Ferguson reflex)
  central calming and analgesic effects in mothers and babies in labor through the postpartum 
period
  positive feedback of central oxytocin on itself, especially in multiparous mothers, augmenting and 
accelerating in-labor effects (animal studies)
  postpartum maternal adaptations that reduce stress, increase sociability, and prime reward cen-
ters, imprinting pleasure with infant contact and care, therefore promoting longer-term infant 
survival
Prelabor increases in uterine oxytocin receptors (human studies) and oxytocin receptors in brain and 
mammary glands (animal studies) maximize these effects. 
The hour or so after physiologic birth is a sensitive period, when skin-to-skin maternal-newborn interac-
tions foster peak oxytocin activity. Benefits may include:
  stronger contractions, likely reducing postpartum hemorrhage risk
  natural warming for the newborn through vasodilation of mothers’ chest
  activation of hormonally-mediated maternal-infant biologic bonding 
  facilitation of breastfeeding initiation, including by reducing maternal and newborn stress
3.3.2 Common Maternity Care Practices That May Impact Oxytocin Physiology
Common maternity care practices may disrupt these and other beneficial oxytocin effects, with short- 
and longer-term impacts in mothers and babies. High-quality research is lacking. 
While the administration of synthetic oxytocin for induction or augmentation is beneficial in selected 
circumstances, adverse impacts have been found in women and babies. Synthetic oxytocin administered 
in labor is not thought to cross into the maternal brain in biologically significant amounts, and so may 
lack calming and analgesic effects. However, when synthetic oxytocin stimulates contractions, positive 
feedback cycles may lead to central oxytocin release, promoting further contractions, labor progress, 
and continued central release.
Synthetic oxytocin may impact maternal oxytocin and physiology. Possible effects include:
  uterine hyperstimulation with potential fetal hypoxia, requiring monitoring
  stronger contractions and increased pain without central oxytocin analgesia
  synthetic oxytocin overexposure causing desensitization of oxytocin receptors, contributing to 
reduced contractility, prolonged pushing, instrumental birth, and/or postpartum hemorrhage
  disruption of newborn breastfeeding behaviors, reduced maternal oxytocin release with 
breastfeeding, and possible reduced breastfeeding duration
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Physiologic principles, animal studies, and evolving human evidence suggest that perinatal synthetic 
oxytocin exposure may have longer-term impacts on offspring. While high-quality research is lacking, 
potential mechanisms include:
  direct fetal brain-hormone effects from synthetic oxytocin transfer through placenta 
  indirect signaling of maternal oxytocin to fetal brain
  indirect effects from subclinical hypoxia
  interference with fetal neuroprotective mechanisms (animal studies)
  fetal/newborn impacts from synthetic oxytocin co-interventions such as epidural
  long-term programming of offspring hormonal systems, likely via epigenetic effects (animal 
studies) 
  indirect effects via disruptions to maternal oxytocin systems that impact attachment, reward, 
breastfeeding, and/or mutual regulation
Epidural analgesia reduces maternal oxytocin in labor, likely due to numbing of the sensory feedback 
that promotes central oxytocin release. Possible impacts include:
  slowed labor with increased need for synthetic oxytocin
  prolonged pushing stage with increased use of assisted vaginal birth
  disruption of maternal adaptations and attachment
These can also adversely affect the newborn. High-quality research is lacking.
With prelabor cesarean section, mothers and babies miss their complete prelabor physiologic oxytocin 
preparations; and with any cesarean section, the full oxytocin processes, including the maternal late-
labor oxytocin surge and postpartum oxytocin peaks, may be reduced or absent. Impacts on breastfeed-
ing, maternal adaptations, and postpartum hemorrhage have been found. Scheduled cesarean carried 
out after the physiologic onset of labor may have fewer adverse oxytocin impacts than prelabor cesar-
ean section.
Postpartum separation of healthy mothers and newborns may have detrimental short-and longer-term 
impacts on the oxytocin system, including:
  reduced oxytocin due to lack of skin-to-skin contact, with increased newborn stress and stress 
hormones, hypoglycemia, and hypothermia 
  disruptions to breastfeeding initiation and long-term success
  deficits in maternal hormones and adaptations, with longer-term impacts on maternal-infant 
attachment
In animal studies, variations in maternal caregiving in the newborn period lead to epigenetic programming 
of offspring oxytocin systems, with enduring effects on offspring stress reactivity, and on the maternal 
care given by female offspring.




Beta-endorphins are included in this report because of their roles in reducing stress and pain 
during childbearing, and, in activating central reward centers that motivate and reward 
reproductive behaviors, including labor, birth, postpartum infant care, and lactation. In 
addition, a growing body of research suggests important roles in health and well-being, 
including mental health. Beta-endorphins are not as well researched as some other hormone 
systems, especially in relation to possible impacts of maternity care interventions. However, 
epidural analgesia and opioid analgesic drugs may especially impact the physiologic 
functioning of beta-endorphins, with uncertain effects into the future.
4.1 Beta-Endorphins: Normal Physiology
Beta-endorphins have important roles in reproduction due to their stress-reducing effects and also involve-
ment with brain-based motivation and reward circuits, which promote mammalian maternal behaviors. 
Beta-endorphin and related hormones (referred to here as “beta-endorphins” or BEs) have not been as 
well researched as oxytocin. However, as with oxytocin, there is a growing awareness of the importance 
of these and other endogenous opioid substances in many biological processes, including reproduction, 
immune function, social interactions, and psychological well-being.706 
Beta-endorphins are included in this report because of their important role in reducing excessive stress 
and pain in mother and baby during physiologic labor and birth and, along with oxytocin (3.1.4), in acti-
vating brain-based motivation and reward circuits that optimize mammalian maternal adaptations.404 In 
addition, according to principles of epigenetics and fetal/newborn programming (3.1.2, 3.2.3), the func-
tioning of BEs in the perinatal period may be important in priming offspring BE systems lifelong. 
4.1.1 Beta-Endorphins: Introduction
Beta-endorphins are a group of peptides (biologic chemicals made from amino acids) that have major 
roles in pain management and brain reward center activation, with effects that overlap with opioid drugs 
such a meperidine and morphine.
Beta-endorphins (“endogenous morphines”) have properties in common with opioid (opiate-related) 
drugs, including pain relief and reward system activation.706 Commonly used opioid drugs (discussed 
further in 4.2.4 and 3.2.4) include:
  opiates, naturally derived from the opium plant: morphine and codeine 
  synthetic opioids: meperidine (Demerol, pethidine), heroin (diamorphine), fentanyl (Sublimaze, 
Duragesic), tramadol, methadone, meptazinol (Meptid), nalbuphine (Nubain), pentazocine 
(Talwin, Fortral), buprenorphine (Temgesic, Buprenax) and butorphanol (Stadol)
Opioid antagonists, including the short-acting drug naloxone (Narcan) and the longer-acting naltrexone 
(Revia), reverse the effects of both endogenous and exogenous opioids by binding with the mu opioid 
receptor (MOR, discussed below).
Beta-Endorphins Effects
Beta endorphins act primarily in the central nervous system, where they inhibit nerve function, producing 
analgesia, among other effects.
Beta-endorphins are produced in both peripheral body tissues and in the central nervous system (CNS), 
including the hypothalamus and pituitary gland, through the chemical cleaving of the pro-hormone pro-
opiomelanocortin (POMC). This produces several endorphin-like substances, including: beta-endorphin 
proper, also called BE (1-31); beta-lipotropin; N-terminal derivatives; and other related peptides, which 
are released into the bloodstream. Because most analytic techniques have not been able to differentiate 
among these,707 they have been collectively called “BE immunoreactive material (BE-IRM)” or “beta-
endorphins,”708 as used in this report.
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Beta-endorphins act primarily within the CNS, where they inhibit the functions of other nerves, including 
those that transmit pain, giving powerful analgesic effects. Nerve cells (neurons) that produce BEs extend 
down into the spinal cord, where they inhibit sensations arising from the body. In addition, BEs are released 
from the pituitary into the bloodstream in situations that include pain, exercise, sexual activity, and 
social interactions. Effects from bloodstream release are not well understood, and, as with OT (3.1.1), 
blood levels of BEs may not reflect brain-based (central) levels and effects.709
Beta-endorphins and the stress response. Release of beta-endorphins in the central nervous 
system is part of the medium-term stress response, designed to restore homeostasis. This response in-
volves other hormones such as cortisol and, in some situations, prolactin. Hormone responses to appropri-
ate, healthy “eustress,” such as the stress of labor and birth, are generally beneficial. However, excessive 
stress, with elevated or prolonged stress hormone levels, can have maladaptive or even harmful effects. 
The balance between healthy and harmful stress and stress hormone levels varies across individuals. 
In humans, as in other mammals, stress, distress, or pain trigger release of the major stress hormone 
corticotropin releasing hormone (CRH, also known as corticotropin releasing factor, CRF) from the hypo-
thalamus, which stimulates the release of BEs both within the brain and from the nearby pituitary into 
the bloodstream. 
Beta-endorphins are generally co-released into the bloodstream with adrenocorticotropic hormone 
(ACTH), which promotes the release of cortisol from the adrenal gland as part of the medium-term (hours 
to days) hypothalamic-pituitary-adrenal (HPA) stress response. Short-term stress responses (usually sec-
onds to minutes), which involve release of the fight-or-flight hormones epinephrine and norepinephrine 
(E-NE, adrenaline and noradrenaline), also stimulate CRH release and the subsequent release of BEs (see 
also 5.1.1). 
As part of this general stress response (also called “general adaptive syndrome” or GAS710), which is de-
signed to restore homeostasis, BEs are also released into the brain, with BE (1-31) acting as a neurotrans-
mitter with central analgesic effects. In addition, BEs promote the release of prolactin (PRL), which can 
also function as a stress hormone, with multiple adaptive effects on the body121 (6.1.1). These complex, 
coordinated processes all enhance adaptations to excessive stress.
In general, brief and/or mild-to-moderate elevations of these stress hormones, or appropriate elevations 
in relation to physiologic events (also termed “eustress”711) are part of the GAS, with beneficial effects. 
This includes elevations in BEs that aid with stress and pain in labor, and that adapt the woman to new 
motherhood after birth. However, extreme and/or prolonged elevations of BEs can have detrimental ef-
fects by reducing motor and social behaviors. 
Too-low levels of adaptive hormones in response to stress and pain may also be detrimental by giving in-
sufficient assistance. It seems that with BEs, as with stress in general,712 there is an adaptive mid-range level 
of response, which depends on individual systems and sensitivity and likely reflects receptor numbers. This 
level is not currently possible to quantify for the individual, which may complicate attempts to correlate 
levels of BEs in response to stress with beneficial or detrimental effects,709 as detailed below (4.1.3). 
Beta-endorphins, other effects. Other effects of beta-endorphins include activating brain reward 
centers that motivate and reward essential behaviors such as eating, mating, birthing, lactating, caring for 
infants, and adult social behaviors. High levels may signal satiety and reduce motivation. Beta-endorphins 
are also involved with the immune, respiratory, and gastrointestinal systems, and implicated in conditions 
that include anxiety, addiction, obesity, depression, and autism.
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Within the brain, BEs not only enhance adaptations to stress, but also activate powerful dopamine-associ-
ated reward circuits, giving pleasure and even euphoria.706 Beta-endorphins are involved with motivating 
and rewarding important survival behaviors, including the following:
  food ingestion713
  sexual activity and mating714 
  labor and birth (4.1.3)
  lactation (4.1.4)
  maternal caretaking behaviors ( 4.1.4) 
BEs are also released during exercise,715 especially if strenuous,716 or repeated.717 Exercise-related mental 
health benefits, equivalent to anti-depression treatments according to a recent review,718 are likely related 
to elevations in BEs, which can persist for one hour following strenuous exercise.719 (See 4.1.3 for effects 
of exercise on labor pain.)
The elevated levels that follow activities such as exercise, sexual activity and food ingestion may also sig-
nal satiety, and promote cessation by reducing motivation. In contrast, low or declining levels of BEs may 
increase motivation. For example, declining BEs in the postpartum period may motivate mothers to seek 
closeness (“proximity seeking”) and to care for newborns (4.1.4). Very high levels of opioids, for example 
high doses of morphine,720 disrupt maternal behaviors in animals, which may reflect high satiety and low 
motivation.
Opioids, including BEs, are also released during mammalian adult social interactions, when they motivate 
and reward social affiliation and cohesion. This has important survival value, both for animals living in 
the wild, and for humans alive today. This may even make aspects of mammalian social behavior “addic-
tive phenomena.”404 
The endorphin BE (1-31) is recognized as a powerful analgesic when released within the CNS, but it is 
ineffective when administered into the body because it does not easily cross the blood-brain barrier.721 
However, central administration gives analgesic effects in animals722, 723 and humans.724 In one clinical 
case, BE (1-31) was shown to give prolonged analgesia over 21 hours when administered directly into the 
brain of a man with intractable cancer pain.724
New understandings of the endogenous opioid system also suggest major and widespread influences 
on health and well-being. Beta-endorphins are involved in functioning of the immune, respiratory, and 
gastrointestinal systems (with inhibiting effects similar to those of opioid drugs); and dysfunctions have 
been implicated in arthritis, epilepsy, binge-eating, and alcoholism.725, 726 Dysfunctions in BEs have also 
been implicated in obesity, depression, anxiety, addictions, and possibly other mental health issues.706, 725, 
726 In addition, excessive opioid activity (levels and/or receptors), which could reduce social motivations, 
has been implicated in autism.727, 728 (See 4.2 for impacts of maternity care interventions on BE systems 
and possible implications.) 
Beta-Endorphins: Regulation and Receptors 
Beta-endorphins are primarily released in response to pain and stress.
Beta-endorphins receptors. The major endorphin, beta-endorphin (1-31), acts by binding with the 
mu opioid receptor. Oxytocin and prolactin promote release of beta-endorphins, and in turn beta-
endorphins promote prolactin. Beta-endorphins inhibit oxytocin release in the lead-up to labor, possibly 
restraining labor onset. 
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Among the BEs, beta-endorphin (1-31) is thought to be the major effector of stress and pain responses,707 
and acts by binding with the MOR, of which there are several subtypes. Mu and other opioid receptors 
have also been found in the myometrium of women in late pregnancy, where mu activation has relaxant 
effects596 (4.1.3).
Regulators and promoters of BEs relevant to the context of childbearing include: oxytocin (OT), which 
promotes release of BEs (3.1.3), assisting with labor stress and pain; and prolactin, which also promotes 
BEs.125 In addition, BE promotes PRL release in the context of stress121 (4.1.3). In the lead-up to labor, 
central BEs inhibit OT release, which may help to prevent premature contractions prior to the physiologic 
onset of labor, according to animal studies.95 
Beta-endorphins complexities. There are significant complexities in understanding the healthy func-
tioning of beta-endorphins and interpreting studies of endogenous BEs at an individual level. These include 
methodological problems with measurements and a wide variation in individual baseline levels that may reflect 
differing sensitivity and receptor systems. Mid-level beta-endorphin responses to stress may be most adaptive.
As discussed above, the technical ability to differentiate the BEs in blood samples, and their relative con-
tribution to physiologic effects such as analgesia, has been problematic. In addition, the major role of 
BEs is within the CNS, where levels are not measurable in human studies. Because levels measured in the 
blood have generally correlated with physiologic effects, it has been presumed that this reflects central 
effects, but, as with oxytocin, this is not certain. In some studies, levels in cerebral spinal fluid (CSF), which 
more accurately reflect central release, have not correlated with blood levels.709
In addition, measurement of baseline BEs in individuals has not always correlated with the expected 
characteristics and effects. As with levels of BEs in response to stress, individual differences likely reflect 
differing receptor numbers and sensitivities, which may be related to early hormonal experiences. For ex-
ample, high baseline BEs has been associated with greater pain sensitivity, likely reflecting lower MORs.709 
In stress responses involving BEs, as with other stress hormones such as cortisol, low levels may reflect an 
inadequate response, while high levels signal excessive stress. Because of apparent individual differences in 
sensitivity, the mid-range, adaptive level of BEs is likely to be unique to the individual, as discussed above. 
4.1.2 Beta-Endorphins in Pregnancy
Levels of BEs rise in pregnancy. Animal studies show peak central BEs and receptors around the physiologic 
onset of labor. The fetus, membranes, and placenta also release BEs. Regular exercise in pregnancy may 
promote the release of BEs in labor, promoting endogenous analgesia.
During pregnancy, levels of BEs rise, as measured in maternal blood.729-731 Plasma levels in pregnancy fol-
low a diurnal pattern, being lowest around 8 a.m. and 8 p.m. and peaking around midday and midnight.239 
The immunosuppressive effects of BEs may also be important in making the mother tolerant to her 
immunologically-foreign fetus.732, 733
Maternal pain tolerance increases in late pregnancy, giving a “pregnancy induced analgesia” that peaks 
on the day when labor starts, as demonstrated in women734, 735 and animals.736, 737 This is likely due to in-
creases in central mu opioid receptor numbers92-94 and central levels of BEs,92, 96 which both peak around 
the physiologic onset of labor, according to these animal studies. In addition, the pregnancy hormones 
estrogen and progesterone trigger the activation of non-BE opioid systems (kappa and delta opioid 
receptors) in the spinal cord, according to animal studies, giving additional analgesia that continues 
through to the postpartum period.77 
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Beta-endorphins are also produced by fetal tissues within the placenta and are also present in high lev-
els in the amniotic fluid from early pregnancy.738 It has been suggested that placental BEs (PBEs), which 
increase with gestation as measured in the maternal blood, may reward the mother for gestating her 
baby.732 The placenta and amniotic fluid also contain placental opioid-enhancing factor (POEF), which po-
tentiates the effects of non-BE opioids, and may also promote maternal behaviors.739 Most non-human 
mammals eat the placenta after birth,740 giving extra sources of rewarding and pain-relieving hormones 
at this time.740 
In women, several studies have correlated levels of BEs in pregnancy with later outcomes, although re-
sults are not easy to interpret. Low levels730 or dysregulation in relation to ACTH741 have been associated 
with greater analgesia requirements in labor. In other research, non-depressed women with higher BEs 
in mid-pregnancy were more likely to experience postpartum depression than non-depressed women 
with lower mid-pregnancy BEs. Researchers suggest that postpartum depression may be related to the 
larger drop in BEs postpartum in these women, who may have an underlying dysregulation of the HPA 
axis that is masked during pregnancy731 (4.1.4). 
One study randomized pregnant women to flexibility and endurance exercises or a control group and 
found higher levels of BEs in labor, with less reported pain, among women who exercised in pregnancy.742 
Another study found that the release of BEs in response to exercise was enhanced in pregnancy.743 To-
gether, these suggest that regular exercise in pregnancy may enhance BEs in pregnancy and labor, with 
reduced need for analgesia. 
The complex central interactions involving BEs and other hormones may be modified in pregnancy and 
labor. As discussed above, high central BEs in late pregnancy inhibit OT release in the brain, which may 
restrain the onset of labor,251 according to animal studies. Conversely, oxytocin within the brain increases 
the release of BEs,744 which may contribute to labor peaks of both hormones (3.1.3, 4.1.3).
4.1.3 Beta-Endorphins in Labor and Birth
Maternal Beta-Endorphins In Labor and Birth
In physiologic labor and birth, eustress raises beta-endorphins (as measured in blood), assisting with stress 
and pain. However, excessive stress and pain may elevate central beta-endorphins above physiologic levels, 
inhibiting oxytocin release and slowing labor, as seen in animal studies. Some non-pharmacologic methods 
of labor pain relief may act via beta-endorphins. Peaks of BEs at birth may induce euphoria by activating 
pleasure and reward centers.
As shown in Figure 3,745 levels of BEs, as measured in maternal blood, rise from early labor, peak in late la-
bor, and decline in the early postpartum period. Levels are positively correlated with contraction strength, 
labor progress, self-reported pain, and rupture of membranes.746-748 Peak levels during the pushing phase 
are four to eight times higher than levels prior to labor,745, 747, 749, 750 and equivalent to those of athletes 
during endurance performance.751 Analgesic effects are likely to be maximal during labor because of in-
creased central MORs at this time (4.1.2).
Researchers using rapid sampling in laboring heifers found that BEs were released in pulses with each con-
traction,752 possibly triggered by pulses of oxytocin, which stimulates its release (see “Beta-Endorphins: 
Regulation and Receptors“ in 4.1.1). Peripheral levels may reflect not only pituitary-derived, stress-related 
BEs, but possibly also BEs released from the placenta and amnion, which may have a local, but as yet un-
defined, role in labor progress753 (4.1.2).
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Figure 3. Women’s beta-endorphins levels non-pregnant, in labor, and after birth
Source: adapted from Hoffman745
These elevations in BE activity (levels of BEs and receptors) may help the laboring woman deal with the 
stress and pain of labor. This keeps the labor experience within eustress levels without disruption to labor 
processes. Physiologic analgesic systems in labor—including BEs, non-BE opioid mechanisms (4.1.2), and 
oxytocin (4.1.3)—do not usually abolish pain entirely, although some women report no pain in labor.754 
Some studies have found that women with higher levels of BEs in labor report less stress and/or pain,742, 
753, 755-757 whereas others have found elevated BEs to be associated with higher levels of stress and pain.758-
760 In one study, multiparous women had higher levels of BEs than primiparous women,748 suggesting that 
prior experience fostered a more responsive BE system. This finding could also reflect stronger contrac-
tions and/or more stimulation for release of BEs. In another study of unmedicated multiparous women, 
“A considerable increase in beta-endorphin was found without severe stress or pain.”747(p.785) 
In relation to studies of BEs and non-pharmacologic measures to reduce pain, exercise training in preg-
nancy, as above,742 and exercising during labor for 20 minutes on a bicycle,756 both increased BEs with 
less pain reported, compared with controls, as did water immersion, in one study.753 According to an-
other study, electro-acupuncture increased levels of BEs and reduced labor pain.761 
Outside of labor, high-frequency transcutaneous electrical nerve stimulation (TENS) has been shown to 
work though opioid mechanisms, likely involving BEs.762 Diffuse noxious inhibitory control (DNIC), which 
involves producing a second pain elsewhere on the body, has also been shown to stimulate opioid mech-
anisms.763 This may be the mechanism for the analgesic effects of procedures such as sterile water injec-
tions and acupressure in labor.764
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In studies involving rats251 and pigs,765 excessive stress from disturbance in labor produced very high levels 
of BEs, which reduced central oxytocin release and inhibited labor. In women, stress-related elevations 
in BEs may act centrally and also locally on uterine MORs, which have been recently discovered in hu-
man myometrium, with inhibiting effects.461 In addition, opioid drugs, which have BE-like effects, may 
slow labor, as discussed in 4.2.4. All of these observations suggest that the BE system may constitute 
another stress pathway in women, acting, in addition to E-NE, to slow labor in situations of stress and 
potential danger.766 (See 5.2.1.)
These findings support a model of physiologic labor and birth in which physiologic elevations of BEs assist 
with the expected pain and eustress of labor, but excessive stress, pain, and elevation of BEs can inhibit 
oxytocin release and labor progress. This model, also supported by understandings of the E-NE system 
(Chapter 5), implies that attention to reducing maternal stress as far as possible, including through attend-
ing to maternal emotional well-being in labor, may be an important priority for supporting the physiologic 
processes of labor and birth of mother and baby. The higher rates of physiologic birth, reduced need for 
interventions, and good maternal-newborn outcomes that are associated with environments and mater-
nity care providers that support maternal emotional well-being (4.2.1, 5.2.1) also support this model.
High levels of BEs also inhibit the transmission of visual and acoustic information767 and may contribute 
to the altered state of consciousness that is reported with physiologic labor and birth.768, 769 Although 
not specifically researched, this altered state might benefit the laboring mother by protecting her from 
external disturbances and directing her attention to sensations in her body, giving physical feedback in 
relation to her baby’s position, so that she is more likely to move to facilitate optimal positioning. (See 
5.1.4 for comments about E-NE aspects of this altered state of consciousness.) 
High levels of endogenous opioids are associated with euphoric states via activation of central reward 
and pleasure centers.404, 706 Central BE effects, including reward center activation with labor, birth, and 
newborn contact, are likely optimized by peak MORs at the physiologic onset of labor, as found in animal 
studies (4.1.2). Peak BEs in unmedicated labor, birth, and the postpartum period, may therefore promote 
“pleasure and transcendence” for the new mother.768
In addition, maternal elevation of BEs in labor may assist with subsequent lactation by promoting prolac-
tin release125 (6.1.1).
Fetal Beta-Endorphins in Labor and Birth
Beta-endorphins, released with labor hypoxia, may give fetal neuroprotection, as found in animal studies.
Both the fetal brain and the placenta can produce BEs during labor and birth. In humans, under normal 
conditions, BEs may be predominantly produced in the placenta.729, 770 However, with hypoxic stress, the 
fetus releases additional BEs from the pituitary, giving central effects. Levels have been found to be sev-
eral times higher in newborns who experienced excessive labor hypoxia.729, 771 In animal studies, elevated 
fetal BEs give neuroprotective effects by maintaining blood flow to the brain under hypoxic conditions,128, 
129 which may also occur for the human fetus.
4.1.4 Beta-Endorphins after Birth
Maternal Beta-Endorphins after Birth
Levels of beta-endorphins, as measured in maternal blood, decline in the hour after birth but central 
levels may be elevated for many hours, with ongoing reward and reward system activation. Postpartum 
maternal-newborn interactions may contribute. 
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Levels of BEs, as measured in maternal blood, peak around the time of birth and decline over 30 to 60 
minutes.745 In one study, another peak occurred as the mother birthed her baby’s placenta.772 
Levels slowly decline to those of late pregnancy over one to three days postpartum.750, 773 In relation 
to BE (1-31), the plasma half-life is estimated to be 37 minutes, but central effects may continue for 21 
hours or longer, according to one human study724 (4.1.1). After birth, ongoing contact between mother 
and newborn, including skin-to-skin contact (SSC) and breastfeeding, may continue to release BEs for 
mothers and babies, as found in animal studies.404 
This not only gives reward and pleasure at the time, but may also prime reward and pleasure responses 
in association with infant contact, so that the new mother will continue to find her offspring rewarding 
into the future. Postpartum OT peaks may also contribute, and OT may assist reward center activation by 
reducing tolerance to BEs and the behaviors that promote release. (See “Beta-Endorphins and Maternal 
Adaptations and Attachment,“ below.)
Newborn and Later Beta-Endorphins
Newborn beta-endorphins also decline after birth, which may reinforce contact-seeking with the mother. 
Beta-endorphins in colostrum may reduce the stress of newborn transitions.
In human newborns, BEs continue to be elevated for several hours after birth, with a gradual decline 
to about 24 hours, possibly due to stress reduction with SSC.774 Declining levels of BEs may trigger new-
borns to seek maternal contact and milk, which again elevates BEs.404 As with the mother (4.1.1), there 
is likely to be an optimal individual level that assists with newborn motivation and reward in relation to 
maternal contact. Animal studies suggest that opioids also help the newborn to learn maternal odors,404 
and both animal and human evidence supports a role for opioids in mediating the positive effects of 
touch (including SSC) on infant calming, analgesia, and self-regulation.774 
Beta-endorphins are present in colostrum at levels two-fold higher than in maternal plasma.775, 776 These 
BEs are available to the newborn and “. . . may be of importance in overcoming stressful perinatal situ-
ations along with vaginal birth and in the postnatal development of several related biologic functions 
of breastfed infants, like analgesia, steroidogenesis, cardiovascular and endocrine functions, neuroim-
munomodulation, sleep-wake patterns and behavior.”776(p.161) These researchers found around 40 percent 
higher levels of BEs in colostrum among mothers experiencing vaginal birth compared with prelabor 
cesarean section (PLCS).776 The possible impacts on babies who miss this assistance due to cesarean or 
formula feeding (4.2.6) are not known.
As with oxytocin, biologic principles suggest optimal epigenetic programming (also called “hormonal 
imprinting”41) for offspring exposed to physiologic levels of BEs and activity that promotes BEs, in the 
perinatal period. This could program offspring hormonal systems to function lifelong in a positive, adap-
tive way, plausibly including, for BEs, beneficial impacts for analgesic, motivation, reward, and immune 
functions, among others. (See also 3.2.3 and 4.2.4 for discussion of possible epigenetic effects due to 
perinatal hormonal disruptions of BEs.)
Beta-Endorphins and Breastfeeding
Maternal beta-endorphins released during breastfeeding promote prolactin release, and the baby also 
ingests beta-endorphins with milk. This exposure during breastfeeding may motivate and reward mother 
and baby in relation to breastfeeding.
101CHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | 4 BETA-ENDORPHINS / 4.1.4
Maternal BEs are also released during lactation,777, 778 with levels in women peaking in the blood around 
20 minutes after initiation,778 giving further motivation and reward for this critical mammalian behavior. 
In addition, BEs promote prolactin release,121, 724 assisting with ongoing breast-milk production.
In animals, central MORs decline from early lactation, which may be important for maternal adaptations. 
Excessive opioid activity can reduce maternal motivation and behavior,94 possibly by signaling satiety403 
(4.1.1). Multiparous mothers have even higher MORs in some brain areas during lactation, according to 
animal studies, and are also less sensitive to disrupting effects from high doses of exogenous opioids.213 
The mechanisms are not clear.
Beta-Endorphins and Maternal Adaptations and Attachment
Beta-endorphins facilitate maternal adaptations and may promote mother-infant contact and attachment 
by priming maternal reward centers at birth. The co-release of oxytocin with beta-endorphins with breast-
feeding and maternal-infant contact may maintain maternal “addiction,” with benefits to infant survival. 
As discussed (4.1.1), BEs are important facilitators of maternal adaptations and behaviors in mammals,404 
motivating and rewarding infant contact and care. As with other aspects of BEs, low levels tend to facili-
tate maternal behaviors, and high levels may signal satiety and inhibit. 
Central MORs in the maternal brain are elevated through the immediate postpartum period,94 enhancing 
and likely priming maternal attachment by activating dopamine-associated reward circuits, according to 
animal studies.403 In rats, new mothers will choose contact with newborns over exposure to cocaine,779 
indicating the extreme reward value of newborn contact at this time. Priming of these maternal reward 
circuits may ensure that the new mother will continue to be motivated to give the devoted care neces-
sary for offspring survival among all mammals.404
Oxytocin additionally stimulates reward circuits (3.1.4) and, when co-released with endogenous opioids, 
may inhibit the development of opioid tolerance.433 Episodic OT release with contact and nursing may 
therefore maintain the rewarding and “addictive” nature of infant contact.403 Up-regulation in central oxy-
tocin receptors (OTRs), including autoregulating OTRs, in multiparous females (3.1.2) may also promote 
BEs and rewarding effects. 
A magnetic resonance imaging (MRI) study (also discussed in 3.1.4) supports this model in women. Among 
new mothers two to four weeks after birth, researchers found that those who had given birth vaginally 
had greater activation of brain reward centers in response to hearing their baby cry, compared with moth-
ers who had experienced prelabor cesarean section.423 (See also 3.1.4 and 3.2.6.)
4.2 Common Maternity Care Practices That May 
Impact Beta-Endorphins Physiology
The impacts of maternity care practices on beta-endorphins are less researched, compared with oxytocin. 
However, several practices may have significant effects on this important system. In particular, the use of 
pain relieving drugs—systemic opioids and regional analgesia—may disrupt endogenous BE systems, with 
potential impacts in mothers and babies. Epigenetic principles suggest that disruption of BEs during the 
perinatal period may program offspring (and possibly maternal) BE systems in the longer term.
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4.2.1  Maternity Care Provider and Birth Environment: Possible Impacts on 
Beta-Endorphins 
The maternity care provider and birth environment may impact beta-endorphins of mothers and babies 
by increasing or decreasing the chances of interventions that are consequential for beta-endorphins 
systems, or by increasing or decreasing stress, with excessive stress possibly slowing labor by elevating 
maternal beta-endorphins, as seen in animals.
No studies were found that directly assessed the impacts of maternity care provider and birth environ-
ment on the BE systems of mother or baby. However, Cochrane systematic reviews have found that 
women who receive midwifery care451 or continuous support in labor780 have a reduced use of analgesic 
drugs and epidurals. The use of labor epidurals, which likely include an opioid drug, is also reduced among 
women planning home birth.453 Other maternity care providers may facilitate similar benefits.781 Reduced 
exposure to opioid drugs in labor will reduce any potential exposure-related impacts on BEs of mother 
and baby, as discussed in 4.2.4.
In addition, as discussed in 5.2.1, the maternity care provider and birth environment may also impact 
BEs by increasing or decreasing stress for the laboring woman. For example, attendance by an unfamiliar 
care provider may be stressful. Excessive stress may elevate BEs, reducing central OT, as occurs in other 
animals, and possibly directly inhibiting uterine contractions in women (4.1.3). Oxytocin (3.1.3), E-NE 
(5.1.3), and prolactin (6.1.3) may also mediate responses to labor stress.
4.2.2  Prostaglandins for Cervical Ripening and Labor Induction: Possible Impacts on 
Beta-Endorphins 
Studies suggest that prostaglandins may elevate beta-endorphins, but this is not well researched. Induc-
ing women by any method may preempt the increases in central opioid receptors with the physiologic 
onset of labor, and diminish endogenous analgesia in labor.
No studies were found that directly assessed the impacts of prostaglandins (PGs) for cervical ripening 
and induction on BEs of mother or baby. However, researchers found immediate but transient increases 
in BEs following administration of prostaglandins to pigs in late pregnancy,782 and cows in labor.752 Re-
searchers also found elevation of BEs, including in amniotic fluid, following PG administration to women 
in mid-pregnancy.783 The mechanisms or consequences are not known.
Any method of induction will preempt the complete preparation of endogenous analgesic systems. This 
may result in fewer MORs, which peak close to the onset of labor;94 reduced non-BE spinal opioid sys-
tems; and deficits in the oxytocin system, which is also analgesic in labor (3.1.3). This may increase the 
laboring woman’s sensitivity to pain and her need for analgesic drugs. Reduced central MORs with induc-
tion could potentially reduce postpartum activation of pleasure and reward circuits in relation to birth 
and to newborn contact and care (4.1.4).
4.2.3  Synthetic Oxytocin for Induction, Augmentation, and Postpartum Care: 
Possible Impacts on Beta-Endorphins
Impacts of synthetic oxytocin on beta-endorphins are unclear. As with prostaglandins, induction may pre-
empt the complete readiness of endogenous opioid systems and compromise endogenous labor analgesia. 
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As discussed in 4.1.2, the stress and pain of labor, along with central surges of oxytocin, trigger the re-
lease of BEs from and within the brain, according to current understandings. Effects of synthetic oxytocin 
(synOT) on this system are not clear.
One study found that women administered synOT to augment labor had no rise in BEs, whereas untreat-
ed women’s BEs more than doubled from early to late labor.784 However, another study found higher BEs 
in women induced with synOT and even higher levels following artificial rupture of membranes, both 
likely causing increased pain.785 Another study found equivalent elevations in BEs following physiologic 
onset of labor, induction with synOT, and induction with PGs.786
As discussed above (4.2.2), induction with synOT or any other method may pre-empt the full development 
of analgesic systems, including central MORs (4.1.2). Given the widespread use of induction with synOT 
and other methods, these are important areas for future research.
4.2.4 Opioid Analgesic Drugs: Possible Impacts on Beta-Endorphins 
Opioid Drugs and the Mother 
Opioid drugs administered systemically have a modest analgesic effect and well-known side effects. Stud-
ies of their impacts on beta-endorphins are contradictory, which may reflect differences in women’s sub-
jective experience of analgesia efficacy.
Opioid drugs are commonly administered systemically by intramuscular (IM) or intravenous (IV) injection as 
labor analgesia, and are also typical components of epidural analgesia. (See 3.2.4 for more background.)
A handful of older studies have looked at levels of BEs following systemic opioid drug administration, with 
conflicting results. Three studies found no reduction in BEs for laboring women following meperidine 
administration,279, 787 one study found a higher peak,788 while one study found lower levels at each stage 
of labor.785 
Outside of labor and birth, systemic opioid drug administration reduces pain and consequently the need 
for, and release of, BEs.767 It is likely that, as one study found,773 in labor, opioid drugs (and other analgesic 
methods) reduce an individual woman’s BEs in proportion to their effectiveness at reducing her stress and 
pain. As discussed in 4.1.2, there may be wide individual variation in BE systems, including MOR numbers, 
which influence opioid sensitivity and the effective dose of systemic opioid drugs. There are also individu-
al differences in opioid responses that affect dosage and side effects.789
In general, laboring women report a modest reduction in self-reported pain scores following systemic 
opioid administration.591 This reduction may be sufficient to shift the experience from distress to eustress. 
However, these drugs can have other significant in-labor side effects in mothers and babies, generally 
related to central opioid effects such as dysphoria, sedation, and gastrointestinal effects.591 In addition, 
because opioids reduce central oxytocin release (3.1.1), opioid drugs may cause slowing of labor, as 
found in animal and human research. (See 3.2.4 for a full discussion of possible opioid impacts on OT and 
labor progress.)
Opioid Drugs and the Fetus/Newborn
Opioid drugs cross the placenta to the fetus and can cause sedation and other side effects. One study did 
not find impacts of maternal opioid drug administration on fetal beta-endorphins. Longer-term impacts, 
including impacts on breastfeeding and possible epigenetic programming effects, have been suggested 
but not studied in high-quality research.
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As discussed in detail in 3.2.4, recognized opioid fetal/newborn effects from maternal administration 
in labor mainly derive from sedation. This can reduce fetal movements and cause fetal heat rate (FHR) 
changes, including reductions in FHR accelerations and variability.600, 790, 791 Sedation can also impact new-
born breastfeeding behaviors and success.315, 350, 351, 602-604 Opioid effects on breastfeeding have not been 
subjected to high-quality research.590, 591 Opioid exposure via epidural analgesia, while generally lower for 
mother and baby than systemic administration by IM or IV injection, can also cause significant effects, 
including newborn sedation (see 4.2.5 below).
In one study, opioid exposure did not change newborn BEs,792 probably reflecting lack of analgesic effects 
on the baby. However, therapeutic doses of opioid drugs, administered directly to the fetus during intra-
uterine procedures, were found to reduce fetal BEs,793 suggesting that an effective analgesic dose can have 
fetal effects.
Longer-term effects of perinatal exposure to opioid drugs on the BE system of offspring have not been 
well studied, although epigenetic programming principles suggest concerns in this area, as with oxytocin 
(3.2.3). Primate studies using a single exposure to meperidine or the opioid alfentanil in labor found 
subtle developmental impacts on exposed offspring such as reduced locomotor behaviors through to 12 
months, roughly equivalent to four to five years in humans. 794
Authors comment, “Disruption of the normal ontogeny of the endogenous opiate system by perinatal 
meperidine is a mechanism for which some precedent has been established.“794(p.625) In rats, researchers 
found that a single, high-dose perinatal exposure to BE (1-31), producing supra-physiologic levels, altered 
brain serotonin, uterine estrogen receptor numbers, and sexual behaviors in adulthood.795 
Long-term impacts on human offspring from perinatal exposure to opioid drugs are not well researched. 
Two cohort studies found that exposure to opioid drugs in labor, especially in multiple doses, was associ-
ated with increased risk of opioid addiction in adulthood.796, 797 Researchers speculate that imprinting of 
the opioid system may be involved. In contrast, another study did not find such effects from meperidine 
exposure.798 
Hartwig comments, “When clinicians administer opioids, they are not simply dealing with pain relievers, 
but with a family of drugs and hormones that interact at a fundamental level with the body’s homeo-
static metabolic functions. The implications of this must not be overlooked.”767(p.77) 
Given the widespread perinatal exposure of babies to opioid drugs, including opioids in epidurals, impacts 
on breastfeeding and possible programming effects are critical areas for future research.
4.2.5 Epidural Analgesia: Possible Impacts on Beta-Endorphins 
Because of their effectiveness at reducing pain, epidurals may reduce maternal beta-endorphins substan-
tially, with potential impacts on mother and baby. 
Epidural analgesia acts by blocking the nerves that transmit pain signals (3.2.5) and is highly effective in 
reducing labor pain.614 Because of this efficacy, maternal BEs and other hormonal responses to stress 
and pain decline significantly following epidural administration, as discussed below (Epidural Analgesia 
and the Mother”; see also 5.2.5.) These effects can also impact the baby.
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Epidural Analgesia and the Mother
Maternal levels of beta-endorphins decline after epidural administration due to reductions in stress and 
pain. Postpartum levels may be significantly reduced in comparison with women not using epidural, which 
could reduce activation of central maternal pleasure and reward circuits, with possible longer-term effects. 
Studies show that maternal BEs drop substantially (around 50 percent) in the hour after epidural admin-
istration,617, 745, 747, 785, 799 with lower levels at birth compared with women not using epidural analgesia788 
(Figure 4). In one study, levels at birth were 20 percent of those in women not using epidural analgesia.792 
One study found no significant differences.800
The use of spinal analgesia in labor, usually involving an opioid drug, has similar effects on maternal levels 
of BEs.802 The excessive pain that women can feel when their epidural is allowed to wear off, frequently 
intended to facilitate pushing,803 may reflect insufficient time to restore endogenous analgesia and BEs. 
Figure 4. Maternal beta-endorphins levels, with and without epidural analgesia
Source: adapted from Riss788 
While the reduction in stress and pain following epidural, with associated reduction in BEs, can be ben-
eficial (5.2.5), it may also diminish the BE–related alteration in consciousness reported with physiologic 
labor (4.1.3). Women laboring with an epidural may therefore behave in a more “normal” and socially 
expected way.804
After birth, epidural-related reductions in both BEs and oxytocin (3.2.5) may adversely impact maternal 
adaptations, including personality shifts (3.2.5) and the activation of reward centers that promote post-
partum pleasure and euphoria (see also “Pleasure and reward” in 3.1.4). Deficits in the perinatal peaks 
of OT (3.1.4) and BEs (4.1.4) that may prime longer-term activation of reward centers in relation to infant 
contact423 may compromise such an effect. (See also 3.2.5 for a full discussion of epidurals and oxytocin.) 























Epidural Analgesia and the Fetus/Newborn
Epidurals do not reduce fetal/newborn stress or pain and may even increase fetal stress and stress 
hormones. Animal studies suggest possible longer-term developmental impacts, which have not been 
researched in humans.
While epidurals generally give very effective analgesia for laboring women, their babies do not experi-
ence analgesia because the local anesthetic drugs are not administered adjacent to the baby’s nerves 
(5.2.5). However, babies will be exposed to epidural drugs, including local anesthetic and opioids, which 
readily cross the placenta. In some studies, newborn drug levels may be up to 80 to 100 percent of ma-
ternal levels.805, 806 In addition, because the baby’s excretory capacity is immature, epidural drugs may 
persist for prolonged periods in the newborn. For example, one study found bupivacaine metabolites in 
newborn urine up to 36 hours after spinal anesthetic for cesarean section.807 
In relation to fetal/newborn BEs, one study of nulliparous women found high levels of BEs and other 
stress hormones (ACTH, CRH, E-NE) in the cord blood of epidural-exposed babies (specific epidural drugs 
not stated), with BEs around double those of babies born by unmedicated vaginal birth.800 Other studies 
have found equivalent levels of BEs (other stress hormones not measured) in epidural-exposed and 
unexposed newborns.628, 792, 808 Local anesthetic drugs, as used in epidurals, may stimulate CRH release, 
with potential effects on newborn stress hormone levels.809 (See 5.2.5 for full account.)
Possible longer-term offspring effects of epidural exposure are very poorly researched in humans. Primate 
researchers administered epidurals (bupivacaine only) to rhesus monkeys in late pregnancy and found 
developmental impacts, including delayed onset of object manipulations in infancy and greater motor 
disturbance behaviors in later infancy. Authors comment, “Not enough is known about the mechanism 
of bupivacaine action on brain to identify systems whose development could be ‘reprogrammed’.”794(p.625) 
Researchers suggest that opioid systems could be involved. 
4.2.6 Cesarean Section: Possible Impacts on Beta-Endorphins 
Cesarean and the Mother
The effects of cesarean section on maternal beta-endorphins may vary with anesthesia and type of cesar-
ean. Following prelabor cesarean (or cesarean following induction), new mothers may have lower central 
opioid receptors, which may reduce postpartum analgesia and reward center activation with newborn 
contact. Early skin-to-skin contact may be important to increase beta-endorphins for mothers and new-
borns following cesarean.
While cesarean section is less activating of maternal stress systems than physiologic birth, the associated 
surgical and psychological stresses have been found to cause some degree of elevation in BEs and other 
maternal stress hormones.745 The use of epidural anesthesia generally blocks this surgery-related increase 
in BEs, because it is so effective in blocking pain (4.2.5), whereas surgery with general anesthetic is associ-
ated with elevations in BEs.810 
Mothers experiencing a cesarean birth with epidural anesthesia have lower levels of BEs compared with 
unmedicated mothers giving birth vaginally.800 In addition, women experiencing PLCS may also miss the 
prelabor upregulation in central receptors, as found in animal studies, with compromise to postpartum 
analgesic and reward systems. After cesarean, new mothers are also more likely to experience a delay in 
first contact with their newborns, which may reduce the possibility of rewarding initial interactions with 
their babies, which may further impact postnatal BEs of mother and baby. 
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It may be especially important to expedite early skin-to-skin contact and breastfeeding after cesarean in 
order to activate maternal physiologic BEs, which have not been maximally activated by labor processes 
(4.1.4). More research is needed on optimizing maternal and newborn postpartum adaptations, including 
in the BE system, following cesarean.
Cesarean and the Fetus/Newborn
Cesarean newborns have generally lower levels of beta-endorphins and other stress hormones at birth, but 
levels may be subsequently elevated in the early newborn hours, possibly because of maternal separation. 
Newborns and infants may display altered responses to stress following cesarean, suggesting programming 
effects due to loss of the beneficial eustress of labor and birth. Long-term implications are not known.
Researchers have measured BE levels in vaginally- and cesarean-born babies, usually as a single measure-
ment in cord blood, with varying results. Some older studies found equivalent levels of BEs in babies born 
vaginally without analgesia, and by cesarean.792, 811, 812 However, more recent studies found lower levels of 
BEs in cesarean newborns, along with lower levels of stress hormones such as cortisol, compared with ba-
bies born vaginally.26, 137, 800, 813, 814 Researchers have concluded that cesarean is “less stressful” for the baby. 
(See “Fetal Epinephrine-Norepinephrine and Related Stress Hormones in Labor and Birth” in 5.1.6.)
Another study measured newborn levels of BEs for up to two hours following vaginal birth or cesarean 
(with epidural), finding that cord blood BEs at birth were higher among vaginally born babies (mean 
111ng/ml) compared with cesarean babies (64 ng/ml). However, at two hours, vaginally born babies’ BE 
levels had halved, while cesarean babies’ levels had doubled.672 They conclude,“. . . irrespective of the 
route, the delivery is stressful to the newborn infant. In newborns delivered by caesarean section the 
stress response comes after birth.”815 These findings may also reflect the common delays in maternal-
infant contact following cesarean, with reduced opportunities to lower excessive newborn stress and 
increase oxytocin through skin-to-skin contact (3.2.7, 4.2.7).
As noted, BEs are also produced in other fetal tissues, including the membranes and placenta, and may 
reach the fetus from these sources. One study found lower levels of BEs in the fetal chorion and amnion 
following cesarean compared with vaginal birth,816 likely reflecting lack of labor eustress, with unknown 
implications. Researchers have also found lower levels of BEs in new mothers’ early breast milk (colos-
trum) following cesarean compared with vaginal birth,775 such that the cesarean babies missed this ben-
efit to newborn adaptation (see 4.1.4). 
A recent study found that cesarean newborns reacted less to brief separation from the mother than vaginal-
ly-born babies, which correlated with lower cortisol levels at birth. Researchers suggest that this altered at-
tachment behavior and response to stress may relate to lack of stress and stress hormones at birth. In animal 
studies, newborn separation distress involves opioid systems.404 Studies also show altered stress responses in 
infancy following CS.814 (See 5.2.6 for further discussion of stress responses following cesarean birth.)
4.2.7  Early Separation of Healthy Mothers and Newborns: Possible Impacts on 
Beta-Endorphins 
Early separation can cause stress for mothers and especially for separated babies. Animal studies show 
significant disruptions to offspring BE systems through to adulthood from brief daily separations in the 
newborn period. This has not been studied in humans. 
No studies were found that directly assessed the impacts of separation of healthy mothers and newborns 
on BEs of mother or baby. 
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As described, BEs are elevated in mothers and newborns following physiologic birth, declining signifi-
cantly over the first hour in the bloodstream,745 but may be elevated for a longer time in the brain of 
both, due to the longer central half-life (4.1.4). Interactions such as mutual touch and breastfeeding may 
continue to episodically elevate this hormone at physiologic levels in the hours and days that follow for 
human newborns, as demonstrated in animal studies.404 As with oxytocin, BEs activate reward circuits 
that motivate maternal-infant contact and may “mutually addict” mother and newborn199, 404 (4.1.4). Ex-
ogenous opioids can reduce newborn separation stress in many species.404 This suggests that maternal 
contact may reduce newborn stress by an opioid mechanism. 
Separation of healthy mothers and their newborns may cause excessive stress with likely excessive BEs 
for both. One human study found high levels of stress, on brain monitoring, in solitary sleeping versus 
cosleeping newborns. (See 5.2.7 for more about early separation, stress, and stress hormones.) Accord-
ing to fetal/newborn programming principles (3.2.3), early separation stress could plausibly contribute to 
longer-term mis-setting of brain-hormone stress systems, including BEs.
Consistent with this, animal studies have found that maternal separation (e.g., 15 minutes daily in the 
first week) disrupts offspring opioid systems, with alterations in pain sensitivity and opioid receptor 
function in adulthood.817 Maternal separation also increases susceptibility to addiction818, 819 and is used 
in rats as an animal model for addiction research.820 821, 822 (See also 3.1.4 and 5.2.7.)
4.3 Beta-Endorphins: Summary
4.3.1 Beta-Endorphins: Normal Physiology 
Beta-endorphins are endogenous opioids that give analgesic and adaptive responses to stress and pain. 
Beta-endorphins also activate brain reward and pleasure centers, motivating and rewarding reproduc-
tive and social behaviors, and support immune function, physical activity, and psychological well-being.
From labor through the postpartum period, beta-endorphins promote:
  endogenous analgesia though prelabor increase in central receptors (animal studies) and 
increases in beta-endorphins as labor progresses
  an altered state of consciousness that may help with labor stress and pain
  fetal neuroprotection from hypoxia (animal studies)
  postpartum peaks of beta-endorphins (along with oxytocin) that may facilitate maternal 
euphoria and prime reward centers, imprinting pleasure with infant contact and care 
  reward and reinforcement of breastfeeding in both mother and baby
  newborn support with the stress of postpartum transition, including via beta-endorphins 
in colostrum 
Excessive maternal stress in labor may lead to excessive (supraphysiologic) beta-endorphins, which may 
inhibit oxytocin and slow labor (animal studies). Alternatively, too-low levels of beta-endorphins (in-
fraphysiologic) may not give adequate stress and pain reduction, or activate postpartum pleasure and 
reward. Optimal levels of beta-endorphins to reduce stress and pain and promote labor progress likely 
vary among women. 
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4.3.2 Common Maternity Care Practices That May Impact Beta-Endorphins Physiology 
Laboring women may experience excessive stress in relation to their maternity care providers and birth  
environments (e.g., if not familiar, calm, and private), which may increase BEs to supraphysiologic levels  
and slow labor. (Stress mechanisms in women are not clear but may also involve oxytocin and/or 
epinephrine-norepinephrine.)
Labor analgesia that effectively reduces pain will reduce maternal beta-endorphins to some degree. This 
may be beneficial if excessive stress is inhibiting labor. However, reduced beta-endorphins, as found 
with epidurals, may also reduce postpartum reward center activation and priming, potentially impacting 
hormonally-mediated maternal adaptations and attachment, also involving oxytocin. 
Women experiencing a cesarean section may miss prelabor opioid receptor increases (animal studies), 
in-labor peaks of beta-endorphins, and/or postpartum reward center activation. Cesarean newborns 
have lower levels of beta-endorphins at birth than vaginally born babies, but levels may rise after birth 
with separation stress. 
Separation of mother and newborn in the early sensitive period following physiologic birth, when levels 
of beta-endorphins are elevated, may interfere with reward center activation of both. In animal studies, 
repeated brief separations in the newborn period leads to detrimental impacts on offspring opioid sys-
tems, likely via epigenetic programing, with enduring effects on pain sensitivity and addiction.





Epinephrine and norepinephrine are major hormones of the fight-or-flight stress response 
system. Although not classically considered to be reproductive hormones, they may have 
important roles for the laboring woman by switching off labor under conditions of excessive 
stress. Epinephrine and norepinephrine are critical in protecting the baby during the powerful 
late-labor contractions and also in preparing for life outside the womb. The stress hormone 
cortisol, also considered in this chapter, facilitates important adaptations of mother and baby.
5.1 Epinephrine-Norepinephrine and Related Stress Hormones: 
Normal Physiology
In situations of perceived stress or danger, epinephrine and norepinephrine activate the flight-or-flight 
reflex, which involves the sympathetic nervous system. Expected and healthy stress (eustress), with physi-
ologic elevations in stress-hormone levels, is beneficial, but excessive stress and stress hormones can be 
harmful, and can inhibit labor processes and other reproductive functions.
Epinephrine and norepinephrine (E-NE, also known as adrenaline and noradrenaline) are chemically related 
hormones that have critical homeostatic functions throughout the body, nervous system, and brain, where 
NE also functions as a neurotransmitter. Although not recognized as classical reproductive hormones, 
their functioning, and especially their role in activating the fight-or-flight response, facilitated by the sym-
pathetic nervous system (SNS), has profound implications for reproduction, including childbearing. 
In addition, stress-related E-NE release can lead to activation of longer-term stress responses involving 
the related stress hormone cortisol, also considered in this chapter. Both short- and longer-term stress 
system activations are known to be detrimental in reproduction, including during childbearing. This sec-
tion (5.1) considers the role of physiologic stress (eustress) in labor and birth, and section 5.2.1 (below) 
includes a discussion of excessive stress in prenatal and childbirth care.
The distinction between healthy, physiologic stress (eustress), and excessive, pathologic stress during 
childbearing is important in relation to E-NE and stress systems, as it is in relation to beta-endorphins 
(BEs) (4.1.1). In general, a certain amount of stress is normal and beneficial to healthy functioning, in-
cluding the physiologic eustress of labor, birth, and the postpartum period for mother and baby. For ex-
ample, as discussed in this chapter, the eustress of labor activates the fetal “catecholamine surge” (CA), 
a large outpouring of E and NE that prepares the baby for life outside the womb (5.1.3). Labor eustress 
may also raise maternal E-NE levels, which keep the laboring woman alert, and cause cortisol elevations 
that enhance early maternal adaptations (5.1.4). In contrast, excessive stress, as discussed in 5.2.1, can 
cause supra-physiologic elevations in E-NE that can disrupt labor and postpartum processes. 
A useful model in understanding the stress system is suggested by Bergman, who describes reproduction, 
nutrition, and defense as mutually exclusive biological systems. This means that defense-related activa-
tion of the SNS, with E-NE elevations, may shut down reproductive functions.20 This is consistent with 
research reviewed in this chapter.
5.1.1 Epinephrine-Norepinephrine and Related Stress Hormones: Introduction
Epinephrine and the related hormone norepinephrine are the major hormones of the fight-or-flight stress 
response, and are chemically referred to as catecholamines. 
Epinephrine-Norepinephrine and Related Stress Hormones Effects
Stress, cold, hunger, and exertion can trigger epinephrine and norepinephrine release, leading to redistri-
bution of blood to enact flight-or-flight. The hypothalamic-pituitary-adrenal system can be co-activated, 
giving medium-term stress responses and releasing cortisol. Effective stress responses are critical for all 
animals, and also function to benefit laboring females.
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In response to danger, or a perceived threat of danger, the SNS is activated and stimulates the adrenal 
glands, situated on top of each kidney, to release high levels of epinephrine into the body, where it facili-
tates fight or flight, as follows:
  increasing blood pressure, which increases blood supply to the heart, brain, and major muscle 
groups
  shifting blood away from the peripheries, skin, and non-essential organs
  dilating the pupils for better vision
  dilating airways to enhance respiration
  mobilizing fuels such as glucose within the bloodstream
  reducing the functioning of digestive and other organs that are not essential to fight-or-flight 
During the fight-or-flight response, the adrenals co-release NE with E, which has overlapping effects on 
the body. Norepinephrine is also released within the brain, where it enhances alertness and memory 
formation to help avoid dangerous circumstances in the future.823 Other circumstances that can trigger 
the fight-or-flight response, with E-NE elevations, include: anxiety, cold, low blood sugar, emotional 
distress, excitement, physical exertion, and hemorrhage.824 These hormones are also released during 
sexual activity, with peaks at female825 and male171 orgasm. Epinephrine and norepinephrine have half-
lives (time taken to reduce levels to 50 percent) of two to three minutes,826 giving very transient direct 
effects. However, activation of the SNS also initiates longer-term stress responses by stimulating the 
hypothalamic-pituitary adrenal system (HPA system), as described below.
Activation of the HPA system, including by the SNS, begins with release of corticotropin releasing hormone 
(CRH, also known as corticotropin releasing factor, CRF) from the hypothalamus, which triggers release of 
adrenocorticotropic hormone (ACTH) and usually beta-endorphins (BEs, see 4.1.1) from the adjacent pitu-
itary into the bloodstream. ACTH travels to the adrenal glands, where it triggers the release of the medium-
term stress hormone cortisol, which gives effects over hours to days. (See “Maternal Epinephrine-Norepi-
nephrine and Related Stress Hormones in Pregnancy” in 5.1.2 and 2.1 for more about CRH in pregnancy.)
Although stress and stress hormones are often considered harmful, effective SNS and HPA responses are 
critical for successful adaptation in every animal, including modern humans.827 These systems are also 
designed to maximize adaptation and safety for mammalian mothers giving birth in the wild. However, 
the stress response can be inadvertently triggered for women in modern childbirth settings, with poten-
tially adverse consequences in mothers and babies (5.2.1).
As well as these elevations with perceived danger and stresses, E, NE, and cortisol are also present under 
normal (baseline) conditions and can be measured in the blood, urine and saliva. Baseline levels vary 
widely according to the individual, even by factors of 10 to 20,828 and to the time of day (diurnal rhythm), 
with E-NE levels lowest during the night, as measured in women.829 This nocturnal decrease, along with 
diurnal changes in the sleep hormone melatonin (2.1), may facilitate the more common nighttime onset 
of labor in day-living species, including humans,830, 831 and conversely the daytime labor onset in noctur-
nal species.832 
The SNS, including E and NE, is part of the autonomic nervous system (ANS), which is also involved with 
the functioning of internal organs and body systems. In general, the functions of the SNS and related 
hormones (E-NE) oppose those of the parasympathetic nervous system (PNS) and related hormone oxy-
tocin (OT), which tend to reduce SNS activity and levels of E-NE and cortisol (3.1.1). Similarly, E and NE 
may reduce OT release and functions (5.2.1).
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Epinephrine-Norepinephrine and Related Stress Hormones: Regulation and Receptors
Epinephrine and norepinephrine have differential effects by generally activating different receptors. In 
pregnancy, norepinephrine causes constriction of uterine blood vessels and stronger contractions, whereas 
epinephrine generally causes vasodilation and uterine relaxation. At extreme levels, co-release can paradoxi-
cally stimulate contractions, with evolutionary benefits for late-laboring females under threat in the wild.
Epinephrine and norepinephrine act on two major receptors—alpha- and beta-adrenoceptors—of which 
there are several subtypes. Receptor differences are important because some maternity care interven-
tions, including beta-adrenergic drugs used to treat premature labor (below) and epidural analgesia (5.2.5) 
may differentially affect alpha- and beta-adrenoceptors.
Norepinephrine mainly activates alpha-adrenoceptors, causing smooth muscle contraction, including 
constriction of blood vessels (vasoconstriction). This increases blood pressure and also redirects blood 
away from organs that are not essential for fight-or-flight, including the uterus. Alpha-adrenoceptor 
activation also promotes uterine contractions.833
Epinephrine mainly activates beta-adrenoceptors, causing dilation of blood vessels (vasodilation) and 
airways (bronchodilation), and relaxing smooth muscle, including in the uterus. Because of this effect, 
beta-adrenergic drugs are used to inhibit premature labor. In one early study, intravenous epinephrine 
administered to ten laboring women reduced uterine activity by 55 percent within two minutes, and its 
discontinuation caused hyperstimulation within a few minutes in four of the ten women,834 likely by a 
“rebound” phenomenon. 
Rebound occurs when a sudden drop in hormone levels provokes exaggerated and opposite effects. In 
the uterus, a sudden reduction in E (which relaxes the uterus and reduces contractions) can cause a sharp 
increase in tone and contractions (hyperstimulation), which can potentially compromise fetal blood sup-
ply.834 This may occur with epidural and spinal analgesia, which can cause rebound hyperstimulation by 
rapidly reducing E levels (5.2.5).
Epinephrine and norepinephrine are co-released in situations of fear or danger. Together, these hormones 
lead to a rise in blood pressure and a reduction in blood flow to non-essential organs, including the uterus, 
due to alpha-mediated blood redistribution.835-839 During labor, fear or stress can reduce fetal blood sup-
ply to some extent by this mechanism. At moderate to high levels, combined E-NE reduces or stops con-
tractions (beta-mediated), whereas, at extreme levels, E can activate alpha-adrenoceptors and, like NE, 
strengthen contractions. This makes extreme levels of stress, and of combined E-NE, paradoxically utero-
tonic, as demonstrated in animal studies.840 This may give important safety advantages by promoting a 
quick birth in the presence of danger in late labor (5.1.3). (See also “Maternal Epinephrine-Norepineph-
rine and Related Stress Hormones in Pregnancy” in 5.1.2 and “Maternal Epinephrine-Norepinephrine 
and Related Stress Hormones in Labor and Birth” in 5.1.3)
Outside of reproduction, E and NE are involved in many biologic functions, including: food intake and 
metabolism, pancreatic function, and insulin activity;841 blood pressure and heart function;842 pain mech-
anisms;843 regulation of tumor growth;844, 845 and wound healing.846 Norepinephrine also has neuroprotec-
tive,847, 848 antidepressant,849 and anti-anxiety850 effects within the brain, and suppresses inflammation.851 
NE also regulates alertness and sleep-wake cycles.852 Dysregulations of E and NE have been implicated 
in anxiety,853 depression,849 attention-deficit hyperactivity disorder (ADHD),854 and post-traumatic stress 
disorder.855 Some antidepressant drugs act by increasing central NE levels and effects.849
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Many factors and substances influence the release and effects of E and NE, both centrally and in the body. 
For example, in animal studies, repeated central administration of synthetic OT (synOT) reduces stress 
responsiveness by reducing NE activity in many parts of the brain.167 (3.1.1)
Cortisol, also discussed in this chapter, is a glucocorticoid (GC) hormone with an essential role in main-
taining homeostasis in response to external and internal stresses and changes. Cortisol release from the 
adrenal gland is the final result of activation of the HPA stress system (see “Epinephrine-Norepinephrine 
and Related Stress Hormones, Effects” above) and exerts its effects by binding with GC receptors, which 
are present in almost every cell, highlighting the extensive effects of this hormone. Cortisol can also bind 
to the related mineralocorticoid receptor, and is inactivated by specific enzymes (hydroxysteroid dehy-
drogenases), which also influence its concentrations and effects.856
5.1.2 Epinephrine-Norepinephrine and Related Stress Hormones in Pregnancy
Maternal Epinephrine-Norepinephrine and Related Stress Hormones in Pregnancy
Maternal stress responses decrease as pregnancy advances, which may be important in protecting the 
growing baby from long-term adverse developmental effects from transplacental cortisol. Maternal 
epinephrine-norepinephrine elevations could also adversely impact the fetus directly and/or indirectly by 
reducing blood supply. Late-pregnancy changes in receptors (adrenoceptors) may promote increased re-
sponsiveness to these hormones in labor. The related stress hormone corticotropin releasing hormone is 
made by the placenta and promotes fetal maturity, maternal readiness, and uterine sensitivity to oxytocin 
and prostaglandins, in the lead up to labor.
Pregnancy involves a reorganization of maternal stress systems, giving an overall reduced response to 
stress. This is very important, as exposure to chronic stress, severe acute stress, and/or stressful life 
events in pregnancy has been shown to have significant detrimental effects on pregnancy and birth 
outcomes in both animals and humans.857 According to human studies, increased risks of stress in preg-
nancy include: premature birth, intrauterine growth retardation (IUGR), and reduced newborn head 
size, reflecting suboptimal brain growth.858, 859 The effects of prenatal stress on offspring, as assessed in 
childhood, may include deficits in emotional regulation, cognitive performance, and structural brain de-
velopment.860 Prenatal stress may impact the baby by several possible mechanisms, including triggering 
maternal and fetal E-NE and/or HPA stress systems involving cortisol, as detailed below. (See also 5.2.1)
There is conflicting evidence about whether maternal E-NE can pass through the placenta to the fetus.861-863 
Placental enzymes may substantially metabolize these hormones, reducing potential fetal effects.862, 864 
However, indirect fetal effects are also possible. For example, stress-related maternal NE elevations may 
activate alpha-adrenoceptors, inducing uterine artery vasoconstriction, and potentially compromising 
fetal blood supply. An acute reduction in fetal blood supply would likely trigger fetal E-NE release, in 
order to preserve blood flow to essential organs (5.1.3), with frequent or ongoing episodes possibly im-
pairing fetal growth. Maternal E-NE elevation also stimulates the HPA system and leads to medium-term 
cortisol release, making it difficult to disentangle the effects of short- versus longer-term stress and of 
these stress hormones.
It is difficult to directly measure NE effects on the uterine arteries in pregnant women. However, in vitro 
studies have found vasoconstriction in response to NE exposure in arteries from pregnant women865 and 
animals.835, 837-839 In pregnant animals, high levels of cortisol increase alpha-adrenoceptors, which mag-
nifies the vasoconstricting effects of NE.838 This may also occur in women late in pregnancy, as below. 
These findings suggest an increased capacity in pregnancy, perhaps even greater in labor, to redistribute 
blood supply away from the uterus and baby, in conditions of stress.
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In the uterus, alpha-adrenoceptors (which promote contractions) are present at term,866-870 possibly con-
tributing to activating effects with the onset of physiologic labor (2.1.3). Whereas some subtypes of beta-
adrenoceptors (which relax the uterus) decrease in late pregnancy, which overall promotes contractions, 
beta-three subtypes (also relaxant) have been found to increase with labor onset.871 These findings also 
suggest increased uterine responsiveness to E-NE in labor and birth (see 5.1.3).
In relation to clinical effects on the uterus and baby, one study directly administered NE to laboring wom-
en and found increases in uterine resting tone, and the intensity and frequency of contractions, although 
the pattern was uncoordinated.826 A similar study administering E to laboring women found generally 
reduced contractions, although two of ten women had increases in contractions,834 possibly reflecting 
alpha-adrenoceptor stimulation at what might be excessive levels for these individual women. Studies in 
pregnant sheep have found reductions in uterine blood supply in response to both NE872, 873 and E,874, 875 
although fetal adaptations preserved blood and oxygen supply in these studies.872, 874 (See also “Maternal 
Epinephrine-Norepinephrine and Related Stress Hormones in Labor and Birth” in 5.1.3, below.)
In relation to cortisol in pregnancy, maternal levels have been found to rise as pregnancy advances, with 
salivary levels at term around two-fold higher than levels in non-pregnant women.876-878 This likely re-
flects elevations due to CRH, derived from placental production (5.1.1), and also to reorganization of the 
HPA system.
Maternal cortisol can cross the placenta in small but biologically significant amounts,861 so that exces-
sive maternal cortisol levels from excessive stress can lead to elevated fetal levels, potentially affecting 
development of fetal neurologic, metabolic, and other systems. Stress-induced elevations of maternal 
cortisol, as measured in the saliva or urine, have been associated with early miscarriage, premature la-
bor, and low birth weight,879 and are implicated in the well-established long-term detrimental effects of 
pregnancy stress on offspring, as discussed above.857
During pregnancy, the placenta also makes CRH, with hormonal reorganization at this time to reduce 
maternal HPA responses to these elevated levels. This hormone has been called the “biological clock,” 
as mid-pregnancy levels of CRH, produced by the placenta, have been correlated with length of gesta-
tion.76 Levels of CRH rise exponentially in late pregnancy,880 reaching 1,000- to 10,000-fold above non-
pregnant levels, and receptor numbers and bioavailability also increase as the physiologic onset of labor 
approaches. The effects of CRH include: promoting fetal growth; amplifying fetal readiness for labor by 
increasing fetal cortisol, which promotes maturity; promoting estrogen production;76 enhancing uterine 
contractions at the onset of physiologic labor by increasing uterine sensitivity to prostaglandins (PGs) 
and OT;89, 90, 881 and stimulating inflammatory changes,91 which also promote labor onset. (See also “Ma-
ternal related stress hormones in labor and birth” in 3.1.3 and 2.1.)
Fetal Epinephrine-Norepinephrine and Related Stress Hormones in Pregnancy
Maternal anxiety and/or epinephrine-norepinephrine elevations may affect the fetus in pregnancy, likely 
via reduction in blood flow to the uterus and baby. Physiologic late-pregnancy increases in fetal cortisol 
promote prelabor preparations, including clearing lung fluid and increasing epinephrine-norepinephrine 
receptors and responsiveness to the in-labor “catecholamine surge.”
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The direct biologic effects of maternal stress and stress hormone elevations on the fetus in pregnancy are 
not well researched. One study subjected women to brief, mild stress at several times during pregnancy 
and found reduced fetal movements and increased fetal heart rate (FHR) variability, both consistent with 
responses to reduced blood supply. While maternal physiologic responses to stress decreased from 24 to 
36 weeks, in accord with reduced stress responses with advancing pregnancy, fetal responses increased, 
which may reflect increased E-NE sensitivity due to maturing of the fetal ANS.882 Increased fetal E-NE re-
sponses at term may benefit adaptations to labor stresses via the catecholamine surge (5.1.3).
Other studies have linked maternal psychological well-being, including specific measures of anxiety, with 
differences in uterine artery resistance (indicating blood flow).883-887 These findings also suggest that ma-
ternal stress may cause NE-mediated vasoconstriction and, conversely, maternal relaxation may improve 
blood flow.887
In relation to fetal E-NE, levels begin to rise a few days before the physiologic onset of labor, triggered 
by rises in cortisol produced by the maturing adrenal78 (2.1). Elevated cortisol levels in the last weeks of 
pregnancy prepare the fetus for birth and for life outside the womb by maturing the lungs, gut, and thy-
roid, among other effects. Fetal adrenal maturation promotes maternal estrogen production (2.1), en-
suring that maternal and fetal readiness for labor and birth is aligned and coordinated. Cortisol prepares 
the fetal E-NE system by increasing beta-adrenoceptors in the fetal heart and lungs,78 which promote 
protective responses in labor via the “catecholamine surge” (5.1.3). Cortisol also activates physiologic 
mechanisms that will clear the lungs of fluid during labor,78, 476 and cortisol-related mechanisms initiate 
a 25 percent reduction in lung fluid, even before labor begins, according to animal studies.888 Late-preg-
nancy prolactin increases may potentiate cortisol’s maturing effects on the fetal lungs.889 (See also 2.1 
and “Fetal Epinephrine-Norepinephrine and Related Stress Hormones in Labor and Birth,” below.)
Researchers suggest that, in response to hypoxia and other stresses, medium-term fetal cortisol release 
may promote placental production of CRH and ACTH, with beneficial vasodilating effects that improve 
fetal blood and oxygen supply. In this model, unresolved hypoxia, causing even greater CRH elevations, 
could stimulate the onset of labor (2.1), possibly explaining some cases of preterm birth.890
5.1.3 Epinephrine-Norepinephrine and Related Stress Hormones in Labor And Birth
Evolutionary Model
Among all mammals, and through human evolution, laboring females have been vulnerable to predators 
and other dangers in the wild, and so have sought a safe, undisturbed environment for labor and birth. 
A perception of danger in labor may promote epinephrine-norepinephrine release, with slowing of labor 
and redistribution of blood away from uterus and baby to facilitate flight or flight. The flight-or-flight 
reflex may also be activated in modern women, slowing or stopping labor in unfamiliar environments 
and/or with unfamiliar attendants. 
Through millions of years of mammalian evolution, biologic processes have evolved to safeguard the 
birthing female.832, 891 All mammals seek a safe place to give birth, usually choosing a familiar environment 
and sometimes creating a nest to receive their offspring.832 Many animals give birth in private or hidden 
locations. For some species—including elephants, mice, dolphins, and humans—one or more familiar 
female companions are usually present during labor and birth.832, 891 This may reflect the extreme vulner-
ability of the laboring female, who will be compromised in her ability to defend herself and her newborn 
offspring against danger through to the postpartum period. In addition, predators are likely to be attract-
ed by her unusual behavior in labor and birth, by the smell of blood and amniotic fluid, and by the small 
vulnerable newborn. 
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Dutch comparative biologist Cornelius Naaktgeboren comments: In all mammalian species, the course of 
delivery can be influenced by environmental disturbances . . . . Anxiety and fright inevitably lead to pro-
longation of the duration of labour . . . . Suppression of uterine activity is a life-saving adaptation, because 
in cases of danger the animal is able to either fight or to flee. Afterwards the animal can give birth to the 
young in peace and safety . . . . This adaptive mechanism clearly shows the importance of a perception 
of safety and avoidance of disturbance during parturition.832(p.801)
A perception of safety and lack of disturbance are also evolutionary requirements for human birth. When 
the laboring woman has a subjective sense of disturbance or danger, her fight-or-flight response is likely 
to be activated. This operates at an instinctive, subcortical level and draws on sensory information such 
as smell, sound, and sight. This may lead to E elevations that can inhibit or even stop labor, with NE rises 
leading to redistribution of blood to her major muscle groups, and away from her uterus and baby. Slow-
ing of labor and some degree of fetal hypoxia, which may be detectable as a non-reassuring fetal heart 
rate (FHR), are therefore possible consequences when the laboring woman does not feel private, safe, 
and undisturbed. (See 5.2.1.)
In modern maternity care, slowing of labor often occurs when women move from home to hospital, 
especially before the processes of labor, including the OT-associated positive feedback loops, are fully 
established (3.1.5). This phenomenon has been called “pasmo,” and may even include the possibility of 
regression of cervical dilation.892 
Midwifery and obstetric texts from the 19th century, as researched by Gaskin,892 document many inci-
dents where labor slowed or even stopped in response to the arrival of attendants, especially unfamiliar 
and/or male attendants, into the female domain of the birth room. For example, Dorland opines in his 
1901 obstetrics textbook, in relation to contractions: Mental emotion of any kind will temporarily dimin-
ish their intensity or even absolutely suppress them; the entrance of the physician into the lying-in room 
may have the same effect.893(p.122) 
These observations highlight the historical knowledge that women, like animals, can be highly sensitive 
to their surroundings in labor. E and NE elevations likely mediate these processes. (See 5.2.1 for more 
about stress in labor and birth.)
Maternal Epinephrine-Norepinephrine and Related Stress Hormones in Labor and Birth 
Maternal Epinephrine-Norepinephrine in Labor and Birth. Epinephrine levels in laboring 
women may increase up to eight-fold, compared with baseline, likely reflecting stress and pain. Norepi-
nephrine levels are more moderately increased. These elevations may promote alertness and vigilance 
and increase metabolic fuels in labor.
According to the evolutionary model, sudden and/or large increases in maternal E and NE in early labor 
due to fear and danger may evoke a fight-or-flight E-NE response, with potentially negative effects on 
labor progress and fetal blood supply (5.2.1). However, studies in laboring women also show a gradual 
rise in these hormones as labor progresses, with E levels reaching up to eight-fold higher than individual 
baseline levels.110, 829, 894 This is likely due to the pain and eustress of labor, with one study finding a close 
correlation between E levels in labor and self-reported pain.895 Norepinephrine elevations are mostly 
confined to late labor, and may reflect the muscular work of this stage.110
118CHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | 5 STRESS HORMONES / 5.1.3
Figure 5894 shows mean in-labor maternal E-NE levels, with significant peaks of both hormones at birth 
and declines after birth, especially for epinephrine. A similar study that uniquely controlled for individual 
and diurnal hormone variations by comparing laboring women’s urinary E-NE levels, collected hourly, 
with their own levels at the same time of day in late pregnancy found that E levels for women in the 
pushing phase were more than eight times their own baseline levels, with NE levels one and one-half 
times higher.110 These labor elevations are consistent with other studies.896-902
Figure 5.  Maternal epinephrine and norepinephrine levels in labor, at birth, and after birth
Source: adapted from Neumark894
Elevations in E-NE would be expected to enhance alertness and attentiveness to sensory input, as occurs 
outside labor,827 and may help to ensure that the laboring female remains vigilant to danger, even in the 
midst of active labor. Women experiencing an unmedicated labor may seem in a dream-like altered state 
of consciousness, due to elevations in BEs (4.1.3), but alert senses may be important to attune them to 
any possible danger to themselves or their babies. In modern maternity care settings, E-NE elevations may 
make laboring women extremely sensitive and alert to the concerns or comments of their attendants.
In contrast, studies in other mammals have found comparatively lower levels of E-NE in early to midla-
bor, with more moderate but steep elevations at birth.903, 904 A hormonal and physiologic study in labor-
ing horses found that, in the absence of disturbance, equine labor is dominated by the PNS, with low 
levels of E-NE and SNS activity.904 While SNS activation in labor may be more detrimental in prey animals 
such as horses, whose main response to danger is an immediate flight reaction that could be counter-
productive in labor, the differences in these studies may be important. Findings could imply that E-NE 
elevations in labor, as found in human studies, may actually be an artifact of labor disturbances, which 
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are common in maternity care (5.2.1). (For example, in this human study, women were catheterized to 
collect urine for E-NE analysis and experienced vaginal examinations every two hours.) It is plausible that 
parasympathetic dominance in early labor (supported by a private and undisturbed environment, with 
low stress and E-NE) may optimize parturition by maximizing the late-labor shift to sympathetic domi-
nance (e.g., fetus ejection reflex and effective pushing stage, discussed below). The ideal ANS balance 
in labor to promote physiologic childbearing in women, and the ideal circumstances to support this, are 
critical areas for future research.
Late-labor elevations in E-NE levels (seen in women and other mammals) cause the release of metabolic 
fuels, including glucose and free fatty acids, which are also used in the synthesis of prostaglandins.905 
Rising maternal E-NE levels near the end of labor, and even higher levels with the fetus ejection reflex 
(see “Fetus ejection reflex,” below) could therefore increase PG production, further augmenting uterine 
contractions.906, 907
The fetus ejection reflex. The “fetus ejection reflex” model is based on physiologic understandings 
of the stimulating effects of extreme epinephrine levels, and clinical observations of a rapid and involun-
tary pushing stage following an essentially undisturbed labor and birth. This reflex may be important for 
safety during mammalian birth in the wild, and may also be triggered in women by fear and/or epineph-
rine elevations in late labor. 
Extreme levels of E-NE in late labor may paradoxically stimulate, rather than inhibit, contractions, augment-
ing the OT positive-feedback cycle (“Ferguson reflex,” discussed in “Maternal Oxytocin in Labor and Birth” 
in 3.1.3) and creating several powerful and involuntary contractions that birth the baby quickly and easily. 
This model, based on physiologic understandings and clinical observations of births with low levels of 
disturbance, has been called the “fetus ejection reflex” (FER),908 and is characterized by signs of E-NE eleva-
tion such as increased muscular strength, dry mouth, upright posture, and verbal or non-verbal expressions 
of what Odent calls “physiologic fear,” such as, “I’m dying.”908 The FER is consistent with the understand-
ing that extreme levels of E can activate alpha- more than beta-adrenoceptors, with uterine stimulating 
(uterotonic) effects (5.1.1). In vitro animal research suggests that extreme levels of mixed E and NE are 
also uterotonic.840 
The FER may have evolved to protect female mammals birthing in the wild where, in the presence of dan-
ger in late labor, an acceleration of contractions leading to a quick birth would be more adaptive than 
physiologic attempts to slow labor when the positive feedback cycles (3.1.3) are well established and the 
birth may have already commenced.
According to Odent,908 a genuine FER may be triggered by a sense of danger and E-NE surge in late labor, 
or may occur spontaneously when labor has been essentially undisturbed, which may reflect PNS domi-
nance, discussed above. This is consistent with studies of E-NE in laboring animals,903 discussed above 
(“Maternal Epinephrine-Norepinephrine in Labor and Birth”). According to this model, the FER represents 
an important adaptation, being the quickest and therefore safest birth for all mammals in the wild, but 
may be rare in modern maternity settings because labor is so commonly disturbed, subtly or overtly 
(5.2.1), such that the SNS system is dominant. Women birthing out of hospital, or those whose babies are 
born unexpectedly quickly before, or just after arrival in hospital are most likely to experience the invol-
untary pushing of an FER, which Odent suggests could be used as a marker of physiologic birth.908 
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Maternal related stress hormones in labor and birth. Cortisol levels rise as much as 10-fold in 
labor compared with baseline, and may contribute to labor efficiency and preparations for breastfeeding. 
Elevations in corticotropin releasing hormone promote uterine sensitivity to oxytocin and prostaglandins, 
and effective contractions.
Levels of cortisol also rise in labor, with salivary cortisol levels in late labor more than ten times the 
woman’s own late-pregnancy baseline levels, according to one study.110 In this study, cortisol levels, ad-
justed for diurnal variation, correlated with self-reported fear and pain during labor. Other studies have 
linked higher cortisol levels in labor with higher self-reported pain, but also with a more positive labor 
experience, as reported 24 hours after birth,909 perhaps reflecting cortisol’s euphoric effects. 
Animal studies show the following beneficial effects of cortisol in labor:
  upregulation of OT receptor production, which increases the positive feedback of OT on local PG 
production (3.1.3) up to 100-fold, and increases labor efficiency98 
  increase in alpha-adrenoceptor formation,838 augmenting pro-contraction effects in labor (5.1.1) 
  promotion of prolactin receptor formation910 (see also 3.1.4)
Note that cortisol’s physiologic role is to restore homeostasis in conditions of stress, including stress and 
pain in labor. Other hormones that help the laboring mother deal with stress and pain include:
  oxytocin, which has analgesic and calming effects (3.1.1)
  beta-endorphins, which have analgesic and stress-reducing effects (4.1.1)
  prolactin, which has calming effects (5.1.1) 
  natural benzodiazepines, which also have calming effects in labor911
The stress hormone CRH may also play an important activating role in labor and birth by increasing 
uterine responsiveness to PGs and OT,89, 90, 881 and possibly by promoting inflammation.91 (See also 
“Maternal Epinephrine-Norepinephrine and Related Stress Hormones in Pregnancy,” above, and 2.1.)
Fetal Epinephrine-Norepinephrine and Related Stress Hormones in Labor and Birth 
For the fetus, E and NE provide critical safety mechanisms during labor and birth. 
Late-gestation elevation in cortisol, produced by the maturing fetal adrenal,78 promotes the formation 
of adrenoceptors in the heart, lungs, and brain78 (2.1). For the fetus, NE is the main catecholamine and 
levels are up to five times greater in early labor than before labor (as measured in newborns following 
prelabor cesarean section, PLCS) and another 10- to 15-fold higher in late labor, as measured in fetal 
scalp blood samples.337 This “fetal catecholamine surge” helps to protect against low oxygen levels dur-
ing the long, strong, closely-spaced contractions of late labor, and also prepares the fetus for life outside 
the womb.78, 337 
Fetal catecholamine surge. The late-labor fetal surge in epinephrine and norepinephrine promotes 
adaptations to labor stress and hypoxia, protects the heart and brain, and prepares the baby for postpar-
tum transitions including respiratory, metabolic, and thermoregulatory. This surge, along with cortisol, 
also activates fetal physiologic systems in preparation for life outside the womb. 
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Late-labor pressure on the fetal head and the inevitable hypoxia due to frequent strong contractions 
stimulate the fetal adrenal to release large amounts of NE, and to a lesser extent E. These facilitate:
  increased blood pressure to maximize blood supply
  preserved blood flow to the essential fetal organs: heart, brain, and adrenals
  slowed fetal heart rate (bradycardia), which conserves oxygen and fuels
A more mature fetus may respond to hypoxia with more E than NE release, reflecting more advanced 
adrenal development. High E levels are more likely to promote tachycardia and/or decreased heart-rate 
variability, rather than NE-associated bradycardia.337 In addition, a baby who misses the final weeks of 
gestation through prematurity or scheduled birth may need to release even more E-NE in an attempt to 
trigger these important adaptations, which may still be less successful, because of foreshortening of the 
late-pregnancy cortisol elevations that increase beta-adrenoceptors (see “Fetal cortisol,” below). 
The fetal CA surge ensures that blood flow to essential organs is maintained in the face of hypoxia. More 
severe hypoxia can cause fetal E-NE levels that are hundreds of times higher than baseline adult levels, 
and sufficient to cause a stroke in an adult,337 but providing a critical adaptive response for the fetus. 
Newborns with low acidity (pH) in the cord blood, indicating hypoxia in labor, but high E-NE levels (even 
10 to 20 times higher than normal) maintain their condition and Apgar score, whereas those with low pH 
and a lesser E-NE response have lower Apgar scores.337
In addition, the CA surge promotes important physiologic changes that optimize fetal-to-newborn 
adaptation.78, 337 These include:
  clearing lung fluid in preparation for breathing
  increasing lung surfactant, which acts as a lubricant
  increasing lung compliance (elasticity), still measurable two hours after birth313
  dilating the airways
  mobilizing metabolic fuels (glucose and free fatty acids), which protect against newborn low 
blood sugar 
  increasing liver glycogen to facilitate ongoing glucose supply after birth
  maintaining blood flow to vital organs (brain, heart)
  increasing alertness
  dilating pupils, which facilitates maternal interactions and bonding
  metabolizing brown fat for heat production (thermogenesis)
Because of the vulnerability of the baby to labor hypoxia, protective feedback systems between baby 
and mother in labor are likely but not as yet delineated. Researchers have suggested that fetal urinary 
E-NE metabolites, excreted into the amniotic fluid, could act on the adjacent decidua and myometrium 
and promote contractions. This mechanism could beneficially hasten labor in response to fetal hypoxia, 
but direct evidence is lacking. 
Many other fetal systems are activated during labor and birth, possibly triggered by the surge in CA 
and cortisol. These adaptations are, in general, fully present for a vaginally-born baby, and significantly 
reduced for babies born by cesarean section (CS) and especially following PLCS.337 The vulnerability of 
PLCS babies to breathing difficulties, low blood glucose, hypothermia, poor tone, and reduced alertness 
can be attributed to lack of the labor-induced CA surge (see 5.2.6). 
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Fetal cortisol. The baby’s cortisol levels rise in the lead up to labor, with critical roles in maturing the 
fetal organs and in preparing for labor. 
Cortisol up-regulates fetal adrenoceptors to ensure an effective CA surge, with all the benefits as listed 
above. The large increase in fetal cortisol with the eustress of labor promotes rapid newborn adaptations 
in multiple systems, supporting the transition to life outside the womb,78, 337, 912 and activating the HPA 
system with possible longer-term programming effects148 (5.2.6). In addition to fetal production, mater-
nal cortisol may cross readily to the baby in labor.913 
Cortisol levels in cord blood have been correlated with acidity (pH, related to hypoxia),814 reflecting the 
stress response to labor hypoxia. Other researchers have found greater increases, with labor stress, in the 
related adrenal hormone corticosterone than cortisol, suggesting that this may be the dominant fetal 
adrenal hormone in labor.913 
5.1.4 Epinephrine-Norepinephrine and Related Stress Hormones after Birth
Maternal Epinephrine-Norepinephrine and Related Stress Hormones After Birth
Maternal epinephrine levels drop rapidly after birth, which may be important to optimize uterine contrac-
tions and prevent hemorrhage. Warmth and undisturbed skin-to-skin contact between mother and newborn 
may facilitate this. Postpartum physiologic elevations in cortisol may promote euphoria and attachment, 
possibly by potentiating oxytocin effects.
Maternal E levels, as measured in the blood, peak at birth and drop steeply after birth894 (Figure 5). In one 
study, mixed maternal CAs (combined E-NE) had dropped at 30 minutes postpartum to almost 50 percent 
of levels measured immediately after birth.914 This rapid drop in E may be important in preventing post-
partum hemorrhage. At the very high levels of late labor and/or the FER, E may paradoxically stimulate 
contractions (via alpha-adrenoceptors) but, as levels decline postpartum, this effect may revert to inhibi-
tory, via beta-adrenoceptors. 
In support of this model, researchers have found correlations between high levels of E-NE and postpar-
tum hemorrhage (PPH).915 Older research found that drugs that inhibit E release are effective in prevent-
ing postpartum hemorrhage.916 These findings suggest that circumstances that decrease E-NE postpartum 
may reduce PPH risk. Facilitators of low E-NE levels in the new mother likely include: a warm environment 
(cold can trigger E-NE release, 5.1.1), low stress, and undisturbed SSC with her baby, which promotes OT 
release (3.1.4), decreasing E-NE and SNS activity (3.1.1). 
Cortisol levels are elevated in the new mother for several days following vaginal birth. Cortisol is not only 
a stress hormone; it is also associated with romantic attachment.917 There is some evidence that elevated 
levels of cortisol-like hormones may potentiate the behavioral effects of OT, possibly by increasing the 
binding of OT to its receptors.187 In relation to attachment, Esch comments, “. . . some degree of strong, 
yet manageable, stress may be necessary for very strong bonds to form.”917(p.177) In addition, cortisol may 
be necessary, along with prolactin, in promoting early milk production (lactogenesis)918 (6.1.4).
Studies have found that new mothers with elevated cortisol levels have more positive recollections of 
labor909 and interact with their newborns more affectionately.919 In one study, first-time mothers with 
elevated cortisol were more attracted to their newborn’s scent,919 which may reflect cortisol’s potentiat-
ing effects on the OT system (above).
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Cortisol declines to normal adult levels over the first week,920 reflecting a gradual return to normal fol-
lowing the major pregnancy adjustments of the HPA system. The initiation of breastfeeding may contrib-
ute to this decline,920 which has also been implicated in postpartum depression.
Newborn and Later Epinephrine-Norepinephrine and Related Stress Hormones
Newborn epinephrine levels drop rapidly, which is crucial to preserve energy stores. Skin-to-skin contact 
with the mother reduces stress and stress hormones. Early norepinephrine elevations promote learning of 
maternal odors. Newborn cortisol peaks after birth aid in newborn physiologic transitions, and promote 
alertness, likely benefitting breastfeeding initiation.
Newborn E-NE levels, as measured in cord blood following labor, are extremely high, and even higher if 
there has been hypoxia (5.1.3). Levels drop rapidly from these peaks, with E dropping by more than 80 
percent within 15 minutes after birth.922 This rapid postnatal decrease is important, as the fetal CA surge 
increases metabolic turnover, depleting newborn energy stores that will not be replaced until breast-
feeding is well established.337 
Skin-to-skin contact with the mother reduces the “stress of being born”175, 337 by increasing OT levels, 
which switch off the fight-or-flight response and reduce E-NE levels.175 Lack of SSC after birth can keep 
newborn E-NE levels elevated, which can have ongoing detrimental effects on the autonomic nervous 
system and newborn metabolism (5.2.7).
Newborn NE levels drop more slowly than E levels. Physiologic NE elevations in the early newborn hours are 
associated with olfactory learning among human newborns, helping the baby learn the mother’s smell.923
Postpartum maternal and newborn E-NE levels may be correlated and reflect previous stresses in labor. 
In one study, women whose babies had nuchal cords, including one baby with a true knot in the cord, 
had higher than average levels of E and NE at birth,901 although other studies have not found correlations 
between maternal and fetal levels.898 (See also discussion of maternal-fetal E-NE transfer in 5.1.3.)
Newborn cortisol levels continue to rise after birth, peaking a few hours later at levels about six times 
higher then those in late gestation. This provides important assistance with newborn transitions, includ-
ing liberating the metabolic fuels that are needed until breastfeeding is established.78 For the newborn, 
as for adults, cortisol may give feelings of well-being and euphoria, and help to form strong bonds. In 
one study, newborn cortisol levels were higher after a longer labor and correlated with alertness,912 
which is likely to benefit breastfeeding initiation.
Epinephrine-Norepinephrine and Related Stress Hormones, and Breastfeeding and 
Maternal Adaptations and Attachment
Maternal cortisol elevations promote prolactin receptor formation, benefitting breast-milk production, and 
enhance newborn transitions via transfer into breast milk. Norepinephrine promotes maternal behaviors.
During early breastfeeding, physiologically elevated maternal cortisol levels may promote prolactin recep-
tor formation, as found in animal studies,910 with benefits to ongoing milk production (6.1.4). In addition, 
elevated levels of cortisol, which is transferred into milk,921 may assist with newborn transition to life out-
side the womb. Cortisol levels in maternal blood correlate with levels in breast milk.775
Animal research suggests that NE released during labor may be important for subsequent maternal be-
havior. Mice bred to be deficient in NE do not care for their infants unless NE is injected back into the 
brain before birth.924 Within the brain, NE centers make critical connections with OT centers, facilitating 
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the processes of labor, birth, and postpartum maternal adaptations, according to animal studies.252 In an-
imals,404 and in human newborns,923 NE is important for olfactory learning. In primates, including humans, 
NE may also facilitate social learning and affiliation, beginning from birth.404
As described above (“Maternal Epinephrine-Norepinephrine and Related Stress Hormones After Birth“), 
postpartum cortisol elevations may elevate maternal mood and promote attachment.
5.2 Common Maternity Care Practices That May Impact 
Epinephrine-Norepinephrine and Related Stress Hormones 
Many common practices can disturb epinephrine-norepinephrine and related stress hormones in mothers 
and babies. This chapter considers the effects of stress in childbearing (including pregnancy, labor, and 
birth), on these hormones, including cortisol, in women and babies in relation to maternity care provider 
and birth environment. Other maternity care practices that may disrupt these systems in mothers and ba-
bies, as described in this section, include the administration of epidural analgesia, cesarean section, and 
the postpartum separation of healthy mothers and newborns. 
5.2.1  Maternity Care Provider and Birth Environment, Including Prenatal and 
Childbirth Care: Possible Impacts on Epinephrine-Norepinephrine and  
Related Stress Hormones
This area has not been well researched in relation to direct effects. One randomized study found no re-
duction in maternal epinephrine and norepinephrine levels following birth attendant (doula) support. 
However, this study found benefits of doula support to mood, labor pain recall, and breastfeeding, sug-
gesting overall benefits to hormonal systems.
One randomized study measured E, NE, and cortisol among laboring women before and one hour after 
allocation to additional care from a supportive birth companion (doula) or control. Researchers found 
no measurable differences in these hormones or in overall labor progress, compared to women without 
doula support.448, 449
However, this research did find that women who received doula care had lower analgesia requirements 
and reduced blood pressure in labor, and subsequently reported: less postpartum anxiety and better 
mood scores, less recollection of labor pain and difficulty, and higher breastfeeding continuation than 
women not receiving labor support. In addition, a follow-up study found lower levels of postpartum 
depression among women randomized to labor support.435 These findings are consistent with enhance-
ment of hormonal physiology.
Several factors might account for the lack of measured hormonal changes in this study. First, the physi-
ologic rise in these hormones in labor, as found in human studies (5.1.4), could mask decreases due to re-
ductions in stress and anxiety. In addition, the second sample, taken just one hour after allocation, may 
not have allowed sufficient time for the laboring women to form a new relationship and benefit from the 
doula’s support. A systematic review of doula support found less analgesia requirements, lower CS risk, 
and lower rates of dissatisfaction,780 also suggesting hormonally-mediated benefits (see “Childbirth and 
Stress,” below). 
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Prenatal Care and Stress 
Maternal stress and stress hormones may be impacted by aspects of prenatal care, including nocebo 
(negative placebo) effects, prenatal testing, fears about fetal well-being, and concerns about pain in labor. 
Prenatal care that benefits maternal relaxation and/or reduces anxiety and fear could benefit maternal 
and fetal outcomes by enhancing hormonal physiology.
Maternity care providers could potentially influence E-NE and related stress hormone levels in pregnant 
women through elevating or reducing maternal anxiety and perceived stress in relation to pregnancy 
care, including prenatal testing.925-927 Given the solid evidence showing adverse impacts of pregnancy 
stress, including impacts on prematurity, birth weight, and infant and child development (5.1.2), reduc-
ing pregnancy stress could have significant benefits for mothers and babies.
Aspects of our current maternity care system may increase, or fail to decrease, anxiety and stress for 
pregnant women. Studies have linked increased maternal anxiety with routine prenatal tests including:
  ultrasound,928-930 with false-positive scan results negatively affecting maternal-infant attachment, 
even after birth931 
  prenatal testing for Down syndrome926, 932, 933 934 
  electronic fetal monitoring in pregnancy935
The World Health Organization estimates that, in many countries, an average woman receives in excess 
of 150 tests during pregnancy.936 False positive findings, which become more likely as the number of 
tests increases, can create anxiety. For example, in a survey from Germany, two-thirds of women report-
ed an abnormal test result during pregnancy, the majority relating to an ultrasound scan and eventually 
found to be normal. More than half of these women reported being acutely worried and, five weeks 
later, one-quarter were still concerned.937
Sakala identifies the nocebo effect, an unintended negative effect (reverse placebo), as of concern in 
relation to conventional maternity care, which can create a “climate of doubt” rather than a “climate of 
confidence” for pregnant women and their ability to gestate, birth, and breastfeed their babies.938 Odent 
comments, “The nocebo effect is inherent in conventional prenatal care, which is constantly focusing 
on potential problems. Every visit is an opportunity to be reminded of all the risks associated with preg-
nancy and delivery.”939 Odent recommends that maternity care providers “create such interactions that a 
pregnant woman feels even happier after a prenatal visit than before . . . or at least less anxious.”925(p.311) 
Common maternity care language and terms can imply deficits in the pregnant woman’s body and its func-
tions. Examples include: “incompetent cervix,” “growth retardation,” “trial of labor,” “failed induction,” 
“failure to progress,” “inadequate pelvis,” and “elderly primagravida.” These may also have a nocebo effect 
on childbearing women.
Maternal fear about the baby’s well-being, which may be exacerbated through prenatal testing, has been 
linked to attention-regulation deficits in infancy, as has fear of pain in labor,940 another area where con-
ventional prenatal care does not generally provide an empowering context for pregnant women. The na-
tional Listening to Mothers II survey of women who gave birth in 2005 found that 53 percent of all women 
felt fearful as they approached labor, including almost two-thirds of first-time mothers.941 
In relation to pregnancy care, increases or decreases in stress hormones could mediate some of the docu-
mented differences in outcomes between different care providers. For example, a Cochrane systematic 
review found that women randomized to midwifery-led continuity of care were less likely to experience 
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preterm birth and to lose their baby before 24 weeks, compared with women using other models of 
care.451 Similarly, a meta-analysis of women who chose to give birth at home, the majority under mid-
wifery care, found lower rates of prematurity, with fewer low birthweight babies, compared with similarly 
low-risk women giving birth in hospital.453 A recent (non-randomized) study of doula support beginning 
in pregnancy, found a four-fold reduced risk of premature birth among socially-disadvantaged women 
compared with women without doula support.942 
Some of these findings could relate to a lower risk status among women choosing midwifery or doula 
care and home birth, although the Cochrane review was limited to randomized controlled trials and US 
studies have shown that midwifery clients include women with a variety of risk profiles.452, 943 Enhanced 
emotional support and reduced anxiety, which may be more likely among women accessing midwifery 
care, could also contribute, reflecting a paradigm of the fundamental normalcy of childbearing, possibly 
acting via low maternal E-NE levels optimizing uterine blood supply. Other maternity care providers 
and models of care that encompass emotional support and minimize nocebo effects in pregnancy may 
similarly benefit maternal and fetal outcomes, according to this model.
A recent systematic review of effects of relaxation techniques in pregnancy found beneficial effects in rela-
tion to: women’s emotional state, maternal and fetal physiologic stress markers and/or hormones, hospital 
admission, premature birth and low birth weight, cesarean section rate, and newborn neurobehavior, 
among other pregnancy and postpartum benefits. Effective techniques included guided imagery (such as a 
guided relaxation audio program), progressive muscle relaxation, yoga, and massage. Researchers sug-
gest that identifying pregnant women at risk and treating from early pregnancy could improve obstetric 
and developmental outcomes for the mother and her fetus.944 This evolving evidence suggests that some 
forms of relaxation and relaxation training may improve not only physiologic and hormone stress markers 
but also meaningful outcomes in mothers and babies. Reduction of stress and anxiety in pregnancy may 
have significant and long-term benefits to offspring, and therefore substantial public health benefits. 
Given the links between maternal and fetal stress responses, and the long-term effects of maternal stress, 
as detailed here, reducing anxiety and fear during pregnancy is likely to be clinically relevant and is an 
important area for high-quality research.
Childbirth and Stress 
Providing an environment that laboring women perceive as private, safe, and undisturbed may be important 
for labor progress, as it is in other animals, and may reduce requirements for interventions. Conversely, 
perceived stress may elevate epinephrine and norepinephrine, slowing labor and potentially reducing fetal 
blood supply. Laboring women may perceive many common maternity care practices as stressful.
In many traditional cultures, a major role of the care provider in labor is to ensure a safe and undisturbed 
environment for the laboring woman, with emotional support when needed, so that perceived stress is 
reduced.945 Techniques used by traditional care providers include massage, physical support, reassurance, 
and rituals, among other practices.945, 946 An emphasis on maternal emotional well-being, with simple, 
nonpharmacologic tools for support, is also applicable in contemporary settings947-952 and is likely to main-
tain physiologic E-NE levels in labor, with benefits to laboring women. This approach may contribute to 
the low requirement for intervention among women giving birth at home452, 453 and in birth centers in the 
United States,953, 954 and internationally.955, 956 
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For women giving birth in hospital, continuous labor support provided by a doula may also reduce stress 
(and possibly excessive E-NE levels, if measured for an adequate time) and has been shown to have the 
following benefits, in comparison with standard care, according to the Cochrane systematic review:780
  reduced need for pain relief and operative birth, including CS 
  reduced duration of labor
  improved newborn Apgar score
  increased chance of maternal satisfaction with the birth experience
Given the costs and risks of high levels of interventions, and the consistent and significant reductions in 
interventions associated with low-technology models such as midwifery care and doula support, under-
standing the mechanism of these benefits, and how to apply them generally in institutional birth settings, 
are important areas for future research. 
Farmers, animal breeders, and zoo staff, among others, recognize that stress in labor and birth is hazard-
ous in other animals832 (see “Evolutionary Model” in 5.1.3 and “Stress in Animals and Birth,” below). This 
has not been well researched in women. Early studies by Lederman and colleagues measured self-report-
ed anxiety and blood levels of E, NE, and cortisol in laboring women in relation to birth outcomes. They 
found associations between anxiety in early labor, elevated early E levels, and both prolonged labor and 
abnormal FHR patterns suggestive of hypoxia.899, 900, 957 A more recent study using urinary E-NE measure-
ments found that women with high E levels in early labor had significantly longer labors.110 
These studies support a hormonal model of labor progress whereby excessive fear and anxiety may poten-
tially elevate maternal E and NE levels, activating both alpha- and beta-adrenoceptors. Effects therefore 
may include beta-mediated slowing of labor, and alpha-mediated reduction in fetal blood supply (5.1.4), 
both found in these human studies. Animal research suggests that a healthy fetus can adapt to moderate 
hypoxia (e.g., from an epinephrine injection) by increasing oxygen uptake from placental blood. Howev-
er, a compromised fetus may already be extracting maximal amounts, and be unable to further compen-
sate.874 In contemporary maternity care, slow labor and suspected fetal hypoxia are common indications 
for labor interventions. This may reflect high levels of stress and anxiety, and high E-NE levels, among 
laboring women. 
Some aspects of contemporary maternity care may contribute to stress. Simkin retrospectively surveyed 
women about the stressfulness of labor events, and more than one-third of women rated each of the 
following as maximally stressful:958
  labor induction or augmentation
  restriction of movement in bed
  administration of anesthesia
  vacuum or forceps delivery
  limited time with newborn 
Other common potential labor stressors in the maternity care environment may include: presence of 
unfamiliar or undesired personnel, including trainees; hurried or brisk personnel; separation from loved 
ones; bright lights; loud noises; time pressure (e.g., for dilation or pushing); lack of privacy; practices that 
restrict or encroach upon the laboring woman’s body (e.g., a bladder catheter or external and internal 
electronic fetal monitoring); and an emphasis on facility routines rather than individualized response to 
women’s needs and preferences.
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The effects of stress and fear in labor may continue beyond birth. Respondents to the national Listening 
to Mothers II survey reported high levels of post-traumatic stress symptoms, with 9 percent of women’s 
responses to a validated instrument consistent with posttraumatic stress disorder and another 18 per-
cent with elevated levels of posttraumatic stress symptoms.685, 941 As discussed in “Pleasure and reward” 
in 3.1.4, elevated levels of OT during physiologic labor, birth, and postpartum period may give feelings of 
euphoria that could plausibly protect against this condition. (See also “Stress in Animals in Birth,” below, 
and “Other hormonal influences on oxytocin in labor and birth” in 3.1.3 for involvement of the OT system 
in labor and birth stress.)
Inter-individual transmission of emotional states via mirror neurons959 and “emotional contagion”960 sug-
gests that fear and stress in care providers could plausibly impact the laboring woman, with possible 
relevance to labor and birth outcomes. In one randomized study, women who had a companion sitting 
calmly, silently, and inconspicuously in the room for the duration of labor experienced reductions in the 
use of maternity care interventions compared with women receiving standard care.961 Odent suggests 
knitting as a silent rhythmic activity to keep E-NE levels low among labor attendants.962 
The specific impacts of the environment on the experiences, stress levels, and outcomes for mothers 
and babies, including greater understanding of the impact of caregivers and their emotional states, are 
important areas for future research.
Labor and Birth Stress in Animals
Animal research shows significant hazards from labor stress, including slow labor and fetal hypoxia. For 
women, as with other mammals, birth environments that support private conditions may be ideal for 
fostering labor progress. Stress may slow labor via epinephrine-norepinephrine directly inhibiting contrac-
tions and/or indirectly reducing oxytocin. Stress may also directly inhibit pulsatile oxytocin and/or may 
reduce central oxytocin by increasing beta-endorphins 
Research with other mammals has increased our understanding of the effects of stress in labor. In a se-
ries of early experiments with laboring mice, Newton found that mild intermittent stress (being held in 
cupped hands between the births of offspring) prolonged labor, even among those animals accustomed 
to handling.963 More severe stress—laboring in a clear bowl with the smell of cat urine—not only slowed 
labor by about eight and a half hours, but also increased offspring mortality by 50 percent compared 
with the control group.964
In relation to E-NE levels, researchers exposed sheep in advanced pregnancy to mild electric shocks and 
found a rapid 25 percent elevation in NE levels, which peaked at 30 seconds and subsided over 10 min-
utes. At the same time, uterine blood flow was reduced by 32 to 52 percent, although there were no mea-
sured adverse effects on the fetus.965
In other studies, primate researchers subjected rhesus monkeys to significant stress in late pregnancy, be-
ginning with the surgical placement of catheters and measuring devices in mother and baby. Subsequent 
stresses, including bright lights, shouting, and the presence of an observer, caused hypoxia and decreased 
fetal blood pressure within 50 seconds of onset, evidenced by bradycardia and late decelerations on FHR 
monitoring, with recovery a few minutes after cessation of stress. There was no change in uterine tone or 
activity, suggesting that effects were mediated by alpha-adrenoceptor vasoconstriction. Monkey mothers 
who were more approachable and responded more calmly to human contact had fetuses with less severe 
reactions.966 In other primate research, fetuses that were already hypoxic (with lower pH) had more se-
vere and prolonged reactions to maternal stresses.967
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As well as illuminating the mammalian response to labor stress, these findings suggest that the mother’s 
perception of stress or danger, rather than objective events, determines her E-NE activation, and that 
this may impact her uterine blood supply and fetus. Effects will also depend on the physiologic state of 
the fetus: in these studies, fetuses that were already hypoxic became severely compromised in response 
to maternal stress.836, 967
Animal studies have found that stress in labor also reduces maternal OT release, illustrating another 
mechanism by which stress can affect mother and baby. In mice, studies suggest that elevations in E-NE 
lead to OT reductions,457 whereas in rats and pigs, endogenous opioids including beta endorphins may 
mediate stress-related reductions in OT and slowing of labor (4.1.3).458, 459 Beta-endorphins could also 
slow labor by acting locally on uterine opioid receptors, which have been found in women.461 Stress in 
labor may reduce pulsatile rather than constant OT release, with inhibiting effects on labor462, 463 (see 
3.2.1). It is not clear which of these pathways are predominantly involved with stress responses in labor-
ing women. (See also 3.2.1.) 
As discussed in 5.1.3, laboring animals are also significantly disturbed by direct observation and/or by  
contact with strangers,832 which can slow or halt labor. This may also be true for laboring women, who will 
often seek the smallest and least visible place for labor and birth (e.g., bathroom, shower),968 when mobile 
and able to choose. Birth environments that support private conditions, which can still be compatible 
with the necessary monitoring and care of mother and baby, may be ideal for fostering labor progress.
5.2.2  Prostaglandins for Cervical Ripening and Labor Induction: Possible Impacts on 
Epinephrine-Norepinephrine and Related Stress Hormones
Maternally-administered prostaglandins may promote fetal lung maturation directly and/or indirectly via 
induction of labor and the catecholamine surge.
No studies were found that directly assessed possible impacts of PGs for cervical ripening and induction 
on E-NE and related stress hormones of mother or baby. 
However, researchers have trialed maternal administration of PG one hour before CS to promote a fetal 
CA surge and improve newborn respiratory transition. While numbers may have been too small to de-
tect a difference in lung function, NE levels were higher in newborns of treated mothers.969 More studies 
may be justified,970 including assessment of possible adverse outcomes such as hyperstimulation. Animal 
studies suggest that PGs may directly promote fetal lung maturation and lung surfactant production,971, 
972 although high levels of PGs can also impair other elements of respiratory transitions.973
5.2.3  Synthetic Oxytocin For Induction, Augmentation, and Postpartum Care: 
Possible Impacts on Epinephrine-Norepinephrine and Related Stress Hormones
The administration of synthetic oxytocin may increase maternal pain, and epinephrine-norepinephrine lev-
els, and may be perceived by laboring women as stressful. Stronger contractions may increase hypoxic stress 
in the fetus, possibly promoting the beneficial catecholamine surge. If labor is induced long before the physi-
ologic onset of labor, lack of prelabor adrenoceptor upregulation could limit fetal adaptations to hypoxia. 
One study was found that assessed possible impacts of the use of synOT for augmentation on maternal 
E-NE systems. Researchers found almost three-fold elevations in late-labor E levels among women ad-
ministered synOT,901 likely related to increases in stress and pain.
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In Simkin’s survey (5.2.1), 76 percent of women rated induction of labor (likely with synOT) as moderately 
or most stressful.958 Another study found almost three-fold elevation of ACTH, another stress hormone, in 
women administered synOT for induction compared with women whose labor was physiologic in onset.880 
In the fetus, induction or augmentation of labor may increase hypoxic stress due to the longer, stronger, 
and more closely spaced contractions.974, 975 Hypoxic stress can increase fetal and newborn E-NE up to 
twenty-fold,976 enhancing fetal adaptations.
Induction in animals with synOT was found to promote fetal lung fluid clearance and surfactant produc-
tion via the CA surge,977 especially when the fetus had been exposed to cortisol,978 which upregulates 
adrenoceptors in the lungs. In addition, animal studies suggest that newborn neurologic transitions and 
longer-term brain function may benefit from the CA surge979 (5.2.6).
One equine study found cortisol levels elevated two-to threefold at birth and for up to ten days thereaf-
ter among induced compared with spontaneously born foals, which researchers linked to abnormalities 
in glucose metabolism148 (see 3.2.3).
These findings support the advantages of labor, including induced labor, over PLCS for lung fluid clearance 
and newborn neurologic transitions via E-NE elevations. However, babies induced at an early gestation 
may have reduced adaptations to labor hypoxia due to lower beta-adrenoceptors337 (5.1.2). Long-term 
impacts of induction on offspring metabolic and stress systems remain unknown.
5.2.4  Opioid Analgesic Drugs: Possible Impacts on Epinephrine-Norepinephrine and 
Related Stress Hormones
Studies support physiologic understandings that maternal cortisol decreases with analgesia to the extent 
that labor stress and pain decrease.
Opioid analgesics drugs administered systemically by intramuscular (IM) or intravenous (IV) injection may 
reduce intrapartum maternal cortisol levels, compared with no analgesic medication, likely in propor-
tion to their efficacy in reducing labor stress and pain, as with BEs (4.2.4). Studies have found lower cortisol 
levels following systemic meperidine administration in women with induced labor, compared with induced 
women with no analgesia,980 and higher cortisol levels in women administered systemic opioid drugs versus 
epidural analgesia894 (see 5.2.5 below). (See also 3.2.4 for more background on opioid analgesic drugs.)
5.2.5  Epidural Analgesia: Possible Impacts on Epinephrine-Norepinephrine and 
Related Stress Hormones
Epidural analgesia has well-documented impacts on the maternal E-NE system, some of which contribute 
to common epidural side effects, with potential indirect impacts on the baby. Direct effects on fetal and 
newborn E-NE systems are suggested in some studies but less well researched.
Epidural Analgesia and the Mother
Following epidural administration, maternal epinephrine levels rapidly decline and remain low through la-
bor. This may benefit women for whom stress, pain, and epinephrine elevations are slowing labor. Epidural 
impacts on epinephrine and norepinephrine can contribute to side effects, including hypotension, hyper-
stimulation, and prolonged and difficult pushing. Reduction in cortisol may impact maternal postpartum 
mood and adaptations. Epidural exposure may alter hormonal release with subsequent breastfeeding.
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Laboring women administered epidural analgesia exhibit a rapid decline in E levels within 30 to 60 min-
utes of administration.617, 894, 981 Levels of E remain significantly lower than those of women not adminis-
tered epidurals, with maternal levels at birth that are 25 to 70 percent of E levels among women using 
meperidine or no pain relief.110, 800, 894, 898 In these studies, NE levels were not significantly decreased.
Figure 6894 illustrates mean E and NE levels during labor, birth, and the early postpartum period among 
18 women administered epidural analgesia and eight women administered meperidine. This figure 
shows loss of the late-labor E surge, with levels at birth around one-quarter of those in women using 
meperidine. Other data in this study (not shown) record a significant drop in each woman’s E levels one 
hour after epidural placement.894 
These lower E and NE levels also reflect reductions in stress and pain following epidural administration, 
which may benefit labor physiology for women in some situations. For example, if stress and pain are 
excessive, with very high E-NE levels inhibiting contractions and even fetal blood supply, epidural-related 
reductions may allow labor to progress, or alternatively, may provide the laboring woman a welcome 
opportunity to rest. (See 3.2.6 for epidural-related reductions in OT.) 
Figure 6.  Maternal epinephrine and norepinephrine levels, with and without epidural analgesia
Source: adapted from Neumark894
However the rapid epidural-related reduction in E (which inhibits uterine contractions) with less reduc-
tion in NE (which stimulates contractions) can also cause rebound uterine hyperstimulation (5.1.1) with 
potentially deleterious effects on the baby, as detected by FHR changes. This is especially likely following 
spinal analgesia (including as part of combined spinal-epidural, CSE), likely because of the swift onset of 
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analgesia, which drops E levels very rapidly.982-984 Hyperstimulation can compromise fetal blood supply 
and necessitate emergency measures including CS. Epidurals increase the risk of CS for “fetal distress”614 
(non-reassuring FHR patterns). 
The sudden decrease in E levels can also cause a drop in maternal blood pressure,614, 985 which may fur-
ther compromise fetal blood and oxygen supply, although severe hypotension is usually prevented by 
IV fluid administration before epidural placement. These rapid blood pressure shifts and stimulating (or 
hyperstimulating) effects are generally temporary, with contraction strength subsequently declining due 
to the epidural-related decrease in OT. Many women receive synOT administration to compensate. (See 
3.2.5 for a full discussion of epidural impact on OT.)
Reductions in E-NE in late labor may cause other significant problems. As noted in 5.1.3, physiologic eleva-
tions in E-NE at the end of labor can stimulate contractions, giving women assistance with the pushing 
stage and birth. Loss of these peaks with epidural analgesia, along with reductions in OT and the Ferguson 
reflex (3.2.5), likely contribute to the epidural-associated lengthening of the pushing phase, the increased 
need for forceps and vacuum assistance, and the associated increased risk of perineal tears.614, 985
Studies have also found lower levels of maternal cortisol in new mothers exposed to labor epidurals 
compared with unexposed mothers, as measured in the blood or saliva.110, 800, 912, 914 
Studies have found no rise in salivary cortisol levels from labor to birth among women using epidurals, 
compared with doubling or tripling of levels for women without epidural analgesia.110, 894 Elevated cor-
tisol in labor may benefit mothers and babies by enhancing OT effects and contraction efficiency, as in 
animal studies (3.1.3), along with postpartum benefits to maternal mood and postpartum adaptations, 
as found in human studies (5.1.4). 
In addition, one study found an exaggeration of the usual cortisol decline (lower cortisol levels) with 
skin-to-skin breastfeeding two days after birth among women exposed to epidural analgesia in labor, 
and a reduced cortisol decline (higher levels) among women exposed to epidural plus synOT, compared 
with women unexposed to these interventions. These findings may reflect alterations in OT release, 
which generally reduces cortisol (3.1.1). In this study, epidural exposure was associated with increased 
oxytocin release with skin-to-skin breastfeeding, and epidural with synOT was associated with reduced 
OT release. The mechanisms are not clear.570
Disruptions to cortisol in the postpartum period could adversely impact breastfeeding, as cortisol pro-
motes the development of prolactin receptors, with benefits to ongoing milk production, according to 
animal studies. (See also “Prolactin receptor theory” in 6.1.4, and 3.2.5 for discussion of epidurals and 
breastfeeding.)
Epidural Analgesia and the Fetus/Newborn
Epidural analgesia has no direct stress or pain reducing effects for the fetus, who may be indirectly im-
pacted by maternal hormonal impacts such as hypotension and hyperstimulation. Local anesthetic drugs 
may directly impact fetal stress systems, and changes in newborn inflammatory markers have also been 
found. Newborn respiratory distress may be increased.
Epidural does not provide analgesia or direct stress-reducing effects to the fetus or newborn (4.2.5). 
However other impacts on fetal/newborn E-NE and stress hormones are possible through direct and 
indirect mechanisms. 
133CHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | 5 STRESS HORMONES / 5.2.5
Clinicians have suggested that epidural-related reductions in maternal stress and stress hormones (above) 
may benefit the baby by increasing uterine blood flow.987, 988 While reductions in excessive maternal stress 
may be beneficial, benefits to FHR, suggesting improved fetal blood supply, are generally not demon-
strated following epidural administration; and in fact studies show increased rates of non-reassuring FHR 
changes following epidural administration,790, 984, 989 with 20 percent or more of exposed babies affected in 
some studies.984, 989 
Such impacts may reflect maternal hormonally-related side effects (see “Epidural Analgesia and the Moth-
er,” above) including hyperstimulation and low blood pressure. Local anesthetic drugs used in epidurals 
may also directly cause constriction of the uterine arteries and reduction of blood flow to the baby.990 
The co-administration of synOT, may additionally predispose to hyperstimulation and fetal hypoxia, as 
detected on FHR.790, 991
Epidurals may also have direct effects on fetal stress systems. Researchers have found that local anesthet-
ic drugs, as used in epidurals, can cause CRH release,992, 993 which generally triggers the release of other 
stress hormones, including E-NE, beta-endorphins, and cortisol.809, 992-994 In the fetus, CRH also triggers a 
positive feedback cycle that may further augment stress hormone release.76 Several studies have found 
elevations in newborn E, NE, and/or other stress hormones following epidural exposure in labor,800, 898, 913, 
914 including very high CRH levels,800 possibly reflecting these processes. 
Studies have generally not shown differences in cord blood cortisol levels between newborns exposed 
and unexposed to labor epidurals.800, 912 This unexpected finding in the context of other stress hormone 
elevations, may reflect the influence of maternal cortisol, which is reduced following epidural, and is 
correlated with fetal levels, likely due to transplacental passage.912 However, elevations in fetal corticos-
terone, which may be more specific to fetal stress responses, have been found with epidural exposure.913 
(See also “Fetal Epinephrine-Norepinephrine and Related Stress Hormones in Labor and Birth” in 5.1.3.) 
Skin-to-skin contact after birth may be especially important for babies exposed to epidurals in labor to 
reduce possible stress and stress hormone elevations, and may also benefit breastfeeding (see “Epidural 
Analgesia and Breastfeeding” in 3.2.5). 
Recent research has found increased risks of newborn respiratory distress on the day of birth following 
epidural exposure. In this study, opioid exposure via intravenous or oral administration did not increase 
risk.995 These findings may relate to the depressant effects of opioid drugs on respiration, but epidural-
related hormonal disruptions may also contribute.996 Ward Platt comments, in relation to this study, 
“The effects of epidurals and other maternal analgesia and anaesthesia have largely been reported in 
relation to benefits and harms for mothers, with little regard for babies.”996(p.F98)
Given the widespread use of epidural analgesia in labor, research into possible impacts on the fetus and 
newborn, including stress activation and respiratory outcomes, are high priorities.
5.2.6  Cesarean Section: Possible Impacts on Epinephrine-Norepinephrine and 
Related Stress Hormones
Cesarean section may have significant impacts on physiologic epinephrine-norepinephrine systems for 
mothers and babies, who will both miss, to some extent, their respective physiologic late-labor epineph-
rine-norepinephrine elevations. 
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Cesarean and the Mother
Following prelabor cesarean, women have lower levels of epinephrine, norepinephrine, cortisol, and other 
stress hormones due to lack of labor eustress, with possible deficits in postpartum mood elevation. 
Researchers have generally found reduced levels of maternal E, NE, and cortisol following PLCS compared 
with vaginal birth.800, 896, 897, 997-1000 In one study, maternal E and NE levels following PLCS were around 50 
percent of levels following vaginal birth, as sampled 60 to 120 seconds after birth. Other maternal stress 
hormones such as BEs, ACTH, and CRH, were also reduced in this study, with cortisol levels around one-
third of those in women following vaginal birth.800, 896, 998, 999 These lower hormone levels may reduce the 
euphoria and early adaptations associated with maternal hormonal elevations, according to animal and 
human studies (3.1.4, 4.1.4, 5.1.4). Delayed contact with her newborn may contribute432 (see 5.2.7). Re-
duced cortisol may adversely impact breastfeeding success following PLCS.1001
Cesarean and the Fetus/Newborn
Babies born by cesarean miss, to some extent, the eustress of labor and birth, which promotes fetal-to-
newborn transitions via the catecholamine surge. Respiratory morbidity is increased, including mild, mod-
erate, and severe conditions, along with hypoglycemia, hypothermia, and neurobehavioral effects. Breast-
feeding initiation may also be compromised. Studies suggest that longer-term stress responsiveness may 
also be altered, and epigenetic impacts for in cesarean newborns, found in human studies, may contribute 
to long-term cesarean effects. Animal studies suggest that lack of perinatal stress hormones may have 
long-term effects on brain function and behavior.
Loss of the fetal CA surge may significantly contribute to increased morbidities among CS-born newborns, 
especially following PLCS, when newborn NE levels are 20 to 50 percent of those of vaginally born 
babies.800, 896, 976, 1002, 1003 Consequences for PLCS newborns may include:
  compromised respiratory transition, with increased risks of transient tachypnea (correlated with 
reduced NE;1004 respiratory distress,1005 even at 40 weeks’ gestation;1006 and the life-threatening 
condition persistent pulmonary hypertension1007
  increased risk of hypoglycemia in PLCS-born newborns,1003, 1008 with low levels of metabolic fuels 
and blood glucose1003
  lower body temperature among PLCS compared with in-labor CS newborns,1009 due to deficits in 
CA-promoted thermogenesis
  lower blood flow into limbs, which may benefit cardiovascular adaptations1002
  neurobehavioral impacts, including increased stress scores1010, and lower neurological score cor-
related with NE and persisting for up to five days following PLCS compared with vaginal birth1011, 1012
These detrimental effects likely contribute to higher rates of respiratory morbidity1007, 1013 and neonatal 
intensive care unit (NICU) admission following CS than vaginal birth.1014, 1015 Even healthy cesarean new-
borns have been found to have poorer lung function,1016 delayed lung fluid clearance,1017 and lower lung 
compliance, correlated with lower NE levels,313 compared with vaginally-born babies. Studies have found 
reduced morbidity,1018, 1019 including respiratory morbidity, among babies born following in-labor CS com-
pared with PLCS, likely due to CA effects.
Fetal and newborn E-NE systems, and the CA surge, will be most impacted by PLCS. An in-labor CS fol-
lowing the physiologic onset of labor will allow E-NE prelabor physiologic preparations and some degree 
of labor-related elevations for the baby. Babies born following in-labor CS have a lower risk of NICU 
admission and of death before hospital discharge than newborns following PLCS, according to one large 
study that compared these two groups.11 (See also 3.2.7.)
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Breastfeeding initiation is less likely following PLCS,679 (3.2.6), with anesthesia and surgery likely reducing 
alertness for mothers and newborns, who are also less likely to achieve important early breastfeeding 
behaviors.1020-1022 (See also “Cesarean and Breastfeeding” in relation to OT in 3.2.6.) Early maternal-infant 
hormonal and adaptation systems may also be compromised following CS (3.2.6, 4.2.6, 6.2.6). 
Studies have also found reduced levels of cortisol in the cord blood of CS- compared with vaginally-born 
newborns,137, 813, 814, 913 along with reduced newborn responses to pain137 and maternal separation.136 
In longer-term studies, infants born by CS, 26 and those with low cortisol at birth814 (also related to expo-
sure to combined spinal-epidural in this study) had reduced cortisol responses to immunization pain at 2 
months of age. These studies suggest that infraphysiologic levels of stress at birth could mis-program the 
HPA system, with unknown duration.
In animal studies, newborn rats born by CS had signs of low-grade brain hypoxia for the first 24 hours 
compared with vaginally-born offspring.30 In adulthood, cesarean offspring were found to have altera-
tions in social behaviors and stress responses,27, 141 and in brain function in areas related to NE31 and the 
related brain chemical dopamine.28 These impacts were modified by either an episode of hypoxia, which 
provoked E-NE release,30 or administration of an injection of E straight after CS,27 suggesting that lack of 
E-NE exposure in the perinatal period may produce these longer-term detrimental brain effects. In these 
studies, males and females were differently affected.31 Elevations in cortisol-like hormones were found 
in infant piglets born by CS,29 also suggesting longer-term disruptions to stress systems (5.1.1).
Researchers have analyzed human newborn tissues, including blood cells, for DNA methylation. This is 
a marker of epigenetic changes, and a mechanism for switching off (“silencing”) genes, with potentially 
widespread and even inheritable impacts on body functions. Studies have found greater methylation in 
specific (single) gene areas in CS offspring,23-25 including in areas associated with type 1 diabetes.23 This 
study also found a beneficial dose-response modification with labor exposure, suggesting that the eu-
stress of labor may have an epigenetic benefit for the baby.23
Many other body systems are activated through physiologic labor and birth, perhaps secondary to the 
fetal surges of CAs and cortisol, with considerable implications for long-term outcomes following CS and 
especially PLCS.40, 148 Changes in immune function following CS may also reflect lack of the beneficial gut 
colonization with vaginal birth.148 
These widespread CS-related alterations in newborn hormonal and physiologic transitions, including loss 
of the eustress of labor and birth with PLCS, may contribute to increased longer-term risks that include: 
asthma and allergies, type 1 diabetes, overweight and obesity, and celiac disease.40, 148
Given the large numbers of mothers and babies experiencing cesarean birth, and the accumulating evi-
dence about possible short and longer-term impacts, these are critical areas for future research.
5.2.7  Early Separation of Healthy Mothers and Newborns: Possible Impacts on 
Epinephrine-Norepinephrine and Related Stress Hormones
Separation of mother and newborn disallows the skin-to-skin contact that reduces stress and stress hor-
mones for both, with benefits to newborn physiology and metabolism and possibly maternal hemorrhage 
risk. Postpartum separation could have longer-term detrimental effects on offspring stress systems, as 
found in animal studies. Separated human newborns display high levels of anxious arousal.
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No studies were found that directly assessed possible impacts of early separation of healthy mothers 
and newborns on E-NE and related stress systems in mother or baby. 
As discussed in 5.1.5 and 5.1.6, there is a rapid decrease in both maternal and newborn E-NE levels in the 
early minutes following unmedicated labor and birth, which may be enhanced by SSC. Skin-to-skin contact 
also benefits mother and newborn by releasing OT, which reduces E-NE and “the stress of being born,”175, 
337 and switches on “calm and connection” via the PNS.175 
Early separation of healthy mothers and newborns may further increase, or fail to decrease, these 
physiologically elevated E-NE levels, with potentially detrimental effects. In the new mother, persisting 
high E-NE levels could antagonize effective uterine contractions and increase the risk of postpartum 
hemorrhage (3.1.4, 5.1.4). In the newborn, ongoing E-NE elevation may cause depletion of glucose and 
free fatty acids—metabolic fuels that will not be replenished until breastfeeding is established (5.1.4). 
Consistent with these understandings of the metabolic effects of newborn separation and E-NE eleva-
tions, one randomized study found that blood glucose in newborns who were placed in a cot was 20 
percent lower compared with SSC newborns.1023 In this study, separated babies were also cooler; cried 
more; and had a slower reduction in base excess, indicating a later return to energy-conserving me-
tabolism, likely due to persisting E-NE elevations and/or lack of beneficial OT (3.1.4). Other studies have 
found more stress and crying, and less organized behavior, among separated newborns compared with 
SSC babies.1024 Separation, with loss of SSC, can also destabilize newborn heart and breathing rhythms, 
because of excessive E-NE with no opportunity for stress reduction and physiologic regulation via con-
tact with the mother’s body.333, 1025
One study found reductions in newborn foot temperature that persisted up to 23 hours for separated 
newborns versus those who received SSC after birth.175 These findings suggest greater separation-relat-
ed activity in the stress-related SNS system, with vasoconstriction, and less activity in the PNS “calm and 
connection” system, which promotes vasodilation and warming. These findings suggest a programming 
effect of unknown duration.20 (See also 3.1.4.)
Newborns following CS may particularly benefit from SSC, which beneficially reduces stress and stress 
hormones following this sudden transition. In addition, SSC elevates newborn OT and provides an envi-
ronment in which the newborn can become calm and enact instinctive breastfeeding behaviors (3.1.4).
Longer-term studies of the impact of early maternal separation on E-NE systems in human newborns are lack-
ing. Primate studies involving relatively brief separations—for example, 30 to 120 minutes daily in the 
first month of life—found increases in E, NE, and cortisol for separated offspring not only at the time, but also 
one year later. Changes in behavior and brain structure were found through to adolescence in this study.1026 
This finding is consistent with a large body of animal research linking newborn separation with stress hor-
mone elevations and permanent changes in brain and behaviors, suggesting an epigenetic programming 
effect 1027 (3.2.7, 4.2.7, 6.2.7). Permanent changes in the HPA stress-response system, as well as in the sero-
tonin system, have also been found in separated animal newborns, who also have depression-like behav-
iors in adulthood.1028 Maternal separation is used as an animal model for adult depression,1028 a condition 
where NE disruption is also implicated.1029 In addition, animal mothers who are separated from their new-
borns also have long-term physiologic maladaptations, with depression-like behavior, even following brief 
separations from their offspring—for example, 15 minutes daily in the first two weeks in rats.703
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Human research is lacking in this area. One study found that solitary-sleeping newborns, even when 
rooming-in with the mother, had high levels of nervous system “anxious arousal,” indicating SNS activa-
tion, along with large decreases in quiet sleep. Both of these effects may have potentially harmful long-
term neurodevelopmental impacts. Researchers comment, ”Maternal separation may be a stressor the 
human neonate is not well-developed to cope with and may not be benign.”1030(p.817)
Contact with her baby may also benefit the new mother’s mental health, with research suggesting that 
SSC in the early weeks may reduce early postpartum depression399 (3.1.4). In contrast, typical postpar-
tum care currently involves some amount of separation in the early sensitive period (3.1.4) and further 
long periods of maternal-newborn separation during hospital stay. 
Given the above concerns, research into the short-and longer-term physiologic impacts of separation 
for mothers and babies, and into workable solutions that preserve mother-baby contact within current 
maternity care systems, is a high priority.
5.3 Epinephrine-Norepinephrine and Related 
Stress Hormones: Summary
5.3.1 Epinephrine-Norepinephrine and Related Stress Hormones: Normal Physiology 
Epinephrine (adrenaline) and norepinephrine (noradrenaline) mediate “fight or flight” stress responses. 
Epinephrine-norepinephrine release with perceived danger has promoted safety for laboring females in 
the wild through human evolution by:
  slowing or stopping labor, giving time for fight or flight 
  redistributing blood to heart, lungs, and major muscle groups, and away from uterus and baby, to 
maximize fight-or-flight actions 
This epinephrine-norepinephrine response, which acts at an instinctive, subcortical level in all laboring 
mammals, may inhibit labor when women do not feel private, calm, safe, and undisturbed in labor.
However, if the laboring female perceives stress or danger in late labor, epinephrine-norepinephrine eleva-
tions may paradoxically stimulate contractions via differential receptor effects. This “fetus ejection reflex” 
may also occur physiologically when labor has been largely undisturbed, creating powerful, effective, and 
involuntary pushing. High-quality research in relation to this reflex and its implications for birth is lacking.
In addition to maternal epinephrine-norepinephrine elevations with perceived stress or danger, a physi-
ologic rise in epinephrine with advancing labor has been found in women. This may benefit laboring 
women by promoting alertness and may promote labor progress by increasing prostaglandin production. 
The healthy stress (eustress) of labor also elevates the medium-term stress hormone cortisol as much as 
ten-fold. Cortisol may promote contractions, increase central oxytocin effects on maternal adaptations 
and attachment, and enhance postpartum mood.
For the baby, late-labor epinephrine-norepinephrine elevations (catecholamine surge) provide critical 
adaptations to labor hypoxia and facilitate newborn transitions, e.g., by:
  preserving blood flow to heart and brain
  promoting respiratory transitions, including clearing of lung fluid 
  mobilizing metabolic fuels for the newborn period
  promoting newborn thermoregulation by burning brown fat
  promoting newborn alertness and energy for breastfeeding initiation
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After birth, epinephrine-norepinephrine levels drop steeply in mother and baby. These decreases pro-
mote uterine contractions, which may limit maternal bleeding, and, for the newborn, reduce energy con-
sumption. Warmth and undisturbed skin-to-skin contact may be important in facilitating maternal and 
newborn epinephrine-norepinephrine reductions.
5.3.2  Common Maternity Care Practices that May Impact Epineprine-Norepinephrine 
and Related Stress Hormones Physiology 
Aspects of contemporary pregnancy care may have unintended negative (nocebo) effects by increas-
ing maternal stress and anxiety. Stress and anxiety in pregnancy can elevate maternal stress hormones, 
including epinephrine-norepinephrine and cortisol, with detrimental long-term effects on offspring, 
including impacts on brain development and stress responsiveness, as established in human and animal 
studies. Studies suggest that maternal relaxation techniques may reduce pregnancy stress and its detri-
mental effects, but high-quality research is lacking in this important area.
In labor, anxiety or situations in which the woman does not feel private, safe, and undisturbed may 
provoke epinephrine-norepinephrine elevations, which may slow or stall labor and reduce fetal blood 
supply via epinephrine-norepinephrine effects. Stress may also slow labor by reducing pulsatile oxytocin 
and/or by increasing beta-endorphins. 
Attention to emotional well-being may promote labor progress. The reduced need for labor interven-
tions associated with doula and midwifery care may reflect this beneficial focus. Conversely, many com-
mon maternity care practices may be stressful for laboring women. High-quality research is lacking in 
relation to physiologic aspects of labor stress, and methods for ameliorating this.
Epidural analgesia can beneficially reduce maternal pain and epinephrine levels, which may have been 
inhibiting labor. However, the rapid drop in epinephrine may contribute to hypotension and uterine 
hyperstimulation. More commonly, contractions reduce over time because oxytocin also decreases. Re-
ductions in both epinephrine-norepinephrine and oxytocin with epidural analgesia may contribute to a 
prolonged pushing stage and assisted vaginal birth. Epidurals do not assist with, and may increase, fetal 
hypoxia, stress, and stress hormones in labor, and the risk of cesarean for fetal distress.
With cesarean section, both mothers and babies may miss late-labor epinephrine-norepinephrine eleva-
tions, and be less alert after birth for breastfeeding initiation. Lack of the fetal catecholamine surge may 
significantly contribute to newborn morbidities following cesarean section, including breathing difficul-
ties, hypoglycemia, hypothermia, and drowsiness that may impact interactions and breastfeeding. Cesar-
ean birth may impair newborn and infant stress responses. 
Separation of healthy mothers and newborns is more likely following cesarean section, leading to new-
born stress and stress hormone elevations. Early separation may also be stressful to the mother, de-
priving her of the opportunity to reduce epinephrine-norepinephrine for herself and her baby through 
oxytocin elevations with skin-to-skin contact and mutual interactions. In animal studies, repeated brief 
separations in the newborn period can lead to detrimental impacts on offspring stress hormone sys-
tems, likely via epigenetic programming, with enduring effects including depression-like behaviors in 
adult offspring and also in separated new mothers.




Prolactin is included in this report because of its critical role in lactation and in maternal 
adaptations, including brain-based (central) adaptations to maternity in all mammals, 
including women. There is less research in relation to the impacts of maternity care 
practices on prolactin compared with other hormone systems. However, its importance for 
breastfeeding, and the contribution of breastfeeding to long-term health and well-being of 
mothers and babies, gives this information great importance in maternity care.
6.1 Prolactin: Normal Physiology
Prolactin has an extensive influence on reproductive physiology, including well-recognized roles in fertility, 
pregnancy maintenance, and postpartum adaptations. Among the hormone systems in this report, pro-
lactin is the least well researched in relation to labor and birth, although its functions at this time may be 
critically important for subsequent lactation
6.1.1 Prolactin: Introduction
An essential hormone for milk synthesis, prolactin is primarily made in the pituitary gland and has effects 
on both the body and the brain of all mammals. 
Prolactin (PRL) is best known as the major hormone of breast-milk synthesis, for which it is essential in all 
mammals. It is structurally related to growth hormone and the placental lactogen hormones, which are 
produced by the placenta in all mammals and cross-react with PRL and PRL receptors (PRLRs)125, 1031 (6.1.2).
Prolactin is predominantly made in the anterior pituitary gland, from where it is released into the body. 
Prolactin can reenter the brain from the body, and may also be released into local brain areas, with both 
routes giving important psycho-emotional and behavioral effects in reproduction.125 Its release is princi-
pally controlled by dopamine, which inhibits PRL release. In addition, high PRL levels inhibit further PRL 
release. These negative feedback effects are significantly lessened from pregnancy through lactation to 
maintain the necessary high PRL levels (hyperprolactinemia)1032 (6.1.2).
Prolactin Effects
Prolactin has more than 300 recognized effects on the brain and body that are primarily concerned with 
reproduction and homeostasis. Prolactin promotes maternal and paternal behaviors in humans, mam-
mals, and other species. 
Prolactin has a large number of physical and behavioral effects—more than 300 in total, according to 
animal studies1033—that primarily organize and coordinate processes necessary for successful reproduc-
tion. These include:
  supporting conception and early pregnancy172, 1034 
  adjusting appetite, fluid balance, and immune function from pregnancy through lactation1032
  optimizing postpartum maternal adaptations, including maternal behaviors, maternal-infant 
attachment, and milk production (lactogenesis)1032
  enhancing infant growth and brain development1032 
Because of these effects, PRL is also known as the “mothering hormone.”125 In women, postpartum PRL 
elevations during breastfeeding have been correlated with personality changes that are adaptive to 
motherhood237, 360 (6.1.4). 
Prolactin has also been named the “hormone of paternity” because of its association with paternal be-
haviors in species from birds and fish to humans.1035 Human studies show elevations in PRL in association 
with fatherhood1036-1039 (6.1.4). Animal studies also show PRL elevation in individuals who are in contact 
with, and/or caring for, unrelated infants (alloparenting).1040, 1041
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In addition to its reproductive functions, PRL has critical homeostatic functions related to appetite, body 
weight regulation, fluid balance, and immune regulation. Prolactin is also released in response to some 
forms of stress, with release varying by gender, hormonal state, and specific type of stress.125, 1032 
In humans, PRL is released during sexual activity, signaling satiety and possibly also promoting implanta-
tion of the fertilized egg.1042 High or dysregulated PRL has been related to infertility (male and female), 
decreased bone density, and elevated risk of breast and prostate cancers.1031, 1043 Prolactin malfunctions 
have also been implicated in autoimmune diseases.1044
Prolactin Regulation and Receptors 
Prolactin release is triggered by factors including estrogen, beta-endorphins, and some forms of stress. 
Pulsatile oxytocin, as occurs with labor and lactation, also promotes prolactin release. Prolactin promotes 
the release of beta-endorphins and oxytocin. Prolactin receptor formation is increased by estrogen, by 
prolactin itself (with cortisol) and by contact with infants, according to animal studies. Previous reproduc-
tive experience may be associated with increased prolactin receptors and prolactin sensitivity in women, 
as found in animals.
Prolactin secretion is promoted by estrogen and thyroid releasing hormone,346, 1045 and also by norepineph-
rine (NE) and some forms of stress125 (see below in this section). Oxytocin (OT) also promotes PRL release 
within the brain, but this may occur only when OT is released in pulses, as with labor and lactation123 (3.1.1). 
Prolactin also promotes OT release.124 Beta-endorphins (BEs) and other opioids also promote PRL release 
by inhibiting dopamine, and PRL promotes the release of BEs.125, 1046 Prolactin has a circadian rhythm, with 
higher levels at night in human studies; and nighttime suckling elevates PRL and stimulates breast-milk 
production more than daytime suckling.125
Prolactin acts via PRL receptors in the brain and body, with several PRLR subtypes.1031 Prolactin receptors, 
indicating physiologic roles for PRL, have been found in the breasts, ovaries, pituitary glands, heart, lung, 
thymus, spleen, liver, pancreas, kidney, adrenal gland, uterus, skeletal muscle, skin, and areas of the cen-
tral nervous system.125 
As with other hormones, higher PRLR numbers increase sensitivity to PRL and enhance PRL functions. 
Prolactin receptor numbers are increased (upregulated) by:
  exposure to estrogen (including during pregnancy)1045 
  elevation of serum PRL levels1047, 1048 (6.1.3)
  contact with infants, according to animal studies125, 1041, 1049 (6.1.4) 
According to animal studies, cortisol-like hormones, released during labor and birth, may also be needed 
for postpartum upregulation of PRLRs.910, 1050 In women, cortisol, which is elevated following vaginal birth, 
is also thought to be necessary, along with PRL, to promote postpartum PRLR formation and effective 
breast-milk production918 (5.1.4, 6.1.4). (See 6.2.6 for possible adverse implications for breastfeeding fol-
lowing prelabor cesarean.) 
Previous reproductive experience increases PRL receptors, according to animal studies,1051, 1052 which 
beneficially increases PRL responsiveness, promoting lactation and maternal adaptations. In rats, a mini-
mum lactation of 21 days (approximately equal to the length of gestation) is needed for this effect. In 
women, low PRL levels, suggesting increased PRL sensitivity and PRLR numbers, have been found follow-
ing the first pregnancy1053-1055 and lactation.1056-1058 (See “Prolactin and Breastfeeding” in 6.1.4.)
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6.1.2 Prolactin in Pregnancy
Maternal Prolactin in Pregnancy
Prolactin levels rise through pregnancy, promoting maternal physiologic adaptations. Levels peak at the 
physiologic onset of labor, and may promote prelabor receptor formation and “nesting” behavior, as found 
in animals. Prelabor increases in central connections between prolactin and oxytocin promote effective 
release and interorchestration in labor and postpartum. Prolactin is also produced within the uterine lining, 
and may be involved in labor and birth.
Prolactin supports success in conception and early pregnancy,172, 1034 when it may be critical in protecting 
the growing baby by reducing stress and stress responses.1059 Other pregnancy effects, as found in other 
mammals, include: promoting appetite, energy intake, food storage, and insulin production;172, 381, 1032 
limiting maternal fever response to protect the developing fetal brain;1060 and stimulating growth in the 
mother’s brain (adult neurogenesis) to adapt to maternity.1061 
Through pregnancy, the expectant woman’s anterior pituitary increases by 30 percent in weight, with 
almost 200-fold increases in PRL-producing cells, compared with nonpregnant women.1062 Maternal PRL 
levels rise steadily as pregnancy progresses due to increases in estrogen and possibly progesterone.1063, 
1064 Late pregnancy PRL levels in women are up to 20-fold higher than early pregnancy levels,1065 with 
steep increases at term, according to one study (6.1.3). Researchers found that PRL levels more than 
doubled between 35 and 38 weeks, and correlated with fetal weight.102 
Prolonged elevations in PRL, usually over several days, promote PRLR formation1066 (6.1.1), so that the 
late-pregnancy PRL peaks in women may be important in upregulating PRLRs and beginning critical prepa-
rations for lactation and maternal adaptations, as occurs in other mammals in the mammary glands103-105 
and brain.126, 1047, 1067 In some species, steep PRL and PRLR elevations occur just before the physiologic 
onset of labor, reflecting the prelabor decline in progesterone that has been inhibiting PRL activity.105 
Progesterone levels do not drop before labor in women, for whom prelabor PRL elevations, and likely 
mammary PRLR formation, are more gradual.
In other mammals, maternal prelabor PRL elevations are associated with “nesting” behavior,124 and may 
be essential for development of the “nipple pheromone,” which newborns use to find and latch.1067 A 
late-pregnancy nesting phenomenon has also been documented in women.1068 
Animal studies show increased central connections between the PRL and OT systems from late pregnancy, 
making OT release in labor a powerful PRL-releasing factor.122 Prolactin also stimulates OT synthesis and 
release,124 contributing to PRL and OT peaks at birth (6.1.3, 3.1.3). The increased central oxytocin recep-
tors (OTRs) that precede the physiologic onset of labor, according to animal studies,88, 1069 (3.1.2), could 
augment these effects. Beta-endorphins also stimulate central PRL release (4.1.1), augmenting PRL during 
labor in preparation for breastfeeding.1045 Scheduled birth may negate or foreshorten these PRL prepara-
tions, as with OT (3.2.3), with possible adverse impacts on breastfeeding and maternal adaptations (6.2.3). 
Progesterone, produced by the placenta, inhibits PRL effects on breast-milk production until after post-
partum placental expulsion. The placenta also produces hormones with PRL-like effects, known as placen-
tal lactogens, which bind to PRLRs and have prolactin-like effects during pregnancy, including promoting 
fetal growth. Human placental lactogen (hPL) also enhances maternal free fatty acids and also acts as an 
“anti-insulin,” inhibiting glucose uptake from the blood and ensuring a steady supply of fuels for the grow-
ing baby. Levels of hPL peak in the last month of human pregnancy.1063 
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Throughout human pregnancy, the uterine lining (decidua) and fetal membranes also synthesize and 
secrete PRL. Prolactin is released into the amniotic fluid, which fills the fetal lungs and is swallowed by 
the fetus (see “Fetal Prolactin in Pregnancy,” below). At term, PRL levels in the amniotic fluid are up to 20 
times higher than in the maternal circulation.1045 Decidual PRL includes different forms of PRL (isoforms) 
that may act differently than pituitary-derived PRL. For example, decidual PRL may, in the presence of 
low vitamin C levels, promote prelabor rupture of membranes and preterm labor.1070 During labor, PRL1071 
and PRLRs1072 increase in the decidua and membranes, suggesting a role for local PRL in labor (see “Ma-
ternal Prolactin in Labor and Birth,” below).
Fetal Prolactin in Pregnancy
Prolactin levels also rise in the fetus, with possibly important roles in fetal development and in prelabor 
physiologic preparations, especially for newborn breathing and heat production.
The human fetus also produces increasing amounts of PRL from the pituitary, with steep increases near 
term to reach levels equivalent to maternal PRL.1073 Prolactin may have a crucial role in fetal growth, 
maturation, and brain development.124, 1073 Decidual PRL, transmitted via amniotic fluid (see “Maternal 
Prolactin in Pregnancy,” above) additionally exposes the fetal lungs to PRL, which may benefit lung 
maturation. (See 6.1.4 for newborn implications.) 
In animals, fetal PRL potentiates the late-pregnancy effects of cortisol, enhancing maturity of the adrenal, 
lungs, liver, and other fetal organ systems,889 and also stimulates the production of surfactant, the lung 
lubricant that protects against respiratory distress syndrome (RDS).1074 In animals, late gestation peaks of 
PRL and cortisol also upregulate PRLRs, increasing PRL activity as labor approaches.1075 In the human fetus, 
higher PRL levels at later gestational ages may also contribute to enhanced respiratory maturity106 (6.1.4).
6.1.3 Prolactin in Labor and Birth 
Maternal Prolactin in Labor and Birth
Prolactin secretion is multiphasic in labor, with an in-labor decline and late-labor surge that persists for 
several hours postpartum. Positive effects on receptors are likely but not researched. Local prolactin may 
promote cervical changes and labor contractions.
Studies in other mammals show a maternal surge in PRL that begins soon before the physiologic onset 
of labor,1067, 1076 with a rapid increase in mammary PRLRs around this time.103, 105 Prelabor shifts in the 
progesterone:estrogen balance may contribute.1077
In women, steep PRL increases as the physiologic onset of labor approaches may also prime the PRL sys-
tem, and promote PRLR formation, in the maternal brain and breasts (see ”Maternal Prolactin in Preg-
nancy” in 6.1.2). Interactions between PRL and prostaglandins may promote cervical ripening and dilation 
before and during labor,102, 1078 and local PRL, which increases with labor,1071 may act directly on uterine 
muscle to stimulate contractions.1078 In animals, drugs that block PRL significantly disrupt labor and birth,1079 
suggesting an important role for PRL (perhaps local PRL) in the processes of parturition, but this is not 
well researched in human birth.1071
Studies in women show a multi-phasic pattern of PRL release during labor and birth102, 1080-1083 (Figure 7).1082 
After an initial PRL elevation in early labor, levels decrease as labor progresses, with a nadir close to full 
dilation. Women with a longer labor may have an even greater decrease in PRL levels.1084 These findings 
suggest a prelabor reorganization in the PRL system, such that the stresses of labor cause a paradoxical 
decrease in PRL levels, instead of the usual stress-associated rise.1085
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At the end of labor, PRL levels sharply increase, likely due to stimulation of the laboring woman’s cervix 
and the associated OT peak,102 which promotes PRL release (6.1.1). Prolactin levels vary by up to nine-
fold among individual laboring women, which may reflect differences in PRLR numbers and PRL sensitiv-
ity, possibly from previous pregnancies and lactation (6.1.4). 
Figure 7. Maternal prolactin levels in labor, at birth, and after birth
Source: adapted from Stefos1082 
Researchers have suggested that this multi-phasic pattern may help to pace labor, with lower first-stage 
PRL levels restraining contractions to some extent, and higher levels in second stage facilitating effective, 
expulsive contractions.102 Prolactin peaks at birth and early postpartum, or even the gradient of rise, could 
plausibly upregulate breast PRLRs, with benefits to breastfeeding (6.1.4). Postpartum OT elevations, espe-
cially pulsatile OT release with early breastfeeding, likely also contributes to PRL release (4.1.2, 4.1.4).
Fetal Prolactin in Labor and Birth
Studies suggest fetal prolactin elevations in labor, both centrally and via amniotic fluid.
Maximal PRL levels in newborns following in-labor planned cesarean section (CS), compared with prela-
bor cesarean section (PLCS)106 (6.2.6) suggest that labor stress may elevate fetal/newborn PRL. The fetus 
is also exposed to local prolactin, via the amniotic fluid, which fills the lungs and is also swallowed, with 
possible benefits (see “Newborn and Later Prolactin,” below).
6.1.4 Prolactin after Birth
Prolactin is a central hormone in breastfeeding and maternal adaptations, optimizing outcomes for moth-
ers and babies in the short- and longer-term. 
Maternal Prolactin after Birth
The function of physiologic prolactin elevations in the hours after birth is not known, but may be impor-
tant in promoting prolactin receptor formation, breast-milk production, and maternal adaptations. 


















In postpartum women, PRL levels remain elevated for several hours, peaking at one to three hours and 
then declining slowly over the next six to eight hours.1082, 1083 One study found a second nadir at nine 
hours that was maintained for up to 24 hours after birth.1063 As with labor, the function of this biphasic 
postpartum pattern is unknown, although it may be involved in promoting breast-milk production 
(possibly via PRLR upregulation) and maternal adaptations, including caregiving circuits, which are the 
major postpartum roles of PRL. Maternal-newborn skin-to-skin contact (SSC) after birth may contribute 
to maternal PRL elevations (6.1.1).
In animals, early maternal postpartum elevations of the stress hormone corticosterone (equivalent to 
human cortisol, 6.1.4) enhance the production and binding of mammary PRLRs,910 suggesting that the eu-
stress of labor and birth (but not excessive stress) may benefit milk production. (See also “Prolactin and 
Breastfeeding,” below.)
Newborn and Later Prolactin 
Newborn prolactin elevations may assist with breathing and thermal transitions, and deficits have been 
associated with respiratory morbidity. In animal studies, PRL is important for offspring development, in-
cluding the development of prolactin and other hormonal systems.
Prolactin levels are elevated in the newborn,106 peaking from 30 to 60 minutes after birth, then declin-
ing.1083, 1086 This PRL surge, which is thought to be triggered by thyroid releasing hormone,106 may assist 
with newborn transitions. Animal researchers have found PRLRs in newborn brown fat, and suggest that 
PRL may also be important for postpartum heat production among mammalian newborns.106 Lower lev-
els of PRL have been found in newborns with RDS,1087-1090 and newborn PRL is also correlated with length 
of gestation.
Bioactive forms of PRL, present in breast milk1091-1093 and ingested during breastfeeding, may be critical 
for infant brain and body development.1032 In animal studies, offspring deprived of PRL in milk in the neo-
natal period were found to have higher mortality, poorer growth, and poorer endocrine system develop-
ment, compared with controls, along with hyperprolactinemia in adulthood, which suggests lower PRLRs 
and PRL sensitivity. Female offspring deprived of PRL were at higher risk of precocious puberty, irregular 
reproductive cycles, and polycystic ovaries.1092-1094 In human studies, preterm infants with lower PRL lev-
els, associated with formula feeding, have poorer growth and clinical outcomes.1091
Prolactin and Breastfeeding
Postpartum progesterone reduction, and elevations of prolactin and cortisol are all necessary for early 
milk production (lactogenesis II).
Following birth, breast-milk production increases slowly in women, with milk usually “coming in” (re-
flecting lactogenesis II) at 30 to 40 hours postpartum. This timing is related to the postpartum decline in 
progesterone, which inhibits PRL’s lactogenic effects.1095 Maternal PRL levels are maximal in women two 
to four days after birth, according to one study.1096 
Cortisol is also necessary for these processes in animals1097, 1098 and humans918 (5.1.4). In women, physi-
ologic postpartum cortisol elevation following the eustress of labor and birth may also be important for 
lactogenesis II.1001 (See 6.2.6 for relevance to PLCS.) However, while labor eustress may benefit milk pro-
duction, excessive, pathologic stress in labor and birth may inhibit lactation,1021, 1099 possibly via excessive, 
supra-physiologic cortisol.1099 (See also “Prolactin release with lactation,” below, for discussion of labor 
stress and lactation.)
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Prolactin release with lactation. Maternal prolactin release with lactation, and prolactin content 
in breast milk, is maximal in early lactation. Central prolactin release with lactation may benefit maternal 
adaptations. Stress may disrupt lactation by reducing prolactin release, possibly via epinephrine-norepi-
nephrine elevation and/or suppression of pulsatile oxytocin. 
During each nursing episode, PRL is released from the maternal pituitary gland in response to suckling 
(nipple stimulation), milk removal, and parallel pulses of OT. Prolactin levels peak in maternal blood 
between 20 and 45 minutes after the start of breastfeeding,1095, 1100 with higher levels during nocturnal 
suckling due to PRL circadian rhythms (6.1.1). Prolactin is also active in the mother’s brain during lacta-
tion and plays an important role in her behavioral and psycho-emotional adaptations to motherhood124 
(see “Prolactin and Maternal Adaptations,” below). Prolactin is also present in breast milk (6.1.4), with 
milk PRL levels highest in the early postpartum period.1101
After the early weeks, basal PRL levels decrease in breastfeeding women, although every nursing episode 
still stimulates a PRL peak.1102 Prolactin has a long half-life, so that frequent feeding, even later in lactation, 
may maintain high PRL levels.1102 1095 Night-time breastfeeding gives higher PRL peaks and greater benefits 
to milk production1103 (6.1.1). Throughout lactation, PRL elevations may contribute to reduced fertility, 
although the exact mechanisms are not clear.1104 At later stages of lactation, PRL release may be permis-
sive rather than essential for milk production, which shifts to control by local factors such as milk removal 
rather than hormonal factors.1095 
Studies have suggested that stress in labor, including due to in-labor unplanned CS, can delay the onset 
of lactation, particularly in first-time mothers.1099 Stress-induced PRL disruption may contribute. In rela-
tion to postpartum stress and lactation, in a study of mothers of preterm infants, high salivary markers 
of epinephrine-norepinephrine (E-NE) were correlated with low PRL, suggesting stress-related E-NE 
elevations as a contributory mechanism by which postpartum stress can impair PRL release and lacta-
tion.1105 In lactating women, even mild stressors such as noise and mental calculation have been shown 
to inhibit460 the let-down reflex1106 and oxytocin pulses,460 which would be expected to also reduce PRL. 
(Outside pregnancy and lactation, stress usually increases PRL.) (See also 5.1.4 for discussion of cortisol, 
stress, and lactation).
Prolactin receptor theory. Early postpartum prolactin elevation from early and frequent suckling, 
may be critical for establishing prolactin receptors and an abundant ongoing milk supply (“prolactin 
receptor theory”).
Animal studies show that PRLRs increase sharply in early lactation,105 and that receptor formation is up-
regulated through suckling.1048, 1107 According to the “prolactin receptor theory,”1108 PRLR numbers increase 
in early lactation then remain constant, with frequent early feeding stimulating maternal PRL release and 
upregulating PRLR numbers to promote ongoing milk production. Conversely, if feeding is infrequent, PRL 
levels may be insufficient to upregulate PRLRs (6.1.1), with detrimental effects on ongoing milk produc-
tion. In addition, according to this theory, breast engorgement may cause PRLRs to become distorted 
and dysfunctional. Both effects could have long-term detrimental effects on milk supply.1102 
In accord with this, studies show that early and frequent breastfeeding, beginning immediately after birth, 
is associated with longer-term breastfeeding success, as evidenced by the Baby Friendly Hospital Initia-
tive.1109 Early and frequent feeding to upregulate PRLRs may be especially important for first-time mothers, 
who have higher PRL levels,1058 suggesting lower PRLR numbers and sensitivity, compared with multipa-
rous women. 
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Exposure to repeated PRL peaks with episodes of lactation is likely to upregulate PRLRs longer term in 
women, increasing PRL sensitivity and effectiveness. Studies in lactating multiparous women have found 
lower basal PRL levels but higher milk production,1058 and also earlier postpartum onset of lactogenesis 
II,1095 compared with first-time mothers. Both of these differences are consistent with upregulated mam-
mary PRLRs (6.1.1). For women who have previously lactated, compared with women who have not 
lactated, increased PRLRs and reduced PRL levels may contribute to significant protection against breast 
cancer, which has been correlated with duration of the first lactation.1057 
Prolactin and Maternal Adaptations
Prolactin promotes postpartum maternal adaptations in all mammals. In women, prolactin fosters adap-
tations that increase vigilance and help the mother prioritize her baby’s needs. Prolactin is also involved 
with non-maternal infant caregiving in many species, including in human fathers.
In animal studies, PRL administration to females that have been hormonally primed to mimic pregnancy 
leads to the rapid and reliable onset of maternal behaviors.1032 Similarly, negating PRL effects through 
receptor-blocking drugs or genetic modifications disrupts maternal behaviors.1110 These findings suggest 
that the PRL system makes a major contribution to the mammalian maternal adaptations and behaviors 
that develop immediately after birth and promote maternal-infant attachment, even in the absence of 
prior maternal experience.1052 
Studies suggest that PRL-related adaptations may also apply to women. Researchers have found cor-
relations between basal and breastfeeding-related PRL levels and personality changes soon after birth. 
Higher postpartum PRL levels have been correlated with:237, 360, 1111
  increased “social desirability,” which helps the new mother put her baby’s needs first
  decreased “monotony avoidance,” which may help with repetitive aspects of infant care 
  decreased tension and muscular tension
  some increases in anxiety and aggression, which may promote maternal vigilance
Animal studies show that, following the first pregnancy and lactation, maternal brain PRLRs are upregu-
lated in brain areas critical for maternity.1051, 1112 This may contribute to the reduced response to stress, 
lowered anxiety, and better memory, found both inside and outside maternity in reproductively experi-
enced females.1052 In women, changes in central PRLRs may explain the reduction in stress-responsive-
ness that continues after lactation.1113, 1114 These findings suggest long-term mental health benefits from 
breastfeeding for women. 
In other mammals, contact with, or carrying of, infants increases PRL levels1040, 1041 (6.1.1). In women, con-
tact-related PRL elevation could contribute to beneficial effects of SSC on milk production1115 and maternal 
depressive symptoms.399 Infant contact and carrying may also release OT (3.1.1), which may also contribute 
to these effects (see “Oxytocin and Maternal Adaptations” in 3.1.4). 
In relation to paternal behaviors, PRL has been shown to rise in men during their partner’s pregnancy, es-
pecially in men who experience sympathetic symptoms and display more concern about their baby’s cries 
after birth.1038 Prolactin levels are higher among: experienced than inexperienced fathers;1116 fathers with 
infants under one year, compared with fathers of older children;1036 and fathers who are more responsive 
to infant cues, compared with less responsive fathers.1038, 1039, 1041
148CHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | 6 PROLACTIN / 6.1.4
6.2 Common Maternity Care Practices That 
May Impact Prolactin Physiology
The impact of maternity care interventions on prolactin has not been well researched. However, many 
common maternity care interventions can potentially impact this important system, with significant long-
term detriments in mothers and babies if breastfeeding is unsuccessful or foreshortened.
6.2.1 Maternity Care Provider and Birth Environment: Possible Impacts on Prolactin
The maternity care provider and birth environment may impact the prolactin systems of mothers and 
babies by increasing or decreasing the chances of interventions that can impact these systems, and/or by 
increasing or decreasing stress during or after birth. The success of breastfeeding may have long-term 
impacts on the prolactin systems of both mother and baby. 
No studies were found that directly assessed the impacts of maternity care provider and birth environ-
ment on the PRL systems of mother or baby. 
However, care provider and birth environment could plausibly impact PRL systems by:
  increasing or decreasing the chance of induction, with possible impacts on the PRL systems of 
mother and baby (6.1.2, 6.2.3)
  increasing or decreasing the risk of prelabor or in-labor unplanned CS, with possible impacts on 
the PRL systems of mother and baby (6.1.2, 6.2.6)
  increasing or decreasing stress in labor, birth, and the early postpartum period, with possible 
impacts on PRL and early lactation, including via cortisol (6.1.4)
  increasing or decreasing the timing and duration of early maternal-newborn contact and breast-
feeding, with possible impacts on maternal PRL and PRLR formation, and breastfeeding success 
(6.1.4, 6.2.7)
In addition, maternity care practices that promote, support, and protect breastfeeding could have long-
term benefits to the PRL systems of mothers and babies (6.1.4). 
6.2.2  Prostaglandins for Cervical Ripening and Labor Induction: Potential Impacts 
on Prolactin 
Administration of prostaglandins may impact maternal prolactin in labor with possible effects on milk 
composition and immunity, according to animal studies. Breastfeeding success may be impaired. 
Studies assessing the effects of induction with prostaglandins (PGs) on PRL levels in labor in women have 
had conflicting results. One study using PGE2 gel found no difference in PRL levels or patterns of release 
during labor, compared to induction with synthetic oxytocin (synOT) or with other studies of physiologic 
PRL release in labor.1078 However, another study using oral PGE2, which gives higher blood levels,1117 found 
reductions in PRL through to birth, compared with women induced with synOT.1118 
Researchers suggest possible gastrointestinal effects of PGs on estrogen. However, prostaglandins are 
known to reduce PRL release, possibly by increasing central dopamine (6.1.1), and have been used as an 
effective postpartum treatment to inhibit lactation.1119 In addition, vaginally-administered PGs can enter 
the fetal circulation,1117 with unknown effects on fetal/newborn hormone systems. 
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Animal studies have found in-labor PRL elevations following PG induction in pigs1120 and goats.1121 These 
studies found associated changes in subsequent milk composition, including lower immunoglobulin lev-
els. Prostaglandin-exposed newborn piglets had lower white cell numbers,1120 suggesting further effects 
on offspring immunity. 
In relation to breastfeeding in women, a study found an 11 percent reduced chance of successfully 
breastfeeding at 48 hours among new mothers induced with PGs compared with no labor medications, 
rising to 15 percent for primiparous women.564 If confirmed in other studies, this may reflect direct PRL 
impacts and/or possible induction-related loss of PRL preparations (see 6.1.2, 6.2.3), although this study 
found no significant breastfeeding impacts following induction with no drugs, with synOT, or with a 
combination of drugs. 
Given the widespread use of PGs for labor induction, research into effects on PRL and breastfeeding is a 
high priority.
6.2.3  Synthetic Oxytocin For Induction, Augmentation, and Postpartum Care: 
Possible Impacts on Prolactin 
Induction may impact prolactin systems by reducing prelabor physiologic preparations in the prolactin 
and oxytocin systems. Ergot drugs, used alone or with synthetic oxytocin to prevent hemorrhage after 
birth, are known to inhibit prolactin release and some studies suggest impacts on breastfeeding success.
Several studies have looked at the impact of synOT on laboring women’s PRL levels, as measured at birth. 
One study found higher in-labor PRL levels following synOT induction without analgesia, perhaps due to 
increased pain and stress, compared with women induced and administered meperidine, or unmedicated 
women following the physiologic onset of labor.980 Stimulation of PRL release by synOT, or by the stronger 
contractions and OT feedback cycles (3.1.3), may also contribute. Other studies have found: PRL elevations 
in women following synOT exposure,1122 and no differences in the pattern or levels of PRL release in women 
induced by amniotomy and low-dose synOT,1078 compared to those with physiologic onset of labor.
With induction by any method, both mother and baby are likely to miss the full prelabor physiologic 
preparations. For the mother, this may include prelabor elevations in PRL (and possibly PRLRs) and in the 
related OT system (3.1.2) that prepare her for breastfeeding and motherhood, according to animal stud-
ies (6.1.2, 3.1.2). The baby is likely to miss the late-gestation PRL elevation that fosters organ maturation 
and promotes respiratory transitions (6.1.2). (See 2.2 for effects of scheduled birth on the baby.)
Researchers measured PRL release with breastfeeding in relation to synOT exposure in labor and found 
that, among synOT-exposed mothers, the PRL peak with breastfeeding occurred earlier and lasted lon-
ger, compared with that in unexposed women.487 In addition, OT release was reduced in a dose-depen-
dent manner, compared with women unexposed to synOT. This finding is unexpected, as reduced OT 
would be expected to also reduce PRL. The mechanisms are unclear. 
Other studies have suggested possible impacts of induction with synOT on breastfeeding success (see 
“Prolactin and Breastfeeding” in 6.1.4 and “Synthetic Oxytocin and Breastfeeding” in 3.2.3.). Impaired or 
foreshortened breastfeeding may have significant and possibly long-term effects on prolactin systems in 
mothers and babies (see 6.1.4).
150CHILDBIRTH CONNECTION | HORMONAL PHYSIOLOGY OF CHILDBEARING | 6 PROLACTIN / 6.2.2 - 6.2.3
Synthetic oxytocin is also used, alone or in combination, to prevent bleeding after birth. Ergot-derived 
drugs such as ergonovine (Ergometrine) and methylergonovine (Methergine), which may be used in com-
bination with synOT (e.g., syntometrine) or as alternatives to synOT, are chemically related to bromocrip-
tine and inhibit PRL release.1123 Older studies showed inhibition of PRL following postpartum ergot admin-
istration,1124-1126 including with a single dose of methylergonovine.1126 
One study measured PRL levels two to three days after birth in new mothers administered a single post-
partum dose of Ergometrine to prevent PPH, and found no difference compared to levels in women 
following “physiologic management.” However, in this study, more treated mothers had stopped breast-
feeding by four weeks, mostly due to perceived insufficient milk.1127 Another study found a 23 percent 
reduced chance of breastfeeding success at 48 hours among women administered combined Ergomet-
rine and synOT (Syntometrine), and 36 percent reduced success with Ergometrine, including almost 50 
percent reduction for primiparous women administered Ergometrine.564 (See also “Synthetic Oxytocin 
and Breastfeeding” in 3.2.3.) 
Given the widespread postpartum use of ergot drugs, alone or in combination with synOT, research into 
effects on prolactin and breastfeeding is a high priority. 
6.2.4 Opioid Analgesic Drugs: Possible Impacts on Prolactin 
Opioid drugs can reduce breastfeeding success. Impacts on the prolactin system are possible but not well 
studied.
Opioid drugs (and endogenous opioids such as BEs) may impact physiologic PRL systems in labor and af-
ter birth by increasing central PRL release.1046 This could give elevated levels in labor, instead of the usual 
decline (6.1.1, 6.2.6), but no studies of this were found in humans. 
One study (mentioned above) found higher PRL levels in women induced with synOT and given systemic 
opioid drugs during labor, compared with those induced but not administered opioids, but effects on breast-
feeding were not recorded.980 Other studies have found reduced breastfeeding success from exposure to 
opioids in labor, which may reflect disruption of PRL and/or OT, as well as sedating effects on mothers and 
newborns. (See 3.2.4 for more background and also a fuller discussion of opioids effects on the OT system.)
6.2.5 Epidural Analgesia: Possible Impacts on Prolactin 
Several studies have found impacts of epidurals on prolactin release in labor, with unclear implications. 
Lower postpartum prolactin levels, as suggested in two studies, could impact developing prolactin sys-
tems and breastfeeding, but this has not been specifically studied. Epidurals may have effects on breast-
feeding success, discussed elsewhere, with significant longer-term impacts on maternal and offspring 
prolactin systems. 
Several studies have looked at the impact of labor epidural analgesia on maternal and/or newborn PRL. One 
study, shown in Figure 8,1128 found relatively higher levels (i.e., a reduced physiologic decline) in PRL from early 
labor through to birth among women with epidurals. This was followed by lower levels after birth and in par-
ticular, absence of the early postpartum PRL peak1128 (6.1.4) and then elevation in PRL at one day. In this study, 
all women were induced with synOT, which could promote stress-related PRL elevations (6.2.3). Other studies 
have found reduced basal PRL levels for up to 24 hours after epidural exposure (local anesthetic only);652 and 
higher PRL at 48 hours among exposed women, along with earlier and greater milk production, compared 
with women in the control group (labor medications in control group not stated, article in Chinese).1129
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Other researchers measured PRL in a single sample of maternal and newborn cord blood after birth. They 
found no significant differences in PRL levels for mothers exposed and unexposed to labor epidurals.800 
However, this single postpartum sample could reflect the juncture between supra-physiologic levels in 
labor and infra-physiologic levels after birth, as seen in Figure 8. 
Figure 8. Maternal prolactin levels, with and without epidural analgesia
Source: adapted from Jouppila1128
One study looked at PRL release during breastfeeding on day two and found that epidural-exposed women 
had some reduction in PRL release throughout the breastfeeding episode, though differences were not sta-
tistically significant in this small study.570 (See also “Epidurals and Breastfeeding” in 3.2.5 for OT impacts in 
this study.) Other studies have suggested possible detrimental impacts of epidurals on breastfeeding success. 
Unsuccessful breastfeeding may have significant and possibly long-term detrimental effects on prolactin sys-
tems in mothers and babies. (See 3.2.5 for a full discussion of epidural impacts on OT and breastfeeding.)
6.2.6 Cesarean Section: Possible Impacts on Prolactin 
As with induction, lack of prelabor physiologic preparations could impact prolactin systems and possibly 
breastfeeding success, as could surgical stress and delays in mother-newborn contact. Researchers have 
found reduced breastfeeding-related prolactin release following in-labor unplanned cesarean compared 
with vaginal birth. Lower fetal/newborn prolactin along with deficits in prelabor preparations, could im-
pact newborn breathing and temperature transitions. All these factors may contribute to reduced breast-
feeding success following prelabor cesarean.
Women experiencing a prelabor cesarean section (PLCS) will likely miss the physiologic PRL elevation 
near term, the in-labor decline, and the subsequent surge at birth, with possible impacts on breastfeed-
ing success (see below), which is reduced following PLCS (see 3.2.6). 




























Surgical and post-operative stresses may also contribute to maternal PRL disruptions. Outside childbearing, 
surgery-related stress and tissue damage generally increase PRL levels, which are also higher when surgery 
is performed under general anesthetic (GA) compared with epidural or spinal anesthetic.1130, 1131 One study 
found transiently elevated PRL levels following CS with GA, likely reflecting surgical tissue damage, with 
subsequent postpartum declines.1083 Other studies (anesthesia not stated) found: almost doubled maternal 
PRL levels immediately following CS, compared with vaginal birth;800 and equivalent levels.998
The presence or absence of maternal-newborn contact (not stated in these studies) may also influence 
maternal PRL levels postpartum. Early and ongoing maternal-newborn contact, ideally with unlimited 
opportunities for SSC and breastfeeding, enhances breastfeeding initiation and continuation.336, 1109 Fol-
lowing CS, SSC may benefit breastfeeding initiation and time to initiation, newborn temperature and 
stress, and maternal bonding and satisfaction; and may reduce formula feeding in hospital, according to 
a recent review.1132 
Optimization of postpartum PRL systems may contribute to these benefits of SSC for breastfeeding. The 
PRL receptor theory (6.1.4) suggests that early and frequent contact and breastfeeding will increase the 
numbers of PRLRs, with benefits to ongoing milk production and breastfeeding success. The OT system 
may also contribute to the benefits of early maternal-newborn contact for long-term breastfeeding 
success (3.1.4).
Several studies have found differences in breastfeeding and breast-milk composition in relation to CS 
compared with vaginal birth. One study found lower rates of breast-milk transfer from days two to six 
following CS compared with low-intervention vaginal birth.1133 Transfer was higher following in-labor CS 
than PLCS, suggesting benefits from experience of prelabor and/or in-labor processes, possibly involving 
PRL. Another study found 20 percent lower levels of protein in new mothers’ colostrum (day two) follow-
ing PLCS, compared with vaginal birth. Authors comment, “. . . breast milk proteins have a critical role in 
the defense against infections and facilitate optimal development of important physiologic functions in 
newborns,”1134(p.4) and suggest that hormonal alterations are a likely explanation.
One study measured new mothers’ hormonal release during breastfeeding on day two in relation to 
mode of birth. Researchers found that women who experienced an in-labor unplanned CS had no PRL 
peak (4.1.4) and fewer OT pulses during suckling on day two, compared with women experiencing vaginal 
birth. Among women giving birth vaginally, those with more OT pulses had a longer duration of exclusive 
breastfeeding. Authors suggest that a reduction in labor-related OT release may disrupt PRL release.354 
Another study found lower breastfeeding rates in the delivery room, at seven days, and at three and six 
months, following PLCS compared with vaginal birth, which correlated with lower PRL levels measured 
during breastfeeding on day three.1001 This study also found lower maternal cortisol levels following 
PLCS, which was also associated with lower early breastfeeding rates. Animal studies show that cortisol 
enhances PRLR production (6.1.2, 61.3), with reductions in both likely following PLCS. 
Some studies have shown higher newborn PRL levels following labor compared with CS,106, 1135 while 
others have found equivalent levels.800, 998, 1090, 1136 The higher PRL levels among babies born following in-
labor CS compared with PLCS106 suggest that fetal PRL release may reflect labor or birth stress. 
Babies born by PLCS may miss the enhanced decidual production of PRL during labor (6.1.3), which may 
reach the fetal lungs and benefit newborn respiratory adaptation. Prolactin effects may be even more 
significant than the late-labor catecholamine (CA) surge for breathing and thermoregulation, according 
to one researcher.106 
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Given the prevalence of CS, including PLCS, and the importance of breastfeeding for lifelong well-being 
of mother and baby, high-quality research into CS impacts on PRL and breast-milk production is a high 
priority. Studies that measure breastfeeding and other hormonally-mediated outcomes following PLCS 
versus in-labor CS, and following induced versus physiologic-onset labor, are also high priorities. 
6.2.7 Early Separation of Healthy Mothers and Newborns: Possible Impacts on Prolactin 
Early postpartum separation could have significant effects on the prolactin systems of mothers and babies 
by delaying first contact and breastfeeding, with possible effects on prolactin receptor formation and breast-
feeding success.
The well-documented benefits of early SSC336 and suckling, and of early and frequent breastfeeding, on 
long-term breastfeeding success, as promoted in the World Health Organization’s Baby-Friendly Hospital 
Initiative,1109 suggest that early SSC and suckling optimize maternal and newborn hormonal physiology, 
including PRL.
Early separation may have detrimental impacts on mother, baby, and/or their interactions, including lim-
iting SSC and breastfeeding, which normally promote the development of PRLRs (see “Prolactin receptor 
theory” in 6.1.4). One study found that women whose first breastfeed was late (at least six hours) after 
CS had later colostrum production and milk letdown compared with women whose first breastfeed was 
early (around one hour) after CS. The authors suggest that disruption to postpartum PRL systems is an 
underlying factor.1137 (See 3.2.7 for effects of separation on the interrelated OT system.)
6.3 Prolactin: Summary
6.3.1 Prolactin: Normal Physiology
Prolactin is a major hormone of reproduction as well as breast-milk synthesis. Prolactin adapts maternal 
physiology for pregnancy and breastfeeding, promotes maternal adaptations, and is a caregiving hor-
mone in mammalian mothers and fathers. Outside of reproduction, it is a stress and growth hormone. 
Maternal prolactin elevations from early pregnancy have stress-reducing effects that also benefit the fetus. 
Late-pregnancy prolactin elevations promote the formation of prolactin receptors in the brain and mam-
mary gland (animal studies). Near term, prolactin production also increases in the uterine lining (decidua), 
and may be involved in labor processes. Prolactin in amniotic fluid, which fills the fetal lungs, may assist 
with respiratory preparations. Fetal prolactic production increases close to the physiologic onset of labor, 
and may promote newborn transitions.
Maternal prolactin paradoxically declines as labor advances (outside of labor, stress triggers prolactin re-
lease). Prolactin increases steeply as birth nears, likely due to peaks of beta-endorphins and oxytocin, both 
of which stimulate prolactin release. In addition, prolactin stimulates oxytocin release, contributing to 
oxytocin peaks in late labor and birth.
Postpartum prolactin elevations, persisting for several hours after birth, may promote breast-milk produc-
tion and maternal adaptations. Peaks in prolactin and cortisol, together with early and frequent breast-
feeding, may promote prolactin receptor formation, with benefits to ongoing milk production (“prolactin 
receptor theory”). Prolactin levels released during early breastfeeding have been correlated with mater-
nal adaptations, including: reduced anxiety, aggression, and muscular tension; and increased social desir-
ability (conformity), which may help mothers to prioritize infant care.
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6.3.2 Common Maternity Care Practices That May Impact Prolactin Physiology
High-quality research is lacking in relation to possible impacts of maternity care practices on prolactin 
physiology. Stress in labor may paradoxically reduce prolactin secretion, giving infraphysiologic levels in 
labor and birth, possibly contributing to the negative impacts of labor stress on breastfeeding. Epidurals 
may cause in-labor prolactin elevations and postpartum prolactin reductions, with unknown impacts. 
Induction with synthetic oxytocin may also impact physiologic prolactin release. Prostaglandins may 
inhibit prolactin with possible impacts on breastfeeding success.
With cesarean section, the expectant mother may miss her pre-labor prolactin elevation, late-labor peak 
and/or postpartum elevations, which may all impact milk production and maternal adaptations. Follow-
ing cesarean section, prolactin release with early breastfeeding may be reduced or absent. These and 
other factors may contribute to reduced breastfeeding success following prelabor cesarean section. Fol-
lowing cesarean section, newborns may have lower prolactin levels, possibly contributing to breathing 
difficulties and low temperature. Lack of the catecholamine surge may also contribute. 
Separation of mothers and their healthy newborns, which typically follows cesarean section, may also 
impact postpartum maternal prolactin levels. If separation interferes with early breastfeeding initiation 
and frequency, disruption to prolactin receptor formation may impact ongoing milk production and 
breastfeeding success.




This chapter presents a summary of the overall conclusions and implications of this material, 
along with a table that summarizes the impacts of interventions on the four hormone systems 
covered in this report. The recommendations that follow give guidance for educators, 
clinicians, researchers, policy makers, advocates, and childbearing families for safely 
optimizing the hormonal physiology of childbearing.
7.1 Conclusions
According to the evidence summarized in this report, the innate hormonal physiology of mothers and 
babies—when promoted, supported, and protected—has significant benefits for both during the critical 
transitions of labor, birth, and the early postpartum and newborn periods, likely extending into the future 
by optimizing breastfeeding and attachment. While beneficial in selected circumstances, maternity care 
interventions may disrupt these beneficial processes. Because of the possibility of enduring effects, includ-
ing via epigenetics, the Precautionary Principle suggests caution in deviating from these healthy physi-
ologic processes in childbearing.
This report documents in detail the hormonal physiology of childbearing, including:
  current understandings of the physiologic onset of labor at term and the possible impacts of 
scheduled birth on mother and baby
  a detailed discussion of the physiologic functioning of four major hormone systems from 
pregnancy through the postpartum and newborn periods
  the impact of common maternity care practices on these hormonal systems, according to current 
and evolving evidence and understandings 
Overall, consistent and coherent evidence from physiologic understandings, and human and animal stud-
ies, as summarized in this report, finds that the innate hormonal physiology of mothers and babies—when 
promoted, supported, and protected—has significant benefits for both during the critical transitions of 
labor, birth, and the early postpartum and newborn periods.
This evidence also suggests that the benefits of physiologic childbearing for mothers and babies may ex-
tend into the future through successful breastfeeding and optimizing of mother-baby attachment, with 
substantial benefits for modern mothers and babies, as they have had for our evolutionary ancestors. 
Maternity care interventions are beneficial and even lifesaving in selected circumstances. This report 
provides considerable evidence that they can also cause significant disruptions to hormonal processes in 
mother and baby with unintended consequences, as summarized in Table 4.
The hormonal physiology perspective provides additional information, germane to the well-being of women 
and offspring, for clinicians, women, and others to consider when weighing benefits and harms of mater-
nity care practices and interventions, both for care of individual mothers and babies and at a policy level.
Biologic principles and solid findings from animal studies suggest that hormonal system functioning in 
the perinatal period, whether optimal or disrupted, may have enduring impacts on offspring hormonal 
and other biologic systems. This may occur via epigenetic programing, with possible longer-term effects 
on development, behavior, and/or hormone system functioning, as seen in animal studies.
The known unintended shorter-term hormonal and other impacts of perinatal interventions, and evolving 
evidence about their possible longer-term effects invoke a strong case for the Precautionary Principle.1138, 
1139 According to the 1998 Wingspread statement, “When an activity raises threats of harm to human 
health or the environment, precautionary measures should be taken even if some cause and effect rela-
tionships are not fully established scientifically.”1140



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In maternity care, the Precautionary Principle would be operationalized by setting a high standard for 
deviating from care that promotes, supports, and protects the healthy physiologic childbearing process-
es of mother and baby, including:
  rigorously verifying the benefits of proposed interventions in individual circumstances before 
undertaking them
  limiting routine practices to those of proven benefit to healthy mothers and babies 
  avoiding the use of interventions for the convenience of women or maternity care providers and 
systems
  initially using less invasive measures to address challenges, and stepping up to more 
consequential interventions only as needed
A hormonal physiology perspective also suggests critical new agendas for research. Recurrent questions 
arise in two broad areas. First, for all of the hormone systems examined in this report, greater elucida-
tion is needed of the underlying innate hormonal physiology as it relates to the processes of childbear-
ing, with a priority for research in humans whenever possible.
Second, better understanding is needed of possible impacts of widely used maternity care interventions. 
A particularly urgent research priority is longer-term follow up to assess whether interventions—includ-
ing elective induction; administration of synthetic oxytocin, before, during and/or after labor and birth; 
epidural analgesia; and prelabor cesarean—impact crucial hormonally-mediated outcomes in women and 
babies, such as breastfeeding, maternal adaptations, maternal-infant attachment, maternal mood states, 
and offspring hormonal functioning. Such impacts are plausible given the principles and processes de-
scribed in this report, but poorly researched. Urgent as well are questions about whether perinatal inter-
ventions have enduring developmental, and possibly epigenetic, effects in humans, as found in animals. 
All who are involved in maternity care are committed the best possible care, with the least harm, to mothers 
and babies. The research results synthesized here, along with underlying hormonal physiology principles and 
understandings, clarify that promoting, supporting and protecting physiologic birth is a simple, low-technol-
ogy approach to health and wellness that is applicable in the vast majority of maternity care settings. 
The perspective of hormonal physiology provides a new framework with which to view childbearing, and 
can contribute to a salutogenic foundation for the care of mothers and babies. This perspective can pro-
vide direction for promoting, supporting, and protecting:
  the physiologic onset of labor at term, with full prelabor physiologic preparations for mother 
and baby
  safe and effective labor and birth for mother and baby
  optimal maternal and newborn transitions 
  breastfeeding, 
  maternal-infant attachment
The findings of this report are well summarized by the distinguished Dutch obstetrician-gynecologist, 
Professor Gerrit-Jan Kloosterman:
Spontaneous labor in a normal woman is an event marked by a number of processes so complicated and 
so perfectly attuned to each other that any interference will only detract from the optimum character. 
The only thing required of the bystanders under these conditions is that they show respect for this awe-
inspiring process by complying with the first rule of medicine, that of nil nocere [do no harm].1141 (p.40)
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7.2 Recommendations to Promote, Support, and 
Protect Physiologic Childbearing
Physiologic childbearing confers valuable benefits to women and babies in the short, medium, and likely 
longer terms. Benefits of hormonal physiology accrue, so that any safe enhancement of hormonal physiol-
ogy will likely benefit women and babies to some degree. Greater conformity with physiologic processes is 
likely to be more beneficial than less conformity. Additional benefits are also likely from averting potential 
harms associated with unneeded interventions. The synthesis presented in this report supports a series of 
recommendations for safely optimizing hormonal physiology within maternity care.
Currently available research, as presented in this report, consistently finds that physiologic childbearing 
confers valuable benefits to women and their babies in the short, medium, and likely longer terms. The 
benefits that accrue from optimizing hormonal physiology for mother and baby extend along a contin-
uum, according to this framework, with greater benefits likely for any mother and baby with greater ex-
perience of physiologic processes. Additional benefits from averting unneeded maternity care practices 
that have potential to harm women and babies, both known harms and any that are currently unknown, 
also likely extend along a continuum. 
Maternity care systems could be readily adapted to safely optimize hormonal physiology for mothers 
and babies. As detailed in this chapter, adaptations of the system could include:
  promoting factors such as professional education, competencies of personnel, protocols, performance 
measures, quality improvement initiatives, innovative payment and delivery systems, and research
  supportive practices directly available to women from pregnancy through the postpartum period, 
such as reducing pregnancy stress as far as possible, primarily using comfort measures for labor 
pain and progress, and keeping mothers and newborns together after birth
  protecting women and babies, whenever possible and safe, from practices that disturb healthy 
physiologic processes 
The following high-level recommendations are provided to encourage those who plan, provide, or re-
ceive maternity care to help women and newborns experience healthy physiologic processes. The recom-
mendations apply broadly. They do not exclude the timely, appropriate, and safe use of maternity care 
procedures, medications, and other interventions when needed for the well-being of women and babies, 
in which case the recommendations can help maximize hormonal physiology as far as possible, and safely 
move women and babies along the salutogenic continuum. 
The Appendix identifies selected resources that support implementation of these recommendations for 
professionals, and for women and childbearing families.
7.2.1 Education, Policy, and Consumer Engagement Recommendations
Education
Educate all maternity care providers in the hormonal physiology of childbearing.
RATIONALE: Shared knowledge and skills for optimizing hormonal physiology as far as possible for each 
mother and baby are foundational for all maternity care providers. This will foster provision of high-qual-
ity care, effective care teams, and more judicious use of maternity care interventions.
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GUIDANCE: It is optimal for all members of teams caring for women and newborns to have a shared ba-
sis of understanding of the hormonal physiology of childbearing, including hormonal processes and their 
benefits, policies and environments that promote them, essential skills and knowledge to support and 
protect them from disruption whenever possible, and any unintended effects of common maternity care 
practices on them. This will enable a more complete and accurate assessment of possible benefits and 
harms. It is important for health professionals to be able to provide physiologic care to the extent safely 
possible for women and babies with special conditions, needs, and care requirements.
This knowledge and associated skills, along with a meaningful practical experience of physiologic child-
bearing, should be a foundational component of all levels of professional education within all of the dis-
ciplines that care for childbearing women and newborns. These subjects should be introduced in entry-
level education, well represented during more advanced professional training, and prioritized within 
continuing education, including maintenance of certification programs. 
Policy
Use effective quality improvement strategies to foster reliable access to physiologic 
childbearing.
RATIONALE: Given the considerable potential gains for maternal-newborn health and well-being from 
more reliable experience of physiologic childbearing, as suggested in this report, a priority for quality 
improvement initiatives is to foster spread of conditions that make such experiences widely available. 
GUIDANCE: Implementation science helps identify effective quality improvement strategies. These 
include: addressing physiologic childbearing within quality collaboratives, developing relevant perfor-
mance measures and using them for quality improvement, developing and implementing protocols that 
promote physiologic childbearing, using innovative payment and delivery systems to foster appropriate 
care practices, and implementing evidence-based clinical practice guidelines including those to safely 
reduce use of cesarean section and other consequential interventions. 
Strengthen and increase access to care models that foster physiologic childbearing 
and safely limit use of maternity care interventions.
RATIONALE: Current evidence shows that physiologic birth is more likely under models of care that include 
birth centers, midwifery care, and doula support. These and other models and maternity care providers 
that prioritize and support physiologic processes should be encouraged. Facilities, maternity care providers 
and/or models of care with good safety outcomes and low rates of maternity care interventions likely 
are skilled in promoting, supporting, and protecting physiologic birth. 
GUIDANCE: Within the context of collaborative practice, models of care that value, prioritize, and en-
hance physiologic processes should receive resource and policy support for broad access and reliable 
insurance coverage. 
Professional development can help maternity care facilities and practitioners with limited ability to facili-
tate physiologic childbearing obtain the needed knowledge and skills to provide optimal care for healthy 
childbearing women and newborns. 
Maternity care providers with skills and expertise in the care of women and babies with higher-risk and/or 
specific conditions provide critical maternity care services. The principles of physiologic birth are benefi-
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cially applied to such care to optimize hormonal physiology of mothers and babies. For example, women 
with challenging conditions would likely benefit from one-on-one care in labor and skin-to-skin contact 
after birth. Similarly, breastfeeding in the early sensitive postpartum period following cesarean section is 
a priority. Models of care and protocols that safely apply these principles to women at higher-risk should 
be developed.
Engaging and supporting childbearing women
Use effective consumer engagement strategies to inform women about physiologic 
childbearing and involve them in related aspects of their care.
RATIONALE: From the perspective of the core principles of health care ethics—autonomy, beneficence, 
nonmaleficence, and justice—it is imperative to inform women of the beneficial innate hormonally-driv-
en childbearing capacities of women and their fetuses/newborns and to support them in gaining access 
to such physiologic processes, as safe and appropriate.
GUIDANCE: A consumer booklet has been prepared as a companion to this report (see Appendix). This 
booklet, and related resources that can help women understand the hormonal physiology of childbearing, 
should be widely distributed and recommended to pregnant women and women planning pregnancy. 
Childbearing women should also have access to publicly reported results of performance measures that 
provide relevant information for choosing a care provider or group and a birth setting. Relevant content 
should be incorporated into childbirth education. Priority decision aids for childbearing decisions of great 
consequence should include relevant information and be routinely incorporated into maternity care prac-
tice. Providers and women are encouraged to engage in shared decision-making, which includes knowledge 
of options, best evidence of the potential risks and benefits inclusive of hormonal impacts, and consider-
ation of the individual woman’s values and preferences. 
All women should have access to care that safely supports physiologic childbearing and to care environments 
that promote such care and protect women from the harm of unneeded disturbance of physiologic processes, 
as described in this report. Where childbearing deviates from optimal hormonal physiology, or extra assis-
tance or interventions are required, women should be fully supported to maximize hormonal physiology. 
Journalists have a role to play in informing childbearing women and the general public about these matters.
7.2.2 Care Practice Recommendations Whenever Safely Possible
Prenatal care
Provide prenatal care that reduces stress and anxiety in pregnant women. 
RATIONALE: Significant levels of stress and anxiety in pregnancy are detrimental to maternal and fetal 
physiology; they may adversely impact maternal well-being, gestational length, and fetal and child 
development. Some aspects of prenatal care, including fetal testing, may contribute to, or fail to reduce, 
maternal stress and anxiety.
Reduction of stress and anxiety in pregnancy may have significant and long-term benefits to offspring, 
and therefore substantial public health benefits. Evolving evidence suggests that some forms of relax-
ation and relaxation training may improve not only physiologic and hormone stress markers but also 
meaningful outcomes in mothers and babies. (See 5.2.1.)
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GUIDANCE: Maternity care providers are encouraged to be aware of, and screen for, stress and anxiety 
in pregnancy, including in the context of pregnancy testing that could arouse anxiety. Current evidence 
suggests that effective relaxation techniques that reduce stress may favorably influence maternal emo-
tional states, stress hormones, and responses; and fetal growth and behavior, premature birth rate, 
mode of birth, and newborn neurobehavior, among other impacts. 
Foster the physiologic onset of labor at term. 
RATIONALE: As described in this report, maternal and fetal readiness for labor and birth at term, for post-
partum transitions, and for ongoing well-being, including breastfeeding and maternal-infant attachment, 
are complex and incompletely understood processes that begin to develop in the weeks before the physi-
ologic onset of term labor. Some of these processes may be ready only in the preceding days or hours. 
Scheduled birth, whether by induction or prelabor cesarean, will foreshorten these processes in mothers 
and babies, with potentially significant consequences for their physiologic transitions. With a prelabor 
cesarean, mothers and babies also miss beneficial processes of labor that activate maternal and fetal 
hormonal systems to optimize postpartum transitions of both. (See chapter 2.) 
GUIDANCE: Maternity care providers are encouraged to support the physiologic onset of term labor and 
avoid induction and scheduled prelabor cesarean, except where indications for individual women are sup-
ported by high-quality evidence and informed decision making. From the perspective of hormonal physi-
ology, when a scheduled cesarean is needed, waiting when possible for labor to start on its own may offer 
benefits to mothers and babies. This has not been well researched. Due to many currently unanswered 
questions about possible hormonally-mediated effects of scheduled birth, policies that support the physi-
ologic onset of labor at term and discourage unneeded induction of labor or prelabor cesarean in healthy 
mothers and babies are prudent.
Encourage hospital admission in active labor. 
RATIONALE: As discussed in this report, the laboring female in all mammals is very sensitive to the en-
vironment. Disturbance in labor—including being in an environment that is not perceived as familiar, 
private, or safe—may slow or stop labor by increasing stress and stress hormone levels. Impacts on fetal 
blood supply are also possible. In women who plan hospital birth, moving from the familiar environment 
of home to the unfamiliar environment of hospital may slow labor, especially before the positive feed-
back cycles that progress labor are fully established, making labor less vulnerable to disturbance. These 
cycles may be slower to establish in primiparous than in multiparous women. Waiting for active labor be-
fore moving from home to hospital may reduce the risk of physiologic disruptions and is associated with 
increased likelihood of vaginal birth. (See “Childbirth and Stress” in 5.2.1; 4.2.1; and “Positive feedback 
cycles” in 3.1.3.)
GUIDANCE: Maternity care providers are encouraged to support women to remain at home until active 
labor is well established. Providing telephone support and/or a caregiver who is available to attend and 
assess the laboring woman at home, if needed, could be a cost-effective way to enhance physiologic 
processes, especially in first-time mothers.
Support privacy and reduce anxiety and stress in labor.
RATIONALE: As discussed above, disturbance in labor—including being in an environment that is not 
perceived as familiar, private, or safe—may slow or stop labor by increasing stress hormone levels, with 
potential impacts on fetal blood supply. (See “Childbirth and Stress” in 5.2.1, and 4.2.1.)
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GUIDANCE: Maternity caregivers are encouraged to ensure that the physical and social environment for 
labor and birth and the early postpartum period helps the laboring women feel private, safe, and undis-
turbed. In addition, caregivers can provide support to reduce anxiety in labor. Ideally, this support is tai-
lored to the laboring woman’s individual requirements and begins in pregnancy with a discussion of her 
needs and possible comfort measures for labor. Establishing a trusting relationship with caregivers is also 
likely to be beneficial. Continuous labor support (doula care), as described below, may facilitate this. 
Make non-pharmacologic comfort measures for pain relief routinely available, and 
use analgesic medications sparingly.
RATIONALE: As described in detail in this report, the administration of opioid and epidural drugs in labor 
can have significant unintended effects on the hormonal physiology of mother and baby, in addition to 
other potential side effects. Disruption of the hormonal physiology in labor, birth, and the postpartum 
period by pharmacologic interventions and their co-interventions may also have detrimental effects on 
breastfeeding and maternal-infant attachment. When mother and baby are in good condition and cop-
ing well, it may be safer and preferable to offer non-pharmacologic comfort measures. This may reduce 
the need for pharmacologic interventions, with benefits for mother and baby. (See 3.2.4, 3.2.5, 4.2.4, 
4.2.5, 5.2.4, 5.2.5, 6.2.4, and 6.2.5.)
GUIDANCE: Maternity care personnel who care for laboring women are encouraged to become skilled in, 
and to offer to women, non-pharmacologic comfort measures and other alternatives to pharmacologic 
pain relief in labor. 
Make non-pharmacologic methods of fostering labor progress routinely available, 
and use pharmacologic methods sparingly.
RATIONALE: As described in detail in this report, the use of synthetic oxytocin to foster labor progress 
may have significant undesirable effects on the hormonal physiology of mother and baby, in addition to 
other potential side effects. Disruption of the hormonal physiology in labor, birth, and the postpartum 
period by pharmacologic interventions may also have detrimental effects on breastfeeding and mater-
nal-infant attachment. Routinely making non-pharmacologic measures to foster labor progress available 
may reduce the need for these interventions, with benefits for mother and baby. (See 3.2.3 and 5.2.1.)
GUIDANCE: Maternity caregivers are encouraged to become skilled in and offer to the women in their 
care, alternatives to pharmacologic methods to foster labor progress. When mother and baby are in 
good condition, it may be safe and preferable to allow labor to progress at a slower rate, with attention 
to any source of stress that may inhibit contractions. Simple measures that may foster progress by op-
timizing hormonal physiology include increasing the laboring woman’s sense of privacy and safety and 
minimizing her anxiety. 
Promote continuous support during labor.
RATIONALE: Continuous support during labor from a supportive companion (doula) has been shown to 
reduce the need for maternity care interventions, likely by reducing stress and stress hormones. 
In addition, doulas are generally skilled in providing non-pharmacologic measures to deal with stress and 
pain and to foster labor progress, thus addressing preceding recommendations and reducing the need 
for stronger interventions and potential hormonal disruption. (See 5.2.1, 3.2.1, 4.2.1, and 6.2.1.)
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GUIDANCE: Maternity care providers are encouraged to support the provision of doula care. This may be 
a cost-effective strategy for reducing stress and stress hormones, reducing interventions, and improving 
outcomes for mothers and babies. 
Foster spontaneous vaginal birth and avoid unneeded cesareans.
RATIONALE: From the perspective of hormonal physiology, and from other perspectives beyond the 
scope of this report, cesarean procedures that lack clear benefit for a woman and/or her baby may have 
consequential downsides. This report identifies many ways that cesareans may impede optimal postpar-
tum transitions in women and newborns.
GUIDANCE: Maternity care professionals and professional societies increasingly recognize that current 
high cesarean section rates may be causing more harm than good to women and babies. Important re-
sources to safely address cesarean overuse include evidence-based guidance documents and a national 
endorsed standardized cesarean section performance measure.
This report identifies care pathways that can help women avoid unneeded cesareans. Care models that 
foster physiologic childbearing, noted above, are associated with reduced likelihood of cesarean section. 
Many quality improvement strategies, as discussed above, can contribute.
Postpartum care
Support early and unrestricted skin-to-skin contact after birth between mother and 
newborn.
RATIONALE: As described in detail in this report, skin-to-skin contact (SSC) between mothers and babies 
after birth has significant favorable effects on the postpartum transitions and hormonal physiology of 
both. Skin-to-skin contact reduces stress and stress hormones, promotes oxytocin release (which may 
also reduce maternal bleeding), and may also benefit the new mother’s prolactin system, with long-term 
optimizing of breastfeeding. Conversely, evidence reviewed in this report suggests that separation of 
mothers and newborns may provoke newborn stress and be detrimental to breastfeeding initiation and 
maternal mood. (See “Skin-to-skin contact” in 3.1.4, 3.2.7, 4.2.7, 5.2.7, and 6.2.7.)
GUIDANCE: Maternity care providers are encouraged to support immediate and unrestricted skin-to-skin 
contact, as the norm in the early postpartum period for mothers and newborns, who should only be sepa-
rated in exceptional circumstances. This includes encouraging rooming in and may require new procedures 
and policies. Institutions can support this by securing the “baby friendly” designation of the Baby-Friendly 
Hospital Initiative (BFHI). 
Support early, frequent, and ongoing breastfeeding after birth.
RATIONALE: Early and frequent breastfeeding, with unlimited newborn access to the mother and her 
breasts, has been shown to optimize breast-milk production and breastfeeding continuation, likely by 
optimizing hormonal physiology. The early days after birth may be a sensitive period for upregulation of 
the prolactin system in particular, with long-term impacts on breast-milk production. (See “Prolactin and 
Breastfeeding” in 6.1.4, 3.1.4, and 4.1.4.)
GUIDANCE: Maternity care providers are encouraged to support ongoing and unlimited postpartum con-
tact between mother and newborn, with extra support if needed during early breastfeeding.
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7.2.3 Research Recommendation
Identify and carry out priority research into hormonal physiology of childbearing, 
and routinely incorporate this perspective in childbearing research.
RATIONALE: This report identifies many critical gaps in current knowledge in relation to both the hormonal 
physiology and the possible impacts of maternity care interventions on mothers and babies in the short, 
medium, and longer terms. Gaps include the frequent omission of priority medium-term outcomes including 
breastfeeding, maternal-infant attachment, and maternal emotional well-being, which are hormonally me-
diated and potentially susceptible to disruption of hormone systems through prior interventions and/or  
maternal stress. A related concern is the lack of long-term follow-up for possible impacts on offspring health 
and development. Biologically plausible effects on hormonally-related functions inside and outside repro-
duction, as described in each hormone chapter, also require high-quality research and long-term follow-up. 
GUIDANCE: Researchers and the institutions that fund research in maternity care are encouraged to fos-
ter and carry out research to expand our understanding of the hormonal physiology of childbearing in 
mothers and babies, including:
  hormonally-mediated processes of physiologic childbearing 
  shorter- and medium-term impacts of maternity care interventions that are discussed in this 
report 
  parallel impacts of other widely used but less researched interventions
  possible longer-term offspring outcomes of maternity care experiences, including developmental 
outcomes, impacts on long-term hormonal functioning, and epigenetic effects
Appropriate research designs and measurements include randomized controlled trials, whenever appli-
cable and possible.
High-quality studies are particularly needed that investigate consequential and biologically plausible, 
but as-yet poorly examined, impacts of maternity care practices and interventions on the medium- and 
long-term health and well-being of mothers and babies. These include outcomes of labor induction, aug-
mentation, opioid and epidural analgesia, and cesarean section, and of stress in childbearing. Effective 
strategies to reduce stress and incorporate stress reduction support into prenatal care are also needed.
7.3 Conclusions and Recommendations: Summary 
Overall, consistent and coherent evidence from physiologic understandings and human and animal stud-
ies finds that that the innate, hormonal physiology of mothers and babies—when promoted, supported, 
and protected—has significant benefits for both in childbearing, and likely into the future, by optimizing 
labor and birth, newborn transitions, breastfeeding, maternal adaptations, and maternal-infant attach-
ment. There are likely additional benefits from avoiding potential harms of unnecessary interventions, 
including possible adverse epigenetic programming effects. 
From the perspective of hormonal physiology, these are not all-or-nothing benefits, but rather accrue 
along a continuum. Every mother and baby is likely to benefit from additional support for physiologic 
childbearing, as far as safely possible, including when interventions are used. The hormonal physiology 
perspective provides additional considerations for weighing possible benefits and harms of maternity care 
interventions, and suggests new agendas for research. Research priorities include better understanding 
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of many aspects of hormonal physiology and of impacts of maternity interventions on breastfeeding, 
maternal adaptations, maternal mood, and other short-, medium-, and longer-term hormonally-mediated 
and developmental outcomes.
Given the uncertainty and potential for significant harms to women and babies in relation to maternity 
care interventions, application of the Precautionary Principle would be wise in maternity care. Such a 
standard would involve:
  rigorously verifying the benefits of proposed interventions in individual circumstances before 
undertaking them
  limiting routine practices to those of proven benefit to healthy mothers and babies
  avoiding the use of interventions for the convenience of women or maternity care providers 
and systems 
  initially using less invasive measures to address challenges, and stepping up to more 
consequential interventions only as needed
A table in the report summarizes the established and potential effects of the maternity care practices 
addressed in the report on the four hormone systems.
The following recommendations for education, policy, practice, and research arise from the synthesis 
presented here. Care practice recommendations below are intended to apply whenever safely possible. 
To optimize hormonal physiology in childbearing:
  Educate all maternity care providers in the hormonal physiology of childbearing.
  Use effective policies and quality improvement strategies to foster consistent access to physi-
ologic childbearing.
  Strengthen and increase access to care models that foster physiologic childbearing and safely 
limit use of maternity care interventions.
  Use effective consumer engagement strategies to inform women about physiologic childbearing 
and involve them in related aspects of their care.
  Provide prenatal care that reduces stress and anxiety in pregnant women.
  Foster the physiologic onset of labor at term.
  With hospital birth, encourage admission in active labor.
  Foster privacy and reduce anxiety and stress in labor.
  Make nonpharmacologic comfort measures for pain relief routinely available, and use analgesic 
medications sparingly.
  Make nonpharmacologic methods of fostering labor progress routinely available, and use 
pharmacologic methods sparingly.
  Promote continuous support during labor.
  Foster spontaneous vaginal birth and avoid unneeded cesareans.
  Support early and unrestricted skin-to-skin contact after birth between mother and newborn.
  Support early, frequent, and ongoing breastfeeding after birth.
  Identify and carry out priority research into hormonal physiology of childbearing, and routinely 
incorporate this perspective in maternity care research.
The Appendix identifies resources for learning more and improving maternity care, including a booklet 
that presents essential findings from this report to childbearing women.
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Appendix:
Resources for Learning More and 
Improving Maternity Care
Resources for Health Professionals
Clinical Practice Guidelines and Recommendations
All Wales clinical pathway for normal labour (2004).
American Academy of Nursing. (2014). Choosing Wisely: Electronic fetal heart rate monitoring. Wash-
ington, D.C.: The Academy. Available at: https://aan.memberclicks.net/assets/images/Choosing-Wisely/
evidence-intermittent%20auscultation%20avery%20revised%2010-3-14.pdf
American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine. (2014). 
Safe prevention of the primary cesarean delivery. Obstet Gynecol, 123(3), 693-711. 
Association of Women’s Health, Obstetric and Neonatal Nurses. (2014). Position statement: Non-
medically indicated induction and augmentation of labor. J Obstet Gynecol Neonat Nurs, 43(5), 678-681.
Childbirth Connection Programs, National Partnership for Women & Families. (2015). Pathway to a 
healthy birth: How clinicians can support beneficial hormonal action in childbirth. Washington, D.C.: 
Childbirth Connection Programs. Available at: www.ChildbirthConnection.org/HormonalPhysiology 
[infographic and printable poster] 
National Institute for Health and Care Excellence. (2014). Intrapartum care: Care of healthy women and 
their babies during childbirth. London: NICE. Available at: https://www.nice.org.uk/guidance/cg190
Queensland Government. (2012). Queensland maternity and neonatal clinical guideline: Normal birth. 
Herston: Queensland Maternity and Neonatal Clinical Guidelines Program.
Royal College of Midwives. (2012). Evidence-based guidelines for midwifery-led care in labour. London: RCM.
Spanish National Healthcare System, Spanish Ministry for Health and Social PolicyMinistry for Science 
and Innovation. (2010). Clinical practice guideline on care in normal childbirth. Health Technology 
Assessment Agency of the Basque Country (OSTEBA).
Toolkits
American College of Nurse-Midwives. (2014). BirthTOOLS.ORG: Tools for Optimizing the Outcomes of La-
bor Safely. Available at: http://BirthTOOLS.org [fostering physiologic childbearing and limiting unneeded 
intervention]
American College of Nurse-Midwives (2014). BirthTOOLS.ORG: Tools for Optimizing the Outcomes of 
Labor Safely. Available at: http://midwife.org/ACNM/files/ccLibraryFiles/Filename/000000004449/
BirthTOOLS-Synopsis-100214.pdf [guide to toolkit]
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Promoting Normal Birth. (2010). Available at: www.dhsspsni.gov.uk/mr-high-impact-promoting-normal-
birth-2010.pdf
United States Breastfeeding Committee. (2014). Best practices guide for implementation of newborn 
Exclusive Breast Milk Feeding in electronic health records. Available at: www.usbreastfeeding.org/
HealthCare/HospitalMaternityCenterPractices/GuideEBMFinEHR/tabid/386/Default.aspx
United States Breastfeeding Committee. (2013). Toolkit: Implementing TJC Perinatal Care core 
measure on Exclusive Breast Milk Feeding. Available at: www.usbreastfeeding.org/HealthCareSystem/
HospitalMaternityCenterPractices///tabid/184/Default.aspx
Books, Articles, and Technical Report
American College of Nurse-Midwives. (2014). Birth matters: Understanding how physiologic, healthy 
birth benefits hospitals and organizations. Silver Spring, MD: ACNM.
Avery MD, ed. (2013). Supporting a physiologic approach to pregnancy and birth: A practical guide. 
Ames, IA: Wiley-Blackwell.
Downe, S., ed. (2008). Normal childbirth: Evidence and debate, second ed. Edinburgh: Elsevier.
Goer, H., & Romano, A. (2012). Optimal care in childbirth: The case for a physiologic approach. Seattle: 
Classic Day Publishing.
Main, E.K., Morton, C.H., Hopkins, D., Giuliani, D., Melsop, K., & Gould, J.B. (2011). Cesarean deliveries, 
outcomes, and opportunities for change in California: Toward a public agenda for maternity care safety 
and quality. Palo Alto, CA: CMQCC.
Simkin P. (2002). Supportive care during labor: A guide for busy nurses. J Obstet Gynecol Neonatal Nurs, 
31(6):721-32.
Simkin, P., & Ancheta, R. (2011). The labor progress handbook: Early interventions to prevent and treat 
dystocia, third edition. Chichester: Wiley-Blackwell.
Simkin, P., & Bolding, A. (2004). Update on nonpharmacologic approaches to relieve pain and prevent 
suffering. J Midwifery Womens Health, 49(6):489-504.
Smith, L.J. (2010). Impact of birthing practices on breastfeeding (2nd ed.). Sudbury, MA: Jones and 
Bartlett Publishers.
Walsh D. (2012). Evidence and skills for normal labour and birth: A guide for midwives, second edition. 
London: Routledge.
Performance Measures
Association of Women’s Health, Obstetric and Neonatal Nurses. (2014). Women’s health and perinatal 
nursing care quality refined draft measures specifications; for testing of feasibility, validity and reliability. 
Washington, D.C.: AWHONN.
The Joint Commission. (2014). PC-01, PC-02 and PC-05. In: Specifications manual for Joint Commission 
national quality core measures: Version 2015A. 
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NCT. (2010). Normal birth as a measure of the quality of care: Evidence on safety, effectiveness and 
women’s experiences. London: NCT. Available at: www.nct.org.uk/sites/default/files/related_documents/
NormalbirthasameasureofthequalityofcareV3.pdf
Consensus Statements
American College of Nurse-Midwives, Midwives Alliance of North America, & National Association of 
Certified Professional Midwives. (2012). Supporting Healthy and Normal Physiologic Childbirth: A Consen-
sus Statement by ACNM, MANA, and NACPM. Available at: www.midwife.org/acnm/files/cclibraryfiles/
filename/000000002179/physioloigical%20birth%20consensus%20statement-%20final%20may%20
18%202012%20final.pdf
Royal College of Midwives, NCT, & Royal College of Obstetricians and Gynaecologists. (2007). Making 
normal birth a reality: Consensus statement from the Maternity Care Working Party – Our shared views 
about the need to recognize, facilitate and audit normal birth. Available at: https://www.rcm.org.uk/
sites/default/files/NormalBirthConsensusStatement.pdf
Initiatives
American College of Nurse-Midwives. (2014). The American College of Nurse-Midwives Healthy 
Birth Initiative. Available at: www.midwife.org/ACNM-Healthy-Birth-Initiative [fostering physiologic 
childbearing and limiting unneeded intervention]
Institute for Healthcare Improvement. (2014). Improving perinatal care: “Keeping Normal Normal.”  
Available at: www.ihi.org/communities/blogs/_layouts/ihi/community/blog/itemview.aspx?List=0f316db6-
7f8a-430f-a63a-ed7602d1366a&ID=31 
Khan, K. (2014). The CROWN Initiative. Obstet Gynecol, 124(3), 487-488. [choosing the best outcomes of 
interest]
Northern New England Perinatal Quality Improvement Network. Trial of labor after cesarean delivery 
(VBAC). Available at: www.nnepqin.org/Guidelines.asp#tabs-6
Resources for Childbearing Families
Essential Guidance from Present Report for Women and Families
Childbirth Connection Programs, National Partnership for Women & Families. (2015). Pathway to a 
healthy birth: Helping your hormones do their most wonderful work. Washington, D.C.: Childbirth Con-
nection Programs. Available at: www.ChildbirthConnection.org/HormonalPhysiology [infographic and 
printable poster]
Childbirth Connection Programs, National Partnership for Women & Families. (2015). Pathway to a healthy 
birth: How to help your hormones do their wonderful work. Washington, D.C.: Childbirth Connection Pro-
grams. Available at: www.ChildbirthConnection.org/BirthPathway [booklet]
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Other
American College of Nurse-Midwives, Midwives Alliance of North America, & National Association of 
Certified Professional Midwives. (2014). Normal, healthy childbirth for women and families: What you 
need to know. Available at: www.midwife.org/ACNM/files/ccLibraryFiles/FILENAME/000000003184/
NormalBirthAndYou-092514.pdf
American College of Nurse-Midwives, Midwives Alliance of North America, & National Association of 
Certified Professional Midwives. (2014). Un parto normal y saludable para la mujer y su familia. Available 
at: www.midwife.org/acnm/files/ccLibraryFiles/Filename/000000004465/NormalBirthAndYou_Span-
ish-0930414.pdf
Association of Women’s Health, Obstetric, and Neonatal Nurses. Go the full 40 campaign. Available at: 
www.gothefull40.com
Childbirth Connection Programs, National Partnership for Women & Families. (2014). New cesarean 
prevention recommendations from obstetric leaders: What pregnant women need to know. Washington, 
D.C.: Childbirth Connection Programs. Available at: www.childbirthconnection.org/article.asp?ck=10685
Childbirth Connection Programs, National Partnership for Women & Families. (2012). Understanding & 
navigating the maternity care system. Washington, D.C.: Childbirth Connection Programs. Available at: 
www.childbirthconnection.org/article.asp?ClickedLink=1084&ck=10662&area=27 
Consumer Reports. (2014). What to reject when you’re expecting: 10 procedures to think twice about 
during your pregnancy. Available at: www.consumerreports.org/cro/2012/05/what-to-reject-when-you-
re-expecting/index.htm 
Gabriel, C. (2011). Natural hospital birth: The best of both worlds. Boston: Harvard Common Press.
Gurevich, R. (2003). The doula advantage: Your complete guide to having an empowered and positive 
birth with the help of a professional childbirth assistant. Roseville, CA: Prima Publishing.
Klaus, M.H., and Klaus P.H. (1999). Your amazing newborn. Cambridge, MA: Perseus Books.
Lamaze International. Lamaze healthy birth practices. Available at: www.lamazeinternational.org/
HealthyBirthPractices [articles and companion videos, translated into nine languages]
Lowe, A., & Zimmerman, R. (2009). The doula guide to birth: Secrets every pregnant woman should know. 
New York: Bantam Books.
Mohrbacher, N., & Kendall-Tackett, K. (2010). Breastfeeding made simple: Seven natural laws for nursing 
mothers. Oakland, CA: New Harbinger Publications.
Simkin P. Comfort in labor: How you can help yourself to a normal satisfying childbirth. Washington, 
D.C.: Childbirth Connection Programs, National Partnership for Women & Families. Available at: www.
childbirthconnection.org/pdfs/comfort-in-labor-simkin.pdf
Simkin P. (2013). The birth partner: A complete guide to childbirth for dads, doulas, and all other labor 
companions, fourth edition. Boston: Harvard Common Press.
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Abbreviations
ACTH  adrenocorticotropic hormone
ADH  antidiuretic hormone
ADHD  attention-deficit hyperactivity disorder
ANS  autonomic nervous system
AVP  arginine vasopressin
BBB  blood-brain barrier
BE  beta-endorphin
BE-IRM   beta-endorphin immunoreactive material
BFHI  Baby-Friendly Hospital Initiative
CA  catecholamine
CNS  central nervous system
CRF  corticotropin releasing factor
CRH  corticotropin releasing hormone
CS  cesarean section
CSE  combined spinal-epidural




DNIC  diffuse noxious inhibitory control
DOHaD   developmental origins of health and 
disease
E  epinephrine
EDD  estimated date of delivery
E-NE  epinephrine-norepinephrine
EPIIC  epigenetic impact of childbirth
FER  fetus ejection reflex
FHR  fetal heart rate
FOAD  fetal origins of adult disease
GA  general anesthetic
GABA  gamma-aminobutyric acid
GAS  general adaptive syndrome
GC  glucocorticoid
HPA  hypothalamic-pituitary adrenal
hPL  human placental lactogen
Ig  immunoglobulin
IM  intramuscular
IOL  induction of labor
IUGR  intrauterine growth retardation
IV  intravenous
LA  local anesthetic
LCHD  lifecourse health development
MOR  mu opioid receptor
MRI  magnetic resonance imaging
NE  norepinephrine
NICU  neonatal intensive care unit
NO  nitric oxide
OT  oxytocin
OTA  oxytocin antagonist
OTKO  oxytocin knock-out
OTR  oxytocin receptor
OT-X  extended forms of oxytocin
PBE  placental beta-endorphin
PG  prostaglandin
PLCS  prelabor cesarean section
PNS  parasympathetic nervous system
POEF  placental opioid-enhancing factor
POMC  pro-opiomelanocortin
PPH  postpartum hemorrhage
PRL  prolactin
PRLR  prolactin receptor
PTSD  post-traumatic stress disorder
PVN  paraventricular nuclei
RDS  respiratory distress syndrome
SNS  sympathetic nervous system
SON  supraoptic nuclei
SP-A  surfactant-related protein A
SSC  skin-to-skin contact
synOT  synthetic oxytocin
UA  umbilical artery
UV  umbilical vein
VCS  vaginocervical stimulation
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